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Background: Nutrition is an important aspect of cancer survivorship care that is not 
routinely addressed. Patients may benefit from dietary modifications to improve quality of 
life and future health outcomes. This PhD aimed to explore dietary habits, awareness of 
nutritional recommendations and experiences of nutritional support in patients who have 
received radiotherapy to the pelvic area following a cancer diagnosis. 
Methods: First, a systematic review regarding diet and nutrition information and support 
needs after a pelvic cancer diagnosis was conducted (Phase 1). In Phase two, people 
diagnosed with a pelvic cancer (anal, bladder, rectal and cancers of the reproductive 
organs), either undergoing [on-treatment (OT): n=266] or having completed pelvic 
radiotherapy 6-24 months previously [post-treatment (PT): n=405], were invited to 
participate in a survey, followed by telephone interviews with a sub-sample of 28 
respondents. In Phase three, the availability and quality of online nutrition information for 
pelvic cancer patients in the UK was assessed.  
Results: The survey was completed by 254 (38%) cancer survivors. High overweight and 
obesity rates (39% and 24% respectively) and presence of treatment side effects (e.g. 
bowel changes, appetite issues, fatigue) (82%) were observed. Two-thirds of respondents 
(n=170) reported at least one dietary change since diagnosis; most notable changes were 
reduction of sugary foods (48%) and alcohol (41%). Forty-three percent (n=108) had 
received dietary support from the healthcare team, of which 67% (n=72) felt their needs 
were well met. Receipt of support from the healthcare team was significantly associated 
with dietary change (OR 3.63, 95% CI: 1.82-7.23). The majority of respondents (68%, 
n=171) would like to receive additional dietary support. Qualitative analysis identified 
seven themes: “Impact of diagnosis and treatments on dietary choices”, “Personal 
resources”, “Social resources”, “Comorbidities and disabilities”, “Influence of work”, 
“Regaining normality” and “Barriers to dietary changes”.. Finally, most online materials 
xiv 
 
about diet and nutrition had comprehensive content and good quality, but they were not 
widely available.  
Conclusion: This thesis identified a lack of routine provision of nutritional care to patients 
following a cancer diagnosis and highlighted the need for reliable information to support 
patients in managing diet-related problems and leading a healthy future lifestyle. 
Contribution to knowledge: This thesis has developed a detailed understanding of diet 
and nutrition information and support needs in an under-researched cancer population, 
with the use of a mixed-methods design. This knowledge will inform the design of future 
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So, why was I interested in this topic? 
I am an Associate Registered Nutritionist, with an education background in nutrition and 
dietetics (Bachelor’s degree in Dietetics and Nutrition, Harokopio University, Athens, 
Greece; Master’s degree in Human Nutrition and Metabolism, University of Aberdeen, 
Scotland). Though I cannot practice dietetics in the UK (not registered), I have always 
been very keen on working with clinical populations, from a research perspective. 
Therefore, I found this PhD project a unique opportunity to conduct a research project in a 
clinical population.  
I was made aware of the work of the National Institute of Health Research (NIHR) 
Nutrition and Cancer Collaboration by my supervisory team, and considering the work 
undertaken / underway by the Collaborative coupled with an awareness of the amount of 
(mis)information on diet, lifestyle and cancer widely available on the Internet, I was 
inspired to explore supportive care needs in diet and nutrition. As the Collaboration 
suggested in the Phase I report (2015), it is essential to understand patient experiences in 
order to improve patient care in the clinical setting.  
The Patient experience survey reported in the Phase I report from the Collaborative was a 
brief exploration of nutritional support and was completed primarily from survivors of 
breast cancer. Despite the small sample, the results indicated lack of communication of 
nutritional advice and limited support. I was particularly interested in these findings and I 
wanted to explore patient experiences of people undergoing treatment which is known to 
have a significant burden in diet and nutrition, such as pelvic radiotherapy. This is how this 
PhD project was “born”. People undergoing pelvic radiotherapy for cancer are a group 
who may present unique needs in diet and nutrition because of the long-lasting treatment 
side effects of the treatment; therefore, a patient group worth further exploring in relation 










Chapter 1. Literature review  
2 
 
1.1. Definition of cancer 
Cancer is defined as a “term for diseases in which abnormal cells divide without control 
and can invade nearby tissues” (National Cancer Institute, 2019). Cancer can start 
anywhere in the body and is categorised into four main types. Carcinomas are the most 
common cancers and begin in the skin or in tissues that line or cover internal organs. 
Sarcoma is a cancer that forms in bone, cartilage, fat, muscle, blood vessels, or other 
connective or supportive tissue. Leukaemia is a cancer that starts in blood-forming tissue, 
such as the bone marrow, and does not form solid tumours; instead, it causes large 
numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and 
multiple myeloma are cancers that begin in the cells of the immune system (Pelengaris 
and Khan, 2013). 
 
1.2. Cancer incidence and mortality 
Cancer is a significant public health problem worldwide and a leading cause of death in 
the 21st century. According to the GLOBOCAN 2018 database produced by the 
International Agency for Research on Cancer (IARC), more than 18 million new cancer 
cases were estimated to have occurred in 2018 (Bray et al., 2018). Lung and breast 
cancers had the highest incidence rates (11.6% for both cancers; approximately 2.1 
million new cases), followed by colorectal (10.2% or 1.8 million new cases) and prostate 
cancer (7.1% or 1.3 million new cases). Cancer incidence has increased by approximately 
4 million since 2012 (Torre et al., 2015) and is projected to further increase in both 
developed and developing countries (Bray et al., 2018). 
According to the GLOBOCAN database, approximately 9.6 million people died due to 
cancer. Lung cancer had by far the highest mortality rate with 1.8 million deaths in 2018 
(18.4% of all cancer-related deaths), followed by colorectal (8.9% or 0.88 million), 
stomach (8.2% or 0.78 million deaths) and liver (8.2% or 0.78 million deaths) (Bray et al., 
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2018). According to the World Health Organisation (WHO), cancer is the first or second 
leading cause of death in most countries (WHO, 2018).  
In the UK, 446,942 new cancer cases were estimated to have occurred in 2018 according 
to the IARC. Prostate and breast cancer were the most common diagnoses, with 56,401 
and 55,439 new diagnoses, respectively (Bray et al., 2018). The Office for National 
Statistics reported that in 2017, a total of 305,683 new cancers (excluding non-melanoma 
skin cancers) were registered in England, with breast (15.1%), prostate (13.5%), lung 
(12.7%) and colorectal (11.4%) cancers accounting for over half of the cancer 
registrations in England for all ages combined (Office for National Statistics, 2019). It was 
also highlighted that cancer incidence continued to rise, up from 303,135 cases in 2016 
(Office for National Statistics, 2018) and 299,923 in 2015 (Office for National Statistics, 
2017). 
 
1.3. Cancer survival 
As well as increasing incidence rates, increased survival rates (or decreased mortality 
rates) are observed worldwide, although there are marked differences according to cancer 
type and between developed and developing countries (Allemani et al., 2018). According 
to the CONCORD programme’s third update, which collected data on cancer survival up 
to 2014 (Allemani et al., 2018), western countries, such as the USA, Australia, New 
Zealand, Japan and the Scandinavian countries (Finland, Norway, Sweden) had the 
highest 5-year net survival rates for most cancers, whereas South-American and South-
Asian countries had lower 5-year net survival rates. Nevertheless, rising survival trends 
have been observed for all cancers in all countries included in the CONCORD-3 update 
(Allemani et al., 2018).  
In England, although the number of people dying from cancer has remained stable 
between 2016 and 2017 (135,775 people died from cancer in 2016 and 135,885 in 2017), 
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the age-standardised mortality rate from cancer has decreased from 275.2 deaths per 
100,000 in 2016 to 270.1 in 2017 (Office for National Statistics, 2019). A study by 
Quaresma et al. (2015) showed that 1-year, 5-year and 10-year net survival rates have 
radically improved for most cancers during the past 40 years in England and Wales. For 
all cancers combined, 1-year, 5-year and 10-year net survival rates in the 1970’s were 
50.1%, 29.8% and 24.0% respectively, whereas the projected 1-year, 5-year and 10-year 
net survival rates in 2010-2011 were 70.5%, 54.3% and 49.8%, respectively. This means 
that almost half of adults diagnosed with a cancer will survive their disease for ten years 
or longer, in contrast to almost a quarter, 40 years ago (Quaresma et al., 2015). 
Increasing cancer incidence and survival act together to increase cancer prevalence, as 
more people are diagnosed but at the same time more people live longer after or with 
cancer. It is estimated that there are currently more than 2.5 million people in the UK living 
with a cancer diagnosis and this number is expected to rise to over 5 million by 2040 
(Maddams et al., 2012).  
 
1.4. Definition of a “cancer survivor” 
According to the National Cancer Institute, a person is considered to be a cancer survivor 
from “the time of cancer diagnosis until the end of life”, although definitions vary. 
(Denlinger et al., 2014). In the UK the term “Living With and Beyond Cancer (LWBC)” is 
preferred to describe any time since diagnosis (Le Boutillier et al., 2019, Department of 
Health et al., 2013). There is currently no agreed universal definition. Throughout this 





1.5. Supporting cancer survivors  
Advances in early detection and management of cancer, in combination with the ageing 
population, have increased 10-year life expectancy rates (Quaresma et al., 2015). 
Allemani et al. (2018) note that although prevention is essential in reducing cancer 
incidence, not all cancers can be prevented and therefore cancer mortality can be 
reduced by improving cancer survival. 
A cancer diagnosis is often viewed as a life-changing experience. Diagnosis and 
treatment have significant effects on people’s physical, psychological, social and spiritual 
wellbeing (Palesh et al., 2018, Cleeland et al., 2012, Duska and Dizon, 2014). Different 
treatments can cause different adverse effects that affect every part of the body. 
Chemotherapy and radiotherapy destroy healthy cells as well as cancerous cells, leading 
to symptoms such as gastrointestinal dysfunction, pain and fatigue (Cleeland et al., 2012, 
Mitsuzuka and Arai, 2018), as well as increasing the risk for cardiovascular disease and 
cardiac-related mortality (Bouillon et al., 2011). The prevalence of taste and smell 
changes is up to 70% in people receiving chemotherapy or radiotherapy, contributing to 
appetite loss, reduced food consumption and weight loss (Spotten et al., 2017). Hormone 
treatment disrupts the endocrine system, leading to bone loss, sexual dysfunction and 
weight gain (Cleeland et al., 2012). According to the Institute of Medicine report From 
Cancer Patient to Cancer Survivor: Lost in Transition (Hewitt et al., 2005), the effects of 
treatments have been known for years; however, survivorship has only relatively recently 
been recognised as a distinct phase of the cancer trajectory, due to increasing survival 
rates worldwide. Although the incidence, the severity and the duration of side effects 
depends on the type of treatment and the combination of treatments and dose, treatment 
side effects have been reported to affect pelvic cancer survivors long after the end of 




1.5.1. National initiatives and cancer outcome strategies 
With the increasing number of cancer survivors, the Department of Health (DoH) has 
highlighted the importance of investigating their needs in order to enhance recovery and 
health after cancer treatment (Department of Health et al., 2013). Many survivors have 
experienced inadequate care support (Faller et al., 2016, Harrison et al., 2009). As there 
is now more evidence that cancer survivors have unmet needs and struggle with 
consequences of treatment, the National Health Service (NHS) considers this to be a 
major target for improvement. 
The DoH, Macmillan Cancer Support and NHS Improvement released a report in 2013 in 
which actions to improve outcomes of a cancer diagnosis were suggested (Department of 
Health et al., 2013). A framework for survivorship has been suggested, highlighting five 
areas of support in cancer survivorship: 
1. Information and support from diagnosis – offering survivors support from an early 
stage so that they make decisions that best reflect their individual needs, including 
work, and using Patient Reported Outcome Measures to collect information for 
symptoms, concerns and quality of life to identify individual unmet needs. 
2. Promoting recovery – use of a “recovery package” that includes education and 
support, treatment summary and a Holistic Needs Assessment, as well as offering 
advice on rehabilitation and lifestyle and access to relevant support services. 
3. Sustaining recovery – offering follow-up as a means to further address unmet 
needs and enhance self-management. 
4. Managing the consequences of treatment – assessing short- and long-term 
consequences and offering relevant information for self-management and 
recommended surveillance tests. 
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5. Supporting people with active or advanced disease – offering a full assessment 
plan in recurrence, relevant care plans smooth transition between cancer support, 
palliative care and end of life services. 
Understanding the need to address the new priorities in cancer care, the Independent 
Cancer Taskforce, which was established by NHS England on behalf of the Care Quality 
Commission, Health Education England, Monitor, Public Health England and the Trust 
Development Authority in 2015, developed a 5-year strategic plan to improve cancer 
outcomes in England (2015-2020), with a focus on six priorities: prevention; early 
diagnosis; communication, information provision and patient experience; supporting 
people living with and beyond cancer; investing on high-quality services and setting clear 
expectations (Independent Cancer Taskforce, 2015).  
Patient experience is set as a central aspect of care, from the point of diagnosis, through 
to treatment and beyond. Survivors require holistic support to address physical, 
psychosocial and financial issues as a result of their diagnosis. Patient experience will be 
improved through effective patient-provider communication, provision of information and 
promotion of shared decision-making. The varying needs of people living with and beyond 
cancer highlights the complexity and the challenges of the development of future services; 
however, it is essential to have a good understanding of the varied needs to shape 
appropriate services and pathways of care in order to address these needs. Services that 
have been recommended to improve quality of life will be part of a recovery package and 
include: a Holistic Needs Assessment; information on management of long-term treatment 
side-effects; information about actions in case of secondary or recurrent cancers; 
treatment summaries; wellbeing events on healthy lifestyle and physical activity; and 
access to rehabilitation, work and financial support services (Independent Cancer 
Taskforce, 2015). 
The NHS supports the move towards a more patient-centred approach in relation to 
management and support after a cancer diagnosis, through personalisation of approaches 
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and patient empowerment to take share of responsibility to stay healthy. To achieve this, 
appropriate support and education should be provided so that people live well outside 
hospitals and return to their lives (Independent Cancer Taskforce, 2015). As a significant 
proportion of costs relate to survivors’ needs after the end of treatment (survivorship 
phase) (Laudicella et al., 2016), tailored patient-centred care has the potential to reduce 
these costs through improvement of survivors’ Quality of Life (QoL). 
 
1.6. The “teachable moment” of a cancer diagnosis 
A cancer diagnosis is often perceived as a “teachable moment” in people’s lives. The term 
“teachable moment” is used to describe life or health events where a patient is receptive 
to counselling and education and to adopt risk-reducing health behaviours (McBride et al., 
2003). Following a diagnosis of cancer, people may be more focussed on their health and 
recovery and may be more receptive to health-related messages, such as lifestyle and 
symptom management. Therefore, it is perceived as an opportunity for health services to 
communicate health messages to cancer survivors that will help them recover fast and 
improve their QoL. A study by Hawkins et al. (2017) showed that cancer survivors may 
practice healthier lifestyle habits such as smoking cessation and maintenance of a healthy 
weight as a result of their diagnosis. 
 
1.7. Diet, nutrition and cancer 
Lifestyle has been implicated in cancer development for several decades and recently in 
survivorship outcomes. This PhD project focusses on one aspect of lifestyle: diet and 
nutrition. According to the Oxford Dictionary, a diet is defined as “the kinds of food that a 
person, animal, or community habitually eats”. Nutrition is defined as “the process of 
providing or obtaining the food necessary for health and growth”. In this thesis, both terms 
will be used together to describe a person’s food consumption.  
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1.7.1. Diet, cancer development and cancer risk 
Over the past decades, there has been extensive research on the role of diet and nutrition 
in the development and progression of cancer. The most recent summary of evidence was 
published by the World Cancer Research Fund and the American Institute for Cancer 
Research (WCRF/AICR) in 2018, as part of the Continuous Update Project programme 
running from 2007 (World Cancer Research Fund/American Institute for Cancer 
Research, 2018). The Third Expert Report highlights that overweight and obesity has 
been linked with the development of 12 different cancers and there is “convincing 
evidence” for seven of these [oesophageal (adenocarcinoma), pancreatic, liver, colorectal, 
breast postmenopause, endometrial and kidney]. Evidence also exists for the role of 
alcohol in increasing the risk of seven different cancers (“convincing evidence” for five of 
them) and decreasing the risk of developing one cancer (kidney). “Convincing evidence” 
also exists for the consumption of processed meats and increased colorectal cancer risk, 
aflatoxins and increased liver cancer risk, high dose beta-carotene and increased lung 
cancer risk and arsenic in water and increased lung cancer risk. Despite the continuous 
research in this field, there is insufficient evidence to draw conclusions in numerous 
combinations of dietary components and different cancers. 
 
1.7.2. Diet, nutrition and cancer survivorship  
The role of diet and nutrition after a cancer diagnosis may be different depending on 
cancer site, cancer stage and treatment stage. After diagnosis and during treatment, 
cancer survivors are at risk of malnutrition due to the metabolic effects of the cancer and 
also due to the side effects from anticancer treatment (Arends et al., 2017b). After the end 
of treatment, survivors may still struggle with long-term and late side effects (Adams et al., 
2014), as well as high overweight and obesity rates (Shoemaker et al., 2016) and 
increased risk for the development of metabolic diseases (Weaver et al., 2013). 
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1.7.2.1. Diet and nutrition during cancer treatment 
Inadequate nutritional intake, muscle protein depletion and systemic inflammation which 
affect metabolic processes, lead to weight loss and impaired physical function. Between 
20% and 70% of on-treatment survivors have been estimated to be malnourished 
according to a number of studies summarised by Arends et al. (2017b). Weight loss, 
cachexia (involuntary weight and muscle mass loss) and sarcopenia (low lean body mass) 
are associated with poorer treatment outcomes (Gangadharan et al., 2017), poorer quality 
of life (Gellrich et al., 2015), increased risk of mortality (Gangadharan et al., 2017, Ryan et 
al., 2016) and increased length of hospital stay (Ryan et al., 2016). 
Treatment side effects, such as appetite problems (appetite loss, anorexia, early satiety or 
increased appetite), gastrointestinal disturbances (diarrhoea, constipation, bloating), taste 
and smell changes, dysphagia, xerostomia, nausea and vomiting, all can have a negative 
effect on weight status and further contribute to the risk of malnutrition. Tumour site and 
stage determine the treatment(s), which means that different people will experience 
different side effects (Cancer Research UK, 2017).  
In order to improve detection and treatment of malnutrition in the cancer setting, the 
European Society for Clinical Nutrition and Metabolism (ESPEN) has published guidelines 
which focus on early screening, assessment and intervention (Arends et al., 2017a). From 
a total of 37 recommendations, only twelve are characterised as “strong” and even fewer 
(four) are based on high or moderate quality evidence, highlighting the need for further 
research to create stronger evidence (Arends et al., 2017a). There are strong 
recommendations about screening and assessment, energy and protein requirements, 
physical activity, use of vitamins and minerals and use of oral and artificial 





Table 1.1: ESPEN recommendations in nutrition and cancer characterised as "strong", and 
their level of evidence (Arends et al., 2017a). 





To detect nutritional disturbances at an early stage, regular 
evaluation of nutritional intake, weight change and BMI is 
recommended, beginning with cancer diagnosis and repeated 
depending on the stability of the clinical situation. 
Very low 
In patients with abnormal screening, objective and quantitative 
assessment of nutritional intake, nutrition impact symptoms, muscle 






Total energy expenditure of cancer patients, if not measured 
individually, is recommended to be assumed to be similar to healthy 
subjects and generally ranging between 25 and 30 kcal/kg/day. 
Low 
Protein intake should be above 1 g/kg/day and, if possible up to 1.5 
g/kg/day Moderate 
In weight-losing cancer patients with insulin resistance, increase of 
the ratio of energy from fat to energy from carbohydrates is 
recommended. This is intended to increase the energy density of the 
diet and to reduce the glycaemic load. 
Low 
Vitamins and minerals should be supplied in amounts approximately 
equal to the RDA and the use of high-dose micronutrients in the 





Nutritional intervention to increase oral intake in cancer patients who 
are able to eat but are malnourished or at risk of malnutrition is 
recommended. This includes dietary advice, the treatment of 
symptoms and derangements impairing food intake (nutrition impact 
symptoms), and offering oral nutritional supplements. 
Moderate 
Use dietary provisions that restrict energy intake in patients with or at 
risk of malnutrition should be avoided. Low 
If a decision has been made to feed a patient, enteral nutrition is 
recommended if oral nutrition remains inadequate despite nutritional 
interventions (counselling, ONS), and parenteral nutrition if enteral 
nutrition is not sufficient or feasible. 
Moderate 
If oral food intake has been decreased severely for a prolonged 
period of time, it is recommend to increase (oral, enteral or 
parenteral) nutrition only slowly over several days and to take 
additional precautions to prevent a refeeding syndrome. 
Low 
In patients with chronic insufficient dietary intake and/or 
uncontrollable malabsorption, home artificial nutrition (either enteral 




We recommend maintenance or an increased level of physical 
activity in cancer patients to support muscle mass, physical function 
and metabolic pattern. 
High 
 
In cancer groups most prone to malnutrition during treatment, such as ovarian cancer, a 
recent systematic review of nutritional interventions showed that nutritional support was 
associated with reduced length of hospital stay and fewer post-operative complications 
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(Rinninella et al., 2019). Nevertheless, large-scale randomised controlled trials (RCTs) 
with more homogeneous types of intervention and clinical outcomes are warranted. 
 
1.7.2.2. Diet and nutrition after cancer treatment 
The “teachable moment” of a cancer diagnosis and the treatment complications may be 
drivers for survivors to consider changing dietary habits. A recent study assessed health 
behaviours of breast, colorectal and prostate cancer survivors and showed that all cancer 
groups consumed on average about five servings of fruit and vegetables per day 
(Bluethmann et al., 2015). Also, one third (33%) of the survivors’ daily energy intake was 
derived from fat (Bluethmann et al., 2015), which is in line with current recommendations 
for healthy eating (Public Health England, 2016). There were considerable differences 
according to BMI status, educational status and gender; people with higher BMI and lower 
educational status, as well as male survivors consumed significantly less fruit and 
vegetables compared to people with lower BMI, college-educated and female survivors. It 
should be noted that the response rate in this survey was 56% and no information about 
non-respondents was provided (Bluethmann et al., 2015). 
On the other hand, results from a retrospective, cross-sectional matched case-control 
study in survivors of breast, colorectal and prostate cancer in the USA (data collected in 
2009) showed that only a minority followed the American Cancer Society 
recommendations for physical activity (30–47%), consumption of five fruit and vegetables 
daily (20–34%), and healthy weight (25–40%). Women with breast cancer were more 
likely to meet the 5-a-day recommendation in the short term, compared to cancer-free 
matched women, but this was not the case in the long term (LeMasters et al., 2014). It 
was, therefore, shown that healthy lifestyle behaviours may be implemented in the short-
term but may not be maintained in the long-term.  
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Also, survivors may be less likely to make changes in relation to diet and nutrition, 
compared to other lifestyles changes, such as smoking. A large cross-sectional study 
conducted in the USA in survivors of six different cancers showed that only 15-19% of 
them were adhering to the recommendation for fruit and vegetable consumption 
(consumption of 5 servings of fruit and vegetables per day) (Blanchard et al., 2008). On 
the other hand, 88-92% of them were non-smokers. Interestingly, only 4-6% of survivors 
in that study adhered to all three lifestyle recommendations (150 minutes of moderate-to-
strenuous physical activity, consumption of five servings of fruit and vegetables per day, 
no smoking) (Blanchard et al., 2008). The relationship between smoking and cancer 
development has been well established and there is robust evidence in comparison to the 
relationship between diet and cancer. Also, smoking cessation promotion campaigns have 
been shown to be more effective on a population level than campaigns which promote 
healthy diet or increased physical activity (Mozaffarian et al., 2012, Liu et al., 2012). 
Although there is limited evidence on the effectiveness of smoking cessation interventions 
in oncology populations (Nayan et al., 2013), general health promotion messages to avoid 
or stop smoking may have been better communicated. 
 
1.7.2.2.1. Overweight and obesity in cancer survivors 
The World Health Organisation defines overweight and obesity as “abnormal or excessive 
fat accumulation that may impair health” (World Health Organisation, 2018). A simple way 
to determine overweight and obesity on a population level is the use of Body Mass Index 
(BMI); an index of weight-for-height. It is calculated by dividing a person's weight in 
kilograms by the square of his height in metres (kg/m2) (World Health Organisation, 2018).  
It has been documented that cancer survivors have high overweight and obesity rates. A 
study on breast, prostate, colorectal and gynaecological cancer survivors showed that 
62% were classified as overweight or obese (BMI>25 kg/m2) (Weaver et al., 2013). In 
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other studies, obesity (BMI>30 kg/m2) was prevalent in about three out of ten survivors 
(Shoemaker et al., 2016, Greenlee et al., 2016). 
With regards to cancer survivorship, there have been several observational studies and 
systematic reviews that have assessed survivors’ weight status and evaluated the effect 
of overweight/obesity in overall survival, cancer-specific or non-cancer specific deaths and 
QoL in cancer populations. A systematic review and meta-analysis of 82 follow-up studies 
has shown that obesity (as defined by BMI status) was associated with poorer breast 
cancer survival, both in pre-menopausal and post-menopausal women (Chan et al., 
2014). More specifically, for every 5kg/m2 increase in BMI after diagnosis the risk of 
cancer-specific mortality was increased by up to 29%, although the authors suggested 
statistical power may have influenced the results. Women who were classified as obese 
12 months after diagnosis had a 21% increased risk for total mortality, compared to 
normal weight breast cancer survivors (Chan et al., 2014).  
Other cancer diagnoses are less studied but there are available systematic reviews to 
summarise the existing evidence. Secord et al. (2016) explored the association between 
post-diagnosis BMI and overall mortality in survivors of an endometrial cancer. Compared 
to women with a BMI<25 kg/m2, women with BMI over 40kg/m2 had a 66% increased risk 
for all-cause mortality [Odds Ratio (OR):1.66, 95% Confidence Interval (CI): 1.10-2.51, 
P=0.02]. The authors also estimated that for every 10% increase in BMI, there was a 9% 
increase in the odds of all-cause mortality; however, a more recent study from the 
Women's Health Initiative does not support the findings of the systematic review (Arem et 
al., 2017).  
With regards to prostate cancer, an earlier systematic review showed a 5kg/m2 increase in 
BMI led to 20% higher, prostate cancer-specific mortality; however this was not 
statistically significant [Relative Ratio (RR) 1.20, 95% CI 0.99–1.46, P=0.06] (Cao and Ma, 
2011). A more recent, retrospective study conducted in the USA showed that overweight 
and obesity were associated with increased prostate cancer-specific mortality in people 
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treated with radical prostatectomy (Vidal et al., 2017). However, Schiffman et al. (2018) 
demonstrated that prostate cancer survivors with obesity were less likely to exhibit 
metastases after radical prostatectomy, highlighting an “obesity paradox”, as it was 
anticipated by the authors that excess adiposity would be associated with increased risk 
of development of metastasis. It was also shown that obesity was associated with 
increased metastases-free survival. Authors highlighted that these findings may not be 
related to prostate cancer patients in active surveillance or treated with radiation. A 
previous meta-analysis of cohort studies has demonstrated a positive association 
between obesity and prostate cancer-specific mortality (Zhang et al., 2015). The above 
indicate that the link between obesity and mortality/survival after cancer diagnosis may be 
more complex than initially assumed, and highlights that different methodological 
approaches can yield conflicting evidence. 
Obesity is also implicated in survival of people diagnosed with colorectal cancer. A 
retrospective observational study showed that BMI was associated with all-cause and 
cancer specific mortality in a non-linear way (Kroenke et al., 2016). People classified as 
underweight (BMI<18.5 kg/m2) and class II obese (>35 kg/m2) had an increased risk of 
mortality (all-cause or cancer-specific). Interestingly, those classified as overweight had 
the best prognosis and those classified as class I obese (30 kg/m2<BMI<35 kg/m2) had no 
different mortality risk compared to those in the “normal weight” (18.5 kg/m2<BMI<30 
kg/m2) category (Kroenke et al., 2016). Moreover, results from the Cancer Prevention 
Study-II Nutrition Cohort conducted in colorectal cancer survivors showed that post-
diagnosis BMI was not associated with all-cause or cause-specific mortality (Campbell et 
al., 2012).  
Apart from its impact on survival, overweight and obesity have been associated with lower 
QoL. Vissers et al. (2017) demonstrated that colorectal cancer survivors with increased 
BMI and/or waist circumference had worse QoL indexes (physical, emotional, cognitive 
and social functioning) and symptoms of fatigue, compared to survivors with normal BMI  
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(18.5kg/m2<BMI<25 kg/m2). Similarly, a systematic review and meta-analysis that 
included a total of 1,363 endometrial cancer survivors showed that women with obesity 
had significantly poorer physical, social and role functioning when compared to non-obese 
women (Smits et al., 2015a). A smaller, cross-sectional study on ovarian cancer survivors 
showed that increasing BMI was associated with lower physical and emotional functioning 
(Smits et al., 2015b). Consequently, although findings on the role of obesity on survival 
may depend on cancer site and study design, evidence on its negative effect on QoL is 
more consistent.  
 
1.7.2.2.2. Dietary patterns, dietary components and outcomes in cancer survivors 
Regardless of weight status, observational studies have evaluated the role of dietary 
components and dietary patterns in cancer outcomes, such as all-cause mortality, cancer-
specific mortality and QoL. 
A recent systematic review on the effect of dietary patterns on prognosis following a 
breast cancer diagnosis showed that better overall dietary intake, as assessed by indexes 
(health/prudent dietary pattern or the Healthy Eating Index or the Alternative Healthy 
Eating Index), may independently improve overall and non-breast cancer survival. 
However, there was very limited and inconsistent evidence regarding breast cancer-
specific survival and recurrence. Only seven studies were included in this review, in which 
dietary intake was taken post-diagnosis and was assessed with Food Frequency 
Questionnaires (Terranova et al., 2018).  
Two studies assessed post-diagnosis diet quality and cancer outcomes in colorectal 
cancer survivors. The first study used the Alternate Healthy Eating Index-2010 (AHEI-
2010), alternate Mediterranean Diet score (aMED) and Dietary Approaches to Stop 
Hypertension score (DASH), as well as two dietary patterns, Western (unhealthy) and 
prudent (healthy) to assess diet quality. The authors found that higher AHEI-2010 score 
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(better diet quality) was significantly associated with lower overall mortality, but no other 
indexes showed any significant associations. Moderate alcohol consumption and lower 
consumption of sugar-sweetened beverages seemed to drive this association, as 
significant inverse associations for overall mortality were shown with these two food 
components when they were examined separately (Fung et al., 2014). The other study 
assessed two dietary patterns [Modified Mediterranean Diet Score (MMDS) and healthy 
Nordic Food Index (HNFI)] and found that high scores (better diet quality) in both indexes 
were associated with lower all-cause mortality (Ratjen et al., 2017).  
Two recent reviews on lifestyle factors and their impact on survival and recurrence 
indicated that evidence on diet and dietary components is currently weak to draw any 
conclusions (van Zutphen et al., 2017, Jochems et al., 2018). Even for dietary 
components which are known for their influence (either positive or negative) on cancer 
development, more research is needed regarding their role on survival and mortality (van 
Zutphen et al., 2017). For example, a study among colorectal cancer survivors in 
Germany showed that red and processed meat consumption was not associated with 
mortality (Carr et al., 2016). Another study found that post-diagnosis total calcium intake 
and milk intake, but not vitamin D intake, was inversely associated with all-cause mortality 
in colorectal cancer survivors of the Cancer Prevention Study-II Nutrition Cohort (Yang et 
al., 2014). Jochems et al. (2018) concluded that there may be some limited evidence to 
indicate that a low-fat diet, a high-quality diet and a prudent diet are beneficial for breast 
cancer survivors, but there is insufficient evidence for all other cancer sites that particular 
behaviours influence cancer-related outcomes.  
One study assessed adherence to the WCRF/AICR guidelines for cancer prevention 
(which are also encouraged to be followed by cancer survivors) and its association with 
mortality in older female cancer survivors. Results showed that women with the highest 
versus lowest adherence score had lower all-cause mortality (Hazard Ratio = 0.67; 95% 
CI: 0.50–0.94). Adherence to physical activity recommendations had greater benefits than 
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adherence to dietary or body weight recommendations, as it was associated with lower 
all-cause, cancer-specific and CVD-specific mortality (Inoue-Choi et al., 2013). 
 
1.7.2.2.3. Dietary interventions in cancer survivors 
There is limited research regarding the impact of dietary or lifestyle modifications in 
cancer outcomes following a diagnosis. Most of the evidence on diet, nutrition, obesity 
and cancer outcomes comes from observational studies and have been discussed in the 
previous sections.  
A recent Cochrane review and meta-analysis by Burden et al. (2019) ) summarised the 
evidence of dietary interventions in outcomes in cancer survivors. Included studies 
provided dietary advice in groups sessions, telephone or face-to-face consultations, or 
written or web-based form. A total of 25 studies, most of which were conducted in breast 
cancer populations, showed some favourable results in relation to Body Mass Index (slight 
decrease), Diet Quality Index (likely improvement) and consumption of fruit and 
vegetables (slight increase). There was little or no effect of a dietary intervention in overall 
survival, development of a secondary cancer, energy intake 12 months post-diagnosis 
and waist-to-hip ratio. QoL results were mixed, due to the variety of tools used from the 
included studies. Most results were based on low or very low quality evidence, highlighting 
the need for more rigorous research with standardised methods to gain a better 
understanding of dietary interventions in cancer outcomes (Burden et al., 2019).   
Interventions that implement dietary and physical activity modifications are also available 
in the literature. The Exercise and Nutrition Routine Improving Cancer Health (ENRICH) 
intervention was a RCT in which cancer survivors and carers were provided with face-to-
face, theory-based sessions on healthy eating and physical activity (intervention group) or 
routine care (control group). At 20 weeks, the intervention group had increased physical 
activity and vegetable intake, while achieving greater weight loss than the control group 
(James et al., 2015). On a 12-month follow-up during which no further intervention was 
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provided, physical activity and weight loss were maintained, but vegetable intake 
decreased, indicating that not all lifestyle behaviours are maintained in the long-term 
(Stacey et al., 2017). 
The FRESH START Trial was a 10-month diet and exercise intervention for breast and 
prostate cancer survivors in the USA. Tailored printed materials promoting fruit and 
vegetables, reducing fat intake and increasing exercise were provided to the intervention 
group, while the control group received generic information. Although both groups 
improved lifestyle behaviours, participants in the intervention group were more active (+20 
minutes, P=0.02), ate more fruit and vegetables (+0.5 servings, P=0.01) and achieved 
modest weight loss in comparison to the control group which did not achieve weight loss 
(Demark-Wahnefried et al., 2007).  
Another diet and exercise intervention in breast cancer survivors (Exercise and Nutrition 
to Enhance Recovery and Good Health for You or ENERGY) aimed to reduce weight to 
those assigned in the intervention group by 7% within 24 months. Results showed that the 
intervention group lost more weight at 12 months and 24 months, compared to the control 
group that received publicly available materials; however, weight loss in the intervention 
group was less than 7%, both in 12 and 24 months (6% and 3.7%) (Rock et al., 2015).  
Dietary or lifestyle interventions are less frequent for other cancer sites. A recent 
systematic review on lifestyle interventions in gynaecological cancer survivors included 
only three studies, none of which examined the effect of lifestyle modification in survival or 
recurrence. Two studies included in the meta-analysis examined the effect of lifestyle 
modification on QoL and found no significant results (Yeganeh et al., 2018).  
In view of limited intervention studies producing inconclusive evidence about the role of 
diet or lifestyle (diet and physical activity) on cancer related outcomes following a cancer 
diagnosis, there is a strong scientific interest in this area of research. Several protocols 
have been published with ongoing studies that have developed dietary or lifestyle 
interventions with the aim to explore cancer outcomes: management of treatment side 
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effects (Sun et al., 2018), disease-free and overall survival (Henriksen et al., 2017, 
Thomson et al., 2016), risk of recurrence (Ramirez et al., 2017) and QoL (Thomson et al., 
2016).  
 
1.8. Dietary support post-cancer treatment 
At present, nutritional guidelines for post-treatment cancer survivors in the UK are 
available from two sources: the ESPEN guidelines (Arends et al., 2017a) and the WCRF 
3rd expert report (World Cancer Research Fund/American Institute for Cancer Research, 
2018). The WCRF guidelines were developed for cancer prevention but are also 
recommended for post-treatment cancer survivors, due to the weak evidence base, as 
indicated in the previous sections. It also highlights that post-treatment cancer survivors 
should follow these recommendations “if possible”, indicating that potential detrimental 
effects of treatments may affect survivors’ life and subsequent dietary habits (World 
Cancer Research Fund/American Institute for Cancer Research, 2018). The two ESPEN 
recommendations are also based on low level of evidence, as most of the available 
studies are observational. Recommendations are summarised in Tables 1.2 and 1.3.  
Following the Department of Health’s initiative towards supporting patients throughout the 
cancer trajectory, it is important to investigate whether and how successfully dietary and 
nutritional information is communicated to cancer patients. Previously published scoping 
and systematic reviews have highlighted a number of unmet needs in cancer patients and 
information on diet and nutrition is one of them (Fletcher et al., 2017, Puts et al., 2012, 
Van Mossel et al., 2012, Kotronoulas et al., 2017). Dietary information is needed in 
different phases of the cancer trajectory, including treatment, rehabilitation/recovery and 




Table 1.2: ESPEN recommendations for cancer survivors (Arends et al., 2017a). 






We recommend that cancer survivors engage in 
regular physical activity. 
Strong Low 
In cancer survivors we recommend to maintain a 
healthy weight (BMI 18.5 – 25 kg/m2) and to 
maintain a healthy lifestyle, which includes being 
physically active and a diet based on vegetables, 
fruits and whole grains and low in saturated fat, 
red meat and alcohol. 
Strong Low 
 
Table 1.3: WCRF guidelines for cancer prevention and cancer survivors (World Cancer 
Research Fund/American Institute for Cancer Research, 2018). 
Recommendations 
Be a healthy weight – Keep your weight within the healthy range and avoid weight gain in later life 
Move more – Be physically active as part of everyday life – walk more and sit less 
Enjoy more grains, veg, fruit & beans – Eat a wide variety of wholegrains, vegetables, fruit and 
pulses such as beans 
Avoid high-calorie foods – Limit consumption of fast foods and other processed foods high in fat or 
sugar 
Limit consumption of red and processed meat – Eat no more than three portions of red meat a 
week and eat little, if any, processed meat 
Limit consumption of sugar-sweetened drinks – Drink mostly water and unsweetened drinks 
For cancer prevention, don’t drink alcohol – If you do, limit alcoholic drinks and follow national 
guidelines 
Don’t rely on supplements – Eat a healthy diet rather than relying on supplements to protect 
against cancer 
Breastfeed your baby – If you can, breastfeed your baby for six months before adding other liquids 
and foods 
 
Recognising patients’ unmet needs in this area and the lack of consistent evidence, the 
National Institute of Health Research (NIHR) created the NIHR Nutrition and Cancer 
Infrastructure Collaboration, with the aim of bringing nutrition research and cancer 
research together, to shape future research pathways and support cancer survivors. 
According to the Phase I report from collaboration (2015), research knowledge about diet 
and nutrition is not currently being translated to improve care, suggesting that many 
patients with cancer do not receive dietary advice from their healthcare professionals 
(Cancer and Nutrition NIHR infrastructure collaboration, 2015). The survey was 
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predominantly completed by breast cancer survivors and there was insufficient information 
for other cancer groups (Cancer and Nutrition NIHR infrastructure collaboration, 2015).  
 
1.9. Pelvic cancers 
The focus of this PhD will be on people who were treated with radiotherapy for a cancer 
diagnosis in the pelvic area. Pelvic cancer refers to a variety of cancers involving the 
structures and the organs in the pelvis. Pelvic cancers include cancers of the anus, 
bladder, rectum, gynaecological cancers (cervix, uterus, ovaries, vulva and vagina) and 
male cancers (prostate, penis and testes) (Paramasivam et al., 2006). Prostate cancer is 
the most common cancer in males in England (26% of registered male cancers), while 
gynaecological cancer accounted for almost 12% of registered cancer cases in women in 
2014 (Office for National Statistics, 2019). Survival rates are higher than average in most 
pelvic cancers; it is expected that 84% prostate, 77% endometrial, 63% cervical, 57% 
rectal and 50% bladder cancer survivors will live for more than ten years (Quaresma et al., 
2015). Only patients with an ovarian cancer diagnosis still have a poor 10-year life 
expectancy (35%) (Quaresma et al., 2015). 
Apart from increasing incidence and survival, people diagnosed with a pelvic cancer share 
a number of common characteristics that may affect future wellbeing and quality of life, 
such as persistent treatment side effects (Adams et al., 2014) and high obesity rates 
(Weaver et al., 2013). Pelvic radiotherapy (external beam radiation or brachytherapy) is 
often an integral part of the multidisciplinary approach used to treat pelvic tumours. 
Although radiotherapy is directed to a specific part of the body there is also often damage 
to normal tissues in the surrounding area and patients can experience a range of side 
effects as a result.  Although technological advances have led to improvement of 
techniques, toxicity still affects the gastrointestinal tract and can lead to functional 
damage, including malabsorption and change in motility of the intestinal tract (Teo et al., 
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2015). These adverse effects can have a significant impact on a patient’s diet, subsequent 
nutritional status and quality of life (Andreyev et al., 2011) and these effects can persist for 
many years (Adams et al., 2014).  
Obesity rates in pelvic cancer populations are higher than in the general population, 
especially for prostate, colorectal and gynaecological cancers (Weaver et al., 2013). 
Systematic reviews of observational studies have demonstrated increased mortality in 
obese ovarian (Protani et al., 2012), prostate (Zhang et al., 2015) and endometrial cancer 
survivors (Secord et al., 2016) in comparison to non-obese cancer survivors, although the 
evidence on obesity and prostate cancer specific mortality is still inconclusive (Vidal et al., 
2017, Schiffmann et al., 2018). Obesity has also been associated with lower physical and 
functional well-being and poorer quality of life among endometrial cancer (Koutoukidis et 
al., 2015), prostate cancer (Dieperink et al., 2012) and colorectal cancer survivors (Adams 
et al., 2016) in observational studies. It is also documented that cancer survivors are at 
increased risk of developing comorbidities, such as type II diabetes, cardiovascular 
disease, osteoporosis (Edgington and Morgan, 2011) as well as a secondary primary 
cancer (Travis et al., 2013). It is evident that individuals diagnosed with cancers that 
typically have high survival rates, such as pelvic cancers, are more likely to die of a 
cardiovascular disease rather than cancer progression or recurrence (Weaver et al., 
2013). 
Common characteristics in pelvic cancer populations (increased incidence and survival, 
pelvic radiotherapy side effects, obesity) provide the opportunity for a researcher to 
explore experiences in diet and nutrition in these cancers as one whole group. However, it 
should be acknowledged that there are also distinct differences in relation to dietary 
management following diagnosis, which are particularly attributed to receipt of treatments 
other than pelvic radiotherapy. People diagnosed with prostate cancer often follow 
additional hormone therapy, which may lead to muscle wasting, fat accumulation and 
weight gain. On the contrary, receipt of chemotherapy is common in rectal and 
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gynaecological cancers, and is linked with loss of appetite, weight loss and increased risk 
for malnutrition. Irrespective of other treatment regimens, patients diagnosed with pelvic 
cancers face a range of issues in relation to diet and nutrition that affect nutritional status 
and body weight.  
Treatment side-effects and the increased risk of developing a secondary cancer or 
comorbidity are likely to influence patients’ sense of well-being (Koch et al., 2013). Pelvic 
cancer patients often express concerns about their diet and are likely to be interested in 
receiving information about healthy eating (Coa et al., 2014, Bours et al., 2015). In 
recognition of the importance of translational research and the need to deliver quality, 
standardised nutritional care tailored to the needs of pelvic cancer patients, it is essential 
to understand their experiences, perceptions and knowledge in relation to their diet and 
nutrition. 
 
1.10. Aim and objectives 
The overall aim of the PhD project is to explore dietary habits, nutritional awareness and 
experiences of nutritional care of cancer survivors with a pelvic cancer and treated with 
radical pelvic radiotherapy. 
An initial search during the early stages of the PhD to explore “what has been done up to 
now”, identified relevant past research published in journals, as well as written materials 
that included practical information on diet and nutrition relevant to pelvic cancer survivors. 
After discussions with the supervisory team, it was decided that the initial search identified 
two potential topics worth further exploring: 
1. A search of the published, peer-reviewed research, which would be organised in a 
systematic literature review (Phase 1; Chapter 2) to identify research gaps and 
inform the mixed-methods study (Phase 2) and  
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2. Original research to evaluate the quality of the written materials (Phase 3; Chapter 
8). 
Based on the initial scoping exercise, the specific objectives of the project are to 
 Review the literature regarding information and support needs in diet and nutrition in 
cancer patients receiving pelvic radiotherapy. 
 Explore survivors’ current dietary habits, including dietary changes as a result of the 
cancer diagnosis 
 Assess survivors’ awareness of and attitudes towards current dietary 
recommendations 
 Explore survivors’ experiences of nutrition support received during or after pelvic 
radiotherapy treatment and highlight unmet needs 
 Identify the availability of online information in diet and nutrition suitable for pelvic 
cancer patients 
Therefore, answers to the following questions are sought: 
 Do pelvic cancer patients change their diet as a result of diagnosis and treatment and 
why? 
 How familiar are pelvic cancer patients with the current nutritional recommendations 
published by the WCRF? 
 Do pelvic cancer patients receive support and information with regards to diet and 
nutrition from their healthcare team or any other source? 
 What information on diet and nutrition is available online for pelvic cancer patients?  
 
 
In order to address the aim and objectives, this PhD is divided in three sections. 
Phase 1 (Chapter 2): A systematic review of the literature regarding diet and nutrition 
information and support needs of cancer patients receiving pelvic radiotherapy.  
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Phase 2 (Chapters 3-7): A mixed-methods study to explore dietary changes, nutritional 
awareness and patient experiences in people diagnosed with a pelvic cancer either 
undergoing or having completed pelvic radiotherapy 6-24 months before.  
Phase 3 (Chapter 8): An original study of the availability and quality assessment of online 
nutrition information for pelvic cancer patients in the UK. 
The long-term goal is to optimise support in diet and nutrition in order to address 
nutritional problems and to improve wellbeing in cancer survivors. In order to achieve the 
long-term goal, gaps in care and unmet needs should be highlighted. The identification of 
unmet needs, along with research relating to the role of diet in cancer survivorship 
outcomes, is expected to improve the level of support in this field.   
The aim and objectives of this PhD will lead to the identification of unmet needs of pelvic 
cancer survivors in diet and nutrition. In order to obtain this information, a mixed-methods 
approach (detailed in Chapter 3) will be implemented to explore aspects of patients’ 
nutritional behaviour, such as dietary changes following diagnosis, supplement use and 
nutritional awareness of current recommendations. Also, it is essential to explore current 
level of support from the healthcare environment, as well as external sources, such as the 
internet. An additional original study will be implemented to identify and evaluate 
nutritional information available online suitable for pelvic cancer survivors (Chapter 8). 
Unmet needs are expected to be vary within a group of patients with a diagnosis of pelvic 
cancer. For example, treatment stage (currently undertaking radiotherapy or having 
completed radiotherapy) could unveil different needs in diet and nutrition. As highlighted 
earlier, on-treatment patients may be more prone to undernutrition and suffer more side 
effects, compared to survivors who have completed treatment and recovered their 
disease. Similarly, expected outcomes may be different according to cancer diagnosis, 
socioeconomic and health factors (e.g. Body Mass Index, additional comorbidities) and 
should be explored in more depth. Fig. 1.1. summarises the link between the study aim 
















Chapter 2. Systematic review 
Diet and nutrition information and support needs after a 






The first phase of this PhD aimed to review information and support needs in relation to 
diet and nutrition following a pelvic cancer diagnosis. A systematic review of the literature 
was conducted according to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines. Peer-reviewed studies of any design that assessed 
diet and nutrition needs after a pelvic cancer diagnosis were included. Narrative synthesis 
was used to integrate findings. Thirty-one studies (12 quantitative, 16 qualitative, 3 mixed-
methods) were included in the analysis. Nutritional guidance was not routinely provided 
after a cancer diagnosis or treatment. Pelvic cancer patients expressed nutritional 
information and support needs following diagnosis and sought tailored, evidence-based 
and practical nutritional advice in relation to their disease. 
 
2.2. Introduction  
Improving the quality of nutritional care provided to people with cancer requires gaining a 
better understanding of their needs and identifying ways to offer solutions to these needs. 
To date, there has been no review of the literature regarding information and support 
needs in relation to diet and nutrition in cancer patients. This PhD focuses on cancers 
receiving pelvic radiotherapy (bladder, lower GI, male and female reproductive organs); 
therefore this review aims to provide answers to the following questions: 
 What dietary information do patients with a pelvic cancer receive in relation to their 
diagnosis? 
 What are pelvic cancer patients’ perceived information and support needs 
regarding diet and nutrition? 
 Are there differences in information and support needs in different survivorship 





This systematic review was conducted according to the PRISMA guidelines, where 
applicable. The review protocol has been registered at the International Prospective 
Register of Systematic Reviews (PROSPERO CRD42018115832). 
 
2.3.1. Search strategy 
A systematic search of six databases (MEDLINE, EMBASE, CINAHL, Web of Science, 
AMED: Allied and Complementary Medicine and PsycINFO) was performed in April 2018 
and was updated in February 2019. There were no restrictions in publication date. The 
following keyword topics were used: 
1. Cancer (cancer OR oncology OR neoplasm OR carcinoma OR tumour) 
2. AND pelvic (pelvic OR bladder OR ovarian OR endometrial OR cervical OR uterine 
OR vaginal OR vulvar OR rectal OR colorectal OR testicular OR prostate OR anal 
OR reproductive organs OR bowel). Although colon cancer is not routinely treated 
with radiotherapy, it was decided to include in the search, as research papers 
usually refer to ‘colorectal cancer’ or ‘bowel cancer’.  
3. AND patients (patients OR survivors OR diagnosis OR survivorship) 
4. AND information needs (information OR advice OR education OR support OR 
guidance OR needs OR views OR concerns) 
5. AND diet (diet OR nutrition OR food OR lifestyle OR nourishment OR supplement 
Subject headings were used, where applicable. Appendix 1a shows the detailed search 
strategy in Web of Science. Initial database searches revealed a number of studies 
published in specific journals: Supportive Care in Cancer; Journal of Cancer Survivorship; 
and European Journal of Cancer Care. In addition to the search of databases, all volumes 
and issues of these journals were searched from 2000 to February 2019 using the words 
“diet and cancer” or “nutrition and cancer”. Also, reference lists of two scoping (Van 
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Mossel et al., 2012, Fletcher et al., 2017) and two systematic reviews (Kotronoulas et al., 
2017, Puts et al., 2012) of unmet needs of cancer patients were also thoroughly searched 
for relevant publications. Finally, the reference lists of all full-text articles were examined 
for any studies that may have been overlooked.  
 
2.3.2. Eligibility criteria 
Studies were considered for inclusion if: 
 They investigated supportive care needs or information needs in relation to diet 
and nutrition of people diagnosed with a cancer in the pelvic area, irrespective of 
disease stage, time-point after diagnosis or treatment.  
 The study design was cross-sectional, prospective, retrospective, a randomised 
trial or qualitative. All quantitative and qualitative research designs were 
considered as the aim was to provide a complete picture, deduce maximum 
information and get a better understanding of the phenomenon (Hong et al., 2017). 
 They were conducted with adult individuals (i.e. aged >=18 years) 
 They were original research published in peer reviewed journals 
 They were published in English (a translation service was not possible) 
Studies were excluded if: 
 They did not highlight diet and nutrition support needs of the target population (i.e. 
if they discussed lifestyle in general) 
 They were an audit of a current hospital service, editorials, case studies, reviews, 
opinion papers or conference proceedings. 
 The sample was a mix of pelvic and other cancer diagnoses except when separate 
sub-groups analyses were reported for pelvic cancers. 




2.3.3. Study selection 
The studies were selected in two stages. First, a title and abstract screening was 
performed by the Principal Investigator (PI) for all identified studies. A randomly selected 
subsample (10%) of the studies was also screened by the supervisory team to ensure 
consistency. Any disagreements were discussed until a mutual decision was reached. 
After title and abstract exclusion, all remaining studies were considered for full-text review. 
Eligibility criteria were applied to full-text articles by the PI. In case of uncertainty or any 
disagreements, discussions took place in supervisory meetings until a mutual decision 
was reached. 
 
2.3.4. Data extraction and synthesis 
Relevant features and results were extracted for each included study. Data were extracted 
by the PI and were confirmed by the supervisory team (Table 2.1). Location of study, 
study design, study duration, aim(s), inclusion criteria, sample size, percentage of women 
in sample, mean/median age and age range of participants, response rate and sample 
cancer diagnosis were extracted, where possible, for all included studies. Studies in the 
data extraction table (Table 2.1) have been grouped according to the research design 
(qualitative, quantitative) and cancer diagnosis (prostate, colorectal, gynaecological 
cancer). 
Findings from all studies were integrated and collated under the three research questions. 
First, thematic analysis was performed to identify common themes and concepts related 
to diet and nutrition information and support needs from qualitative studies. Thematic 
analysis was conducted according to Braun and Clarke (2006) which involves six steps: 
familiarisation with the data; coding; searching for themes; reviewing the themes; defining 
and naming the themes; and producing the report. Then, findings from the quantitative 
studies were integrated with the findings of the thematic analysis of qualitative studies. 
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Thematic synthesis, which is a type of synthesis commonly used in qualitative research, is 
also used as a means of organising and summarising the findings from large, diverse 
bodies of research (Lucas et al., 2007). Quantitative data fitted well with the themes 
developed in thematic analysis of qualitative data; hence results are presented according 
to these themes. 
 
2.3.5. Quality assessment 
For the assessment of cross-sectional studies, the Appraisal Tool for Cross-Sectional 
studies (AXIS) was used (Downes et al., 2016). The tool comprises 20 questions, seven 
of which relate to the quality of reporting, seven to study design and six to study biases. 
For the assessment of qualitative studies, a previously adapted appraisal tool for 
qualitative studies (Cesario et al., 2002, Hannes, 2011) was used. The tool comprises five 
categories: descriptive vividness (credibility); methodological congruence (dependability 
and confirmability); analytical preciseness; theoretical connectedness (transferability); and 
heuristic relevance (Collaco et al., 2018). A score range of 1-24 was given to each 
qualitative study based on the scores for each of the five categories. The quality of a study 
was considered good for a score of 18-24 (75-100% of the total criteria met), fair for a 
score of 12-17 (50-74% of the total criteria met) and poor for a score lower than 12 (less 
than 50% of the total criteria met). The quantitative and qualitative arm of the mixed-
methods studies was assessed separately. 
 
2.4. Results 
The initial search yielded 4,529 results. After removal of duplicates (1,407), 3,048 articles 
were excluded following review of title and abstract and a further 44 were excluded after 





Figure 2.1: Article selection PRISMA flow chart (Moher et al., 2009) 
 
 
2.4.1. Characteristics of selected studies 
Of the 30 included studies, eleven studies were conducted in the UK (Anderson et al., 
2013, Avery et al., 2014, Beaver et al., 2010, Beaver et al., 2011, Brown et al., 2016, Er et 
al., 2017, Evans et al., 2007, Kassianos et al., 2015, Koutoukidis et al., 2017, Rozmovits 
et al., 2004, Sutton et al., 2017), five in the USA (Clark et al., 2016, Demark-Wahnefried et 
al., 2000, des Bordes et al., 2016, Tseng et al., 2015, Zaleta et al., 2017), four in Australia 
(Dunn et al., 2006, Hardcastle et al., 2017, Hardcastle et al., 2018, Nikoletti et al., 2008), 
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two in Canada (Fitch et al., 2000, Fitch et al., 2001), two in New Zealand (Cha et al., 
2012, Pullar et al., 2012), two in South Korea (Lee et al., 2016, Jang et al., 2018) and one 
each in Israel (Perl et al., 2016), the Netherlands (Hoedjes et al., 2017), Sweden 
(Samuelsson et al., 2018) and Malaysia (Lee et al., 2017). Twelve studies employed a 
quantitative design (Beaver et al., 2011, Cha et al., 2012, Clark et al., 2016, Demark-
Wahnefried et al., 2000, Fitch et al., 2000, Fitch et al., 2001, Lee et al., 2016, Nikoletti et 
al., 2008, Perl et al., 2016, Pullar et al., 2012, Tseng et al., 2015, Zaleta et al., 2017), 
fifteen were qualitative (Anderson et al., 2013, Avery et al., 2014, Beaver et al., 2010, 
Brown et al., 2016, Dunn et al., 2006, Er et al., 2017, Evans et al., 2007, Hardcastle et al., 
2017, Hardcastle et al., 2018, Kassianos et al., 2015, Koutoukidis et al., 2017, Rozmovits 
et al., 2004, Sutton et al., 2017, Lee et al., 2017, Samuelsson et al., 2018) and three were 
mixed-methods studies (des Bordes et al., 2016, Hoedjes et al., 2017, Jang et al., 2018). 
Sample size varied according to research design, with the range being 8-58 participants in 
qualitative studies and 20-1198 participants in quantitative studies. Twelve studies (40%) 
were conducted on colorectal cancer patients (Anderson et al., 2013, Beaver et al., 2010, 
Beaver et al., 2011, Brown et al., 2016, Cha et al., 2012, Dunn et al., 2006, Hardcastle et 
al., 2018, Hoedjes et al., 2017, Nikoletti et al., 2008, Pullar et al., 2012, Rozmovits et al., 
2004, Samuelsson et al., 2018), nine studies (30%) on gynaecological cancer patients 
(Zaleta et al., 2017, Tseng et al., 2015, Lee et al., 2016, Koutoukidis et al., 2017, 
Hardcastle et al., 2017, Fitch et al., 2000, Fitch et al., 2001, Clark et al., 2016, Jang et al., 
2018), five studies (17%) on prostate cancer patients (Avery et al., 2014, Er et al., 2017, 
Sutton et al., 2017, Kassianos et al., 2015, Lee et al., 2017) and four studies (13%) had a 
sample with mixed cancer diagnoses (Demark-Wahnefried et al., 2000, des Bordes et al., 
2016, Evans et al., 2007, Perl et al., 2016). All studies were published after the year 2000 
and most (80%) after 2010. Table 2.1 shows the characteristics of the included studies.  
Table 2.2 describes the main findings reported across the papers in relation to diet and 
nutrition information needs, the tool(s) used to collect data and the related themes from 
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the thematic analysis. Ten cross-sectional studies, including one mixed-methods study, 
used non-validated questionnaires developed by the study authors (Cha et al., 2012, 
Clark et al., 2016, Demark-Wahnefried et al., 2000, Fitch et al., 2000, Fitch et al., 2001, 
Hoedjes et al., 2017, Lee et al., 2016, Nikoletti et al., 2008, Pullar et al., 2012, Tseng et 
al., 2015). Three studies, including one mixed methods, used validated tools for one or 
more of their research questions (Zaleta et al., 2017, Perl et al., 2016, Jang et al., 2018) 
and two (including one mixed-methods study) used adapted validated questionnaires 
(Beaver et al., 2011, des Bordes et al., 2016). Twelve qualitative studies (including two 
mixed-methods) conducted interviews (Beaver et al., 2010, Brown et al., 2016, des 
Bordes et al., 2016, Er et al., 2017, Evans et al., 2007, Hardcastle et al., 2017, Hardcastle 
et al., 2018, Kassianos et al., 2015, Rozmovits et al., 2004, Sutton et al., 2017, Jang et al., 
2018, Samuelsson et al., 2018), two (including one mixed-methods) conducted focus 
groups (Anderson et al., 2013, Hoedjes et al., 2017) and four used a combination of 
interviews and focus groups (Dunn et al., 2006, Koutoukidis et al., 2017, Avery et al., 
2014, Lee et al., 2017). Three main themes were identified: “content of dietary 
information”; “sustaining dietary change”; and “views on the role of diet in survivorship”.   
All studies included participants that had completed treatment and seven of these, all 
qualitative studies, also included patients undergoing treatment at the time of the study 
(Avery et al., 2014, des Bordes et al., 2016, Er et al., 2017, Evans et al., 2007, Kassianos 
et al., 2015, Pullar et al., 2012, Sutton et al., 2017). The studies that included participants 
in different treatment stages did not present results according to treatment stage (on-
treatment/post-treatment), so it was not possible to identify any sub-themes related to 
differences in information and support needs according to treatment stage. The three 
themes provided insights in relation to the first two research questions: “What information 
do pelvic cancer patients receive in relation to their diagnosis?” and “What are their 




2.4.2. Theme 1: Content of dietary information 
A total of 27 studies discussed patients’ receipt of information on diet and nutrition. Six of 
these, all quantitative (Beaver et al., 2011, Clark et al., 2016, Fitch et al., 2000, Fitch et al., 
2001, Nikoletti et al., 2008, Tseng et al., 2015), reported that a majority of participants (50-
59%) received advice related to their diet and four reported levels of satisfaction with 
received information (53-59%). Twenty-one studies, most of them qualitative, highlighted 
diet and nutrition counselling as an unmet need (Anderson et al., 2013, Avery et al., 2014, 
Beaver et al., 2010, Brown et al., 2016, Cha et al., 2012, Demark-Wahnefried et al., 2000, 
Dunn et al., 2006, Er et al., 2017, Evans et al., 2007, Hardcastle et al., 2017, Hardcastle 
et al., 2018, Koutoukidis et al., 2017, Pullar et al., 2012, Rozmovits et al., 2004, Sutton et 
al., 2017, Samuelsson et al., 2018, Jang et al., 2018, Lee et al., 2017, Kassianos et al., 
2015, Hoedjes et al., 2017, des Bordes et al., 2016). Participants reported receipt of 
vague and often contradictory advice in six studies (Anderson et al., 2013, Er et al., 2017, 
Hardcastle et al., 2018, Kassianos et al., 2015, Koutoukidis et al., 2017, Lee et al., 2017). 
Patients also reported being advised or following themselves a “trial and error” approach, 
particularly in relation to diet adaptation to altered bowel habits (Anderson et al., 2013, 
Beaver et al., 2010, Hardcastle et al., 2018), which was perceived as “unhelpful” 
(Anderson et al., 2013). In Avery et al.’s study (2014), lack of reliable information was 
considered to be a barrier to dietary change for prostate cancer patients. It was 
highlighted across studies that patients look for simple, clear messages (Anderson et al., 
2013, Avery et al., 2014, Hardcastle et al., 2018, Hoedjes et al., 2017, Rozmovits et al., 
2004) and reliable, evidence-based information (Avery et al., 2014, Kassianos et al., 2015, 
Koutoukidis et al., 2017, Sutton et al., 2017) which could influence dietary change. Also, 
tailored advice was expected and should be provided (Anderson et al., 2013, Avery et al., 
2014, Beaver et al., 2010, Hardcastle et al., 2018, Hoedjes et al., 2017, Kassianos et al., 
2015, Brown et al., 2016, Koutoukidis et al., 2017, Sutton et al., 2017, Lee et al., 2017, 
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Samuelsson et al., 2018). Hoedjes et al. (2017) reported that not only content, but also 
format, intensity and timing of counselling should be individualised.  
Patients frequently asked about dietary support in relation to physical symptoms, such as 
management of bowel problems and weight changes. Queries about management of 
bowel problems were reported in ten studies with colorectal cancer patients (Anderson et 
al., 2013, Beaver et al., 2010, Brown et al., 2016, Dunn et al., 2006, Hardcastle et al., 
2018, Hoedjes et al., 2017, Nikoletti et al., 2008, Pullar et al., 2012, Rozmovits et al., 
2004, Samuelsson et al., 2018) and two studies with gynaecological cancer patients 
(Koutoukidis et al., 2017, Lee et al., 2016). In particular, patients expressed concerns on 
which specific diet would be appropriate after removal of part of the bowel (Beaver et al., 
2010, Rozmovits et al., 2004). In the Rozmovits et al. study (2004), patients reported 
difficulties adjusting their dietary habits to the altered bowel function but could not find the 
information they wanted. Anderson et al. (2013) reported that colorectal cancer patients 
sought practical dietary advice on which foods to avoid for controlling diarrhoea and 
flatulence, which affected them on a daily basis. According to two studies, dietary support 
was more frequently provided to colorectal cancer patients with a stoma, in comparison to 
those who did not have a stoma (Rozmovits et al., 2004, Hardcastle et al., 2018).  
Regarding weight changes, a study showed that colorectal cancer patients experienced 
both weight loss and weight gain during their treatment and attributed these changes to a 
lack of guidance (Anderson et al., 2013). In Samuelsson et al. study (2018), older patients 
lost weight during treatment and were experiencing difficulties regaining weight; yet only a 
few of them reported dietetic support. Studies in overweight and obese gynaecological 
cancer survivors showed that weight management counselling was not routinely provided 
as part of the follow up consultations (Tseng et al., 2015, Zaleta et al., 2017). Most 
gynaecological cancer survivors were largely receptive to weight management 
counselling, which would reinforce the importance of attempting weight loss (Clark et al., 
2016, Tseng et al., 2015, Zaleta et al., 2017). 
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Apart from dietary information in relation to physical symptoms, a number of other 
education needs were highlighted across several studies. Patients requested advice in 
relation to recipes (des Bordes et al., 2016, Hardcastle et al., 2018, Lee et al., 2016), 
shopping practices (des Bordes et al., 2016), classification of foods (Hardcastle et al., 
2018), portion sizes (Hardcastle et al., 2018), energy intake (Hardcastle et al., 2018), food 
labels (Hardcastle et al., 2018), supplements (Evans et al., 2007, des Bordes et al., 2016, 
Hoedjes et al., 2017), general healthy eating (Anderson et al., 2013, Hardcastle et al., 
2017) and healthy lifestyle (Koutoukidis et al., 2017). 
Healthcare professionals, such as oncologists, consultants, cancer specialist nurses, 
primary care physicians and dietitians were considered the most reliable sources of 
information (Avery et al., 2014, Brown et al., 2016, Clark et al., 2016, Er et al., 2017, 
Hardcastle et al., 2017, Koutoukidis et al., 2017, Sutton et al., 2017, Hoedjes et al., 2017); 
however, in few studies patients noted that health professionals were lacking adequate 
knowledge in this topic (Kassianos et al., 2015, Koutoukidis et al., 2017, Rozmovits et al., 
2004) or were uncertain about the role of diet in survivorship (Er et al., 2017). It was not 
possible to compare experiences of information and support according to different 
healthcare disciplines (e.g. oncologist Vs dietitian) due to insufficient information from the 
included studies. 
 
2.4.3. Theme 2: Sustaining dietary change 
Several studies reported lack of dietary counselling during follow up (Hardcastle et al., 
2017, Hardcastle et al., 2018, Koutoukidis et al., 2017, Samuelsson et al., 2018) and 
highlighted the need for regular ongoing monitoring as a means of sustaining healthy 
behaviours, including dietary changes and weight management (Hardcastle et al., 2017, 
Hoedjes et al., 2017, Kassianos et al., 2015, Zaleta et al., 2017, Samuelsson et al., 2018). 
Also, patients expressed an interest in having their current dietary habits assessed and 
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receive feedback on what could improve in their diets (Hoedjes et al., 2017, Kassianos et 
al., 2015, Sutton et al., 2017). Patients perceived health professionals to have an 
important role in engaging them in regular conversations that could help them sustain 
healthy dietary habits (Hardcastle et al., 2017, Zaleta et al., 2017). In a study conducted in 
endometrial cancer survivors, participants expressed a need for accountability and 
external support to commit to lifestyle behaviour change (Hardcastle et al., 2017). On the 
other hand, a study in cancer survivors showed that self-management was another 
important aspect of keeping a healthy diet (Hoedjes et al., 2017).  
 
2.4.4. Theme 3: Views on the role of diet post-treatment 
Although dietary support is valued as an important topic of discussion with health 
professionals across most included studies, a few qualitative studies conducted on 
prostate and colorectal cancer patients showed that diet was not always perceived as an 
important aspect of survivorship, particularly after curative surgery (Anderson et al., 2013, 
Avery et al., 2014, Er et al., 2017, Sutton et al., 2017, Kassianos et al., 2015). Anderson et 
al. (2013) reported that some colorectal cancer survivors did not believe that a healthy diet 
would reduce the risk of recurrence, since it had not prevented its development. In 
another study, prostate cancer patients who underwent radical treatment were less likely 
to consider dietary changes than those on active surveillance (Avery et al., 2014). In the 
Er et al. (2017) pilot study of assessing prostate cancer survivors’ interest in a dietary 
intervention program, participants perceived their current diet to be healthy and 
questioned which further changes could be made to improve it. For others, 
implementation of dietary changes following counselling was viewed as returning control 
and allowing patients “to do something after diagnosis” or as adjunct therapy by some 
studies in prostate and colorectal patients (Anderson et al., 2013, Avery et al., 2014, 
Kassianos et al., 2015). Three studies also highlighted the need for a holistic package of 
survivorship care, including diet alongside physical activity, and mental, sexual and 
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psychological wellbeing (Anderson et al., 2013, Evans et al., 2007, Koutoukidis et al., 
2017). 
 
2.4.5. Quality of the included studies 
The results of the quality assessment of the included studies are presented in Appendix 
1b. Quality of reporting and quality of study design were generally high across the 
quantitative (cross-sectional) studies. Aims, population, recruitment settings and basic 
data were presented clearly and study design was appropriate in all quantitative studies. 
Most studies provided adequate information regarding statistical analysis, conflicts of 
interest, ethical approval and study limitations; however, no studies justified sample size 
and only three described the characteristics of non-respondents. Non-response bias may 
have occurred in 13 studies (including all mixed-methods). Most studies used non-
validated questionnaires. Results were internally inconsistent in four studies. 
Quality was overall characterised as “fair” (score 12-17) in eleven qualitative studies 
(including three mixed-methods) and “good” (18-24) in seven studies. No studies scored 
lower than 12 points and no studies achieved the maximum score of 24. All studies 
provided an adequate description of the methods and ethical procedures and most 
referred to policy and research recommendations. All studies had enough information to 
ensure transferability (fair or good scores) and most of them to ensure confirmability. On 




Table 2.1: Characteristics of the selected studies, grouped according to cancer diagnosis (colorectal, prostate, gynaecological) and study design 





duration  Aim of study Sample, N, sex, age  
Response 







To explore patient needs for advice on 
diet, activity and lifestyle; patient beliefs 
about the role of diet, activity and 
lifestyle for reducing disease risk; and 
preferred formats, timings and routes of 
delivery for such guidance 
N=40, 50.0% women; mean 
age (SD)  60 (12.2) years; 
range 27-84 
 NS Diagnosed with and treated for 
colorectal cancer and not 
undertaking active cancer 
treatment 
Colorectal 
Beaver (UK)  Qualitative, 
NS 
To explore patient perceptions of their 
experiences of follow-up care after 
treatment for colorectal cancer 
N=27, 48.1% women; mean 
age 72 years; range 59-86 
NS Patients diagnosed with colorectal 
cancer who completed active 
treatment and had no current 
clinical problems 
Colorectal 
Brown (UK)  Qualitative, 3 
months 
To explore awareness of long-term and 
late treatment consequences of 
colorectal cancer survivors when they 
are nearing discharge from oncology 
N=19, 42.1% women; mean 
age 67.1 years; range 37-84 
NS Participants with a colorectal 
cancer diagnosis, at least 12 
months post treatment, over 18 
years old, able to communicate in 
English and without a terminal 






To examine quality of life and 
psychosocial variables most salient to 
colorectal cancer patients 
N=20, 60% women; mean 
age and range not reported 
28% Diagnosed with colorectal cancer 
within the past 18 months, under 
80 years old, spoke English, and 
had no mental or intellectual 
impairment 
Colorectal 
Evans (UK)  Qualitative, 
NS 
To investigate why men choose to use 
Complementary and Alternative 
Medicine (CAM), and the extent to 
which CAM is used to fill ‘gaps’ in 
conventional care provision 
Total sample N=34. Prostate 
cancer survivors: N=10; 
colorectal cancer survivors 
N=10; Mean age and range 
not reported for the 
subsamples 
NS Men with a cancer diagnosis and 
Complementary and Alternative 








To explore colorectal cancer survivors’ 
information and support needs in 
relation to health concerns and the 
promotion of healthy eating and 
physical activity 
N=24, 45.8% women; mean 
age 69.4 years; range 63-77 
19% Colorectal cancer diagnosis within 
the past two years and presence 
of comorbidities which put them at 








duration Aim of study Sample, N, sex, age  
Response 







To describe current hospital follow-up 
policy and to explore patients’ needs 
and preferences for follow-up 
N=39; 48.7% women; mean 
age 60.1 years; range 33-87 







To describe older patients' experiences 
from diagnosis of colorectal cancer, to 
recovery and aftercare and evaluate 
how information provision was 
perceived by patients 
N=16, 50% women, median 
age 82.5 years; range 76-89 
years 
84% People aged 75 years and above 
who had undergone elective CRC 
surgery with curative intent at 
least 3 months prior to the 
interview 
Colorectal 
Beaver (UK)  Cross 
sectional 
survey, NS 
To explore patient satisfaction on 
different aspects of follow-up service 
provision following treatment for 
colorectal cancer 
N=187, 43.3% women; mean 
age (SD) 72.8 (8.5) years; 
range 46-90 
63% Adults (>18 years) who had 
received resection with curative 
intent for either cancer of the 







To describe dietary intakes and dietary 
patterns of colorectal cancer patients in 
the Auckland region, and to investigate 
what the current information resources 
are, and patient satisfaction with these 
resources 
N=29, 31% women; Age 
band most frequently 
selected 70+ years 
73% Participants with a diagnosis of 
colorectal cancer who had 
received surgical resection (with 
curative intent) of their tumour in 







To explore long-term information needs 
and self-care practices relating to bowel 
management after sphincter-saving 
colorectal surgery 
N=101, 29.7% women; mean 





Adults (>18 years of age), 
diagnosed with a colorectal 
cancer, undergoing sphincter-
saving surgery in the past 6-24 
months and able to speak and 
understand English 
Colorectal 
Perl (Israel)  Cross 
sectional 
survey, NS 
To characterize gastrointestinal cancer 
patients’ specific physical and 
psychosocial needs and quality of life 
concerns 
Total sample N=50. 
Colorectal cancer N=40, 
50% women. Mean age and 
range not reported for the 
subsample 
94% Young adults (18-40 years old) 
diagnosed with cancer of the GI 
tract (oesophagus, gastric, colon, 
rectum, anal) between 6 months 
and two years prior to enrolment; 
had a Karnofsky Performance 
Status of 80 or above or an 
Eastern Cooperative Oncology 








duration Aim of study Sample, N, sex, age  
Response 









To establish the dietary patterns of 
colorectal cancer patients, the level of 
dietary advice they currently received 
and its impact on their behaviour 
N=40, 47.5% women; 70% 
were 60 years or older 
NS Adults (>18 years of age), 
diagnosed with colorectal cancer 
(stages II, III or IV), with sufficient 




Mixed, NS To explore needs and preferences for 
dietary support among colorectal 
cancer survivors 
Survey: N=1198; 40.0% 
women; mean age (SD) 69.1 
(9.5). Focus groups: N=16; 
37.5% women; mean age 
and range not reported for 





Survey: a colorectal cancer 
diagnosis between 2000-2009 and 
no cognitive impairments. Focus 
groups: at least one year after a 
colorectal cancer diagnosis and a 
Body Mass Index >27 kg/m2 
Colorectal 
Avery (UK)  Qualitative, 4 
years 
To explore views about diet and 
motivations for and barriers to dietary 
change in men at elevated risk and 
those diagnosed with PC 
At elevated risk: N=21, all 
men; mean age 65.4 years; 
range 52.5-72.3. Diagnosed 
with cancer: N=37, all men; 





56% (5/9 in 
phase 2) 
At elevated risk: prostate specific 
antigen (PSA) level of 2.0-2.9 
ng/ml or ≥3.0 ng/ml with a 
negative biopsy. Diagnosed with 
cancer: diagnosis (PSA ≥3.0 
ng/ml) and either treatment of 
prostate cancer, active monitoring 
or active surveillance 
Prostate 
Er (UK)  Qualitative, 
12 months 
To explore the facilitators and barriers 
to dietary and lifestyle changes and the 
acceptability of a lifestyle intervention 
among African Caribbean prostate 
cancer survivors 
N=14, all men; mean age 
69.6 years; range 52-80. 
NS Men aged 18 and above who self-
identified as African Caribbean 








To identify factors that are believed to 
be associated with changes in diet 
following diagnosis 
N=8, all men; mean age 64.9 
years; range 55-76  
NS A prostate cancer diagnosis and 






To explore the post-treatment impact 
and related needs of prostate cancer 
survivors in Malaysia 
N=24, all men; mean age not 
reported, range 58-79 years 
NS Diagnosis of prostate cancer Prostate 
Sutton (UK)  Qualitative, 6 
months 
To explore the experiences of men with 
prostate cancer and their partners on 
the provision of dietary and physical 
activity advice following diagnosis of, 
and treatment for, prostate cancer 
N=16, all men; age range 
53-79 years 
NS Men diagnosed with prostate 
cancer, who had recently 
undergone radical prostatectomy 
or were undergoing radiotherapy 







duration Aim of study Sample, N, sex, age  
Response 










To assess health behaviours among 
cancer survivors; readiness to make 
changes and interest in lifestyle 
interventions 
Total sample N=978. 
Prostate cancer survivors 
N=447, all men; mean age 
and range not reported for 
the prostate cancer 
subsample 
60% Patients with early stage (in situ or 
localized) prostate carcinoma 
diagnosed between January 1, 






To assess information needs on bone 
health in survivors of prostate and 
breast cancer and identify the preferred 
method to deliver health information 
Survey: Total sample N=20; 
prostate cancer survivors 
N=10, all men. Interviews: 
Total sample N=20; prostate 
cancer survivors N=10, all 
men. Mean age and range 
not reported for the prostate 
cancer subsample 
31% Diagnosed with prostate cancer, 
adults and no cognitive deficit, 







To investigate survivors' recollections 
regarding the content of lifestyle advice 
received following cessation of their 
active treatment and explore the factors 
that impact on lifestyle behaviour 
change 
N=22, all women; mean age 
62.6 years; range 49-72 
20% Adult (25-80 years old) 
participants who had completed 
active treatment of endometrial 
cancer within the preceding 3 
years and were deemed to be in 
remission; had at least one risk 
factor for CVD (i.e. body mass 
index [BMI] of 30 or more; 
hypertension; 
hypercholesterolemia; and 
diabetes mellitus); and were able 







(1) To examine the perceived 
importance of health behaviours after 
endometrial cancer treatment, and the 
factors influencing adherence to a 
healthy lifestyle after treatment and (2) 
to explore the information that 
endometrial cancer survivors obtain 
after treatment, and their preferred 
method of information delivery 
N=16, all women; median 
age 57 years; range 33-84 
47% Endometrial cancer survivors 









duration Aim of study Sample, N, sex, age  
Response 
rate Inclusion criteria 
Cancer 
type 




(1) To assess patient’s knowledge of 
the role of obesity in endometrial 
cancer and to determine patient 
perceptions of provider’s counselling 
with regard to obesity, weight loss and 
health improvement and (2) to 
characterize lifestyle changes made by 
patients after diagnosis and barriers to 
change 
N=108, all women; mean 
age 66.0 years; range 41-
91  
46% Any patient with a diagnosis of 
endometrial cancer between June 
2011 and June 2012 and without 









To investigate the experiences of 
younger women with ovarian cancer 
N=39, all women; mean 
age 38 years; range 21-45 
NS Women under 45 years old with a 
diagnosis of ovarian cancer and 









To investigate the experiences of older 
women with ovarian cancer 
N=146, all women; mean 
age 70 years; range 61-93 
NS Women over 61 years old with a 
diagnosis of ovarian cancer and 









To investigate diet-related problems 
and nutritional care needs according to 
the survival stage among female cancer 
survivors in South Korea 
Total sample N=186; 
gynaecological cancer 
survivors N=82. Extended 
stage (2-5 years since 
diagnosis) mean age (SD) 
49.7 (8.0) years; long-term 
stage (>5 years since 
diagnosis) mean age (SD) 
51.2 (7.3) years 
NS Adult women (18-65 years old) at 
least 2 years after a 
gynaecological cancer diagnosis 
who have finished active 














(1) To describe the experiences, 
attitudes, and perceived barriers of 
uterine cancer survivors related to 
weight loss and lifestyle counselling 
and (2) to characterize survivor 
preferences for physician intervention in 
this regard 
 
N=180, all women; median 
age 58 years; range 29-76 








duration Aim of study Sample, N, sex, age  
Response 
rate Inclusion criteria 
Cancer 
type 




To examine perceptions of weight 
management counselling among 
gynaecologic cancer survivors 
N=244, all women; mean 
age (SD) 57.1 (12.4) years 
 NS All women diagnosed with a 
gynaecological cancer diagnosis 










To evaluate the information 
requirements for knowledge and self-
management health behaviours related 
to metabolic syndrome 
Survey: N=70, all women, 
mean age (SD) 58.7 (9.2) 
years, range 36-81. 
Interviews: N=27, all 
women, mean age (SD) 






Women older than 18years with a 
diagnosis of ovarian or 
endometrial cancer, and diagnosis 
of MetS according to the NCEP-
ATP III criteria, capacity to 
communicate and understand the 
questionnaire and ability to 






NS: Not stated; SD: Standard Deviation. 
49 
 
Table 2.2: Summary of diet and nutrition information and support needs. 
Study first 
author  Tool used Description of provision (or lack of) of information and identification of needs Themes  
Anderson  Focus groups Diarrhoea and flatulence were daily problems for which patients sought simple practical dietary 
advice on foods to avoid. Participants reported mixed messages which created anxiety and 
confusion, such as messages opposite to general healthy eating (e.g. counter intuitive to 5-a-day) 
and eating high fat, low quality foods. Participants were advised to adopt a "trial and error" 
approach while they were looking for solid advice/parameters to work with. Some participants also 
expressed the need for dietary advice to reduce disease recurrence or progression; however, 
others were sceptical about how diet could reduce the risk of disease in the future, since it did not 
prevent the development. 
Content of dietary 
information 
Views on the role of diet in 
survivorship  
Beaver  Face-to-face 
interviews 
A commonly expressed concern was related to diet and what specific type of diet would be 
appropriate following removal of part of the bowel.. There was an expectation that specific dietary 
advice was important and should be provided. Support and advice are not mentioned by 
participants. 
Content of dietary 
information 
Brown  Face-to-face 
interviews 
Respondents highlighted gaps in information provision and support services, the biggest of which 
was related to changes in bowel habit and diet adaptation. Bowel changes and their associations 
with diet had the biggest impact in patients' life. Input from a dietitian was regarded as helpful. 
Content of dietary 
information 




A difficulty reported by participants was about obtaining information about what they could expect 
in the long term. The most frequent concern expressed was that they did not receive any 
information on diet. Most found that they had difficulty digesting a number of foods after their 
treatment, yet they had not been advised about what they should and should not be eating. 
Although a nutritionist visited some of them in hospital, there was no follow up. 
Content of dietary 
information 
 
Evans  Face-to-face 
interviews 
As part of a more holistic approach, participants wanted advice on diet and lifestyle, so that they 
could keep themselves as fit as possible and reduce the chance of disease recurrence. Emphasis 
was also given to mental wellbeing. These topics were rarely discussed in their conventional 
consultation. 
Content of dietary 
information 
Views on the role of diet in 
survivorship 
Hardcastle  Face-to-face 
interviews 
Participants felt unsupported regarding bowel changes and management of bowel movements, 
especially the ones without stoma. They didn’t know what kinds of foods they should or should not 
be eating, so they had to use trial and error to work out which foods are appropriate. Some 
participants mentioned receiving conflicting and inconsistent information after discharge in relation 
to bowel management. They also reported lack of knowledge as to what constitutes a healthy diet 
(classification of foods and portion sizes). Some participants wanted to know why some foods are 
not very healthy. Participants needed knowledge of nutrition and calorie intake in order to 
understand food labels. Monitoring would be beneficial to sustain a healthy behaviour. 
 
Content of dietary 
information 





author  Tool used Description of provision (or lack of) of information and identification of needs Themes  
Rozmovits  Face-to-face 
interviews 
Respondents reported being given little or no advice after surgery. Some had severe difficulties 
readjusting their eating and bowel habits. Patients described needs for realistic and non-
contradictory information about diet, as they reported receiving contradictory and even 
inappropriate advice to eat "a high fibre diet". There is confusion on what constitutes an 
appropriate diet post-surgery to manage bowel function and no one had such knowledge.  
Content of dietary 
information 
 
Samuelsson  Face-to-face 
interviews 
Older patients expressed concerns related to diet and nutrition during recovery and follow up. Most 
of them perceived nutritional support during recovery from surgery as inadequate to match their 
individual requirements. They also reported not being given guidance on how to manage side 
effects. On follow up, a lot of participants experienced difficulty regaining weight after surgery but 
very few received dietetic support. Older people ask for individually tailored information throughout 
the entire process (diagnosis to follow up). 
Content of dietary 
information 
Sustaining dietary change 
Beaver  Questionnaire Most (59%) respondents stated they received all information they needed about diet in relation to 
their disease and 56% were satisfied. Those who didn’t receive information expressed a need of 
getting advice on the role of diet and how diet could help from now on. 
Content of dietary 
information 
Cha  Questionnaire 43% of the participants reported that they had received dietary information after surgery. 50% of 
participants suggested that they would like to have had more information provided to them.  
Content of dietary 
information  
Nikoletti  Questionnaire 53% of respondents expressed a need to receive dietary information to manage bowel function 
and this was rated as important. Most participants who did receive advice perceived it as 
inadequate. Respondents expressed a need for information on what foods to eat when they dine 
out to avoid bowel problems (28%). 
Content of dietary 
information 
Perl  Questionnaire As part of an overall needs assessment, 70% respondents expressed a need for nutritional 
counselling after diagnosis and it was highlighted significantly more by women rather than men. 
Content of dietary 
information 
Pullar  Questionnaire 33% of respondents received advice on dietary change. Most of them felt they had not received 
enough information in relation to their condition. Half of the respondents received advice in relation 
to survivorship (reducing red/processed meat and increasing fruit and vegetables) and half in 
relation to their treatment (formation of a stoma, future weight gain and managing low appetite). No 
participant classified as obese reported any discussions around diet and nutrition. They would be 
interested in getting more information and would more likely consider changing habits, particularly 











author  Tool used Description of provision (or lack of) of information and identification of needs Themes  
Hoedjes  Questionnaire 
and focus 
groups 
17% reported the need for dietary support, which was significantly higher in participants classified 
as overweight or obese. Focus groups highlighted that individuals with treatment-related 
complaints expressed a need for advice for appropriate nutrition to reduce side effects, such as 
lack of strength and energy, stoma-related problems and bowel changes. Some participants 
needed information and individually-tailored advice on lifestyle-related issues, such as appropriate 
nutrition and use of dietary supplements, in order to make an informed, autonomous decision on 
adapting their lifestyle or not. Some wanted feedback on their lifestyle and how healthy or 
unhealthy it is and what areas may need improvement. A gastrointestinal oncology nurse, an 
oncology dietitian and a stoma nurse specialist were regarded the most appropriate providers for 
dietary advice and support. 
Content of dietary 
information 
Sustaining dietary change 
Avery  Face-to-face 
& telephone 
interviews 
and a focus 
group 
Irrespective of whether they made changes, most men expressed confusion and dissatisfaction 
with available dietary information and/or its contradictory nature. Some men described unreliable 
information as a barrier to making dietary changes. Men said they would welcome scientific and 
evidence-based dietary advice from authoritative sources (primary care physician, consultant or 
nurse) but information needs varied according to treatment success and disease status. 
Content of dietary 
information 
Views on the role of diet in 
survivorship 
Er  Face-to-face 
interviews 
Participants reported mistrust of dietary messages from media, because they were conflicting. 
They preferred receiving information from HPs who they regarded as experts and a trusted source 
of health information and that had a positive influence on their health behaviour. Some of men 
were sceptical about the role of diet in cancer progression, especially if treatment was effective. 
Content of dietary 
information 
Views on the role of diet in 
survivorship 
Kassianos  Telephone 
interview 
Participants had high expectations but felt health professionals' did not have sufficient knowledge 
on diet and nutrition support for future health. They felt that lack of/conflicting information could 
lead them to get wrong messages and inappropriate action. Credible, evidence-based information 
was considered important for the management of their condition and for reducing the risk of 
recurrence. Some participants expressed uncertainty about the nature of the relationship between 
dietary change and recurrence. The health professionals' advice was an important trigger for 
dietary change and health action. 
Content of dietary 
information 
Sustaining dietary change 
Views on the role of diet in 
survivorship 
Lee P  Focus groups 
and one 
interview 
Patients wanted information on diet and supplements tailored to their disease, in order to prevent 
recurrence and improve overall health. The advice they got about healthy eating was perceived as 
generic and therefore not helpful to prevent recurrence. 
Content of dietary 
information 




Men (who did not participate in a Lifestyle coaching program) did not recall any discussions about 
diet with health professionals. They would have valued an assessment of their diet or evidence-
based advice that could be beneficial long term. Few patients believed that dietary changes would 
not be necessary successful removal of the prostate. A trusted healthcare professional, regardless 
of the role, was viewed as a credible source of information. Some men were given leaflets which 
were hard to read. 
Content of dietary 
information 
Sustaining dietary change 





author  Tool used Description of provision (or lack of) of information and identification of needs Themes  
Demark-
Wahnefried  
Questionnaire Few respondents reported discussions with HPs regarding increasing F&V or reducing fat. 48% of 
respondents were very or extremely interested for diet-related programs, particularly the younger 
ones. 
Content of dietary 
information 
Des Bordes  Questionnaire 
and 
interviews  
Patients expressed a need for information on nutrition, particularly nutritional supplements, to 
maintain or improve bone health. Most of them didn't know the negative effects of salt and alcohol 
on bone health while few prostate cancer survivors knew the optimal calcium requirement in diet. 
Content of dietary 
information 
Hardcastle  Face-to-face 
interviews 
Most participants do not recall receiving lifestyle advice, including dietary information. Oncologists 
are viewed as an authoritative and trustworthy source of information and they would feel obliged to 
follow their advice on healthy eating and weight loss. Apart from advice, regular monitoring was 
expressed as a need, because it motivates patients to stick to a healthier diet and a lower weight.  
Content of dietary 
information 
Sustaining dietary change 




None of the participants received any lifestyle advice from a health professional post-treatment. 
Those who underwent radiotherapy received dietary advice for bowel symptom management 
during treatment, but there was no follow up. Participants prompted discussions with health 
professionals but received unsatisfactory advice. Health professionals were unaware of support 
groups or just advised to eat healthy. Participants searched for information on their own e.g. online, 
but it was difficult to find reliable information. They would welcome tailored advice regarding 
recovery, symptom management and healthy lifestyle overall.  
Content of dietary 
information 
Sustaining dietary change 
Views on the role of diet in 
survivorship 
Clark  Questionnaire 52% reported weight loss counselling from a primary care physician and 35% from a gynae-
oncologist. 47% reported dietary advice from a primary care physician and 25% from a gynae-
oncologist. Receipt of weight loss counselling was significantly associated with attempting weight 
loss. Provider counselling and encouragement can help overcome motivation barriers. 
Content of dietary 
information 
Fitch  Questionnaire Several respondents reported changes in diet (eating healthy foods and taking supplements, 
especially vitamins C & E). 79% of women rated diet and nutrition as important discussions in the 
survivorship phase. However, not all were satisfied with the information they received. 
Content of dietary 
information 
 
Fitch  Questionnaire 66% of women rated diet and nutrition as important discussions in the survivorship phase. 
However, not all were satisfied with the information they received. 
Content of dietary 
information 
Lee  Questionnaire Most respondents demanded nutritional care and education in a variety of topics; mainly foods to 
avoid, appropriate nutrition to prevent recurrence, information on how to improve nutritional status, 










author  Tool used Description of provision (or lack of) of information and identification of needs Themes  
Tseng  Questionnaire 50% of respondents reported weight management or lifestyle counselling, primarily from a 
gynaecologic oncologist or a primary cancer provider. Providers discussed the need for weight loss 
but did not make specific recommendations regarding how to achieve this. However, most found 
the counselling motivating to make a change. Of those who did not receive counselling, most 
believe would have been motivated to set goals and make positive lifestyle changes. Several of 
them expressed a desire to discuss weight and lifestyle during most clinic visits. Oncologists and 
nutritionists were the most preferable sources of information. 
Content of dietary 
information 
Sustaining dietary change 
Zaleta  Questionnaire Most women have attempted weight loss thought diet restriction but only few under guidance and 
even fewer routinely. Although most agree that oncologists should discuss weight loss with the 
patients, only very few reported this sort of counselling, in contrast with counselling for smoking 
cessation. Most respondents believe that weight management counselling would prompt them to 
attempt weight loss. The oncologist was viewed the most reliable source for information. 
Content of dietary 
information 
Sustaining dietary change 
Jang  Survey and 
face-to-face 
interviews 
As part of the information needs assessment, 27% of participants requested information/education 
on diet in relation to metabolic syndrome and 14% information on weight management (survey 
data). Requests on dietary information were also expressed in interviews. Participants consider 
diet management as an important self-management tool for controlling metabolic syndrome. 






This review collected evidence on information and support needs in relation to diet and 
nutrition after a pelvic cancer diagnosis. To our knowledge, this is the first systematic 
review to focus on survivors’ support needs in diet and nutrition after a cancer diagnosis. 
Provision of information and support in relation to diet and nutrition will help survivors lead 
a healthier lifestyle and improve quality of life. 
Results showed that provision of information and support in relation to diet and nutrition 
was not routinely provided to survivors of a pelvic cancer. In most qualitative studies, most 
survivors reported a lack of information and support from their healthcare team and for 
those who did receive this, it frequently did not meet their individual needs. Survivors 
wanted information related to future wellbeing, management of gastrointestinal side 
effects and weight changes. The content of the requested information was different across 
cancer diagnoses, with advice in relation to the management of bowel symptoms being 
sought mostly from colorectal cancer patients and advice regarding weight management 
and future wellbeing from gynaecological and prostate cancer patients.  
Survivors sought evidence-based information that would prompt them to change their 
current dietary behaviours and improve their quality of life. Some expressed concerns 
about the lack of comprehensive research in this area and therefore a lack of consistent 
evidence about the role of  diet or weight loss in outcomes following a cancer diagnosis. 
This lack of evidence may, in part, account for the reported lack of information provision or 
provision of generic advice about a healthy diet. Coa et al. (2015) noted that healthcare 
providers also hold varied beliefs about lifestyle changes in the survivorship phase 
because of the lack of evidence base and therefore are hesitant in engaging in 
conversations about diet. Irrespective of their beliefs, health professionals are perceived 
by survivors as the most suitable sources to provide dietary support. In some of the 
included studies there was patient dissatisfaction with health professional’s knowledge or 
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attitude towards diet and nutrition, indicating that health professionals may not be 
adequately trained on nutritional care of cancer patients (Dempsey et al., 2011, 
Koutoukidis et al., 2018). To date, dietary recommendations for cancer survivors that have 
been developed by the WCRF/AICR (2018) and the European Society for Parenteral and 
Enteral Nutrition (ESPEN) (Arends et al., 2017a) are based on limited evidence. Also, to 
date, no recommendations tailored to a specific cancer diagnosis have been published. 
Lack of strong evidence further contributes to the differing views about the role of diet in 
the survivorship phase for patients and the “trial and error” approach sometimes 
recommended by health professionals or used by patients independently. 
Another important finding in this review was the perception from survivors that they should 
have their dietary behaviour and weight monitored on a regular basis in order to sustain 
dietary changes. A recent systematic review and meta-analysis showed that supervision 
and social support improved adherence to a weight loss program in overweight and obese 
populations (Lemstra et al., 2016). A qualitative study in breast cancer survivors who 
followed a 12-month weight loss program showed that regular monitoring by dietitians was 
viewed as a facilitator for sustaining healthy behaviours (Terranova et al., 2017). This is 
an important point for future interventions evaluating nutritional education and weight loss 
in pelvic cancer survivors. It should, however, be noted that regular monitoring may have 
feasibility and cost implications which need to be taken into consideration.  
There was a considerable difference in the amount and type of information extracted from 
the qualitative and quantitative studies included in this review. Qualitative studies 
examined issues and concerns around diet and nutrition in more depth and contributed 
more information to this narrative synthesis compared to quantitative studies. Therefore, it 
is possible that qualitative design features, such as sampling procedures (purposive 
sampling) and researcher bias in data collection and interpretation may have influenced 
the findings. Also, some studies focussed exclusively on diet and nutrition issues whereas 
some assessed follow-up care needs in general. Consequently, available data extracted 
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from follow-up care studies was limited and, in some quantitative studies, in a form of 
statement about receipt of dietary information (Beaver et al., 2011, Demark-Wahnefried et 
al., 2000, Nikoletti et al., 2008), importance of receiving dietary information (Fitch et al., 
2000, Fitch et al., 2001, Nikoletti et al., 2008) or need for receiving more dietary 
information in relation to cancer (Cha et al., 2012, Perl et al., 2016, Jang et al., 2018). 
Although limited, the data could clearly be extracted and therefore the studies were 
eligible for inclusion in this review. Due to the large heterogeneity of the studies, it was 
decided that a narrative synthesis was the best approach of presenting the results in this 
review. 
It was not possible to extract any information from the included studies about dietary 
support needs for patients currently undergoing treatment. Studies in breast cancer 
survivors have shown that information needs may vary according to the survivorship 
stage. A study by Halbach et al. (2016) showed that breast cancer respondents were 
more interested in information about nutrition shortly after surgery compared to 40 weeks 
later. Overall, health promotion needs were increased during or shortly after treatment and 
decreased over time (Halbach et al., 2016). Another study showed that cancer patients 
are more active in seeking information in the pre-treatment period compared with the post-
treatment period (Eheman et al., 2009).  
 
2.5.1. Strengths and limitations 
This review has a number of strengths and limitations. A comprehensive systematic 
search of the literature was conducted according to the PRISMA guidelines. Searching 
was performed across six big databases, eligibility criteria were applied and the quality of 
all included studies was assessed. Any unclear abstracts were included for full-text 
review. Findings were synthesised using thematic analysis, which is an effective way of 
combining results from quantitative and qualitative studies (Lucas et al., 2007). Synthesis 
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of findings was conducted in an unbiased manner, although it is acknowledged that 
thematic analysis may induce personal/researcher bias. The researcher’s background 
(degrees in nutrition and dietetics) could be a potential bias in the analysis and 
interpretation of the data. Reviewing themes with one of the Director of Studies (Prof Eila 
Watson) who does not have a background in nutrition and has extensive knowledge in 
qualitative analysis has contributed to reduce potential researcher bias.  
It should be acknolwedged that this review included cancer diagnoses that share common 
characteristics (e.g. obesity rates, pelvic radiotherapy) but can also vary considerably in 
other outcomes, as described in Chapter 1 (1.8). All three themes in the Results section 
describe in detail the differing needs per cancer diagnosis, where applicable. Findings are 
also limited by the scientific quality of the papers. Quality appraisal showed that cross-
sectional studies presented high selection and non-response bias. Similarly, most 
qualitative studies failed to provide adequate evidence of credibility and dependabilty. 
Therefore, it may be difficult to generalise the results to all pelvic cancer survivors. 
Furthermore, in most quantitative studies, the measurement tools were developed by the 
authors and no information on validity and reliability of these tools is reported. Also, there 
was no attempt to contact any authors for clarification on study findings. The search was 
not exhaustive, as it was limited in large databases and grey literature was not explored. 
The search was also limited to English language publications only due to lack of 
translation options; however, initial screening did not reveal any non-English publications.  
 
2.6. Conclusion 
This review has highlighted the need for provision of information and support in diet and 
nutrition after a pelvic cancer diagnosis. Survivors sought evidence-based, clear 
information on how to improve their future wellbeing and manage physical symptoms 
deriving from their diagnosis and treatment. However, there were several issues regarding 
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the methodological quality of the included studies. Future studies that combine collection 
of quantitative and qualitative data could provide in-depth insights on patient support and 
information needs and reduce the impact of methodological limitations. 
Future interventions and future clinical practice should take into account  patients’ needs 
for quality evidence and tailored advice with the aim of sustaining healthy behaviours and 
overcoming disease problems in the long term. Stronger evidence from prospective 
studies on the role of diet in outcomes related to cancer survivorship is also needed, in 















A concurrent, mixed-methods design was chosen to address the research aim and 
objectives of this PhD. People who have been diagnosed with cancer and either currently 
being treated with curative pelvic radiotherapy (on-treatment group) or having completed 
curative pelvic radiotherapy treatment 6-24 months before (post-treatment group) were 
invited to fill in a paper-based survey. The survey included questions about current dietary 
habits and changes since diagnosis; perceptions of the role of diet in managing cancer 
treatment and for future health, experiences of nutritional support and interest in receiving 
more information about diet in the future. Recruitment of participants was in collaboration 
with the Radiotherapy Department, Cancer and Haematology Centre, Oxford University 
Hospitals (OUH) NHS Foundation Trust.  
A sub-sample of the participants who completed the questionnaire was invited to 
telephone interviews to explore in more depth patient experiences in diet and nutrition 
after diagnosis. The subsample was selected using maximal variation sampling. 
Telephone interviews were audio recorded and transcribed verbatim. Interviews took 
place until “data saturation” was achieved.  Thematic analysis using the Framework 
approach was conducted to identify important themes. 
 
3.2. Methodology  
3.2.1. Choosing a mixed-methods design 
Mixed methods research combines quantitative and qualitative research within a single 
study with a view to providing more robust answers to the research questions than each 
method alone would provide (Bryman, 2012). Quantitative and qualitative research 
methods each have their own strengths and weaknesses and combining them allows the 
researcher to offset their weaknesses and draw on the strengths of both. The strengths of 
quantitative research include accurate measurement of a specific construct and the ability 
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to conduct comparisons, strength of association between variables and test hypotheses. 
Qualitative research, on the other hand, provides a “whole person” naturalistic approach 
by evaluating human experiences (views, beliefs and emotions) in a way that no 
quantitative tool can assess (Castro et al., 2010). In other words, the quantitative arm of a 
mixed-methods approach investigates “what the behaviour is”, whereas the qualitative 
arm explores “why people behave the way they do”.  
It is well established in the literature that quantitative and qualitative research are 
underpinned by distinct philosophical assumptions, which are taken into consideration 
when deciding data collection methods to answer research questions. These assumptions 
relate to ontology (i.e. what is there to know?), epistemology (how knowledge can be 
generated?) and methodology (how should research proceed?) (Bryman, 2012). 
Ontology refers to a person’s understanding of the world as an entity. Quantitative 
research usually assumes that social phenomena are stable and cannot be influenced 
(objectivism). On the contrary, qualitative research assumes that social phenomena are 
produced through social interaction and they constantly change (constructionism) 
(Bryman, 2012).  
Epistemology refers to the way knowledge can be produced. Positivism is an 
epistemological position related to objectivity and is a main characteristic of quantitative 
research. On the other hand, qualitative researchers tend to embrace subjectivity, to 
accept the role of researcher in data interpretation and to reflect upon it (the term 
interpretivism is used) (Bryman, 2012).  
Quantitative research tends to embrace deductive theory; a hypothesis is developed to 
examine the research question. Data will either confirm or reject the proposed hypothesis 
and conclusions are undeniable if data are derived by objective methods. Qualitative 
research usually works in a different way; collection of data will result in the development 
of theory (inductive approach) (Bryman, 2012). 
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Despite the clear differences in ontological and epistemological positions underpinning 
each research design, Bryman (2012) argues the connections are not settled. Instead, the 
positions should be regarded as “tendencies and not definite connections”. For example, 
while hypotheses are frequently developed prior to undertaking a study in quantitative 
research, this assumption better reflects experimental studies. Survey-based studies are 
often more exploratory and offer opportunities for the generation of theories and concepts. 
Also, even if there is clear distinction between the collection of numbers (data) in 
quantitative research and words (data) in qualitative research, qualitative researchers 
sometimes quantify a limited amount of their data. It has also been suggested that 
thematic analysis, which is one of the most common methods for analysis of qualitative 
data, could sometimes be operated by the frequency of occurrence of certain words or 
phrases, implying some level of quantification. 
Bryman (2012) suggests that research methods are more autonomous in relation to 
epistemological commitments than is often appreciated. The “technical version” is a 
position among researcher in which philosophical assumptions between quantitative and 
qualitative research are recognised but they are not viewed as fixed. Instead, greater 
value is given to the strengths of data collection and analysis tools from the two methods, 
as one method can be used in the service of the other.  
Considering the aim and objectives of this PhD, it was felt that a mixed methods design 
was the most suitable, with both methods addressing each research objective to varying 
degrees, and with the interviews adding depth to the information gathered from the survey 
and covering any gaps. 
Bryman (2012) conducted a content analysis of articles based on mixed-methods 
research and identified sixteen possible rationales for combining quantitative and 
quantitative research, some of which apply to this mixed-methods study:   
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1. Offset: research methods associated with both quantitative and qualitative 
research have their own strengths and weaknesses so that combining them allows 
the researcher to offset their weaknesses to draw on the strengths of both. 
2. Completeness: the researcher brings together a more comprehensive account of 
the area of enquiry in which they are interested by employing both quantitative and 
qualitative research methods. 
3. Explanation: one method is used to help explain findings generated by the other. 
4. Credibility: employing both approaches enhances the integrity of findings. 
5. Illustration: qualitative data are used to illustrate quantitative findings. 
6. Utility or improving the usefulness of findings: combining quantitative and 
qualitative approaches will create findings more useful to practitioners and others. 
7. Enhancement or building upon quantitative/qualitative findings: making more of 
either quantitative or qualitative findings by gathering data using a qualitative or 
quantitative research approach. 
There is increased interest in the use of mixed-methods research in health sciences. Over 
the past few years, researchers have begun to acknowledge the complexity of health-
related research and employ a combination of methods to answer research questions. 
Moreover, the challenges of conducting patient-centred research in the real world can 
sometimes be best understood through multiple forms of measurement (Currie and 
Nunez-Smith, 2017).  
 
3.2.2. Concurrent mixed methods design 
According to Bryman (2012), it is important to define the role of the quantitative and the 
qualitative component in a mixed-methods study according to priority and sequence. In 
terms of priority, mixed methods studies can have either the quantitative or the qualitative 
component as the main data collection component or have equal weight components in 
the data collection process. In terms of sequence, collection and analysis of quantitative 
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data can precede the collection and analysis of qualitative data collection or vice versa 
(sequential mixed methods design) or data collection can occur more or less concurrently 
in the quantitative and the qualitative component (concurrent mixed methods design).  
Phase two of the PhD consisted of two parts. Part I was a quantitative, cross-sectional 
survey which was the primary data collection component supplemented with qualitative 
interviews (Part II) with a sub-sample of the participants from Part I to explore the topics of 
interest in more depth. The study is considered to have a concurrent mixed-methods 
design, as quantitative and qualitative data for the whole sample were collected during the 
same period (November 2017 – February 2019) and analysed after the end of collection. 
Only on an individual basis quantitative data collection (completion of survey) preceded 
qualitative data collection (telephone interview). Participants’ survey responses were 




Figure 3.1: Classification of mixed methods research in terms of priority and sequence. 
Figure adapted from Bryman (2012).  Note: Capitals and lower case indicate priority; arrows 
indicate sequence; + indicates concurrent. Priority and sequence options for this project are 
highlighted. 
 
3.2.3. Rationale for selection of participants 
Different needs in relation to diet and nutrition at different stages after the cancer 
diagnosis may arise. This was the reason why survivors were recruited at two different 
stages of the cancer trajectory (on-treatment group and post-treatment group). Whilst the 
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ideal would have been for a prospective, longitudinal study to explore patient experiences 
over time, this was not feasible within the timeframe of the PhD studies.  
It was decided that the post-treatment group would include survivors of a pelvic cancer 6-
24 months after the end of curative radiotherapy treatment. Six months was considered a 
sufficient period in which survivors would have begun to return to their normal lifestyle 
after treatment and was decided after consultation with the clinical collaborators at Oxford 
University Hospitals (OUH). 
 
3.2.4. The use of a paper-based survey 
For the quantitative arm of the mixed-methods study, a self-report paper-based survey 
was developed. With the increased use of the internet, there have been suggestions to 
use web-based surveys instead of paper-based ones as they significantly reduce costs 
and data collection is easier (Ebert et al., 2018); however, it is not clear if web surveys 
affect response rates compared to paper surveys (Hohwü et al., 2013, Horevoorts et al., 
2015, Ebert et al., 2018). After consultation with the clinical collaborators at OUH NHS 
Foundation Trust, a paper-based survey was considered the best option, given that the 
population of interest (survivors of a pelvic cancer diagnosis) are generally older and may 
be more reluctant in using the internet to complete a survey.  
 
3.2.5. The use of telephone interviews 
In this study, telephone interviews were preferred to face-to-face interviews for practical 
reasons, such as geographically dispersed interviewees around Oxfordshire and other 
counties, costs and flexibility in scheduling. Telephone interviews are considered a 
valuable method of interviewing and findings are comparable to those of face-to-face 
interviews (Drabble et al., 2016, Sturges and Hanrahan, 2004). Although there is no direct 
contact between the interviewer and the interviewee, telephone interviews have the 
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advantage of providing anonymity and privacy and reducing distraction (Drabble et al., 
2016). Telephone interviews have successfully been conducted in previous research 
projects at the Supportive Cancer Care Research group at Oxford Brookes University 
(OBU) (Collaco et al., 2019, Wagland et al., 2019).  
 
3.2.6. Sample size estimation 
3.2.6.1. Survey  
In order to estimate sample size for the survey, the equation as described by Scheaffer 
(2012) was used. The equation was: 
𝑛 =
𝑁𝑝𝑞
(𝑁 − 1)𝐷 + 𝑝𝑞
 




where n=survey sample size, N=population of interest, p=variance of heterogeneity, 
B=margin of error. 
According to the National Cancer Registration and Analysis Service (NCRAS), around 
42,000 people were treated with pelvic radiotherapy between 2013 and 2014 in England 
(bladder cancer n=3,718; cervical cancer n=2,126; prostate cancer n=24,691; rectal 
cancer n=7,629; endometrial cancer n=3,189). Due to lack of resources with more recent 
information, the population of interest was estimated at N=42,000 (National Cancer 
Registration and Analysis Service, 2017).  
Assuming a 50% estimated variance of heterogeneity of population (which produces the 
maximum sample size; p) and a 5% magnitude of error (B=0.05), the estimated survey 




= 0.000625  
𝑛 =
42,000 𝑥 0.5 𝑥 0.5





The clinical team at OUH advised on the number of patients treated with radiotherapy 
each year. Based on their feedback, the timeframe of the PhD studies and a minimum 
response rate of 30-40%, it was decided it would be feasible to recruit a sample of 100-
150 participants on treatment within 12-18 months. The estimated response rate was 
based on the results from the 2010 English Cancer Patient Experience Survey, in which 
response rate varied across NHS organisations and was as low as 39% (Saunders et al., 
2016). The recruitment period was also determined by the time constraints of the PhD. As 
the incidence of prostate cancer is higher than other pelvic cancer types and in order to 
avoid surveys being completed predominantly by prostate cancer survivors, it was 
decided that recruitment of prostate cancer patients would stop when 50 completed 
questionnaires were received. 
The sample size for the post-treatment group was determined based on the number of 
patients that were treated with curative radiotherapy 6-24 months before the 
administration of the survey and an expected minimum response rate of 30-40%. To avoid 
saturation of the sample with prostate cancer patients, a randomly selected subsample of 
prostate cancer survivors was invited to take part. A sample size of 120-160 participants 
was expected for the post-treatment group.  
The sample size of n=396, as estimated by the equation, could not be achieved for 
pragmatic reasons. Instead, a sample size between 200 and 300 was expected and the 
two groups (on treatment and post-treatment) would have a comparable sample size. In 
order to identify the potential impact of a smaller sample size on the results, the maximum 
margin of error (the value B in the equation) was calculated again assuming survey 
sample n=200 and n=300. The margin of error was B=0.070 (or 7%) for n=200 and 





Onwuegbuzie and Collins (2007) noted that sample size in qualitative research can be 
estimated based on the research design (e.g. case study, ethnography, phenomenology 
or grounded theory), sampling design (subgroup sampling or nested sampling design) or 
data collection procedure (interview or focus group). Adequate sample size was 
determined in this study by achieving “data saturation”. Data saturation is a term deriving 
from grounded theory but is commonly used in other qualitative research designs, and 
refers to the number of interviews needed to “get a reliable sense of thematic exhaustion 
and variability within [their] data set” (Bryman, 2012). Charmaz (2014) suggested that 25 
interviews may be adequate to reach theoretical saturation in small projects, although 
more may be needed when information is contradictory to established research. The 
systematic review (Chapter 2) included qualitative studies with a sample size between 8 
and 58 participants but most of them were conducted with participants of a particular 
cancer diagnosis. 
 
3.2.7. Integration of quantitative and qualitative data 
The integration of the quantitative and qualitative findings is an essential aspect of a 
mixed-methods study, as it increases the amount of knowledge deriving from the two 
components of the study. Effective data integration can produce a more robust set of 
insights. Without integration, it is perceived that findings come from two studies 
undertaken independently (Barbour, 1999).  
A data analysis plan was developed a priori for each component of the study. Curry and 
Nunez-Smith (2015) highlighted three key considerations regarding the data analysis plan 
in mixed-methods studies; aim/objectives, research design and analysis need to be 
aligned; priority of components needs to be determined; and the point of integration has to 
be defined. As described in Section 3.2.2, quantitative and qualitative data were collected 
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concurrently. Also, the quantitative arm was the primary data collection component, 
supplemented by the collection of qualitative data. Analysis of the quantitative and the 
qualitative component was performed independently (Fig. 3.2). Regarding integration, the 
interpretation stage is considered the most common point of integration in mixed-methods 
studies and determines the conclusions that result from analysing findings across 
components (Curry and Nunez-Smith, 2015). In this mixed-methods study, integration 
took place in the interpretation stage (after presentation of results in Chapters 4 and 5; 
before discussion in Chapter 7. 
Integration followed the triangulation protocol, as described by O’Cathain et al. (2010). 
The process of triangulation usually takes place at the interpretation stage of a study 
when quantitative and qualitative data have been analysed separately (O’Cathain et al., 
2010). Therefore, it was considered the most appropriate method of integrating the 
findings in this project. As O’Cathain et al. (2010) suggest, findings from each component 
were listed and the researcher considered where findings from each method agreed 
(convergence), contradicted each other (divergence) or offered additional information on a 
topic (complementarity). This method also offered the opportunity to detect whether 
unique information on a topic emerges from one component, when the other component 
offered no information at all (silence). 
 
 




A narrative approach is the most common approach for the interpretation and presentation 
of findings in health sciences and it was selected for the presentation of the integrated 
findings in this study (Currie and Nunez-Smith, 2015). Weaving is a narrative approach 
technique in which quantitative and qualitative data are presented within specific themes 
or concepts (Currie and Nunez-Smith, 2015). Chapter 6 provides details of the concepts 
used for the integration of findings. 
 
3.3. Methods 
3.3.1. Part I: The cross-sectional survey 
3.3.1.1. Sample  
The population of interest was people diagnosed with cancer and who received pelvic 
radiotherapy as part of the treatment regimen. A cancer diagnosis that is frequently 
treated with pelvic radiotherapy includes cancer of the lower gastrointestinal tract (rectal 
and anal cancer), bladder, female reproductive organs (endometrial, cervical, ovarian, 
vaginal and vulval cancer) and male reproductive organs (prostate and testicular cancer) 
(West and Davidson, 2009). Recruitment of cancer patients from the Radiotherapy 
Department, Cancer and Haematology Centre, OUH NHS Foundation Trust, was deemed 
practical and feasible within the timeframe of the PhD studies. OUH was the Patient 
Identification Centre for this project. 
3.3.1.2. Inclusion/exclusion criteria 
Inclusion and exclusion criteria were applied for the eligibility of participants in both groups 
(on-treatment and post-treatment groups). Inclusion criteria were as follows: 
1. Diagnosis with a cancer in the pelvis; anus, bladder, rectum, endometrium/uterus, 
cervix, ovaries, vulva, vagina, prostate and testes 
2. Current receipt of radiotherapy with curative intent (on-treatment group) or having 
received radiotherapy with curative intent 6-24 months before (post-treatment 
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group). As indicated by the clinical team, radical radiotherapy involved ionising 
radiation doses of >20 gray (Gy).  
3. Ability to read and write in English 
Exclusion criteria were as follows: 
1. Diagnosis of cancer in any other part of the body  
2. Receipt of palliative radiotherapy treatment or short courses of radiotherapy 
treatment 
3. Patients unable to make informed decisions for themselves 
4. Patients less than 6 months or more than 24 months from the end of their 
treatment (for the administration of survey in post-treatment participants only) 
5. Patients unable to read or write. 
 
3.3.1.3. Procedure  
3.3.1.3.1. Recruitment of on-treatment survivors 
Survivors attending a routine clinical treatment review appointment mid-way during their 
radiotherapy treatment (week 3) were asked by either their therapeutic radiographer or 
clinical nurse specialist if they would be interested to hear about a research being 
conducted by Oxford Brookes University. If the participant agreed to hear more about the 
study, the member of the clinical team informed them about the study and its main aim 
and, if still interested, the clinical team gave them a survey pack which contained: 
• A Study Invitation Letter (SIL), signed by Dr Amanda Horne, consultant 
oncologist and clinical collaborator (Appendix 2a) 
• A Participant Information Sheet (PIS), which provided details of the project and 
the involvement of the participant (Appendix 2b) 
• A copy of the survey (Appendix 2c) 
• A paid and stamped reply envelope (for return of completed questionnaire) 
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Potential participants were encouraged to fill in the survey within a week of receipt of the 
pack. It was expected that one week would allow plenty of time to process all information 
provided and make a decision to take part. Informed consent was implied by completion 
and return of questionnaires, as was acceptable to the National Research Ethics Service 
(NRES) at the time of this study. Recruitment took place from November 2017 to February 
2019 (16 months). 
Health professionals who were responsible for recruitment were provided with training on 
the study, so that they were aware of the inclusion/exclusion criteria. They were also 
provided with a predetermined script (Appendix 2d) which included all necessary 
information they needed to communicate with the patients and invite them to participate. It 
was made explicit, by the recruiting clinical staff member and in the SIL and PIS, that 
participation was voluntary. 
Between November 2017 to February 2019, a total of 266 patients were considered 
eligible to participate and therefore invited to take part: 119 with a prostate cancer 
diagnosis, 70 rectal or anal (lower gastrointestinal cancers), 70 gynaecological, 4 bladder 
and 3 other pelvic cancer diagnoses. Consent was implied by completion and return of the 
questionnaire.  
 
3.3.1.3.2. Recruitment of participants post-treatment 
People who had completed radical pelvic radiotherapy (ionising radiation of >20 gray) 6-
24 months (1st April 2016 – 30th September 2017) before the administration of the survey 
(April 2018), were identified through the Cancer and Haematology Centre, Radiotherapy 
Services Team database. An administrative member of the Radiotherapy Department 
then checked for deaths using the hospital Electronic Patient Records system.  
All eligible survivors treated for a rectal, bladder, gynaecological, testicular or other pelvic 
cancers between April 2016 and September 2017 were sent the survey pack.  Participants 
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were posted the same survey pack as the one given to on-treatment participants, with a 
modified SIL (Appendix 2e). To avoid saturation of the sample with prostate cancer 
survivors, a randomly selected subsample of prostate cancer survivors was sent a survey 
pack. Patients who received pelvic radiotherapy for a prostate cancer diagnosis between 
April 2016 and September 2017 were divided in three groups (completion of treatment 
between April – September 2016, October 2016 – March 2017, April – September 2017) 
and the first 50 patients on the list within each group were sent the survey (total of 150). 
Similarly to the invitation of on-treatment patients to take part, it was made explicit in the 
SIL and PIS that participation was voluntary. 
In total, 405 survivors were sent a survey pack: 151 with a prostate cancer diagnosis, 126 
colorectal (120 rectal and 6 colon/bowel), 40 anal, 30 bladder, 26 endometrial, 23 cervical, 
4 testicular, 3 vulvar and 2 vaginal. Consent was implied by completion and return of the 
questionnaire. 
 
3.3.1.4. Survey Development 
Initially, a literature search was performed to identify previously validated questionnaires 
that would address the aim and objectives of this PhD project. In the absence of validated 
questionnaires for any of the objectives, the survey incorporated modified versions of 
previously used, non-validated questionnaires (Demark-Wahnefried et al., 2000, Bours et 
al., 2015, NIHR, 2015) and used information from the WCRF/AICR Second Expert Report 
(2007). A number of additional questions were developed, with input from the clinical team 
at OUH.  
Most survey questions required binary (Yes/No) or Likert scale responses. Free text 
boxes were added to give the opportunity to expand and capture the respondents’ views 
on diet and nutrition perceptions, needs and experiences in relation to their cancer 
diagnosis. In order to ensure acceptability, the survey was initially reviewed by clinical 
colleagues and twelve members of the NIHR Cancer and Nutrition infrastructure 
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collaboration Public and Patient Involvement (PPI) Group. Feedback was used to optimise 
both the content and the appearance of the survey. In relation to content, for example, 
one PPI member suggested adding a question about weight changes, which is common in 
cancer patients. A few PPI members suggested adding more open-comment boxes in a 
number of questions, in order to get more detailed information. Also, PPI contributors 
advised on the acceptable length of the survey, which should take up to a maximum of 
thirty minutes to complete.  
The final version of the questionnaire consisted of five sections and included questions 
regarding demographic, clinical and health characteristics; dietary habits and changes 
since diagnosis; awareness of current nutritional recommendations for cancer survivors; 
perceptions of the role of diet and nutrition after a cancer diagnosis; receipt of advice and 
support; and interest in receiving further support in this area. A copy of the questionnaire 




3.3.1.4.1. Collection of demographic, clinical and health information 
The following demographic, clinical and health information was sought:  
 Date of birth (to determine age), height and weight (to determine Body Mass 
Index), marital and socioeconomic status and ethnic background (demographic 
characteristics) 
 Tumour site and treatment(s) received (clinical characteristics) 
 Smoking habits, presence of comorbidities (heart problems, diabetes, 
hypertension, asthma, osteoporosis, problems with pancreas, stomach, kidney or 
liver, Alzheimer’s disease, epilepsy or other neurological problems) and weight 
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changes since diagnosis (weight gain, weight loss, no weight changes; health 
characteristics). 
Questions about diagnosis and treatments were taken from the Phase One survey 
conducted by the NIHR Nutrition and Cancer Infrastructure Collaboration (Patient 
Experience Survey) (NIHR, 2015). 
 
3.3.1.4.2. Presence of side effects 
Participants were asked to indicate whether they were currently experiencing any of the 
following side effects: loss of appetite, changes in taste or smell, wind/bloating, 
nausea/vomiting, diarrhoea, constipation, fatigue/lack of energy, dry mouth, incontinence, 
mouth sores, difficulty swallowing. These side effects are common in patients undergoing 
treatment for a pelvic cancer (Macmillan Cancer Support, 2017, Macmillan Cancer 
Support, 2018a, Macmillan Cancer Support, 2018b, Macmillan Cancer Support, 2018c) 
and can affect dietary intake, as they affect either the individual’s sensory perceptions or 
the function of the gastrointestinal tract.  
 
3.3.1.4.3. Assessment of dietary habits 
Participants were asked if they had changed their diet after their diagnosis (Yes/No). For 
those who had, they were asked if they had increased, decreased or did not change the 
consumption of the following food groups: whole grains, refined grains, fruit, vegetables, 
milk and dairy products, meat and poultry, fish, sugary foods, processed meats and 
alcohol. An open question provided the participants the opportunity to indicate any other 
changes. Questions were adapted from Bours et al. (2015). Participants were also asked 
about supplement use [idea also taken from Bours et al. (2015)] and daily water/fluid 
intake (suggestion from clinical colleagues). Also, consumption of homemade and ready-
to-eat meals and social occasions of eating (“Who do you have meals with?” and “Who 
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prepares your meals?”) was assessed. Questions were adapted from the Flexible 
Consumer Behaviour Survey (FCBS) module used in the National Health And Nutrition 
Examination Survey (NHANES) 2007-2008 (Variyam and Lin, 2007). 
 
3.3.1.4.4. Nutritional awareness 
These questions were incorporated to assess participants’ familiarity (never heard of 
it/slightly familiar/mostly familiar/very familiar) with the dietary recommendations 
guidelines published in 2007 by the World Cancer Research Fund for cancer prevention, 
which also apply to cancer survivors. The idea was taken from a similar project regarding 
awareness of dietary and alcohol guidelines in colorectal cancer survivors (Hawkins et al. 
2015). 
 
3.3.1.4.5. Perceptions of diet and nutrition 
Participants were asked to indicate what they considered the importance of diet and 
nutrition to be (not important at all/a little important/important/very important) in preventing 
cancer recurrence; improving overall health; supporting recovery; alleviating treatment 
related side effects (appetite problems, gastrointestinal problems and fatigue). Questions 
about perceptions of the role of diet and nutrition in current and future health were taken 
from a similar survey conducted in colorectal survivors in New Zealand (Pullar et al., 
2012) and were formed according to the Food and Agriculture Organisation of the United 
Nations guidelines for assessing nutrition-related Knowledge-Attitudes-Practices (KAP) 




3.3.1.4.6. Diet and nutrition support 
Questions in this section assessed any support participants may have received from a 
health professional or another source (online sources, newspaper/magazine, family, friend 
or other patient). For those that received support, they were asked the type of information 
they received (general healthy eating/nutritional management of symptoms/weight 
management/healthy recipes/survivorship courses/supplements), whether it met their 
needs and whether they were influenced to change their diet. An open question was 
available for respondents to indicate dietary support they would like to have received. For 
those who did not receive support, they were asked what support they would like to have 
received. Questions were all taken from the survey in the NIHR Phase One study (NIHR, 
2015).  
 
3.3.1.4.7. Interest in receiving support/information 
Participants were asked to convey their general interest (Likert scale: 1=not at all 
interested, 2 =a little, 3=somewhat, 4=very, and 5=extremely interested) in receiving 
information on diet and nutrition in relation to their cancer, as well as preferred modes of 
information delivery (face to face/brochures/internet/DVD/telephone) and optimal time of 
delivery (at diagnosis/during treatment/at the end of treatment/on a follow up 
visit/anytime). Questions were adapted from a previous study on health behaviours and 
readiness to pursue changes in cancer survivors (Demark-Wahnefried et al., 2000).  
 
3.3.1.4.8. Other information 
An open question (“Anything we missed?”) was available at the end of the questionnaire 






Descriptive statistics were used to summarise the data. Mean and frequency tables were 
used to describe socio-demographic, cancer-related and health-related characteristics. 
Results in tables are presented as N (%) with the exception of age, which is presented as 
median (Interquartile Range) and range. Median (IQR) was chosen as the variable “age” 
did not follow a normal distribution (Shapiro Wilk test of normality, P<0.001; Fig. 3.3 and 
3.4). Tables present information for the whole sample and per treatment status (on-
treatment, post-treatment).  
Chi-squared tests for categorical and nominal data were used to identify differences of 
socio-demographic, cancer-related and health-related characteristics according to 
treatment status (on-treatment, post-treatment) and cancer diagnosis [urological (prostate 
and bladder), lower GI (rectal/anal) and gynaecological (cervical, ovarian, endometrial, 
vaginal, vulval)]. Reduction of the number of cancer diagnosis groups was necessary, as 
there were very small numbers for several cancer types. For example, there were only 10 





Figure 3.3: Histogram of the variable "age". 
 
 
Figure 3.4: Normal Q-Q plot of the variable "age". 
 
It was not possible to carry out analysis for variables that included very small numbers. 
For example, in the variable “Ethnicity”, the option “White” was chosen by the majority of 
the sample, therefore all other options had an expected number of <5 and a non-
parametric chi-squared test for the variable “Ethnicity” could not be performed. To identify 
differences between groups with regards to age, the non-parametric Mann-Whitney and 
Kruskal-Wallis tests were used. As there were multiple comparisons, significance levels 
were set at 99% for the descriptive analysis (P<0.01) (Abdi, 2007). 
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Binary logistic regression analysis was conducted to identify potential explanatory factors 
that are associated with the four main outcomes of interest:  
• Report of dietary change 
• Report of supplement use 
• Receipt of dietary support/information from a health professional 
• Receipt of dietary support/information from another source 
These outcomes of interest are relevant to specific objectives as described in Section 1.10 
(Aim and objectives): 
 Explore current dietary habits, including dietary changes as a result of diagnosis 
 Explore experiences of nutrition support and highlight unmet needs 
For the logistic regression analysis, it was necessary to reduce the number of groups for 
some nominal variables, because one of the response options was selected much more 
often than others. For example, the variable “marital status” had four options: married or 
living as married; divorced or separated; widowed; single. The group “married or living as 
married” was predominantly reported compared to all others (see 4.2.3). Therefore, for the 
logistic regression analysis, the variable “marital status” was recoded to include two 
categories: married/other than married. A similar grouping procedure was followed for the 
variables “cancer diagnosis”, “qualifications”, and “employment”. 
Factors that were entered in the model as potential explanatory variables included 
treatment stage (on-treatment, post-treatment), diagnosis (urological, lower GI, 
gynaecological), age, Body Mass Index, qualifications (<=high school, > high school), 
employment (retired/not retired), marital status (married/not married), presence of a 
comorbidity (yes/no), presence of a side effect (yes/no), report of a dietary change 
(yes/no; when not a dependent variable/outcome), report of supplement use (yes/no; 
when not a dependent variable/outcome), support from health professionals (yes/no; 
when not a dependent variable/outcome). These variables were selected for inclusion in 
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the models based on previous research (Bours et al., 2015, Hoedjes et al., 2017) and 
expected outcomes, as stated in section 1.10.  
First, univariate logistic regression analyses were conducted with each of the outcomes of 
interest (yes/ no) as dependent variable and one of the above factors as independent 
variable. Multivariate logistic regression was also conducted using all independent 
variables in the same model.  
In order to determine which multivariate regression analysis method would be used (enter, 
stepwise forward or stepwise backward), meetings with a statistician (Dr Hoshang Izadi) 
were conducted. The stepwise backward method (i.e. all variables included in the model 
and each one is deleted one at a time if they do not contribute to the regression equation) 
was preferred to the most commonly used “Enter” method (i.e. all variables are “forced” 
into the model) for two reasons. First, the number of independent variables was 
considered large, due to the exploratory nature of the study and second, neither the 
researcher knew, nor the relevant literature supported which independent variables would 
create the best prediction equation. 
The stepwise method has been criticised as an automated procedure that may lead to 
“overfitting” the model with too many independent variables. For this reason, the analysis 
in this study was repeated using the “Enter” method and results between the two methods 
were very similar. Only results from the Stepwise backward method are presented in the 
Survey Results section (Chapter 4). In the stepwise backward method, a 10% cut-off was 
used to retain an independent variable in the model (Default in SPSS Software). 
Multicollinearity of the independent variables was assessed before each logistic 
regression analysis. There was no multicollinearity between any of the variables (Variance 
Inflation Factor for all variables lower than 5; Appendices 3a-3d). 
Univariate and multivariate logistic regression analyses were conducted for the whole 
sample, the urological cancer subsample and the lower GI subsample. It was not possible 
to conduct this analysis for the gynaecological cancer subsample, as it was very small 
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(n=16 for the on-treatment group and n=16 for the post-treatment group). Statistical 
significance for the logistic regression models was set at P<0.05. Results are presented 
as Odds Ratios (OR) and 95% Confidence Intervals (CI). SPSS (v25.0) was used for the 
analysis of the survey data. 
The survey included a total of five open questions: 
1. C4: Is there anything else you changed in your diet since diagnosis? 
2. D9: What, if any, additional nutrition support would you like to receive/have 
received? 
3. D8: Did dietary information/advice influence you to change dietary habits (support 
from health professionals) – please describe how? 
4. D18: Did dietary information/advice influence you to change dietary habits (support 
from other sources) – please describe how? 
5. Final question: Anything we missed? 
Questions C4, D9, D8 and D18 were very specific to topics of the survey (Section C: 
Dietary changes; Section D: Support from health professionals or other source) and are, 
therefore, presented in Chapter 4 (Findings from the survey). Findings from the final, 
broader question were analysed thematically (see 3.3.2.4) and are presented in Chapter 5 
(Findings from the interviews). 
 
3.3.2. Phase II: The interviews 
3.3.2.1. Sample 
A sub-sample of participants who completed and returned the cross-sectional survey in 
Part I was invited to participate in Part II. Maximal variation sampling was used to recruit 
participants for the interviews. Maximal variation sampling is a type of purposeful sampling 
and is used to identify important characteristics of a phenomenon among cases that vary 
from each other (Benoot et al., 2016). Maximum variation sampling is commonly used in 
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the qualitative arm of mixed-methods studies (Palinkas et al., 2015). The aim was to 
recruit survivors with a range in terms of  diagnoses (prostate, bladder, gynaecological, 
rectal, anal cancer), Body Mass Index status (underweight, normal weight, overweight, 
obese), treatment stage (on- and post-treatment), age (<65 or >65 years of age) and 
educational status (with or without a University degree). Other particular unique 
characteristics were also considered when contacting potential interviewees, such as 
dietary patterns (e.g. being vegetarian), having a stoma after cancer diagnosis and 
reporting being an ethnicity other than white.  
 
3.3.2.2. Procedure  
At the end of the questionnaire, there was a section in which participants filled in their 
contact details if they wanted to be contacted for a telephone interview. Within 10 days of 
receipt of the completed questionnaire, participants were contacted and asked whether 
they would be interested to have a telephone conversation at a time suitable for them. All 
necessary information for the interview was provided, including the purpose, the content 
and the expected duration (approx. 30 mins). Telephone interviews were conducted from 
a private room in Marston Campus, OBU, Oxford UK ensuring that the interview content 
remained confidential. Verbal consent to each item on the study consent form (Appendix 
2f) was sought before the beginning of the interview and a copy of it was provided to 
participants upon request. Three participants asked for a copy of the consent form, which 
was sent to them via post.  
The first two interviews were used as a pilot to test the content of the questions and the 
interview format. In the first two interviews, participants were initially invited to provide 
information about their cancer diagnosis and treatment, but the PI noticed they were 
hesitant and appeared to be a little uncomfortable. A main adjustment was made to start 
the conversation by asking participants to give a description of their current dietary habits 
using the prompt: “Could you give me a description of what you ate yesterday?”. This 
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question was followed by discussion around dietary changes and adjustments as a result 
of diagnosis. This prompt was found to be a useful introduction to the discussion, as all 
participants were feeling comfortable answering questions about their current and past 
diet. Information about treatments and related side effects followed questions about 
dietary habits. As no other significant changes were made to the topic guide, the first two 
interviews were included in the analysis. The prompt “Could you please tell me a bit more 
about that?” was used when the PI wanted the participant to expand on topics related to 
the research questions or topics dictated by the participants (e.g. comorbidities and diet, 
weight issues and diet).  
At the end of each interview, the PI wrote a summary of the content of the conversation 
and reflected on issues that may have arisen. Reflexivity is a technique used in qualitative 
research, in which the researcher addresses how their own positions and attitudes as 
researchers affect the interpretation of the content of the interviews (Primeau, 2003). 
Summaries were also useful for comparison and contrast, in order to understand when no 
new information emerged (data saturation). Interviews were audio-recorded. 
 
3.3.2.3. Topic guide development 
A topic guide (Appendix 2g) was developed based on the topics in the survey: dietary 
changes, beliefs of the role of diet in future health and symptom management and 
experiences of nutritional support after diagnosis. The topic guide had five sections: 
 Introduction: The PI reminded the participant of the scope of the study and 
obtained verbal consent  
 Dietary habits: The PI asked questions about current dietary habits and changes 
since diagnosis and (where applicable) after the end of treatment. Questions 
around diet and nutrition included diet quality (macro- and micronutrients), food 
groups preferences, supplement use and weight changes since diagnosis. 
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 Attitudes/beliefs about diet in managing side effects and keeping healthy: The 
initial question was “What does keeping healthy mean to you?”. The interviewer 
asked questions about the participant’s beliefs on the role of diet and nutrition (diet 
quality, specific foods or supplements) to alleviate treatment side effects and 
whether they have done any relevant dietary modifications. Another question was 
about attitudes towards the role of diet and nutrition in keeping healthy and 
improving quality of life in the future.  
 Experiences of nutritional support: Participants were asked whether they received 
information and support regarding diet and nutrition from healthcare professionals, 
online sources, support groups or any other way. They were also asked to 
describe their experiences and whether there was any other information they 
wanted.  
 Conclusion: The interviewer thanked participants for taking part and also provided 
information about two online cancer support charities, Macmillan Cancer Support 
and Cancer Research UK, which have reliable and consistent information on diet 
and nutrition after a cancer diagnosis.  
Although there was a topic guide and questions were formed based on the structure of the 
cross-sectional survey, the interviews were semi-structured, allowing participants to talk 
about their experiences in relation to diet and nutrition in as much depth as they desired. 
Questions were adapted in each interview depending on the participant’s answers. 




Thematic analysis was used to analyse the data from the telephone interviews. Thematic 
analysis is a widely-used qualitative method of analysis and includes identifying, analysing 
and reporting themes deriving from the data (Braun and Clarke, 2006). It is commonly 
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used in qualitative research in nutrition and dietetics and is considered a flexible and 
practical type of analysis for non-experienced qualitative researchers (Fade and Swift, 
2011). Thematic analysis was conducted according to Braun and Clarke (2006) which 
involves six steps: familiarisation with the data, coding, searching for themes, reviewing 
the themes, defining and naming the themes and producing the report. 
The Framework approach is a method for organising the qualitative data during the 
process of thematic analysis. The Framework method was originally created by Ritchie 
and Spencer and applied to policy research; however it has become an increasingly 
helpful tool for organising data in applied health research (Gale et al., 2013). Framework 
uses a matrix output in which the data are organised by cases (rows) and codes 
(columns), providing the researcher an easy way to compare data across cases and 
within codes. The Framework method is not aligned with a particular epistemological, 
philosophical, or theoretical approach, making it practical and flexible for non-experienced 
qualitative researchers (Gale et al., 2013).  
Gale et al. (2013) describe the use of the tool in six steps. As expected, the steps are 
similar to those described by Braun and Clarke (2006), as Framework is a tool for 
thematic analysis: 
1. Transcription: After the end of each interview, the PI wrote a summary of the 
content of the interview and reflections of the interactions over the phone with the 
participant. All interviews were transcribed verbatim by the PI and all verbal and 
some non-verbal (e.g. coughs, pauses, laughs) utterances were transferred in 
Word documents. Personal data, dates or places mentioned in interviews were not 
transcribed to preserve anonymity. 
2. Familiarisation with the interviews: Transcripts were read repeatedly to obtain a 
better understanding of the depth and breadth of the content. This was an 
essential part of the analysis, as it gave the opportunity to create initial ideas of 
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coding (step 3). Any difficulties in the transcription process were solved after 
discussion with the supervisory team. 
3. Generating initial coding: A list of initial ideas was produced after carefully re-
reading five transcripts.  
4. Developing a working analytical framework: After coding the first five transcripts, 
the research team met to discuss and compare codes and agree on a set of 
codes. An initial working framework with eight themes and 35 sub-themes was 
created. 
5. Applying the analytical framework: The agreed set of codes was applied to all 
remaining transcripts. New codes deriving from the remaining transcripts were 
entered to the matrix.  
6. Charting data into the framework matrix: The matrix was created on a Microsoft 
Excel spreadsheet. Each row represented a participant and each column 
represented a code. Data were summarised by code from each transcript. Where 
applicable, quote(s) were added under summaries. Care was taken so that data 
were reduced to a summary while retaining all important information. 
7. Interpreting the data: Themes and subthemes were generated from the data set by 
reviewing the framework matrix and identifying common characteristics among 
participants and categories. A combination of deductive and inductive analysis was 
taken; although there was a topic guide informed by topics relevant to the content 
of the questionnaire (Phase I), analysis also allowed for new topics to emerge. 
 
3.3.2.5. Rigour 
Lincoln and Guba use the criteria of credibility, transferability, dependability and 
confirmability to establish trustworthiness of the qualitative research. The interview topic 
guide was pilot tested in the first two interviews and any necessary changes were made. 
There were frequent meetings with the supervisory team to discuss emerging analysis 
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with input from academics with considerable experience conducting thematic analysis 
using the Framework approach (Dr Jo Brett, Dr Lauren Matheson). Dr Matheson and Dr 
Brett are not part of the PhD team. There were also frequent debriefings to the 
supervisory team and any enquiries were resolved. An audit trail of the analysis process 
was maintained. Finally, reflections on the research process are discussed in Chapter 9. 
 
3.3.3. Ethics & ethical considerations 
3.3.3.1. Ethics approvals 
Approval for the administration of the survey and conduct of telephone interviews to on-
treatment participants was granted by the Faculty Research Ethics Committee (FREC 
2016/43) at OBU on 15/06/2017; the East of Scotland Research Ethics Service (REC 
Reference 17-ES-0112) on 18/08/2017; the Health Research Authority on the 04/09/2017; 
and OUH Research and Development (Reference PID13101) on 19/09/2017 (Appendix 
2h). Approval was also sought from the Late Phase Oncology Trial Steering Committee at 
OUH NHS Foundation Trust. 
A substantial amendment for the administration of the survey and conduct of telephone 
interviews to include the post-treatment participants was submitted in January 2018. 
Approval was granted by the Faculty Research Ethics Committee (FREC 2016/43) at 
Oxford Brookes University on 22/01/2018; the East of Scotland Research Ethics Service 
(REC Reference 17-ES-0112/AM01) on 14/02/2018; the Health Research Authority on the 
03/04/2017; and OUH Research and Development (Reference PID13101 -A001-SI001) 
on 10/04/2017 (Appendix 2i). All relevant documents, including amendments and updates 




3.3.3.2. Ethical considerations 
Ethical considerations were around anonymity of participants, confidentiality and data 
storage. No personal data were recorded regarding the administration of the survey.  On 
receipt of a questionnaire, a unique identification number was provided by the PI. Data 
were stored in line with the Data Protection Act 1998 and policies of OBU. Information 
about the use, retention and destruction of data were given to all participants in the 
Participant Information Sheet. Completed questionnaires were stored in a locked filing 
cabinet accessible only to the research team in a lockable office at OBU. Data will be 
stored for a period of 10 years in accordance with the Policy for Academic Integrity. 
At the end of the survey, participants who wanted to be interviewed provided their 
personal data on the last page of the survey, which was subsequently separated from the 
rest of the survey by the PI immediately after receipt. Personal data were stored in a 
locked filing cabinet, different to the one where the questionnaires were kept, accessible 
only to the research team in a lockable office at OBU. Personal data forms were 
destroyed after dissemination of findings (September 2019). Consent forms for the 
telephone interviews were stored in another locked filing cabinet. Audio recordings of 
interviews were stored on a password-protected computer accessible only by the PI. At 
the point of transcription, all data were de-identified. Data will be stored for a period of 10 
years in accordance with the Policy for Academic Integrity. 
There were minimal risks to patients participating in this study; however, in case the 
survey triggered the participant to look for nutrition information in relation to their 
condition, at the end of the survey there were information details of sources from which 
they could obtain support. These sources were the Helpline of Macmillan Cancer Support 
and Cancer Research UK. In case a participant felt distressed during an interview, the 
interview would be paused and the participant would be offered a break, the opportunity to 

















This chapter presents the results of the survey that was administered to people diagnosed 
with a pelvic cancer. Results are presented for the whole group, as well as according to 
treatment stage (on-treatment or post-treatment). The chapter is divided in sub-sections: 
sample characteristics; treatment side effects and weight changes; dietary 
habits/changes; supplement use; nutritional awareness; perceptions of the role of diet 
after diagnosis; support by health professionals or other sources; and interest in learning 
more about diet and nutrition. Analysis was conducted to identify any differences 
according to treatment stage (on-treatment and post-treatment group) and across 
diagnoses (urological, lower gastrointestinal (GI) and gynaecological). Qualitative analysis 
of open comments further enhanced the findings from the survey (see also Chapter 5). 
 
4.2. Sample characteristics 
Of the 671 people who were invited to participate, a total of 254 questionnaires were 
returned (102 from on-treatment and 152 from post-treatment participants). The response 
rate was 38.3% (102/266) for the on-treatment group and 37.5% (152/405) for the post-
treatment group. Three questionnaires from the post-treatment group were excluded 
because they contained substantial missing demographic and scale data. Therefore, 
results are presented for a total of 251 participants: 102 on-treatment and 149 post-
treatment. The maximum acceptable error for the achieved sample size was B=0.063 (or 
6.3%; see section 3.2.6.1). 
 
4.2.1. Cancer diagnosis and treatment 
Table 4.1 shows the reported cancer diagnosis of the study participants. Cancer 
diagnoses were similar between the on-treatment and the post-treatment groups (bladder 
cancer: x2(1)=1.277, P=0.258; cervical cancer: continuity correction test 0.956, P=0.328; 
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endometrial cancer: continuity correction test 0.137, P=0.711; prostate cancer: 
x2(1)=1.404, P=0.236; rectal cancer x2(1)=0.294, P=0.588), with the exception of anal 
cancer where there was a significantly higher proportion in the post-treatment than on-
treatment group (15% post-treatment Vs 5% on-treatment, x2(1)=6.780, P=0.009). In both 
groups, prostate cancer survivors accounted for almost half the sample. Numbers were 
smaller for lower GI (rectal and anal) and gynaecological cancer patients. More survivors 
in the on-treatment group reported a recurrent cancer diagnosis compared to the post-
treatment group (23% Vs 7%, x2(1)=12.688, P<0.001). 
In addition to pelvic radiotherapy treatment, 41% of respondents (n=104) received 
chemotherapy, 18% (n=44) hormone therapy, while 28% (n=71) also underwent surgery 
(Appendix 4a). 
 
Table 4.1: Cancer diagnoses of the studied population (n=251). 





Cancer diagnosis (1)  n (%) n (%) n (%) 
Prostate 124 (49) 55 (54) 69 (46) 
Bladder 12 (5) 3 (3) 9 (6) 
Rectal 56 (22) 21 (21) 35 (24) 
Anal 28 (11) 5 (5) 23 (15) 
Endometrial 10 (4) 3 (3) 7 (5) 
Cervical 12 (5) 7 (7) 5 (3) 
Other gynaecological (ovarian, vulvar, 
vaginal) 10 (4) 6 (6) 4 (3) 
Testicular 1 (<1) 0 (0) 1 (1) 
Other (2) 10 (4) 8 (8) 2 (1) 
 (1) A total of 264 tumour sites were reported (thirteen participants reported two tumour sites). The percentage values exceed 
100%. 
(2) Other pelvic diagnoses include lymph nodes (n=3), “pelvic” (n=2), Extramammary Perianal Paget's Disease (n=1), bowel 




4.2.2. Age and gender 
The age of participants ranged between 30 and 92 years. Median (IQR) age for the whole 
sample was 70 (62-77) years. Median (IQR) age for the on-treatment group was 70 (62-
76) years with a range between 43 and 84 years and median (IQR) age for the post-
treatment group was 71 (62-77) years with a range between 30 and 92 years. There was 
no difference in age according to treatment stage (U=6,357.5, P=0.294). Urological cancer 
survivors were significantly older than lower GI cancer survivors (median (IQR) 74 (70-77) 
years vs 62 (57-73) years; U=2,316.5, P<0.001) and gynaecological cancer survivors 
(median (IQR) 74 (70-77) years vs 59 (50-66) years; U=421, P<0.001). Women with a 
gynaecological cancer diagnosis were younger than people with a lower GI diagnosis but 
this was not significant (U=698, P=0.026). Figure 4.1 shows the age distribution for the 
whole sample, the on-treatment group and the-post treatment group. 
  
 
Figure 4.1: Age distribution of the study sample (n=239). Data are missing for 12 
participants. 
 
More men than women completed the survey as prostate cancer was the most frequently 
reported diagnosis. Sixty-one percent (n=153) of the participants were male, 30% (n=76) 
were female and data on gender was missing for 9% (n=22) of the participants. There was 
































represented 65% (n=66) of the on-treatment group and 58% (n=87) of the post treatment 
group, while women represented 27% (n=28) and 32% (n=48) respectively.  
 
4.2.3. Marital, ethnic background, employment and educational status 
Most participants were married (74%), retired (66%) and identified themselves as “white” 
(96%). Participants reported various educational backgrounds, with the “University 
qualification” reported most often (24%; Appendix 4a). There was no difference in any of 
the above demographic characteristics according to treatment stage (on treatment vs 
post-treatment; P>0.01 for all comparisons). As a result of older median age, significantly 
more urological survivors were retired compared to lower GI (x2(1)=35.178, p<0.001) and 
gynaecological (x2(1)=21.838, p<0.001) survivors. Marital status, ethnicity and educational 
status were similar among cancer diagnoses (P>0.01 for all comparisons; Appendix 4a).  
 
4.2.4. BMI, smoking and comorbidities 
Table 4.2 presents the participants’ BMI status – calculated by the PI from self-reported 
height and weight – and self-reported comorbidities. Thirty-six percent of the sample 
(n=90) was classified as overweight (BMI >25 kg/m2) and 23% (n=57) as obese (BMI >30 
kg/m2). There was no difference in BMI status according to either treatment status 
(Fisher’s Exact Test=1.356, P=0.727) or diagnosis (Fisher’s Exact Test=7.419, P=0.274). 
The most frequently reported comorbidity was high blood pressure (n=84, 33%) followed 
by arthritis (n=47, 19%) and heart disease (n=38, 15%). Most participants were either ex-
smokers (n=132, 53%) or never smoked (n=97, 39%). There was no difference in the 
report of any comorbidity according to either treatment status or diagnosis, with the 
exception of heart problems according to diagnosis (x2(2) =10.679, P=0.005). More 
urological cancer survivors reported heart problems compared to gynaecological cancer 
survivors (x2(1)=7.466, P=0.006). Overall, survivors of urological cancer were more likely 
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to report comorbidity than survivors with lower GI (x2(1)=11.625, P=0.001) and 
gynaecological cancers (x2(1)=6.821, P=0.009).  
 
Table 4.2: Health characteristics of the studied population (n=251). 




Post-treatment   
n=149 
BMI status !1) n (%) n (%) n (%) 
Underweight (BMI <18.5 kg/m2) 5 (2) 2 (2) 3 (2) 
Normal weight (18.5 kg/m2<BMI<24.9 
kg/m2) 82 (33) 32 (31) 50 (34) 
Overweight (25.0 kg/m2<BMI<29.9 kg/m2) 90 (36) 35 (34) 55 (37) 
Obese (BMI>30 kg/m2) 57 (23) 27 (26) 30 (20) 
Missing 17 (7) 6 (6) 11 (7) 
Comorbidities  
Heart disease 38 (15) 17 (17) 21 (14) 
Diabetes 24 (10) 11 (11) 13 (9) 
High blood pressure 84 (33) 29 (28) 55 (37) 
Asthma/chronic lung diseases 24 (10) 10 (10) 14 (9) 
Arthritis 47 (19) 15 (15) 32 (21) 
Problems with stomach/gallbladder 23 (9) 12 (12) 11 (7) 
Osteoporosis 11 (4) 6 (6) 5 (3) 
No comorbidity reported 59 (24) 27 (26) 32 (21) 
Other (2) 60 (24) 20 (20) 40 (27) 
Missing 16 (6) 7 (7) 9 (6) 
(1)Body Mass Index (BMI) calculated based on self-reported height and weight. BMI=weight in kg / (height in m)2. 
(2) Other comorbidities include high cholesterol (n=5), kidney disease (n=4), underactive thyroid (n=4), problems with 
pancreas (n=3), atrial fibrillation (n=3), liver disease (n=2), Alzheimer disease (n=2), epilepsy (n=2), other neurological 
disease (n=2), Barret’s oesophagus (n=2), fibromyalgia (n=2), Crohn’s disease (n=2), fitting of a pacemaker (n=2), hiatus 
hernia (n=2), osteopenia (n=1), acid reflux (n=1), iron deficiency anaemia (n=1), stricture of urethra (n=1), pulmonary 
embolism (n=1), ulcerative colitis (n=1), depression (n=1), other mental conditions (n=1) , high uric acid (n=1), kyphosis 
(n=1), ulcerative colitis (n=1), excess fluid retention in bladder (n=1), gout (n=1), polymyalgia rheumatic (n=1), rhinitis (n=1), 
sarcoidosis (n=1), dropped foot (n=1), knee replacement (n=1), proctitis (n=1), pharyngeal pouch (n=1), peripheral 
circulation problems (n=1), Bowens disease (n=1), gum problems (n=1).  
 
4.3. Treatment side effects 
Overall, on-treatment patients reported more side effects than the post-treatment group. 
After excluding participants who reported no side effects, on-treatment survivors reported 
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a mean of 3.1 side effects, whereas the post-treatment group a mean of 2.6 side effects. 
However, statistical significance was shown only for nausea/vomiting (x2(1)=8.466, 
P=0.004) whereas marginal statistical significance was shown for wind/bloating 
(x2(1)=6.369, P=0.012), diarrhoea (x2(1)=6.686, P=0.010), taste changes (x2(1)=5.993, 
P=0.014) and appetite loss (x2(1)=5.947, P=0.015; Fig. 4.2 and Appendix 4b). For the 
post-treatment group, there was no difference in the report of side effects and the time 
since end of radiotherapy treatment (6-12, 13-18 and 19-24 months post-treatment; 
x2(2)=0.132, P=0.936), indicating the persistence of the presence of side effects two years 
post radiotherapy completion. Age was not associated with presence of side effects 
(U=3,982.5, P=0.444).  
 
 
Figure 4.2: Report of treatment side effects (n=251). Other side effects include hot flushes 
(n=5), mouth sores (n=5), difficulty swallowing (n=5), weight changes (n=3), pain (n=3), 
itching (n=1), erectile dysfunction (n=1), mucus (n=1), irritable bladder (n=1), radiation 
induced cystitis (n=1), lymphoedema (n=1), blood in urine (n=1), depression (n=1), lack of 
concentration (n=1), infection of the buttocks (n=1). 



























According to cancer diagnosis, more lower GI survivors reported loss of appetite 
(x2(1)=13.897, P<0.001), taste changes (x2(1)=18.325, P<0.001) and nausea 
(x2(1)=9.370, P =0.002) compared to urological cancer survivors. Similarly more 
gynaecological cancer patients reported loss of appetite (x2(1)=20.413, P <0.001), taste 
changes (x2(1)=8.780, P=0.003) and nausea (x2(1)=19.172, P <0.001) compared to 
urological cancer survivors. There were no differences in symptom reporting between 
lower GI and gynaecological cancer survivors (Appendix 4b).  
 
4.4. Weight changes 
Overall, 82 (33%) participants reported weight gain, 65 (26%) weight loss and 98 (39%) 
did not experience weight change since diagnosis (Fig. 4.3). Weight changes were similar 
across treatment groups (P>0.01 for all comparisons). More women with gynaecological 
cancers reported weight loss compared to patients with urological cancers (x2(1)=8.506, 
P=0.004). There was no other difference in weight changes among cancer diagnoses 
(P>0.01 for all comparisons; Appendix 4c). 
 
 
Figure 4.3: Reported weight changes after diagnosis (n=241). Data are missing for 10 


























4.5. Dietary changes 
4.5.1. Descriptive analysis 
A total of 170 (68%) participants reported changing at least one component in their diet 
after diagnosis. Responses were similar for the on-treatment (n=70, 69%) and the post-
treatment group (n=100, 67%) (x2(1)=0.063, P=0.801), as well as across cancer groups 
(x2(2)=5.762, P=0.056). Changes were made to maintain general health (n=99, 58%), 
assist with treatment side effects (n=77, 45%), support therapy and recovery (n=70, 41%) 
and reduce the risk of recurrence (n=52, 31%). Other responses included losing weight 
(n=4, 2%) and diagnosis of diabetes (n=3, 1%). More people on treatment reported 
changing their diet to assist with treatment side effects (x2(1)=16.934, P<0.001) and to 
support therapy and recovery (x2(1)=6.879, P=0.009) compared to the post-treatment 
group. There was no difference in the responses according to cancer diagnosis (Appendix 
4d). 
Among the most notable changes, one in three respondents increased their fruit (33%) 
and vegetable intake (33%), 29% consumed more oily fish and 25% more wholegrain 
products. Almost one in two (48%) reduced the consumption of sugary foods, 41% 
alcohol, 40% processed meats and 29% full-fat dairy (Figure 4.4). 
According to treatment stage, more on-treatment participants increased their intake of 
refined grains, compared to the post-treatment group (16% Vs 5%; x2(1)=8.863, P=0.003). 
Also, more on-treatment respondents decreased their alcohol intake, compared to the 
post-treatment group (52% Vs 33%; x2(1)=8.985, P=0.003). No other differences in dietary 
changes were observed (P>0.01 for all other comparisons). According to cancer 
diagnosis, more lower GI survivors reported reduction of wholegrains (26% Vs 2%; 
x2(1)=28.485, P<0.001) and fruit (19% Vs 4%; x2(1)=13.130, P<0.001) compared to 
urological cancer survivors. Also more gynaecological cancer survivors reduced the intake 
of wholegrains compared to urological cancer survivors (22% Vs 2%; x2(1)=18.770, 
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P<0.001). No other differences in dietary changes were observed based on diagnosis 
(P>0.01 for all other comparisons; Appendix 4d).  
Regarding fluid intake, half of the respondents (n=126) reported the consumption of 6-8 
glasses (250 ml) of fluids daily and a quarter (27%, n=69) 3-5 glasses, whereas 16% 
(n=40) had more than 9 glasses and 5% (n=12) 2 glasses or less. 
 
 
Figure 4.4: Reported dietary changes after cancer diagnosis for the whole sample. 
 
Most respondents (72%; n=181) reported having meals with their spouse or partner. One 
in four respondents (25%, n=63) also had meals with members of their family, and one in 
ten (10%, n=26) with friends. Twenty-three percent (n=57) also reported having meals on 
their own. Meals were prepared either by the respondents themselves (37%, n=94), by 
their spouses/partners (37%, n=93) or it was a shared task (24%, n=60). Less frequently, 

























n=6). There were gender differences with regards to preparation of meals in the 
household. More men reported having their meal made by spouse/partner than women 
(x2(1)=30.710, P<0.001). On the other hand, more women prepared meals by themselves 
than men (x2(1)=31.032, P<0.001). There was no difference in meal preparation according 
to treatment stage (Appendix 4d). 
Respondents had frequently consumed homemade meals over the past 4 weeks; 64% 
(n=160) had homemade meals more than five times a week and 24% (n=61) one to four 
times a week. Ready-made meals were eaten less frequently, as 31% (n=79) had not 
consumed ready-made meals in the past four weeks and 43% (n=109) consumed ready-
made meals one to three times a month. Urological cancer patients reported eating ready 
meals less often than lower GI (x2(1)=13.289, P=0.004) and gynaecological cancer 
survivors (x2(1)=9.225, P=0.026). There was no difference in consumption of ready meals 
between survivors of a lower GI and gynaecological cancer.  
 
4.5.2. Logistic regression 
4.5.2.1. Whole sample 
Univariate logistic regression was performed to ascertain the effects of each of the 
following variables on the likelihood that participants change a component of their diet: 
treatment stage (on-treatment, post-treatment), diagnosis (urological, lower GI, 
gynaecological), age, Body Mass Index, qualifications (<=high school/ > high school), 
employment (retired/not retired), marital status (married/not married), presence of a 
comorbidity (yes/no), presence of a side effect (yes/no), report of supplement use (yes/no) 
and nutrition support from health professionals (yes/no). The analysis showed that cancer 
diagnosis, age, qualifications and nutrition support from a health professional were 
significantly associated with dietary change (Table 4.3). 
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Multivariate logistic regression was performed to ascertain the effects of all the above 
variables together on the likelihood that participants change a component of their diet. 
Using the stepwise method, the variables “age” and “nutrition support from a health 
professional” were retained in the model.  The logistic regression model was statistically 
significant, χ2(1) = 18.673 , P<0.001. The model explained 14.2% (Nagelkerke pseudo R2) 
of the variance in dietary change and correctly classified 67.1% of cases. Participants 
were 3.6 times more likely to make a change in their diet when they received nutrition 
support from a health professional compared to participants who did not receive nutrition 
support from a health professional. The variable “age” was retained in the model, but it 
was not statistically significant at the 5% level (P=0.094; Table 4.4). 
 
4.5.2.2. Urological cancer patients only 
Univariate logistic regression analysis for the urological cancer group showed that the 
variable “qualifications” and “nutrition support from a health professional” were 
significantly associated with dietary change (Table 4.3). In multivariate logistic regression 
analysis using the stepwise method, the variables “Body Mass Index”, “qualifications” and 
“nutrition support from a health professional” were retained in the model.  The logistic 
regression model was statistically significant, χ2(3) = 16.235, P=0.001. The model 
explained 23.1% (Nagelkerke pseudo R2) of the variance in dietary change and correctly 
classified 68.6% of cases. Respondents were 3.4 times more likely to make a change in 
their diet when they received nutrition support from a health professional compared to 
patients who did not receive support from a health professional. Participants with a higher 
BMI were also more likely to report a dietary change (OR=1.15, 95% CI: 1.01-1.31) 
compared to participants with lower BMI. Although the variable “qualifications” was 





Table 4.3: Univariate logistic regression for whole sample, urological cancer group only and 
lower GI group only (dietary change as dependent variable). 
Variables  Whole sample Urological group Lower GI group 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Treatment status On-treatment 1 1 1 
Post treatment 0.93 (0.54-1.60) 0.83 (0.41-1.70) 0.75 (0.24-2.39) 
Cancer diagnosis Gynaecological  1 N/A N/A 
Urological 0.50 (0.29-0.86) N/A N/A 
Lower GI 1.68 (0.93-3.04) N/A N/A 
Age   0.97 (0.94-0.99) 0.96 (0.89-1.02) 0.96 (0.92-1.01) 
Body Mass Index   1.00 (0.94-1.06) 1.10 (1.00-1.21) 0.95 (0.85-1.05) 
Qualifications <=high school 1 1 1 
>high school 0.47 (0.23-0.95) 0.49 (0.13-0.99) 0.95 (0.28-3.20) 
Employment Not retired 1 1 1 
Retired 0.57 (0.32-1.03) 0.58 (0.21-1.60) 0.88 (0.31-2.47) 
Marital status Not married 1 1 1 
Married 0.74 (0.39-1.39) 0.45 (0.18-1.15) 0.84 (0.24-2.94) 
Presence of a comorbidity No 1 1 1 
Yes 0.98 (0.53-1.83) 1.69 (0.65-4.43) 0.70 (0.23-2.14) 
Presence of a side effect No  1 1 1 
Yes 1.55 (0.80-3.03) 1.60 (0.65-3.96) 1.71 (0.50-5.85) 
Supplement use No 1 1 1 
Yes 1.00 (0.57-1.78) 0.87 (0.41-1.86) 1.54 (0.39-6.12) 
Nutrition support from health 
professional 
No 1 1 1 
Yes 3.94 (2.15-7.21) 4.44 (1.91-10.31) 3.81 (1.21-11.96) 
 
4.5.2.3. Lower GI patients only 
Univariate logistic regression analysis for the lower GI group showed that only support 
from a health professional was significantly associated with dietary change (Table 4.3). In 
multivariate logistic regression analysis using the stepwise method, the variables “age”, 
“Body Mass Index” and “nutrition support from a health professional” were retained in the 
model.  The logistic regression model was statistically significant, χ2(4) = 10.304, P=0.016. 
The model explained 24.1% (Nagelkerke pseudo R2) of the variance in dietary change 
and correctly classified 74.1% of cases. Lower GI survivors were 4.7 times more likely to 
make a change in their diet when they received nutrition support from a health 
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professional compared to survivors who did not receive nutritional support from a health 
professional. Increasing age was associated with decreased likelihood of making a dietary 
change (OR=0.94, 95% CI: 0.89-1.00). The variable “Body Mass Index” was retained in 
the model but it was not statistically significant on 5% level (P=0.076; Table 4.4). 
 
Table 4.4: Multivariate logistic regression (stepwise method) for whole sample, urological 
cancer group only and lower GI group only (dietary change as dependent variable). 
Variables  Whole sample Urological group Lower GI group 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Age   0.97 (0.94-1.01)  0.94 (0.89-1.00) 
Body Mass Index    1.15 (1.01-1.31) 0.87 (0.75-1.01) 
Qualifications <=high school  1  
>high school  0.38 (0.12-1.22)  
Nutrition support from 
health professional 
No 1 1 1 
Yes 3.63 (1.82-7.23) 3.42 (1.24-9.40) 4.74 (1.18-19.01) 
 
 
4.5.3. Additional comments (open question C4) 
Seventy-three respondents (36 from the on-treatment group and 37 from the post-
treatment group) provided additional information about dietary changes after cancer 
diagnosis. The on-treatment group described dietary changes related to radiotherapy or 
other treatments and their potential side effects on appetite, bowel function and feelings of 
nausea, whereas the post-treatment group made dietary changes primarily for future 
health and prevention of cancer recurrence. 
Twenty on-treatment participants made dietary changes to support gastrointestinal health 
during radiotherapy. These changes included reduced or no consumption of caffeinated 
(n=10), carbonated (n=6) and citrus drinks (n=3), alcohol (n=5), spices (n=4), dairy 
products (n=2), chocolate, pulses and cruciferous vegetables and fibre.  Six participants 
reported drinking more water. Three on-treatment participants reduced their food intake as 
a result of reduced appetite.  
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Six post-treatment participants described experiences of managing side effects, three of 
which no longer experienced any. One participant consumed beans to manage 
constipation and eggs to manage diarrhoea; another participant did not consume 
breakfast to control output and another one limited food intake to avoid the feeling of 
nausea. Selected quotes are presented in Table 4.5. 
 
Table 4.5: Selected quotes from Question C4: “Is there anything else you changed in your 
diet since diagnosis?” 
Management of treatment side effects 
“Only drinking decaf tea/coffee. No alcohol. No orange/lemon drinks or fizzy soft drinks. 
No chocolate.” (prostate cancer, on-treatment) 
“Removal of: fizzy drinks, beans, broccoli, onions.” (prostate cancer, on-treatment) 
“I have not had any alcohol and have been drinking de-caffeinated drinks. I have been 
cutting down my ‘5-a-day’ on recommendation of the nurse in order to calm my bowel. 
And I have avoided spicy foods.” (rectal cancer, on-treatment) 
“Have no appetite so changes have been made so I eat.” (ovarian cancer, on-treatment) 
“During radiotherapy/chemo, appetite reduced and lost weight. After treatment, appetite 
returned and weight increased.” (rectal cancer, post-treatment) 
Support of health and recovery 
“More brown bread, sunflower margarine, more fruit and veg. Less biscuits cakes, 
crisps, sugar, sweets.” (prostate cancer, on-treatment) 
“Reduced portion sizes to reduce weight.” (prostate cancer, post-treatment) 
“Increase nuts, seeds, yogurt, water. Decrease sweets.” (rectal cancer, post-treatment) 
“Greatly decreased consumption of red meat. Increased consumption of turmeric and 
garlic and flaxseed. Try to get more variety of vegetables, fruit etc.” (rectal cancer, post-
treatment) 
“Tried to be more careful in identifying and cutting out hidden sugar, particularly that 
added to supposedly savoury foods.” (endometrial cancer, post-treatment) 
“I take relevant vitamin supplements which may help recovery & (prevent) recurrence.” 
(rectal  cancer, post-treatment) 
 
Participants, more from the post-treatment (n=25) and fewer from the on-treatment group 
(n=7), made dietary changes to improve future health and in relation to weight 
management. Most commonly reported changes included reduction or avoidance of red 
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and processed meats (n=9), reduction of portion sizes (n=7; three of which did so to 
reduce body weight), alcohol (n=4; post-treatment group only), salt (n=2) and convenience 
foods (n=2). Three post-treatment participants increased water/fluid intake and two on-
treatment participants increased consumption of eggs. One post-treatment participant 
started taking vitamin supplements to prevent cancer recurrence. Selected quotes are 
presented in Table 4.5. 
 
4.6. Supplement use 
4.6.1. Descriptive analysis 
Thirty-one percent (n=77) of participants reported current use of nutritional supplements. 
Responses were similar for the on-treatment (n=26, 25%) and the post-treatment group 
(n=51, 34%) (x2(1)=2.388, P=0.122). The most frequently reported supplement was 
Vitamin D (n=38, 49%), followed by omega-3 (n=32, 42%), multivitamins (n=27, 35%), 
Vitamin C (n=22, 29%), B vitamins (n=10, 13%), calcium (n=9, 12%), glucosamine 
sulphate (n=9, 12%), iron (n=6, 8%) and zinc (n=6, 8%). There was no difference in 
consumption of Vitamin D, omega-3, multivitamin or Vitamin C supplements across 
treatment stages or cancer diagnoses (P>0.01 for all comparisons). 
Participants reported consuming supplements to maintain general health (n=54, 70%), 
support therapy and recovery (n=21, 27%), assist with treatment side effects (n=18, 23%), 
and reduce the risk of recurrence (n=8, 10%). There was no difference in the reasons for 
supplement use according to treatment status or cancer diagnosis, except for the fact that 
survivors of lower GI cancer were more likely to take supplements to support recovery 
compared to urological cancer survivors (x2(1)=16.319, P<0.001). Sixty-three percent of 
lower GI survivors who take supplements (10/16) did so to support recovery, compared to 




4.6.2. Logistic regression 
4.6.2.1. Whole sample 
Univariate logistic regression was performed to ascertain the effects of each of the 
following variables on the likelihood that participants consume supplements as part of 
their diet: treatment stage (on-treatment, post-treatment), diagnosis (urological, lower GI, 
gynaecological), age, Body Mass Index, qualifications (<=high school/ > high school), 
employment (retired/not retired), marital status (married/not married), presence of a 
comorbidity (yes/no), presence of a side effect (yes/no), report of dietary change (yes/no) 
and nutrition support from health professionals (yes/no). Univariate logistic regression 
analysis showed that none of the above variables was significantly associated with 
supplement use (Table 4.6). 
Multivariate logistic regression was performed to ascertain the effects of all the above 
variables together on the likelihood that participants consume supplements. Using the 
stepwise method, the variables “treatment stage”, “report of a side effect” and “nutrition 
support from health professional” were retained in the model. The logistic regression 
model was statistically significant, χ2(4) = 12.895, P=0.012. The model explained 10.0% 
(Nagelkerke pseudo R2) of the variance in supplement use and correctly classified 65.3% 
of cases. Participants were 2.5 times more likely to consume supplements if they 
experienced at least one side effect compared to participants without any side effects. 
Participants were also more likely to consume supplements in the post-treatment stage 
and when they had nutrition support from health professionals, but both variables did not 





4.6.2.2. Urological cancers only 
Univariate logistic regression analysis for the urological cancer group showed that 
treatment stage was significantly associated with supplement use (Table 4.6). In 
multivariate logistic regression analysis using the stepwise method, the variable “report of 
a side effect” was the only variable retained in the model. The logistic regression model 
was statistically significant, χ2(1) = 4.518, P=0.034. The model explained 7.0% 
(Nagelkerke pseudo R2) of the variance in supplement use and correctly classified 62.8% 
of cases. Supplement use was 3.7 times more likely if a urological cancer survivor 
experienced a side effect but it was non-significant (Table 4.7). 
 
Table 4.6: Univariate logistic regression for whole sample, urological cancer group only and 
lower GI group only (supplement use as dependent variable). 
Variables  Whole sample Urological group Lower GI group 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Treatment status On-treatment 1 1 1 
Post treatment 1.55 (0.89-2.72) 2.67 (1.19-5.97) 1.00 (0.30-3.27) 
Cancer diagnosis Gynaecological  1 N/A N/A 
Urological 0.95 (0.55-1.62) N/A N/A 
Lower GI 0.55 (0.30-1.02) N/A N/A 
Age   1.00 (0.98-1.03) 1.01 (0.94-1.08) 1.01 (0.96-1.06) 
Body Mass Index   1.01 (0.95-1.07) 1.04 (0.95-1.14) 0.84 (0.72-0.98) 
Qualifications <=high school 1 1 1 
>high school 1.55 (0.79-3.02) 1.41 (0.54-3.70) 6.38 (0.76-53.28) 
Employment Not retired 1 1 1 
Retired 1.38 (0.77-2.48) 1.58 (0.54-4.65) 1.26 (0.42-3.79) 
Marital status Not married 1 1 1 
Married 0.94 (0.50-1.76) 0.64 (0.27-1.54) 2.33 (0.48-11.47) 
Presence of a comorbidity No 1 1 1 
Yes 1.21 (0.64-2.31) 0.83 (0.30-2.26) 1.47 (0.45-4.81) 
Presence of a side effect No  1 1 1 
Yes 1.75 (0.82-3.75) 2.55 (0.81-8.04) 1.94 (0.39-9.63) 
Report of dietary change No 1 1 1 
Yes 1.00 (0.57-1.78) 0.87 (0.41-1.86) 1.54 (0.39-6.12) 
Nutrition support from 
health professional 
No 1 1 1 
Yes 1.19 (0.69-2.04) 1.20 (0.56-2.57) 1.03 0.34-3.11) 
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4.6.2.3. Lower GI cancers only 
Univariate logistic regression analysis for the lower GI group showed that “Body Mass 
Index” was significantly associated with supplement use (Table 4.6). In multivariate 
logistic regression analysis using the stepwise method, the variable “Body Mass Index” 
was retained in the model. The logistic regression model was statistically significant, 
χ2(1)=4.922, P=0.027. The model explained 13.3% (Nagelkerke pseudo R2) of the 
variance in supplement use and correctly classified 77.8% of cases. Increasing BMI was 
associated with decreased likelihood of consuming dietary supplements (Table 4.7). 
 
Table 4.7: Multivariate logistic regression (stepwise method) for the whole sample, 
urological group only and lower GI only (supplement use as dependent variable). 
Variables  Whole sample Urological group Lower GI group 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Treatment status On-treatment 1   
Post treatment 1.87 (0.92-3.82)   
Body Mass Index     0.82 (0.67-1.00) 
Presence of a side effect No  1 1  
Yes 2.46 (1.01-6.02) 3.72 (0.98-14.05)  
Nutrition support from health 
professional 
No 1   
Yes 1.76 (0.91-3.43)   
 
4.7. Nutritional awareness 
Overall, respondents were familiar with dietary recommendations as published in 2007 by 
the WCRF/AICR (Figure 4.5). Between 91% and 95% of participants were mostly or very 
familiar with the recommendations for weight, high calorie foods, consumption of at least 
five fruit and vegetables per day and alcohol and supplement use. Respondents were less 
familiar with the recommendations on red and processed meat consumption (30% mostly 





Figure 4.5: Respondents' familiarity with the dietary recommendations published by the 
WCRF/AICR Second Expert Report (2007). 
 
4.8. Perceptions of diet and nutrition in cancer care 
Participants considered the role of diet and nutrition as either important or very important 
in managing side effects, preventing recurrence, supporting recovery and improving 
overall health (50-94% of respondents for all statements). Responses were similar across 
treatment stage and cancer diagnoses (P>0.01 for all comparisons). Participants were 
more sceptical about the role of diet in reducing appetite side effects and fatigue (36% 


































































Table 4.8: Respondents' perceptions of the role of diet after a cancer diagnosis (n=251). 








  n (%) n (%) n (%) n (%) n (%) 
Reducing GI side effects? 12 (5) 34 (14) 85 (34) 109 (43) 11 (4) 
Reducing appetite side effects?  45 (18) 46 (18) 76 (30) 51 (20) 33 (13) 
Reducing the feeling of fatigue?  38 (15) 30 (12) 71 (28) 93 (37) 19 (8) 
Preventing cancer recurrence?  19 (8) 39 (16) 82 (33) 102 (41) 9 (4) 
Improving overall health?  1 (<1) 10 (4) 73 (29) 163 (65) 4 (2) 
Supporting therapy and 
recovery?  4 (2) 22 (9) 82 (33) 135 (54) 7 (3) 
 
4.9. Support from health professionals 
4.9.1. Descriptive analysis 
Fifty-seven percent of the participants did not recall receiving nutritional advice and 
support from their healthcare team (Table 4.9). Responses did not differ between 
treatment stage (x2(1)=1.139, P=0.286) or cancer diagnosis (x2(2)=3.592, P=0.166).  
For those who received support (43%, n=108), information was provided mainly from a 
cancer or radiotherapy specialist nurse (59%, n=64), followed by radiographer/oncologist 
(19%, n=21), dietitian (17%, n=18), general practitioner (9%, n=10) and nutritionist (6%, 
n=6). Content of information provided was mainly about general healthy eating (75%, 
n=81) followed by nutritional management of treatment side effects (31%, n=33) and 
weight management (16%, n=17; Figure 4.6). Dietary information was most often provided 
as written material (71%, n=77) or in a face-to-face meeting (50%, n=54) and less 
frequently as links to websites (n=9, 8%), via telephone (n=7, 6%) or in survivorship 
courses (n=3, 3%). There was no difference in source, content or form of provision of 





Table 4.9: Report of dietary and nutritional support from the healthcare team (n=251). 
Have you received any nutrition 
support in relation to your cancer from 







 n (%) n (%) n (%) 
Yes 108 (43) 48 (47) 60 (40) 
No 143 (57) 54 (53) 89 (60) 
 
 
Figure 4.6: Content of information and support in diet and nutrition for survivors who 
reported receipt of information and support (n=108). Data missing for one participant. 
 
Most participants who received nutritional support perceived their needs to be well or very 
well met (77%), the advice to be consistent or very consistent (72%) and easy or very 
easy to follow (76%). Around one-quarter of respondents had neutral responses in relation 
to satisfaction with information and a few (5-6%) did not have their needs met, perceived 
the advice to be inconsistent and/or difficult to follow. Provision of support influenced 67% 




































Table 4.10: Influence for dietary change (for participants who reported receipt of support 
(n=108)). 
Did information influence you to change 







 n (%) n (%) n (%) 
Yes 73 (67) 38 (79) 35 (58) 
No 33 (31) 10 (21) 23 (38) 
Missing 2 (2) 0 (0) 2 (3) 
 
Among participants who did not have discussions with health professionals about diet and 
nutrition, most were not offered any (n=101, 71%), while some did not know this support 
existed (n=46, 32%), chose not to receive any (n=13, 9%) and did not think nutrition was 
important (n=5, 3%). Responses did not differ according to treatment stage or cancer 
diagnosis (P>0.01 for all comparisons). Participants who did not receive any support 
would have liked to get information about healthy eating (n=53, 37%), nutritional 
management of treatment side effects (n=39, 27%), weight management (n=37, 26%), 
nutritional supplements (n=30, 21%) and workshops related to survivorship (n=7, 5%; Fig. 
4.7).  
 
Figure 4.7: Information and support needs in diet and nutrition for survivors who did not 








































There was a significant difference in the need for information in relation to weight 
management for the different diagnoses (x2(2)=9.564, P=0.008). More urological cancer 
survivors expressed this compared to GI survivors (x2(1)=7.708, P=0.005), which may be 
related to treatment regimes. No other significant differences on the type of support were 
observed according to treatment stage or cancer diagnosis (P>0.05 for all comparisons). 
 
4.9.2. Logistic regression  
4.9.2.1. Whole sample 
Univariate logistic regression was performed to ascertain the effects of each of the 
following variables on the likelihood that participants receive nutrition support from health 
professionals: treatment stage (on-treatment, post-treatment), diagnosis [urological, lower 
GI, gynaecological], age, Body Mass Index, qualifications (<=high school/ > high school), 
employment (retired/not retired), marital status (married/not married), presence of a 
comorbidity (yes/no), presence of a side effect (yes/no), report of dietary change (yes/no) 
and supplement use (yes/no). Univariate logistic regression analysis showed that report of 
dietary change was significantly associated with nutritional support from health 
professionals (Table 4.11). 
Multivariate logistic regression was performed to ascertain the effects of all the above 
variables on the likelihood that participants receive nutrition support from health 
professionals. Using the stepwise method, only the variable “dietary change” was retained 
in the model. The logistic regression model was statistically significant, χ2(1) = 15.747, 
p<0.001. The model explained 11.9% (Nagelkerke pseudo R2) of the variance in nutrition 
support from health professionals and correctly classified 62.9% of cases. Survivors were 
3.8 times more likely to have received nutrition support from a health professional if they 




4.9.2.2. Urological cancers only 
Univariate logistic regression analysis for the urological cancer group showed that the 
variables “age” and “report of a dietary change” were significantly associated with receipt 
of nutrition support from health professionals (Table 4.11). In multivariate logistic 
regression analysis using the stepwise method, the same variables were retained in the 
model. The logistic regression model was statistically significant, χ2(2) = 16.164, p<0.001. 
The model explained 23.3% (Nagelkerke pseudo R2) of the variance in nutrition support 
by health professionals and correctly classified 74.4% of cases. Urological cancer 
survivors were 3.4 times more likely to have received nutrition support from a health 
professional if they made a change in their diet compared to those who did not change 
their diet. Younger survivors were also more likely to report nutrition support from health 
professionals (Table 4.12). 
 
4.9.2.3. Lower GI cancers only 
Univariate logistic regression analysis for the lower GI group showed that “report of dietary 
change” was significantly associated with nutrition support from health professionals 
(Table 4.11). In multivariate logistic regression analysis using the stepwise method, the 
variables “marital status” and “report of a dietary change” were retained in the model. The 
logistic regression model was statistically significant, χ2(2) = 6.523, p=0.038. The model 
explained 15.2% (Nagelkerke pseudo R2) of the variance in nutrition support by health 
professionals and correctly classified 61.1% of cases. Lower GI survivors were 3.9 times 
more likely to have received nutrition support from a health professional if they made a 
change in their diet compared to survivors who did not make a change in their diet. The 
variable “marital status” was retained in the model but it was not statistically significant on 




Table 4.11: Univariate logistic regression for whole sample, urological group only and lower 
GI group only (nutrition support from health professionals as dependent variable). 
Variables  Whole sample Urological only Lower GI only 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Treatment status On-treatment 1 1 1 
Post treatment 0.76 (0.46-1.26) 0.60 (0.29-1.22) 0.79 (0.30-2.06) 
Cancer diagnosis Gynaecological  1 N/A N/A 
Urological 0.68 (0.41-1.12) N/A N/A 
Lower GI 1.66 (0.97-2.83) N/A N/A 
Age   0.98 (0.95-1.00) 0.91 (0.85-0.98) 1.02 (0.98-1.06) 
Body Mass Index   1.01 (0.96-1.06) 1.02 (0.93-1.11) 0.99 (0.90-1.08) 
Qualifications <=high school 1 1 1 
>high school 0.77 (0.42-1.42) 0.45 (0.18-1.12) 1.20 (0.40-3.59) 
Employment Not retired 1 1 1 
Retired 0.85 (0.50-1.44) 0.46 (0.18-1.18) 2.08 (0.84-5.17) 
Marital status Not married 1 1 1 
Married 0.57 (0.32-1.03) 1.05 (0.44-2.51) 0.21 (0.06-0.72) 
Presence of a comorbidity No 1 1 1 
Yes 1.18 (0.65-2.14) 1.32 (0.47-3.73) 2.33 (0.87-6.20) 
Presence of a side effect No  1 1 1 
Yes 1.63 (0.82-3.20) 1.42 (0.54-3.75) 3.34 (0.96-11.64) 
Report of dietary change No 1 1 1 
Yes 3.94 (2.15-7.21) 4.44 (1.91-10.31) 3.81 (1.21-11.96) 
Supplement use No 1 1 1 




Table 4.12: Multivariate logistic regression for whole sample, urological group only and 
lower GI group only (support from health professionals as dependent variable). 
Variables  Whole sample Urological group Lower GI group 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Age    0.88 (0.80-0.97)  
Marital status Not married   1 
Married   0.27 (0.05-1.39) 
Report of dietary change No 1 1 1 
Yes 3.77 (1.90-7.46) 3.37 (1.24-9.17) 3.93 (1.06-14.51) 
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4.9.3. Additional comments (Influence of support in dietary change – D8) 
In total, 82/108 participants (37 from the on-treatment group and 45 from the post-
treatment group) who received dietary support also provided additional information about 
the influence of dietary support in dietary change. Most of the comments referred to actual 
dietary changes, which were presented in the sub-section “Dietary habits/changes”.  
Alleviation of side effects was the main reason to influence dietary change, both in the on-
treatment (n=8) and the post-treatment group (n=5). Realisation of the importance of diet 
in future wellbeing was another reason to influence dietary change following support from 
health professionals (n=5). Participants valued the role of diet in keeping healthy (n=8) 
and the potential to reduce recurrence (n=1).  Reasons for no change were the perception 
of having had a healthy diet prior to receipt of support (n=11), high perceived awareness 
of what constitutes a healthy diet (n=4), receipt of confusing information (n=2) and lack of 
interest in diet and nutrition (n=1). Selected quotes are presented in Table 4.13. 
 
Table 4.13: Selected quotes from Survey Question D8: “Did dietary information/advice 
influence you to change dietary habits (nutrition support from health professionals)” 
People who were influenced to change their diet following diagnosis 
“I changed my dietary habits while I was receiving radiotherapy treatment because it 
helped to offset the effects of the treatment.” (cervical cancer, on-treatment) 
“I needed a low fibre diet to combat my diarrhoea, which was very bad.” (bladder 
cancer, on-treatment) 
“Increasing realisation of importance of diet.” (prostate cancer, on-treatment) 
“More aware of impact certain foods have on my own body, especially after & during 
treatment.” (rectal cancer, post-treatment) 
People who were not influenced to change their diet following diagnosis 
“I already have a good balanced diet and drink sensibly.” (prostate cancer, post-
treatment) 
“It confirmed that what we were already doing was correct even if we didn’t always get it 
right.” (prostate cancer, post-treatment) 




4.9.4. Additional comments (Requests for additional support – D9) 
In open question D9, respondents who received support were asked if they would have 
liked any additional support from their healthcare team. Twenty-seven respondents (14 in 
the on-treatment and 13 in the post-treatment group) added comments.  
Most comments from on-treatment participants were related to the effect of treatments on 
diet. Eight participants enquired about additional support on which foods to consume or 
avoid during treatment. Three participants enquired about the use of nutritional 
supplements and two wanted to have a face-to-face consultation with a dietitian for 
tailored advice.  
Post-treatment participants wanted guidance in relation to management of side effects 
(n=3), use of supplements (n=3), weight management (n=2), recipes (n=1) and general 
healthy eating (n=1). Two participants enquired about tailored nutritional guidance for 
cancer and other comorbidities. Selected quotes are presented in Table 4.14. 
 
Table 4.14: Selected quotes from Survey Question D8:  “What, if any, additional nutrition 
support would you like to receive/have received?” 
“I would like to have had diet/nutritional guidance when first diagnosed to help maintain 
healthy weight and to avoid bowel problems during radiotherapy. Would also like advice 
on vitamin and mineral supplements.” (prostate cancer, on-treatment) 
“Would like to see a dietitian after surgery, as I will have a permanent stoma.” (rectal 
cancer, on-treatment) 
“Face to face assistance on dietary issues & weight management.” (prostate cancer, 
post-treatment) 
“More in-depth support because I also have IBS, as well as cancer. So it’s not one 





4.10. Support from other sources 
4.10.1. Descriptive analysis  
Seventy-nine (32%) respondents looked for information online or from other sources. 
Responses were similar for the on-treatment (n=28, 27%) and the post-treatment group 
(n=51, 34%) (x2 (1)=1.394, P=0.238), as well as across cancer groups (x2 (2)=1.127, 
P=0.569; Table 4.15). Most of these participants searched for information online on 
cancer charity websites (n=46, 58%) or medical websites (n=28, 35%), followed by receipt 
of information from a family member/friend (n=19, 24%), a newspaper/magazine/book 
(n=17, 22%), a recipe book (n=15, 19%), a blog (n=7, 9%) or from other patients (n=5, 
6%).  
 
Table 4.15: Report of dietary and nutritional support from other sources (n=251). 
Did you seek any information or 
support in diet and nutrition in relation 








 n (%) n (%) n (%) 
Yes 79 (32) 28 (27) 51 (34) 
No 166 (66) 72 (70) 94 (63) 
Missing 6 (2) 2(2) 4 (3) 
 
Respondents looked mostly for information about general healthy eating advice (n=61, 
77%). Fewer searched for recipes (n=22, 28%), nutritional management of side effects, 
(n=19, 24%), weight management (n=15, 19%) and nutritional supplements (n=13, 15%).  
Most participants perceived information from other sources to meet their needs well or 
very well (53%), to be consistent or very consistent (60%) and easy or very easy to follow 
(60%). Twenty-eight to 35% of respondents had neutral responses in relation to 
satisfaction with information and few (5-12%) did not have their needs met, perceived the 
advice to be inconsistent and/or difficult to follow. Satisfaction with information from other 
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sources was overall lower than satisfaction with information from health professionals. 
Information from other sources influenced 57% of participants (n=45) to change their diet 
(Table 4.16).  
 
Table 4.16: Influence for dietary change (for participants who reported receipt of support 
from other sources (n=79)). 
Did information influence you to change 







 n (%) n (%) n (%) 
Yes 45 (57) 20 (71) 25 (49) 
No 27 (34) 7 (25) 20 (39) 
Missing 7 (9) 1 (4) 6 (12) 
 
4.10.2. Logistic regression  
4.10.2.1. Whole sample 
Univariate logistic regression was performed to ascertain the effects of each of the 
following variables on the likelihood that participants receive nutrition support from other 
sources: treatment stage (on-treatment, post-treatment), diagnosis (urological, lower GI, 
gynaecological), age, Body Mass Index, qualifications (<=high school/ > high school), 
employment (retired/not retired), marital status (married/not married), presence of a 
comorbidity (yes/no), presence of a side effect (yes/no), report of dietary change (yes/no), 
supplement use (yes/no) and nutrition support from a health professional (yes/no). 
Univariate logistic regression analysis showed that “age”, “report of dietary change” and 
“nutrition support from health professionals” were significantly associated with nutrition 
support from other sources (Table 4.17). 
Multivariate logistic regression was performed to ascertain the effects of all of the above 
variables on the likelihood that participants receive nutrition support from other sources. 
Using the stepwise method, the variables “Body Mass Index”, “report of a dietary change” 
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and “nutrition support from a heath professional” were retained in the model. The logistic 
regression model was statistically significant, χ2(3) = 24.798, p<0.001. The model 
explained 19.0% (Nagelkerke pseudo R2) of the variance in nutrition support from other 
sources and correctly classified 64.9% of cases. Survivors were 3.8 times more likely to 
look for information in other sources if they have made a change in their diet compared to 
those who did not make a change in their diet. Also they were 2.2 times more likely to look 
for information from other sources if they have received nutrition information from health 
professionals. Respondents with a higher BMI were less likely to look for information from 
other sources but it was not significant (P=0.054; Table 4.18). 
 
4.10.2.2. Urological cancers only 
Univariate logistic regression analysis for the urological cancer group showed that the 
variables “report of a dietary change” and “support from health professional” were 
significantly associated with receipt of nutrition support from other sources (Table 4.17). In 
multivariate logistic regression analysis using the stepwise method, the same variables 
were retained in the model. The logistic regression model was statistically significant, χ2(2) 
= 11.366, P=0.003. The model explained 17.4% (Nagelkerke pseudo R2) of the variance 
in support by other sources and correctly classified 67.4% of cases. Urological cancer 
survivors were 3 times more likely to look for information on other sources if they have 
made a change in their diet compared to those who did not change their diet and 2.8 
times if they have received nutrition support from health professionals (Table 4.18), 
compared to those who did not receive nutrition support from health professionals.  
 
4.10.2.3. Lower GI only 
Univariate logistic regression analysis for the lower GI group showed that “Body Mass 
Index” and “supplement use” were significantly associated with nutrition support from 
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other sources. (Table 4.17). In multivariate logistic regression analysis using the stepwise 
method, the variables “age” and “Body Mass Index” were retained in the model. The 
logistic regression model was statistically significant, χ2(1) = 10.292, p=0.006. The model 
explained 24.4% (Nagelkerke pseudo R2) of the variance in support by other sources and 
correctly classified 73.6% of cases.  
 
Table 4.17: Univariate logistic regression for whole sample, urological group only and lower 
GI group only (support from other sources as dependent variable). 
Variables  Whole sample Urological group Lower GI group 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Treatment status On-treatment 1 1 1 
Post treatment 1.40 (0.80-2.43) 1.69 (0.76-3.76) 0.91 (0.32-2.57) 
Cancer diagnosis Gynaecological  1   
Urological 0.72 (0.42-1.24)   
Lower GI 1.23 (0.69-2.18)   
Age   0.97 (0.95-1.00) 0.96 (0.90-1.04) 0.97 (0.92-1.01) 
Body Mass Index   0.97 (0.91-1.04) 1.06 (0.96-1.16) 0.88 (0.77-0.99) 
Qualifications <=high school 1 1 1 
>high school 1.00 (0.53-1.92) 0.70 (0.27-1.85) 3.23 (0.81-12.90) 
Employment Not retired 1 1 1 
Retired 0.64 (0.36-1.12) 0.67 (0.24-1.83) 0.67 (0.25-1.77) 
Marital status Not married 1 1 1 
Married 1.09 (0.58-2.06) 0.95 (0.37-2.39) 1.30 (0.40-4.21) 
Presence of a comorbidity No 1 1 1 
Yes 0.84 (0.45-1.56) 0.90 (0.32-2.57) 0.82 (0.30-2.25) 
Presence of a side effect No  1 1 1 
Yes 0.92 (0.46-1.83) 1.12 (0.40-3.11) 0.62 (0.19-2.03) 
Report of dietary change No 1 1 1 
Yes 5.03 (2.42-10.45) 4.59 (1.75-12.06) 3.45 (0.90-13.24) 
Supplement use No 1 1 1 
Yes 1.53 (0.87-2.71) 1.10 (0.49-2.51) 6.43 (1.88-21.99) 
Nutrition support from health 
professional 
No 1 1 1 





Lower GI survivors with a lower Body Mass Index were more likely to look for nutrition 
information from other sources compared to lower GI patients with higher BMI. Younger 
patients with a lower GI cancer were also more likely to look for information online but it 
was not statistically significant (P=0.081; Table 4.18). 
 
 
Table 4.18: Multivariate logistic regression for whole sample, urological group only and 
lower GI group only (support from other sources as dependent variable). 
Variables  Whole sample Urological groups Lower GI group 
  OR (95%CI) OR (95%CI) OR (95%CI) 
Age     0.95 (0.89-1.01) 
Body Mass Index   0.92 (0.85-1.00)  0.78 (0.65-0.95) 
Report of dietary change No 1 1  
Yes 3.76 (1.67-8.47) 3.00 (1.01-8.85)  
Supplement use No    
Yes    
Nutrition support from health 
professional 
No 1 1  
Yes 2.17 (1.07-4.40) 2.77 (1.02-7.49)  
 
4.10.3. Additional comments (Open Question D18) 
In total, 51/79 participants (32 from the on-treatment group and 19 from the post-treatment 
group) who received dietary support from other sources also provided additional 
information about the influence of dietary support in dietary change. Most of the 
comments referred to actual dietary changes, which were presented in the sub-section 
“Dietary habits/changes”.  
Similarly to what is described in Section 4.9.3. (Additional comments Open Question D8), 
information from online sources helped a few participants alleviate treatment side effects 
(n=4 in on-treatment group, n=1 in post-treatment group) and general wellbeing (n=1 in 
on-treatment group and n=2 in post-treatment group). Reasons for no change were the 
perception of having had a healthy diet prior to receipt of support (n=12), having already 
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made the necessary dietary changes (n=2), receipt of generic information (n=1) and lack 
of interest in diet and nutrition (n=1). Selected quotes are presented in Table 4.19. 
 
Table 4.19: Selected quotes from Survey Question D9:  “Did dietary information/advice 
influence you to change dietary habits (support from other sources)” 
People who were influenced to change their diet following diagnosis 
“To improve/maintain one’s general health and fitness” (vaginal cancer, on-treatment) 
“Helped me to reduce symptoms/side effects.” (other pelvic cancer,  on-treatment) 
“For my wellbeing.” (prostate, post-treatment) 
“Yes, it made me feel I could do something positive and be in more control (rectal 
cancer, post-treatment) 
People who were not influenced to change their diet following diagnosis 
“Changes had already been made” (prostate cancer, on-treatment) 
“Already aware of the advice provided and mostly eat a diet based on the guidelines 
(anal cancer, post-treatment) 
 
4.11. Interest in getting more information 
Most respondents were somewhat to extremely interested in receiving more information 
about diet and nutrition in relation to their cancer (68%, n=171). Thirty-five participants 
(14%) were not interested at all (Table 4.20). There was no difference in responses in 
relation to treatment status [Yes (somewhat, very or extremely interested) Vs No (not or 
little interested): x2 (1)=1.535, P=0.215] or cancer diagnosis [Yes (somewhat, very or 
extremely interested) Vs No (not or little interested): x2 (2)=3.832, P=0.147].  
Written information was the preferred method of delivery of information (58%, n=145) 
followed by face-to-face support by a health professional (28%, n=71), via the internet 
(22%, n=56), via telephone (10%, n=25) or a DVD (5%, n=13).  There was no difference in 
responses according to treatment status or cancer diagnosis (all P values >0.001; 




Table 4.20: Interest in receiving (additional) information and support in diet and nutrition 
(n=251). 
Would you be interested in receiving 
more information about your diet in 







 n (%) n (%) n (%) 
Not interested at all 35 (14) 10 (10) 25 (17) 
A little interested 37 (15) 15 (15) 22 (15) 
Somewhat interested 43 (17) 14 (14) 29 (19) 
Very interested 75 (30) 37 (36) 38 (26) 
Extremely interested 53 (21) 23 (23) 30 (20) 
Missing  8 (3) 3 (3) 5 (3) 
 
In terms of the optimal time point to discuss diet and nutrition, respondents gave a variety 
of answers: 35% (n=88) would welcome diet-related discussions at any time since 
diagnosis, 24% (n=59) during treatment, 23% (n=57) during diagnosis, 21% (n=53) at the 
end of treatment and 12% (n=31) on a follow up visit. Most respondents who were not 
interested in getting dietary support did not answer the questions about optimal mode and 

















5.1. Summary  
The first part of this chapter presents the findings of the interviews that took place with a 
sub-sample of participants who completed the survey. First, basic descriptive information 
on the sample is presented. Then, the chapter is divided according to the themes and 
subthemes that were identified from the thematic analysis using the Framework approach, 
as described by Gale et al. (2013). One overarching theme includes seven themes in 
which the qualitative findings are organised.  
The second part of the chapter presents the free-text findings from the survey, which were 
also analysed thematically. Themes are similar to themes identified from the analysis of 
the interview data.  
 
5.2. Sample characteristics  
One hundred and fifty-two questionnaire respondents indicated their interest in taking part 
in a semi-structured telephone interview, and provided contact details. Forty-five were 
contacted for the telephone interview. Participants who were invited for an interview were 
selected based on treatment stage, cancer diagnosis, age, Body Mass Index status and 
qualifications, with a view of obtaining a diverse sample. Attention was also drawn to 
particular characteristics of participants, such as following a specific dietary pattern (e.g. 
vegan diet), identifying as from an Ethnic Minority Group and having or having had 
temporary ostomy. Twenty-eight participants agreed to take part (62%). Each participant 
was allocated a pseudonym. Interviews were conducted between December 2017 and 
January 2019. Interviews lasted between 19 and 74 minutes, with an average of 36 
minutes of recorded material per interview.  
Data saturation was achieved after 26 interviews. Two additional interviews were 
conducted after data saturation was perceived to have been achieved as the PI felt that 
the unique characteristics of the study participants were worth exploring. One of them was 
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conducted with a gynaecological cancer on-treatment survivor; this was the only interview 
with a gynaecological cancer on-treatment survivor. The last interview was with a rectal 
cancer on-treatment survivor with a temporary stoma bag, as it was important to capture 
their dietary adjustments and experiences of nutritional support in relation to having a 
stoma bag. No new information emerged from the last two interviews. 
The characteristics of the interviewees are presented in Table 1. Thirteen participants 
from the on-treatment group and 15 from the post-treatment group were interviewed. 
Thirteen participants had a prostate cancer diagnosis (46%), eight had rectal cancer 
(29%), two anal cancer (8%), three endometrial cancer (11%) and two cervical cancer 
(7%). Age range was 52 – 80 years. The majority of participants had a Body Mass Index 
over 25 kg/m2 (29% classified as overweight and 36% as obese) and eight participants 
(29%) had a University degree. Although attempts were made, it was not possible to 
conduct interviews with people diagnosed with bladder cancer or some of the more rare 
gynaecological cancers. Contact details were provided by a few participants from these 
patient groups (three with bladder, two with vaginal and two with vulvar cancer), however 
when contacted to take part in a telephone interview they were no longer interested.  
 
5.3. Identifying the themes 
Thematic analysis using the Framework approach was used. As described by Braun and 
Clarke (2006) and Gale et al. (2013), transcription and familiarisation of the data took 
place first. Initial coding was performed on five interviews and an initial analytical 
framework was applied to the remaining 23 interviews. Identification of new codes led to 
further reviewing and applying the analytical framework to the interviews. The Framework 
matrix was used to organise the data by cases (rows) and codes (columns) and was a 




Table 5.1: Characteristics of the participants who took part in a telephone interview (n=28). 




(years) BMI status 
(1) Qualifications 
Thomas Prostate On-treatment 72 Obese Postgraduate degree 
Oscar Prostate On-treatment 80 Underweight University degree 
Ethan Prostate On-treatment 68 Normal weight University degree 
Theodore Prostate On-treatment 70 Overweight Postgraduate degree 
Joshua Prostate On-treatment 74 Overweight O level 
Benjamin Prostate On-treatment 72 Obese NS 
Logan Prostate On-treatment 62 Obese A level 
Dylan Prostate On-treatment 78 Normal weight NS 
Gabriel Prostate On-treatment 55 Obese A level 
Caleb Prostate Post-treatment 64 Overweight Professional qualification 
Aaron Prostate Post-treatment 69 Obese NS 
Toby Prostate Post-treatment 67 Obese NS 
Stanley Prostate Post-treatment 70 Overweight O level 
Sophia Rectal On-treatment 78 Obese None 
Grace Rectal On-treatment 69 Normal weight NS 
Tyler Rectal On-treatment 68 Normal weight O level 
Lillian Rectal Post-treatment 52 Normal weight University degree 
Dexter Rectal Post-treatment 55 Normal weight A level 
Zoey Rectal Post-treatment 56 Obese O level 
Isaac Rectal Post-treatment 74 Overweight Professional qualification 
Frederic Rectal Post-treatment 55 Normal weight A level 
Ellie Anal Post-treatment 56 Obese O level 
Blake Anal Post-treatment 57 Overweight Professional qualification 
Claire Cervical Post-treatment 74 Overweight O level 
Eleanor Cervical Post-treatment 65 Normal weight Postgraduate degree 
Penelope Endometrial On-treatment 56 Normal weight University degree 
Chloe Endometrial Post-treatment 72 Overweight A level 
Scarlett Endometrial Post-treatment 62 Obese University degree 
(1) BMI: Body Mass Index. Body Mass Index status calculated from self-reported height and weight from 
participants’ surveys. BMI=weight in kg / (height in m)2. Classified as underweight (BMI <18.5 kg/m2); Normal 






Analysis led to the identification of a number of themes and sub-themes which mapped to 
the overarching theme “Managing diet and lifestyle post-diagnosis” (see Fig. 5.1). The 
themes are: “Impact of diagnosis and treatments on dietary choices”, “Personal 
resources”, “Social resources”, “Comorbidities and disabilities”, “Influence of work”, 
“Regaining normality” and “Barriers to dietary changes”.  
 
5.4. Theme 1: Impact of diagnosis and treatments on dietary choices 
Participants described dietary changes after cancer diagnosis in two ways: as a response 
to treatment-related effects and seeing the diagnosis as a “trigger” to consider and 
implement healthy eating habits. 
 
5.4.1. Subtheme 1: Managing altered gastrointestinal function  
Participants referred to gastrointestinal side effects, such as diarrhoea, flatulence and 
bloating, affecting aspects of their daily life. Gastrointestinal problems were particularly 
reported by people with a lower GI cancer diagnosis (rectum or anus). Participants in the 
post-treatment phase also described experiences of gastrointestinal side effects, 
indicating persistence of these problems up to at least 24 months post radiotherapy 
completion. Alteration of the amount of fibre in diet, reduction of foods that cause bloating 
(e.g. onions, pulses) and avoiding spicy food were some of the techniques participants 




Figure 5.1: Overarching theme (in black box), themes (grey boxes) and subthemes (white boxes). 
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"I stopped having an Indian meal… during treatment. The spices nearly gave me… the 
spices gave me diarrhoea for 24 hours. The one time I tried … I used to eat an Indian 
meal now and again as one of my evening meals. I did it by mistake probably, not by 
mistake but not thinking while I was being treated and the result of diarrhoea because of 
the irritation of bowel was awful. So I haven’t had one of those since." (Theodore, prostate 
cancer) 
Provision of advice on how to manage gastrointestinal issues was reported by only a few 
participants, mainly in writing. Information and support influenced people to modify their 
diet and alleviate side effects.  
"I have had less vegetables and less beans and less onions, due to being told that they 
increase the level of flatulence that was happening post-surgery and through 
radiotherapy." (Gabriel, prostate cancer) 
Other participants did not find written information particularly helpful. People who did not 
recall receiving any guidance described a “trial and error” approach to identify which foods 
had a negative impact on their gastrointestinal function. 
"It contained information like: if you get bladder problems avoid coffee, alcohol, tea and 
things that would irritate… yeah that was one of the leaflets. The leaflet is called 
“Managing bladder problems during radiotherapy: Information for patients”. […] Nothing 
specific, not… you know… just this is a list of drinks that you’ll find with water and this is a 
list that can irritate you." (Theodore, prostate cancer) 
“I don’t think anybody has spoken to me, you know, through the time about my diet or 
anything. I’ve just … they’ve just asked questions about what I’ve been eating, but I don’t 
think I really had any help. I’ve just done it myself and you know, magazines, and I’ve 
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picked up “Eating for cancer” (leaflet) in the hospital. Yeah, so I’m just doing it by trial and 
error myself”. (Grace, rectal cancer) 
 
5.4.2. Subtheme 2: Managing altered appetite 
A few participants currently receiving treatment experienced taste changes and altered 
appetite. One post-treatment participant also described altered taste currently affecting 
them. Other post-treatment participants, who mentioned appetite loss and taste changes 
during treatment, no longer had these symptoms. All participants who described taste 
changes and loss of appetite received chemotherapy as part of their treatment.  
“And also food doesn’t taste quite the same as it did. It’s quite strong foods I can taste and 
others I can’t really taste the same anymore. An example I can really give you is, you 
know, curry has quite a strong taste, so I can still taste that but some others are… yeah… 
not the same." (Frederick, rectal cancer; 11 months post-treatment and still experiences 
altered taste) 
“Well I didn’t have any desire to eat, I couldn’t taste anything… food was a necessity, 
which, you know, I was being told I had to have, quite rightly, but I would have been quite 
happy not bothering" (Isaac, rectal cancer; post-treatment and does not experience 
appetite problems any more) 
None of the participants recalled any dietary advice from health professionals with regards 
to appetite or taste changes. A few participants with a prostate cancer diagnosis currently 
receiving treatment mentioned increased appetite, which they attributed to the receipt of 
hormone treatment (along with radiotherapy). For example, Dylan experienced increased 
appetite but did not discuss this with a health professional: “…the (hormone) treatment 
does seem to have made me put on weight but also it has given me more of an appetite."  
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5.4.3. Subtheme 3: Impact of an ostomy 
Three participants (one on-treatment, two post-treatment), all with a rectal cancer 
diagnosis, described the effect of having temporary or permanent ostomy on their diet. 
Tyler (rectal cancer) described how the foods he ate affected the output and the 
adjustments he made to make sure the ostomy hole was not blocked. He had to remove 
high fibrous foods, fruit and specific vegetables from his diet, such as onion, garlic, 
sweetcorn and peas, as these were not digested and increased the overall output in the 
ostomy bag. Stoma nurses offered the support he needed to control the stoma output and 
he was pleased with the guidance on low fibre diet, as he subsequently did not experience 
gastrointestinal problems.  
“I basically kept it to whatever the professionals did tell me to do. [...] Basically whatever is 
in the booklets I got from the professionals is what I follow. That’s my bible." 
Lillian (rectal cancer) recently had an ostomy reversal and described how it affected her 
diet: “I don’t eat breakfast but that is down to having had […] the (stoma) reversal. So I got 
into the habit of not having breakfast after the reversal so as not to kick the… the digestive 
process. […] I can’t eat things like pulses, lentils, chickpeas; I can’t eat any of those. 
Because my bowel is a bit sensitive really after (reversal) […] I would (avoid), you know, 
the usual things, broccoli, cauliflower; you know any of those types of vegetables.” All 
adjustments were made by herself and she did not receive any dietary advice after the 
reversal, which had a negative impact on her quality of life: “… and then the stoma 
reversal I didn’t get any support at all. I was really left on my own. […] And even when I 




5.4.4. Subtheme 4: Dietary adjustments as preparation for treatments 
Interviewees currently in receipt of radiotherapy mentioned dietary adjustments necessary 
for radiotherapy or other treatments. Guidance to avoid alcohol, caffeine and red meat 
and drink more water was provided by health professionals, to ensure that participants 
were well hydrated and side effects were minimised. Participants adhered to this guidance 
but some found it challenging to follow the recommendation to be well hydrated.  
"So basically for a period of five weeks I cut out three things from my diet; alcohol, maybe 
apart from one or two occasions but pretty well cut out, alcohol; caffeine, so now I drink… 
I still like some tea but I drink decaffeinated tea, so caffeine; and also red meats. For a 
period of five weeks I didn’t eat beef and lamb and pork." (Logan, prostate cancer) 
“… because I’ve been having pelvic radiation, I have to drink a lot of fluids, to be very well 
hydrated […] I am not a very good drinker. Some people like to drink all the time. I am not 
one of them […] I used to drink quite a lot of sparkling water and even now I am struggling 
to drink.” (Penelope, endometrial cancer) 
 
5.4.5. Subtheme 5: The “teachable moment” to change dietary habits 
Cancer diagnosis was a trigger for some participants to consider making dietary changes 
for future wellbeing. The level of reported changes varied from small changes in one 
dietary component to adopting a whole new approach towards diet and nutrition.  
"I have changed slightly. We did use to base it on two ounces of meat, which is 56 grams 
of meat, but […] I cut it down to the safe, 45 to 50 grams. That’s about the only change, so 
the same basics meals as before, but slightly smaller." (Thomas, prostate cancer) 
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“I'm more likely now to eat maybe more vegetables or more greens. […] …more fruit, less 
red meat, more white meat, more fish. So all of those things I now do as a matter of 
course” (Caleb, prostate cancer) 
Some interviewees acknowledged the need to pay more attention to their diet as a result 
of diagnosis. Oscar (prostate cancer) took “a lot more notice than I used to, to be perfectly 
honest. Before, frankly, I would eat anything that was there, pretty much, except for the 
things I don’t like”. Diagnosis was a trigger for weight loss for another participant: “"It is a 
wakeup call I suppose but that’s it basically. I do feel good, eating less and I am going to 
lose weight.” (Benjamin, prostate cancer). 
Several post-treatment and a few on-treatment participants (mainly those with a prostate 
cancer diagnosis) talked about healthy eating practices. These participants experienced 
fewer side effects from treatment, thus were able to implement healthy dietary practices 
rather than focussing on alleviation of symptoms. Reported dietary changes included 
reduced consumption of meat and processed meats, alcohol, salt, caffeine, ready meals 
and increased consumption of fruit, vegetables (especially tomatoes for survivors of a 
prostate cancer), fibre, fish, nuts and water. Some examples of dietary changes are 
presented below: 
“I am drinking alcohol now but not at the level I drank before… I’ve kept off caffeine, I am 
still not… wherever I possibly can, not have caffeine. And as far as the red meat is 
concerned I probably don’t eat as much of that actually. I eat more white meat and 
vegetables. I also eat… also through this period I started to eat more fruit, as a matter of 
course drink  more water as a matter of course and probably have more fish as well.” 
(Logan, prostate cancer) 
"I don’t eat as much meat as I used to … probably one or two times a week I’ll eat meat. 
[…] (Before diagnosis) I probably ate more meat so out of the seven meals of the week I 
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was probably eating… five or those would be meat where it’s probably the opposite now.” 
(Dexter, rectal cancer) 
A few participants described dietary changes to support recovery during and after 
treatment for cancer, such as using nutritional supplements (e.g. multivitamins), because 
“the radiation process is poison of my body and I want to give my body as much support 
as I can … trying to rectify anything else it’s been done over the past six months.”  
(Gabriel, prostate cancer). Lillian followed a vegetarian diet before cancer diagnosis and 
decided to add animal protein (but not red meat) in her diet after diagnosis to support 
recovery from the treatment. 
Dietary change was not necessary for some participants, as they considered their 
previous dietary habits to be healthy and side effects either did not exist anymore or did 
not have a significant impact on their daily life.  
I was lucky enough not to feel nausea or sick so I ate exactly the same whilst the 
treatment was going on, before, after and still now. Exactly the same" (Claire, cervical 
cancer) 
"I don’t feel I had to adjust nutrition or eating or lifestyle too much.” (Ethan, prostate 
cancer) 
Diagnosis prompted a few participants to consider further improvements in their diet, 
despite perceiving their diet to have been healthy prior to diagnosis: "I would say I didn't 
eat extremely unhealthfully before […] ...we tend to eat a lot more chicken since I’ve had 
this problem and a lot more fish. So we have fish twice a week now." (Caleb, prostate 
cancer) 
Compared to dietary support for side effects, discussions with health professionals around 
a healthy diet and future health were more often reported. Guidance was provided mainly 
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in written format, such as booklets available in the waiting room at the hospital or given by 
nurses and oncologists. Provision of such advice influenced dietary change for some 
participants but not those who perceived themselves to have had a healthy diet and 
lifestyle before diagnosis.  
“It (the booklet) was telling me to stay away from processed meats which of course I did, it 
gave me advice on what were good vegetables to eat, which is why I started eating a lot 
more tomatoes, because that was my other thing, it was strongly recommended. I started 
eating more fruit as a recommendation.” (Oscar, prostate cancer) 
“I was given a dietary book by Macmillan, which kind of outlined things to avoid, if 
possible, and also things that they thought would benefit. Most of that is just healthy foods 
anyway, you know, keep away from fatty foods and things, which everything kind of fit it 
the way we live anyway, really.” (Frederick, rectal cancer) 
 
5.4.6. Subtheme 6: Impact of treatments on body weight  
Most participants mentioned weight changes as a result of diagnosis and treatments. 
There was a mix of experiences, with some participants losing weight, others gaining 
weight and a few describing fluctuations over the period of diagnosis, treatment and 
survivorship. The effect of treatments on weight was expected by most participants. In 
some cases, changes were perceived as small, while others put on weight as an attempt 
to keep themselves strong during treatment and avoid weight loss. Health professionals 
had warned some of the participants about the potential to put on weight as a result of 
treatment. 
"Yes, so… when I had the chemotherapy I put on weight because I think it was probably 
due to the steroids that they give you each time you have it, so obviously it’s to stop the 
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reaction but it makes you hungry. So I did put on a bit of weight. About…I probably put on 
3 kg. And then I lost that 3 kg. So since I’ve been on radiotherapy, I’ve lost 3 kg. Pretty 
much, I’ve lost what I’ve gained. So it’s not got worse than that." (Penelope, endometrial 
cancer) 
"I put weight on after diagnosis and during treatment, because I was eating what I could to 
try and keep myself strong, and at which point I added back in chicken… [...] Following the 
bowel surgery it was pretty normal really, but since having had the reversal, I’m probably 
down half a stone, which kind of fluctuates. But not much." (Lillian, rectal cancer) 
Despite weight changes and the potential impact of treatment on weight, the advice from 
healthcare professionals was to keep stable body weight during radiotherapy, as it 
determined the amount of radiation. Some of them managed on their own to keep a stable 
body weight successfully. One participant had put on weight during treatment but the 
healthcare team were more concerned about weight loss, rather than weight gain. 
“I was told I’d put two stone of weight on. I didn’t, because I managed that myself. I was 
determined not to put weight on” (Oscar, prostate cancer) 
"I gained weight during the chemotherapy and radiotherapy treatment for a year. Nearly a 
stone in weight, which they (the healthcare team) weren’t concerned about because, you 
know, rather than losing weight, it was healthy. (Claire, cervical cancer) 
 
5.4.7. Subtheme 7: Perceptions of weight status and weight changes 
There were contrasting views in relation to the perception of weight status. Some 
participants correctly identified themselves as having excess weight and acknowledged 
weight problems. Other participants perceived their diet, fitness or weight to be good, but 
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were classified as overweight or obese based on self-reported information on height and 
weight from the survey. One participant classified as “normal weight” based on Body Mass 
Index perceived they needed to lose weight: “I’d like to be a bit lighter, if possible." (Dylan, 
prostate cancer), whereas one participant classified as “overweight” perceived his weight 
to be within the normal range: "I’ve never had a weight issue or a weight problem" 
(Stanley, prostate cancer).  
Emotions were expressed with regards to current weight status and body image by some 
participants, especially from the ones on post-treatment stage. Cancer diagnosis was a 
trigger to consider weight status and weight loss. One participant managed to lose weight 
and was feeling good about being able to do activities he was struggling with before and 
had a positive body image: "I was getting down on the floor yesterday with my 
granddaughter and my aches… I didn’t ache the same. […] I wear a lot of T-shirts now 
and trousers and jeans fit a lot better” (Benjamin, prostate cancer) 
On the other hand, a few participants had put on weight since diagnosis and had a 
negative body image. "… because I’ve given up smoking I’m always hungry. […] I don’t 
like it. […] I feel like I am trying to find a substitute. I know food is not the answer, because 
my clothes now don’t fit me” (Ellie, anal cancer) 
Scarlett (endometrial cancer) expressed concerns about current weight status, and feared 
that excess weight was related to the development of her cancer and was a reason for 
future cancer recurrence; therefore she needed to lose the excess weight but was unsure 
how. She also did not know what she was doing wrong and could not lose weight. She 
discussed weight problems with a nurse, who gave her a weight loss target but without 
guidance on how to achieve that. 
"I think since I was diagnosed with the cancer that I worried it was because of weight 
around my tummy so I think… well, now I’ve had my treatment and I need to lose that 
(weight) otherwise it might come back. […] I think I am frightened if I don’t lose weight I 
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sort of almost not deserve… but it may come back. And I think “Did I cause it, did I cause 
the cancer in the first place? […] It’s got to be the quantity of cheese and biscuits or … I 
don’t know. I don’t know. That is my problem, I don’t know" (Scarlett, endometrial cancer). 
Cancer diagnosis had a significant emotional impact on some interviewees, which had a 
direct effect on their weight – either loss or gain.  
“So when I was troubled with the cancer, obviously with all the worry and… I mean you 
wouldn’t eat and whatever, and I went into hospital and had the operation and come out, 
and he then said you’ve got to put weight on [...] I went right down to about 100 kilos then” 
(Toby, prostate cancer) 
"...there’s been an increase in weight due to certain amount of lack of exercise, emotions 
and… what do they call it… comfort." (Gabriel, prostate cancer) 
 
5.4.8. Subtheme 8: Need for health care professional support 
Several participants mentioned that there had been no provision of advice or discussions 
with health professionals regarding any dietary issues they may have faced during and 
after treatment. As described above, issues were related to treatment side effects and 
weight management and lack of support proved challenging for some of them. 
Ethan (prostate cancer) was surprised no discussions were made in relation to 
consumption of fruit and vegetables and weight management: "I was surprised they didn’t 
stress more the, sort of, benefits of, you know, the 5-a-day type of diet or diet to make 
sure you don’t put more weight, well, you didn’t put on more weight.” 
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Dexter (rectal cancer) had discussions with the stoma nurses but perceived the advice 
unsuitable for his individual needs: “I think, from a NHS point of view I don’t think they are 
really giving detailed dietary or nutritional information, well certainly for me they didn’t.” 
One participant actively sought support on nutritional practices to support recovery, such 
as the use of nutritional supplements: "So I said to him (the consultant): “So, since I’m 
going to have this treatment, as well as getting ready mentally, from a nutrition point of 
view what should I be doing to get ready for it? Should I be enhancing my body with 
Vitamin C or should I be eating seaweed or anything like that?" […] And generally most of 
the answers I got back were that I didn’t need to do anything […] …if they say there is 
nothing you can do, I have to accept that. It is pointless; there is nothing I can do."  
(Gabriel, prostate cancer) 
Participants were generally interested in learning more about diet in relation to the 
management of side effects. Health professionals were considered the most credible 
sources of information. "I think it perhaps would be nice, sort of while you’re there, 
perhaps have a quarter of an hour with somebody, it would be quite… […] You know, with 
the bowel not working as it used to be… how to, sort of, work things out, might be helpful. 
So something like that would give you some guidance." (Grace, rectal cancer). Grace 
continued saying that she acknowledged how challenging it is to provide dietary advice 
given that each individual may experience different treatment side effects.  
"I mean, again, it is individuals I think because at the hospital we were all having different 
types of treatment. Some were having the chemo tablets, some weren’t. So I realise it’s 
sort of difficult for people to, you know… If you generalise things, that’s not helping, is it?" 
Post-treatment participants would also welcome guidance on weight loss and regular 
monitoring would act as a trigger for change.  
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"I would like perhaps to go to a proper diet regime because I would like to lose some 
weight. So if they do a proper diet… whether they could give me any information on that." 
(Aaron, prostate cancer) 
"I need to motivate myself better to actually do it. […] I do feel that if somebody gave me a 
target as such that I could […] if someone else said it, I am more likely to go for it and try 
it, yeah. Yeah, because I feel I am letting them down if I haven’t got some weight loss next 
time. So I think that will help." (Scarlett, endometrial cancer) 
Some participants looked for information about diet on the internet or the media. There 
were mixed reactions with the information they read; some information was useful, some 
was conflicting. Credible online sources, such as charity websites, were preferred. 
“A lot of stuff on the internet you can’t believe […] they contradict each other." (Toby, 
prostate cancer) 
Zoey (rectal cancer) had received conflicting information from different sources (media, 
newspapers, health professionals) and she expressed scepticism on which source was 
more reliable.  
"You speak to one person and then another person says something else. You watch the 
telly and that will say something completely different. Or you look at a newspaper or a 
magazine or something and it will say something different again. I just don’t know who 




5.5. Theme 2: Personal resources 
This theme describes participants’ level of knowledge regarding diet and nutrition and how 
they applied this knowledge in living with and beyond cancer. It also highlights how 
personal interest in diet, awareness of research, health literacy and ability to cook and 
access healthy foods affected their dietary choices post-diagnosis.  
 
5.5.1. Subtheme 1: Pre-existing knowledge 
Most participants showed high awareness of a healthy diet by giving examples of healthy 
or less healthy foods and dietary practices. Participants’ views of a healthy diet were 
largely in agreement with dietary recommendations available from Public Health England 
(Eatwell Guide) (Public Health England, 2016) or the WCRF (World Cancer Research 
Fund/American Institute for Cancer Research, 2018). Some participants emphasised 
portion control, reading food labels and watching the caloric content of foods as a means 
of maintaining a healthy diet, indicating personal interest in diet. One participant described 
how they preferred to consume vegetables over fruit because of the increased natural 
sugar content of fruit: "Eating vegetables. And fruit, but mainly vegetables, because fruit 
obviously have their natural sugars” (Claire, cervical cancer). 
In the case of Dexter (rectal cancer), perceived benefit of a high fibre diet led him to reject 
the nurse’s advice for a low fibre diet as a way for controlling stoma output; he considered 
the dietary approach “bland” and lacking in nutrients. He would rather experience 
increased output than losing the health benefits of a high fibre diet.  
Participants’ level of knowledge on diet and nutrition was shaped from past experiences. 
Some participants, who acknowledged the importance of keeping a healthy weight after 
diagnosis, had attempted weight loss in the past. Others had worked in health-related 
environments (e.g. as a nurse or at the Department of Health) and were familiar with what 
constitutes a healthy diet.  
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“I’ve got a nursing background so I am fairly au fait with dietary requirements and calories, 
amounts and, you know, what people need when they’re ill, what people need when they 
are inactive and that sort of thing” (Penelope, endometrial cancer) 
 
5.5.2. Subtheme 2: Ability to cook 
Most participants were able to cook or shared cooking responsibilities with the spouses: "I 
always make my food” (Claire, cervical cancer). Cooking from scratch using fresh 
ingredients was a habit before diagnosis for several participants and was considered part 
of having a healthy lifestyle. 
Other participants did not have the ability to cook or were not interested in preparing 
meals. Zoey (rectal cancer) reported mobility problems and found it difficult to stand for 
long in the kitchen and prepare a meal from scratch. She described how she made quick 
and (perceived as) healthy meals: "I’ve just put the cooker on for some… we call it a 
mince mess, but it is beef mince, a low fat beef mince with vegetables, tomatoes and 
sauce and … just a mess, I always call it a mess. I tend to use sauces rather than cooking 
from scratch for things like curries and stews and things like that." She understood that 
ready-made sauces were classified as processed food but she felt there was nothing else 
she could do given the circumstances. "...the only I have processed really is the ready-
made sauces and if I don’t have that in my life then we won’t live, because that’s the 
easiest thing for me to use." 
 
5.5.3. Subtheme 3: Ability to access healthy foods 
A number of participants had access to and could afford to buy higher quality food. A few 
bought foods from local markets and some bought organic food as they believed it was 
better quality. Others bought foods from supermarkets and they often mentioned 
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“Waitrose” and “Marks and Spencer”, which they would trust because of (what was 
perceived as) higher quality food. 
"… where we live, a lot of my stuff is bought in either M&S or Waitrose, cause I trust them" 
(Lillian, rectal cancer) 
"Quite close to where I’m living there is a place, [...] which is a small-ish farm and they just 
grow organic food. And we have a market not far away and we go to the market and there 
are lots … some people that grow their own foods and things and bringing them to sell.” 
(Dylan, prostate cancer) 
Four participants had allotments where they grew their own fruit and vegetables. They 
commented on the superior quality of the foods they produced and on the fact that 
gardening contributed to their physical activity levels. 
“I am a keen gardener and I have at least one allotment and I was always very conscious 
on how fresh fruit tasted so much better and I am sure the way I was going… it was a 
nutritionally higher content, you know.” (Ethan, prostate cancer) 
“I have an allotment, so I have plenty of vegetables and I always have two or three 
vegetables and some meat […]… gardening and allotment keeps you fit” (Claire, cervical 
cancer) 
On the other hand, a few participants acknowledged that finances restricted their choices 
for healthy food: “...because we are pensioners and we can’t, we can’t always buy what 
we want to buy. We have to buy what we can afford. So we are very careful about 




5.6. Theme 3: Social resources 
This theme describes the influence of family in participants’ diet and highlights the role of 
the spouse in preparing food and caring for the patient. 
 
5.6.1. Subtheme 1: Spousal support 
Participants described how their spouse was often in charge of preparing food for the 
household. Male participants more often mentioned having meals prepared by their 
spouses than female participants, who were usually in charge of preparing food for the 
household, but this was often a shared task. On several occasions, participants used the 
pronoun “we” instead of “I” when referring to dietary habits, cooking and shopping 
practices. 
Spouses had a significant role in actively supporting nutritional needs of participants 
during and after treatment, through preparation of meals. Factors that influenced quality of 
meals were appetite problems during treatment and a drive towards a healthy diet and 
lifestyle post-treatment. 
"...and I had people here that would make sure I ate. […] "My wife, you know, was trying 
to make it interesting for me and came up with various ideas. So I was blessed with a lot 
of help." (Isaac, rectal cancer) 
“She has changed the types of food that we eat, so she has deliberately gone out and we 
eat more fresh fish and we do eat less red meat now so… and, you know, we do have 
more vegetables… [...] So she has changed the diet actually, she has changed the types 
of things that we eat now, so … [...] And it is because of, the typical family meals changed 
somewhat." (Logan, prostate cancer) 
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People who were living alone or without a spouse shared experiences of support from 
their children or other family members. Children had an important role in supporting 
participants to recover during and after treatment.  
"...she shops with me and she makes sure, well she makes sure, she advises me on 
things not to eat and what I should eat because obviously I live by myself.” (Oscar, 
prostate cancer) 
"My daughter bought me some Complan (energy supplement) because I couldn’t face 
food. That obviously helped to keep me going" (Chloe, endometrial cancer) 
 
5.6.2. Subtheme 2: Familial dietary habits 
Dietary habits of family members sometimes influenced participants’ dietary habits, 
especially if participants had their meals prepared for them. For some participants, family 
meals were more important than their individual needs or preferences. 
“I would like to eat a lot more fish, but the rest of my family generally don’t want to eat fish. 
So on occasion we can have some fish but it is not a regular thing that will be tolerated as 
a meal. […] There has to be some amount of consensus, because it’s pointless to cook a 
meal that no one’s going to eat."  (Gabriel, prostate cancer) 
“Obviously we try to eat together if we all cook so I wouldn’t want us to spoil it for anybody 
else, you know, so I am quite happy to, sort of… if it is a little bit bland then I just soak it 
up with it really. I don’t necessarily change anything.” (Frederick, rectal cancer) 
Spousal dietary habits also influenced participants to adopt a healthier diet.  
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"But we do try to eat as healthily as we can because she likes to keep count of her weight 
obviously. So she eats lots of vegetables and consequently I do as well" (Stanley, prostate 
cancer). 
 
5.7. Theme 4: Comorbidities and disabilities 
In some cases, additional comorbidities and/or disabilities affected the diet or lifestyle of 
participants. Toby (prostate cancer), diagnosed with gout in the past and recently 
diagnosed with diabetes, described dietary adjustments over time. "I have cut out all 
sugars before that (diabetes) because I had gout and I looked into it and red meat and 
sugar and stuff like that are all uric acid, is what builds it up. So I cut out all sugar, I mean 
ages before that, but I still got it (diabetes)." 
Stanley perceived that the recent diagnosis of coeliac disease affected his diet more 
directly than the cancer diagnosis: “I’m sure they (the general practitioner) will come up 
with a coeliac plan or coeliac diet sheet of some sort telling me what I can and can’t eat 
because it’s directly attributed to diet isn’t it… obviously the coeliac disease. Whereas the 
cancer, the prostate cancer, isn’t directly, you know… connected to the diet.” 
Zoey also mentioned suffering from depression which had affected her desire to eat well. 
"Because I am stuck in the house all the time, I suffer with depression and if I have a bad 
diet, I just don’t bother at all." 
Benjamin’s diagnosis of psoriatic arthritis further affected his ability to exercise (apart from 
fatigue as a treatment side effect for prostate cancer): I can’t do them (exercises) heavy 




5.8. Theme 5: Influence of work  
Several participants were currently working and described how work or travelling to work 
impacted on their food choices.  
“… A light, very light breakfast, for lunch probably a sandwich, some fruit and a cold drink. 
I work in London so I travel, I get home quite late so my eating meal would be around 8 
o’clock " (Logan, prostate cancer) 
Most of them, were trying to choose healthier options whilst travelling and managed 
effectively to combine travelling and work commitments with any effects the cancer 
diagnosis had on their diet. Ellie (anal cancer), however, started attending a weight loss 
group but had to stop because of starting her new job. "So I went to the first one [...] and 
then unfortunately I started my new job. So I couldn’t attend because I had to work in the 
evenings". She had not managed to join another weight loss group.   
 
5.9. Theme 6: Regaining normality 
In this theme, participants described aspects of their lifestyle that provided them with a 
sense of “regaining normality”, that is getting back to how life was before diagnosis.  
The idea of “going about my daily life unhindered by physical constraints” was often 
expressed as an important need to maintain normality in daily life. Although the interview 
questions focussed on diet, several participants, especially survivors of a prostate cancer, 
linked normality with mobility, activity, and the ability to do everyday activities and keeping 
fit. People who experienced fatigue as a treatment side effect highlighted the negative 
effect of fatigue on the ability to deal with daily activities and carry on with life. 
“I was quite lucky until about the fourth week and started getting tired and, uhm, when 
everything went wrong… I was so tired all the time, I just didn’t… I just couldn’t care less. 
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It was a horrible way to be for a while and I am coming down now of that now.” (Sophia, 
rectal cancer) 
For some respondents, diet was not seen as the sole lifestyle factor to address after 
diagnosis, but exercise was also fundamental to regaining normality. These participants 
often referred to diet as an adjunct to keeping fit, active and healthy and perceived diet as 
a means to provide the energy in order to keep being active. 
"I presume you’ve got to support that (being active), you know, (diet) to be appropriate for 
how you’re trying to live." (Thomas, prostate cancer) 
A few interviewees gave examples of activities that kept them currently fit and healthy. 
Activities included regular exercise, walking, gardening and having a strenuous job, all of 
which were activities they were doing before diagnosis. 
“But keeping healthy is also to do with activity levels as much as… you are what you eat 
but also what you do. And I am very active. So it is in some way fuel, you know, if… I tend 
to my normal day; I walk the dog twice a day, so that’s probably up to five miles, four or 
five miles walking." (Penelope, endometrial cancer) 
Others were referring to a combination of exercise and a healthy diet to maintain current 
health. They also gave examples of specific aspects of diet that would help them keep 
healthy, such as consumption of fruit and vegetables, portion sizes, having variety in their 
diet and eating in moderation. 
"So that combination for me of exercise and eating well with vegetables and all the good 




"…eating a good diet with plenty of vegetables and fruit and having as much exercise as 
you can." (Claire, cervical cancer) 
Several participants had a more holistic view of their health and their perceptions of 
keeping healthy included not only diet and physical activity, but also avoiding alcohol 
consumption and smoking and maintaining a healthy weight.  
“…exercising regularly, eating a balanced diet and by that, I mean the types of foods I’d 
described, no smoking and having either zero or low alcohol intake” (Dexter, rectal 
cancer) 
 
5.10. Theme 7: Barriers for dietary change 
Participants’ knowledge of what constitutes a healthy diet was frequently reflected in their 
dietary habits. However, low motivation and lack of interest in the area of diet and nutrition 
were barriers to dietary changes. Some participants acknowledged dietary and lifestyle 
habits that were less healthy but they did not intend to change their habits.  
"I am not particularly interested in food. I think if I was… I used to like cooking and now 
I’ve just… I am not bothered if I do it or not." (Scarlett, endometrial cancer) 
"I do drink alcohol and I would think I probably drink more than… well, not probably, I am 
sure I drink more than it is good to drink but… […] I’ve got used to it; it has become some 
sort of a habit or a ritual" (Dylan, prostate cancer) 
In addition, participants with high levels of awareness of the role of diet in health and 
higher educational background (university or postgraduate degree, as stated in the 
survey) sometimes expressed scepticism about the importance of diet in survivorship. 
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They referred to “research”, lack of “evidence”, “probability” and “likelihood”, in their 
accounts.   
“I am not convinced that… as long as I eat a reasonably healthy diet, a reasonably 
balanced, let me not use the word healthy, a reasonably balanced diet and take enough 
exercise to keep me vaguely fit, um… I’ll be fine. And if they won’t move from that 
situation then you need to provide me evidence.[…] The lifestyle influence on prostate 
cancer appears to be fairly small, concerning the evidence." (Theodore, prostate cancer) 
"I am not aware of any foods that can stop me of recurrence of the cancer or particularly 
that can help me if I do get it.” (Chloe, endometrial cancer) 
Many of these participants perceived themselves to have led a healthy lifestyle before 
diagnosis and there was nothing more to do to have a healthier life from now on. Others 
believed that diet and lifestyle were unrelated to the development of cancer; therefore no 
further action was required in the survivorship stage. Instead, participants stated that other 
factors, such as genetics, gut microbiota and hormone imbalance influenced cancer 
development. 
"I can’t quite get my head around the fact that it is supposed to be all because of food. I 
think it is much worse in the world going on, that we could be just as capable of getting 
cancer from as anything else. And I don’t think this was relevant to my cancer." (Sophia, 
rectal cancer) 
“And I have the sneaking suspicion that, actually, we are very ignorant about what actually 
causes overweight. […] I noticed there was a report the other week by somebody saying 
that the gut microflora are incredibly important and the British people, as it happens, are 
not very best in this respect, compared with the microflora of, for instance, Mediterranean 
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people. […] Likewise, there are all these hormone balance things which seem to come 
up…” (Thomas, prostate cancer) 
People with high awareness of a healthy lifestyle and perceived healthy lifestyle prior to 
diagnosis requested evidence based nutritional information in order to be persuaded for 
dietary change.  
“Up to that point, I would consider that my diet was pretty healthy. But I still got the cancer. 
[…] It would take me a bit of convincing, because I, you know, I’m surprised” (Ellie, anal 
cancer) 
In relation to supplement use, a few participants believed supplements were not needed 
as they were getting all necessary nutrients from their diet and expressed scepticism on 
their effectiveness. Supplements were considered necessary only when consumed for 
health-related reasons, such as anaemia or arthritis.  
"They are a brilliant marketing tool for taking money off from people.[…] I have seen no 
consistent long-term evidence that any of the supplements do any good whatsoever as 
long as you eat a balanced diet”. (Theodore, prostate cancer) 
 
5.11. Analysis of survey free-text comments 
 
At the end of the final section of the questionnaire, participants were invited to add 
comments on any issues about their diet that they think might be important. Seventeen 
on-treatment and 63 post-treatment participants added free-text comments. Thematic 
analysis identified two themes that were similar to themes and subthemes found in the 
qualitative analysis of the interviews: “Self-management of dietary problems after 
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diagnosis” and “perception of a healthy diet prior to diagnosis”. Findings from the free-text 
comments, which come from a much larger sample of participants, supplement and 
enhance the findings from the interviews. 
 
5.11.1. Self-management of dietary problems after diagnosis 
Several participants described their experiences and self-management techniques in 
relation to diet after the cancer diagnosis. Diet had been affected by treatments, as well as 
the presence of comorbidities that had been developed prior or after the cancer diagnosis. 
In both situations, participants had adjusted their diet in order to support recovery and 
manage side effects.  Sometimes, dietary adjustments were a result of support from the 
healthcare team. 
 “I found it very difficult to eat a very low fibre diet but it was a necessity.” (rectal cancer, 
post-treatment)  
“During treatment my taste was affected but I was determined to stay fit so limited my diet 
in foods which didn’t give me a nauseous experience i.e. porridge every morning. […] 
After treatment finished, I began to ring the changes, but found chocolate, muesli, dried 
fruit and lettuce cause repeated loose stools. White toast moves reluctant stools. While 
travelling for five weeks, I was especially careful avoiding highly spiced foods and rich 
sauces” (anal cancer; post-treatment)  
“I have been able to maintain necessary weight loss through increased exercise and 
portion control.” (endometrial cancer, post-treatment) 
Some participants described weight changes and how they managed to control their 
weight during and after treatment. Others lost weight to improve health post-treatment: 
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 “It took a great effort and a strict 5:2 diet to get my weight and waist size back to where I 
was.” (prostate cancer, post-treatment) 
After treatment I chose to join Slimming World to lose weight. (rectal cancer, post-
treatment) 
 
5.11.2. Perception of a healthy diet prior to diagnosis 
Several participants perceived their diet to be healthy before diagnosis and that it 
continued to be healthy at present. These participants were more likely to report no 
dietary changes after diagnosis in the questionnaire (Question C1: Have you changed 
your diet since diagnosis?). They described current dietary habits, such as high 
consumption of fruit and vegetables and reduced consumption of red meat, which 
indicated high awareness of what constitutes a healthy diet. 
“We eat fruit and vegetables (green, root & potatoes) regularly also meat occasionally. We 
rarely indulge in pre-prepared meals and currently I only drink alcohol at weekends 
(Friday and Saturday)” (prostate cancer, on-treatment) 
My diet has not changed significantly since diagnosis or therapy. We have always taken 
care with the known problems – high fat/sugars/alcohol etc. and tried to eat modestly with 
a balanced diet. (prostate cancer, post-treatment) 
I was healthy and eating sensibly before diagnosis and now again. (anal cancer, post-
treatment) 




 “Tend to eat healthy foods, home cooked. Don’t drink or smoke. Eat lots of fruit & veg. 














In this chapter the quantitative findings from the survey and the qualitative findings from 
the telephone interviews are integrated. Data are integrated through triangulation and 
presented using a narrative approach (as described in Chapter 3). Data are presented in 
five sections, according to the study’s objectives and to significant findings from the 
independent analysis of the quantitative and the qualitative arm of the study. 
 
6.2. Structure of integrated findings 
For the integration of the results, the study’s objectives were taken into account:  
 Dietary changes following diagnosis 
 Assessment of awareness of and attitudes towards of nutritional recommendations 
 Receipt of information support from health professionals or other sources on diet 
and nutrition.  
Significant findings from the survey are listed below and were used for the structure of the 
integrated findings: 
 The association between dietary change and receipt of support  
 Increased awareness of dietary recommendations 
 Varied attitudes towards the importance of diet and nutrition in the survivorship 
phase 
 Lack of routine support and provision of information from health professionals  
 Low use of other sources of support 
Independent qualitative analysis of interviews confirmed the above topics and revealed 
additional important topics: 
 Concerns about weight 
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 Importance of family support through the cancer journey in relation to diet and 
nutrition.  
 Importance of regaining normality 
 
6.3. The association between dietary change and provision of 
information and support 
The survey results showed that 68% of the respondents changed at least one component 
in their diet after cancer diagnosis. Most of the changes were towards healthy eating 
recommendations, such as increasing intake of fruit, vegetables and wholegrains and 
reducing alcohol, sugary foods and processed food. Some respondents changed their diet 
in the other direction by reducing wholegrains (13%) and fruit (10%) and increasing 
refined grains (10%). Significant differences were shown between on-treatment and post-
treatment respondents in relation to consumption of refined grains and alcohol. On-
treatment participants reported increasing consumption of refined grains and decreasing 
consumption of alcohol compared to post-treatment participants. Also, there were 
differences among cancer diagnoses in relation to wholegrain intake as more participants 
of lower GI or a gynaecological cancer reduced wholegrain intake compared to urological 
cancer participants. Changes were implemented mainly to maintain general health (58%), 
alleviate treatment side effects (45%) and support recovery (41%). More people on 
treatment reported changing their diet to assist with treatment side effects and to support 
therapy and recovery (P<0.01) compared to the post-treatment group. 
Qualitative findings enhance the survey findings and provide more details of dietary 
changes as a means of alleviating treatment side effects and improving overall health. 
The theme “Impact of diagnosis and treatments on dietary choices” describes these 
dietary changes. Presence and severity of side effects varied, with gastrointestinal 
problems and appetite loss being reported particularly by lower GI and gynaecological 
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cancer survivors, and fatigue by prostate cancer survivors. In the survey, loss of appetite, 
taste changes and nausea were reported significantly more often by survivors of a lower 
GI or gynaecological cancer (P<0.01) compared to urological cancer respondents. 
Interviewees gave rich descriptions of the ways they managed gastrointestinal side 
effects, which included alteration of the amount of fibre in their diet (some increased and 
some decreased fibre intake and related foods), reduction of foods that caused bloating, 
and avoiding spices. Rectal cancer patients with a permanent or temporary ostomy were 
more careful with their dietary choices and adjustments, to ensure that output was 
controlled.  
Dietary change was not associated with the presence of side effects in logistic regression 
analysis. Participants who reported at least one side effect were more likely to consume a 
dietary supplement as part of their diet (OR: 2.46, 95% CI: 1.01-6.02). Results from 
interviews showed that very few participants consumed supplements, mainly for other 
health reasons or comorbidities (vitamin B12 and glucosamine sulfate), rather than the 
alleviation of side effects. 
For some participants, cancer diagnosis was also seen as a trigger or a “teachable 
moment” to take more care of their diet and health. This was particularly mentioned in the 
interviews by people on the post-treatment phase and among prostate cancer 
interviewees who experienced fewer side effects. Dietary changes included reduced 
consumption of meat and processed meats, alcohol, salt, caffeine, ready meals and 
increased consumption of fruit, vegetables (especially tomatoes for survivors of a prostate 
cancer), fibre, fish, nuts and water.  
On the other hand, 32% of the survey participants did not report any dietary changes 
following diagnosis. Also, when assessing dietary changes per food group, it was shown 
that 49% to 76% of participants reported no change in specific food groups. Qualitative 
findings revealed that some participants felt no changes were necessary, as previous 
habits were – subjectively – considered good, and presence of side effects did not have a 
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significant impact on their daily life. Even for participants who reported a change in their 
diet, qualitative findings showed that most of them perceived themselves to have already 
had a healthy diet and lifestyle overall. Others were not interested in diet and nutrition, 
despite acknowledging that further improvements could be made in their diet. In the 
survey, a small percentage (3%) of respondents who did not have discussions with health 
professionals were not interested in discussing diet and nutrition because they perceived 
the topic to be unimportant. Also, 14% of participants were not interested at all in receiving 
additional information about diet and nutrition. Other barriers for dietary change included 
scepticism of the role of diet post-diagnosis, low motivation and perceived lack of link 
between diet, nutrition and cancer. 
Dietary change was significantly associated with receipt of dietary information and support 
from the healthcare team (OR: 3.63, 95% CI: 1.82-7.23); however, support was not 
routinely provided; only 43% of the survey respondents received information. Information 
was mainly about general healthy eating and less about alleviation of treatment side 
effects. Findings from interviews further emphasised the lack of routine support and 
revealed a mix of views and emotions with regards to the quality of the information 
provided. More interviewees described discussions around general healthy eating and 
very few reported discussions related to treatment side effects. For some, lack of advice 
about gastrointestinal problems was a negative and stressful experience. 
Most participants who received nutritional support perceived their needs to be well met 
(77%) and information easy to follow (76%). The rest of the participants either had neutral 
responses or negative experiences. Provision of support influenced 67% (73/108) to 
change their diet. Responses from interviews were mixed in this aspect. For example, 
some participants had a very positive experience of dietary support from the health 
professionals but other participants considered support inadequate. Support was mainly 




People who did not recall receiving dietary support (57%) would like to have had 
discussions about topics such as management of side effects, weight management and 
general healthy eating. This is also depicted in the overall high interest in getting more 
information about diet and nutrition (68% were moderately to extremely interested). 
Provision of support in a paper format was preferred by most, and at any time after 
diagnosis. Interviews also revealed high interest for information and for face-to-face 
discussions with a health professional. People who were interested in weight 
management also expressed a request for regular monitoring. 
Fewer respondents looked for dietary information in other sources and those who did 
mainly sought information from cancer charities websites or medical websites. People 
who looked for information from other sources were more likely to have also received 
support from health professionals (OR 2.17, 95% CI: 1.07-4.40) and to have changed their 
diet (OR 3.76, 95% CI: 1.67-8.47). Interviewees also expressed preference for credible 
online sources, such as the Macmillan website. Experiences of support from other 
sources were mixed, with several interviewees showing mistrust in online sources. Survey 
results showed that only about half of the people who sought information from other 
sources were satisfied with it.  
 
6.4. Weight problems 
Based on self-reported height and weight and calculation of Body Mass Index (BMI), 36% 
of the participants were classified as overweight and an additional 23% as obese. In total, 
59% of the sample (n=147) had a BMI over 25kg/m2. There was no difference in BMI 
status according to treatment status or among diagnoses.  
A third of participants reported weight gain since diagnosis, 26% weight loss and for 39% 
weight did not change. Qualitative findings showed that some participants experienced 
fluctuations in their weight, from diagnosis through to survivorship. Concerns about 
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current weight status and body image dissatisfaction were expressed by several 
interviewees. Some described their effort to lose weight, as they acknowledged weight 
problems. There were, however, others who perceived their weight to be within the normal 
range, although their calculated BMI was over 25kg/m2 based on self-reported survey 
data. 
Provision of advice and support in relation to weight management from health 
professionals was reported by only 17 participants in the survey, while 15 participants 
looked for such guidance in other sources (survey data). This corresponds to 16% of 
those who received support by health professionals and 19% of those who searched for 
information in other sources.  Similarly, only a few interviewees mentioned discussions 
with health professionals in relation to weight.  
 
6.5. Awareness of and attitudes towards diet and nutrition 
Results from the survey showed overall high awareness of nutritional recommendations. 
Between 91% and 95% of participants were mostly or very familiar with the content of the 
WCRF (2007) recommendations for weight, high calorie foods, consumption of at least 
five fruit and vegetables per day and alcohol and supplement use. Lower levels of 
awareness were shown in relation to the recommendations on red and processed meat 
consumption (30% mostly and 42% very familiar) and salt intake (26% mostly and 57% 
very familiar).   
Awareness of what constitutes a healthy diet was also evident during the interviews.  The 
theme “Personal resources” described knowledge and attitudes towards the current and 
future role of diet and nutrition. Overall, participants were aware of different topics around 
diet and nutrition and how a healthy diet can assist in future health. Several participants 
also gave examples of dietary habits they considered healthy and they implemented in 
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their daily life. However, not all of them practiced what they perceived was good for their 
health. 
Participants generally believed diet and nutrition is an important aspect post-diagnosis. 
Diet and nutrition were perceived as important or very important by 74%, 94% and 87% of 
respondents in relation to reducing the chance of cancer recurrence, improving overall 
health and supporting recovery, respectively. Respondents were less confident about the 
role of diet in alleviating side effects. Diet and nutrition were perceived as important or 
very important by 77%, 50% and 65% of respondents in relation to alleviation of GI side 
effects, appetite side effects and fatigue, respectively, which are common pelvic 
radiotherapy side effects. Eighteen percent of respondents believed nutrition was not 
important at all in improving appetite and 15% did not think nutrition could alleviate fatigue 
symptoms.  
Interviews also revealed some scepticism among participants about the role of diet post-
diagnosis. Several participants perceived nutrition to be an important element for future 
health. They also believed they were following a healthy diet and any changes were 
temporarily implemented for the alleviation of treatment side effects. People with a higher 
educational background requested evidence-based dietary advice. Others believed there 
was no connection between their diet and development of cancer; believing other factors 
were more important in the development of cancer. Some participants were not convinced 
about the usefulness of dietary supplements to support health post-diagnosis or post-
treatment. These participants were more likely to mention they had no discussions with 
health professionals because they did not feel they needed any guidance.  
 
6.6. The role of family 
This section includes findings predominantly from the qualitative analysis of the 
interviews. The survey did not include questions about family support since diagnosis in 
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relation to diet and nutrition. A few questions were indirectly related to family support, 
such as preparation of meals and consumption of homemade and ready meals. 
Interviews, on the other hand, provided rich content for this section. 
Results from the survey showed that most respondents had meals with the 
spouse/partner (72%) and/or other family members (25%). Also, for some participants, the 
preparation of meals was the spouse’s/partner’s responsibility (37%) or a shared task 
(24%). Participants had frequently consumed home-made meals (64% had home-made 
food 5 or more times per week) and had avoided ready-made meals (31% had not 
consumed ready meals and 43% consumed less than 3 meals over a month). 
Results from the interviews showed that family members, particularly the spouse, 
supported participants to deal with treatment side effects and adopt healthier dietary 
habits since diagnosis. Survivors often referred to dietary habits, as well as cooking and 
shopping practices with the spouse. Provision of verbal advice and assistance shopping 
for the household were some of the support practices of family members. 
 
6.7. Ability to self-manage diet after diagnosis 
Information in this section also derives exclusively from the qualitative findings, 
highlighting the advantages of using a mixed-methods research design. The importance of 
trying to carry on with life as before diagnosis was strongly expressed by several 
participants. Also, diet was not seen as an isolated lifestyle factor that could change 
following diagnosis, but also physical activity was frequently mentioned. Several 
interviewees perceived the combination of a healthy diet and regular physical activity as a 
means of living healthier from now on.  
A number of facilitators and barriers were expressed from participants regarding their 
ability to self-manage their disease. Perceived high awareness of a healthy diet, family 
and healthcare support, the ability to shop and cook high quality food and the ability to 
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grow own fruit and vegetables were all enablers of engagement to healthy eating habits. 
On the other hand, inadequate healthcare support, receipt of conflicting information, 
weight problems, treatment side effects, comorbidities and disabilities were seen as 
barriers to dietary change. Figure 6.1 summarises the enablers and barriers to self-
management, as these were identified from the quantitative and the qualitative analysis. 
 
 
Figure 6.1: The ability to self-manage diet after a cancer diagnosis: Enablers and barriers to 













This mixed-methods study aimed to explore dietary changes and experiences of 
nutritional support from the time of diagnosis through to the post-treatment survivorship 
phase in people diagnosed with a pelvic cancer and treated with pelvic radiotherapy, with 
a view to highlighting unmet needs in the area of diet and nutrition. Pelvic cancer survivors 
were mostly aware of what constitutes a healthy diet and the importance of having a 
healthy weight and some made dietary changes, but the majority of participants had 
increased weight, indicating that behaviour change may be a more complex issue. In 
addition, dietary support was not routinely provided and treatment side effects affected 
most survivors, further highlighting unmet needs in diet and nutrition post-diagnosis. 
There is compelling evidence that cancer patients have unmet support needs in a range of 
different domains and the NHS has set as a priority addressing these needs to improve 
quality of life. This PhD provided important information regarding pelvic cancer survivors’ 
nutritional problems in relation to cancer, as well as the current level of support and 
information on this topic available to patients from a number of sources (i.e. healthcare 
team, internet, peers, support groups). Exploration of survivors’ attitudes towards diet and 
nutrition and current practices to manage their disease further contributed to the 
identification of unmet nutritional needs. 
It is hoped that the findings from this PhD will feed into the development of appropriate 
support services, designed to improve patient experiences and outcomes.  For example, 
identification of people who are classified in the overweight or obese category, in the 
clinical setting, could initiate discussions and support around the need for weight loss after 
the end of treatments. Self-reported unmet needs are a widely accepted indicator of the 
difficulties in accessing health care services (Sanmartin et al., 2002). From a health policy 
perspective, it is important to understand the factors that act as barriers and facilitators to 
ensure care is equally received by all. Failure to access needed services may result in 
poorer health and to health inequalities (Allin et al., 2010). 
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Gaining an understanding of needs, concerns and attitudes of cancer survivors with 
regards to diet could also lead to the implementation of targeted – and successful –  
interventions. It is important to first understand a particular behaviour before intervening 
(Michie et al., 2015). Findings from this PhD related to unmet needs also support the 
outcomes of Phase I of the Cancer and Nutrition NIHR Collaboration and contribute 
towards the goals of the collaborative (Cancer and Nutrition NIHR infrastructure 
collaboration, 2015), which are to highlight the importance of diet and nutrition in cancer 
treatment and survivorship care. 
Dietary support during the course of treatment is important to prevent malnutrition and 
address any potential treatment side effects that may interfere with dietary intake and 
quality of diet (Arends et al., 2017a). Research on the role of diet and nutrition in 
survivorship, particularly after the end of treatments, is currently limited but findings 
support the benefits of a healthy diet and weight management in improving quality of life in 
cancer survivors (World Cancer Research Fund/American Institute for Cancer Research, 
2018). Prospective, long-term studies will be required to provide stronger evidence 
regarding the role of diet and weight on cancer recurrence and cancer mortality. 
 
7.2. Treatment side-effects and comorbidities 
Seventy-eight percent of respondents reported at least one comorbidity, with hypertension 
and arthritis being the most prevalent. Comorbidities are common in cancer populations, 
as shown in Elliot et al’s study (2011) (13% prostate cancer, 11% colorectal cancer), in 
which one in two cancer survivors  reported at least one comorbidity, with arthritis and 
heart disease being the most prevalent. A recent, retrospective study conducted in cancer 
survivors in the USA (prostate 31%, colon 11%, uterus 11%, urinary bladder 9%), showed 
higher rates of comorbidity than the current study, with 64% of survivors diagnosed with 
hypertension, 56% with dyslipidaemia and 34% with arthritis (Roy et al., 2018). However, 
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the sample was older than the sample of the present study (mean age 72.5 years Vs 
median age 70 years/mean age 68.8 years) (Roy et al., 2018). Age is a crucial factor for 
the presence of comorbidities; the older the cancer patient, the higher the number and 
severity of comorbidities are (Piccirillo et al., 2008). The results highlight that pelvic cancer 
patients may be a population with multi-morbidity. Results indicate that the needs for 
nutritional support may also be related to other morbidities, which affect QoL and future 
health and wellbeing. One of the main themes of the qualitative analysis was the presence 
of comorbidities and disabilities and their negative impact in managing cancer outcomes 
nutritionally and everyday life in general. Nutritional support should not be limited to the 
cancer diagnosis when other morbidities are also present and people should be provided 
necessary, tailored guidance to deal with all issues. 
Similarly, side effects were frequently reported in the present study. Presence of side-
effects is common when undergoing pelvic radiotherapy; however, in this sample, 
treatment side effects still had an impact 6-24 months post-radiotherapy treatment and 
were reported to a similar extent as the on-treatment group. It has been previously 
documented that pelvic cancer survivors can experience bowel and urine urgency up to 
11 years after the end of radiotherapy treatment, which highlights the long-term impact of 
the side effects (Adams et al., 2014). Associations of side effects with parameters of QoL 
were not assessed in the present study; however, previous studies have shown that side 
effects and comorbidities have been associated with poorer QoL in cancer survivors 
(Mazzotti et al., 2012, Cummings et al., 2018). Fatigue was the most commonly reported 
symptom in the present study, followed by wind/bloating and diarrhoea. In the qualitative 
interviews, fatigue was also perceived as one of the physical constraints patients had to 
overcome to maintain normality. Several interviewees described how fatigue affected their 
life and that diet and nutrition can assist in speedy recovery and being active again.  
Presence of comorbidities and side effects varied across cancer diagnoses, highlighting 
potential heterogeneity. Results from the survey showed that urological cancer survivors 
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were older and reported more comorbidities (particularly heart problems) compared to 
lower GI or gynaecological cancer survivors. Lower GI and gynaecological cancer 
survivors reported more treatment side effects, such as nausea, taste changes and loss of 
appetite, compared to urological cancer patients. GI problems were more often mentioned 
in qualitative interviews by survivors of a lower GI cancer, although participants from all 
cancer groups faced GI problems. Reduced appetite was most often highlighted by people 
who received chemotherapy and increased appetite from people who were also treated 
with hormone therapy. It is, therefore, indicated that treatment regimens and age are likely 
to be factors for these differences among diagnoses. 
 
7.3. Dietary change, supplement use and nutritional support from 
health professionals 
Presence of side effects and the need to support recovery and future health post 
diagnosis were the main drivers for dietary change in the surveyed sample. Although 68% 
reported a dietary change post diagnosis, report of changes per food group were lower. 
Findings are in line with the study from Kassianos et al. (2017) in prostate cancer 
survivors, where 72% reported a change to their diet post-diagnosis, but changes per food 
group were lower, with 43 – 60% of respondents reporting making a healthy change in 
consumption of fruit, vegetables, red meat, dairy, alcohol, sweets or fish. In another study, 
29.2% of men diagnosed with localised prostate cancer reported a dietary change in one 
or more of five foods/nutrients, generally towards healthy eating patterns (Avery et al., 
2013). Less than half colorectal survivors (36%) have reported changing their diet in the 
PROFILES study which was conducted in the Netherlands (Bours et al., 2015). Most of 
them reduced consumption of fat, meat, sugar, alcohol and salt, and increased fish, 
vegetables, fruit and water (Bours et al., 2015).  
The most notable changes in the present study were increases in vegetables, fruit and 
wholegrains and reduction in sugary foods, processed meats and alcohol. The changes in 
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dietary behaviour were in line with the recommendations in the latest report from the 
WCRF/AICR (World Cancer Research Fund/American Institute for Cancer Research, 
2018); respondents reported avoiding products that promoted weight gain, increased 
intake of plant foods, and decreased intake of processed meat and alcohol. It was not 
possible to determine whether absence of change was due to the fact that respondents 
had already been following the recommendations for each food group or because of lack 
of appropriate guidance. According to the latest National Diet and Nutrition Survey 
(NDNS) report, mean intakes of saturated fat and free sugars were well above the 
recommendations and mean intakes of fruit, vegetables and fibre were below the 
recommendations for people 65-74 years old (Public Health England, 2016). 
Some participants reported making dietary changes in the opposite direction, by reducing 
wholegrain products and fruit and increasing refined grains. In the case of refined grain 
consumption, significantly more people with a rectal and gynaecological cancer diagnosis 
increased refined grains following diagnosis, compared to urological cancer survivors. 
These changes are likely to be related to altered gastrointestinal function. Although 
prevalence of gastrointestinal side effects was not different between diagnoses in this 
study, severity of side effects was not assessed. Findings from the interviews also 
revealed that some participants successfully managed to control symptoms of 
gastrointestinal toxicity and diarrhoea by reducing the amount of fibre and foods that 
caused bloating. Anecdotal evidence suggests that many patients are advised to reduce 
fibre intake during and after pelvic radiotherapy to manage gastrointestinal problems. 
However, a Cochrane review on nutritional interventions for reducing gastrointestinal 
toxicity in people undergoing pelvic radiotherapy showed that fibre modification did not 
have a significant effect in reducing diarrhoea (Henson et al., 2013). Also, a recent 
randomised-controlled trial in lower GI and gynaecological cancer patients undergoing 
radiotherapy showed that a high fibre diet was associated with reduced gastrointestinal 
toxicity (Wedlake et al., 2017). The authors concluded that restriction of dietary fibre 
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during radical pelvic radiotherapy should be avoided, as fibre enhances the production of 
short-chain fatty acids, which in turn would reduce inflammatory processes (Wedlake et 
al., 2017). 
Dietary supplement use was reported by fewer cancer survivors compared to other 
studies (Patterson et al., 2002, Demark-Wahnefried et al., 2000, Bours et al., 2015, Song 
et al., 2017, Inoue-Choi et al., 2014). Higher supplement use was reported mainly in older 
studies with similar or larger sample size (Demark-Wahnefried et al., 2000, Patterson et 
al., 2002), which may reflect a health-related practice that is no longer recommended. 
Indeed, one of the WCRF recommendations is to rely on foods, rather than supplements, 
for optimal health. Previous studies have shown that supplement users tend to have a 
higher level of education, have a higher socioeconomic status, and have healthier dietary 
patterns than non-users (Dickinson and MacKay, 2014). These characteristics were not 
found to be significantly associated with supplement use in this study; only presence a 
side effect was associated with supplement use. 
The study also showed that provision of advice and support from health professionals in 
relation to diet and nutrition was associated with survivors making changes to their diet 
after diagnosis. However, less than half respondents received such advice. Previous 
research has shown mixed results for pelvic cancer populations; some are in line with the 
present study (Cha et al., 2012, Clark et al., 2016, Kenzik et al., 2016), few reported 
higher rates of support (Tseng et al., 2015) and some reported lower rates of support 
(Zaleta et al., 2017, Sabatino et al., 2007, Holla et al., 2016). 
Information and support on diet and nutrition was provided mainly by cancer specialists in 
the form of written materials. Written materials are generally considered an essential 
source of additional support for patients (Wills and Holmes-Rovner, 2003). They can be 
stored and read several times at a patient’s own convenience and, therefore, may 
contribute to knowledge in the long term (Wills and Holmes-Rovner, 2003, Wallace et al., 
2009). It is also worth noting that written materials were the most preferred mode of 
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information provision for survivors who were interested in receiving more information on 
diet, nutrition and cancer. Although information materials are seen as important, 
interventions such as participation in behaviour management groups or regular contact 
with health professionals have been found to be more effective in outcomes such as 
weight loss compared to provision of written information (Ash et al., 2006) as they may 
have a more direct influence towards behaviour change. 
Health professionals are viewed by patients as the experts for provision of dietary 
information (Zaleta et al., 2017). Members of the clinical care team are in regular contact 
with cancer patients throughout the cancer trajectory and, therefore, could potentially play 
a role in initiating discussions about diet and nutrition, providing accurate information on 
nutritional issues and weight management or guiding patients in appropriate, evidence-
based external information resources (Murphy and Girot, 2013). Face-to-face support by a 
health professional was the second most preferred method for provision of advice in this 
study. However, research has shown there are inadequacies regarding health 
professionals’ nutrition education and knowledge, leading to provision of conflicting 
information or no provision of information (Williams et al., 2015a). Also, several barriers to 
health professionals providing lifestyle advice have been suggested from small-scale 
cross-sectional studies, such as lack of guidelines (O'Hanlon and Kennedy, 2014),  lack of 
knowledge (O'Hanlon and Kennedy, 2014), lack of time (Karvinen et al., 2010) and 
provision of advice not being perceived to be part of their role (Spellman et al., 2014). In 
the UK, a recent qualitative study among surgeons, physicians, nurses and allied health 
professionals highlighted lack of time, lack of evidence, coexistence of multiple suboptimal 
behaviours and fear of blaming the patient as barriers to provision of lifestyle advice 
(Koutoukidis et al., 2018).  
Certain socioeconomic and demographic characteristics were significantly associated with 
dietary change for survivors of a specific pelvic cancer diagnosis. For urological cancer 
patients, those with a higher Body Mass Index were more likely to report a dietary change, 
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whereas for lower GI cancer patients, younger patients were more likely to report a dietary 
change. Younger urological cancer patients also were more likely to report support from 
health professionals. It is perhaps not surprising that younger patients may be more 
interested in diet and nutrition after diagnosis and more engaged with improving their 
future wellbeing (Hoedjes et al., 2017). However, these results should be treated with 
caution due to small sample size. Socioeconomic and demographic characteristics were 
not associated with dietary changes in a large population-based cohort study conducted in 
people with a prostate, breast and GI cancer in France (Fassier et al., 2017). In another 
large US population-based case-control study, women diagnosed with cancer were shown 
to have healthier eating behaviours and were more likely to follow dietary 
recommendations compared to men diagnosed with cancer (LeMasters et al., 2014). In 
the present study, gender was not entered in the regression analysis, because of high 
collinearity with the variable “cancer diagnosis”. 
Overall, there is an increased need and interest for dietary information (68% being 
moderately to extremely interesting in receiving such support), which was also reflected in 
the survey free text comments and the telephone interviews. The findings of this mixed-
methods study further support the results of the systematic review (Chapter 2), in which a 
number of qualitative studies highlighted the current provision of conflicting information or 
no discussions at all and the need for clear and evidence-based messages (Sutton et al., 
2017, Hall et al., 2012, Hardcastle et al., 2018, Koutoukidis et al., 2017, Hardcastle et al., 
2017, Anderson et al., 2013). Results also showed that patients may prefer different time 
points during the cancer trajectory when they would be more receptive to dietary 
information, suggesting a potential individualised approach to information provision. 
Interest could be a result of the perceived importance of the role of diet in survivorship, the 
lack of routine support from the healthcare team or the combination of the two. On the 
other hand, some respondents were not interested in receiving information, which could 
be attributed to barriers towards dietary and behaviour change. 
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7.4. Weight problems 
Thirty-six percent and 23% were classified as overweight and obese, respectively, based 
on self-reported height and weight. Although self-reported height and weight are valid 
measurements in epidemiological studies in the UK population (Bolton-Smith et al., 2000, 
Spencer et al., 2002), underestimation of weight is possible (Fillenbaum et al., 2010). The 
results are slightly lower compared to the results of a national UK survey in cancer 
survivors (Wang et al., 2015) but similar to other studies with prostate  (Thomas et al., 
2013), colorectal (Schlesinger et al., 2014), ovarian and endometrial cancer populations 
(Smits et al., 2015c, Basen-Engquist et al., 2009, van Broekhoven et al., 2017).  
Weight loss and weight gain were reported by a substantial proportion of respondents 
(26% and 33% respectively) and findings were similar between on-treatment and post-
treatment patients. During radiotherapy, a stable body weight is a requirement for 
effectively targeting and treating the tumour. However, patients undergoing pelvic 
radiotherapy have been shown to experience modest weight loss and up to 15% 
decreased energy intake (Guren et al., 2006). Weight changes in the present study may 
also be a result of chemotherapy (42% of the sample underwent chemotherapy) and 
hormone therapy (18% of the sample received hormone therapy) A study that evaluated 
weight changes in women who underwent chemotherapy for an ovarian cancer showed 
that among advanced cancer patients, 37% lost weight, 19% gained weight and 44% had 
a stable weight during six cycles of chemotherapy. In early ovarian cancer patients, the 
percentages were 27%, 18% and 55%, respectively (Mardas et al., 2017). Assessment of 
body weight took place at before the first cycle of chemotherapy and during the third and 
sixth cycles (Mardas et al., 2017). In a sample of colorectal cancer patients in the USA, 
20% lost weight, 27% gained weight and 53% had a stable weight between diagnosis and 
at 15-21 months post-diagnosis (Meyerhardt et al., 2017). Also, hormone treatment is a 
commonly used treatment for prostate cancer and known to be related with metabolic 
changes, including weight gain and fat accumulation (Mitsuzuka and Arai, 2018). Findings 
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from the present study enhance the need for regular body weight monitoring during and 
after treatment, as different survivors may have different experiences in terms of weight 
change. 
None of the above studies examined weight fluctuations over time and neither did the 
present study, due to its cross-sectional design. Weight fluctuations from diagnosis to 
treatment to survivorship were described in the qualitative interviews by some 
participants. Weight changes (both weight gain and loss) during treatments were 
anticipated as a treatment side effect. It may be possible that weight changes are not a 
concern during treatment, as the priority is the cure of the tumour. Instead, concerns and 
negative emotions about weight status were expressed mainly by post-treatment 
participants in the interviews. Participants, mainly in the post-treatment stage, 
acknowledged excess weight and the desire to lose weight and requested guidance and 
regular monitoring.  
Survey findings indicated that only few participants received support in relation to weight 
management. A study by Tseng et al. (2015) in the USA showed that 50% of endometrial 
cancer patients discussed weight management with health professionals but they were 
rarely offered specific guidance and only 6% of them were referred to nutrition specialists 
for further support. In another study on gynaecological cancer survivors, only 14% of the 
patients reported weight management counselling (Zaleta et al., 2017). Discussions on 
weight management may be perceived as a sensitive topic for both patients and health 
professionals, however it seems many patients would welcome such guidance (Zaleta et 
al., 2017). Given the detrimental impact of obesity on QoL and cancer outcomes after a 
cancer diagnosis (Vissers et al., 2017, Smits et al., 2015a), it is important that survivors 
have the opportunity to engage in weight loss and weight monitoring programs that would 
incorporate healthy eating and regular physical activity. There is ample evidence of the 
benefits of maintaining weight within the healthy range (BMI between 18.5 kg/m2 and 25 
kg/m2), which is the reason why it is one of the recommendations from both ESPEN 
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(Arends et al., 2017a) and the WCRF (World Cancer Research Fund/American Institute 
for Cancer Research, 2018) for cancer survivors. A cross-sectional study in the UK 
showed that advice about weight management was routinely provided only to participants 
with a BMI > 37 kg/m2 but to very few participants with a BMI between 25 – 36 kg/m2 
(Jackson et al., 2013).  A barrier to provision of such information has been shown to be 
the perception that weight management advice may not be viewed as part of the health 
professionals’ role (Koutoukidis et al., 2018), despite the National Institute for Health and 
Care Excellence NICE recommendation for health professionals to engage in 
conversations about weight management and offer support (Centre for Public Health 
Excellence at and National Collaborating Centre for Primary, 2006).   
 
7.5. Awareness of and attitudes towards diet 
In the present study, most participants were aware of the nutritional recommendations 
issued by the WCRF in 2007. This was also reflected in interviews with some participants, 
where survivors perceived they had already been following a healthy diet and lifestyle, in 
line with the current recommendations, before diagnosis. However, survivors in this study 
were unsure about the recommendation regarding consumption of red and processed 
meats, as one in four participants indicated lack of or limited awareness about this 
recommendation.  A study by Hawkins (2015) in colorectal cancer survivors in the USA 
showed lower levels of awareness compared to this study, especially in relation to 
consumption of wholegrains, fruit, vegetables and alcohol. However, the statements 
included in the study were slightly different and reflected recommendations for the US 
population. Survivors who were most familiar with recommendations were also more likely 
to follow those (Hawkins et al., 2015). In the current study, this relationship was not 
assessed due to the very small numbers of survivors who reported “lack of awareness” in 
each of the recommendations. 
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Survey results also revealed the survivors’ perceived importance of diet and nutrition in 
overcoming certain problems and supporting future wellbeing. Similar to the survey 
findings, recent findings from the PROFILES study in colorectal cancer survivors in 
Holland showed that over half the respondents (52%) held a strong “belief that nutrition 
influences feelings of wellbeing” (van Veen et al., 2019). Survivors with strong beliefs 
were more likely to report having received support and information in diet and nutrition 
from health professionals than survivors with no belief in the link between diet and 
wellbeing (van Veen et al., 2019). In the same study it was also shown that respondents 
with a strong belief of role of diet in wellbeing also had a strong belief of diet assisting in 
recovery after treatment (79% of respondents had a “strong belief”), but there were mixed 
beliefs about diet preventing recurrence (only 36% had a “strong belief”). In the present 
study, scepticism was expressed for the role of diet and nutrition in reducing side effects, 
particularly appetite problems and the feeling of fatigue and, on a smaller scale, reducing 
cancer recurrence. Indeed, evidence is still limited about the role of diet in reducing 
fatigue and preventing cancer recurrence and, as a result, there are no specific nutritional 
recommendations towards this direction. A few interventions have been conducted 
examining the effect of physical activity in improving cancer-related fatigue, but the role of 
nutrition has not been explored in depth (Baguley et al., 2017). Also, it is challenging to 
conduct long-term observational or Randomised Controlled Trials, which are required to 
evaluate the role of diet in cancer recurrence.  
A number of themes from the interviews summarised the perceived role of diet in 
participants’ life and revealed attitudes towards the importance of diet and nutrition, which 
acted as enablers or barriers towards self-management. Some participants considered the 
role of nutrition as important in coping with altered bowel function and reduced appetite 
and believed a healthy diet could help them regain normality in their life after the end of 
treatments. On the contrary, lack of interest and motivation, scepticism about the 
importance of making dietary changes and the perception that current dietary habits were 
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already sufficient led some people to believe diet is less important. Attitudes towards diet 
were mostly in line with a recent qualitative study, which examined factors which 
motivated prostate, colorectal and breast cancer survivors to change lifestyle behaviours, 
such as diet and physical activity (Corbett et al., 2018). Maintenance of health, prevention 
of cancer recurrence and the drive to feel better after treatment were enablers to 
behaviour change, whereas absence of support to implement changes, rejection of the 
link between cancer and lifestyle and lack of interest were barriers to behaviour change 
(Corbett et al., 2018). Interestingly, in the Corbett et al. study (2018), presence of side 
effects were a barrier to behaviour change (in relation to engaging in physical activity), 
whereas in the present study side effects were mostly a drive towards dietary change to 
reduce their impact and improve overall recovery. Findings in both Corbett et al. and the 
present study are qualitative and it would be interesting to evaluate whether a quantitative 
assessment of enablers and barriers of engagement in nutrition and physical activity 
would provide similar results. People may feel more vulnerable and hesitant in engaging 
in physical activity when they experience side effects, such as gastrointestinal 
disturbances and fatigue. They may also perceive that physical activity may worsen 
existing side effects. On the other hand, dietary modification may be viewed as an 
effective way to alleviate side effects. 
The limited evidence base on the role of diet and nutrition in cancer outcomes does make 
the provision of information challenging, both for patients and providers. For example, 
management of gastrointestinal problems is primarily based on anecdotal information. 
Therefore, a reason why support is not provided routinely could be the fact that research 
is limited and outcomes are not communicated to health professionals, who in turn do not 
advise their patients or guide them towards appropriate support. However, this should not 
be the case in support for weight management, as there is good evidence to suggest 
promotion of weight loss or weight maintenance, where appropriate. Also, a healthy diet 
has the potential to improve QoL and general health. Given these benefits, appropriate 
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guidance should become part of standard routine care. However, it is generally 
acknowledged that the evidence on the role of diet in health after a cancer diagnosis is 
limited and therefore more research is warranted.  
 
7.6. The role of family 
The importance of family and social environment in a cancer patient’s recovery and 
wellbeing has been well documented (Glajchen, 2004). Social support – defined as the 
“availability of a network of family and friends for information, encouragement, emotional 
support, and enhancing the environment to support a behaviour” (Spahn et al., 2010) – 
has been identified as an important determinant of nutritional behaviour (Spahn et al., 
2010). Brug (2008) summarized the evidence from systematic reviews on the association 
between environmental factors and healthy dietary behaviours and concluded that the 
social environment (family and friends) appeared to have a consistent influence on 
individuals’ dietary behaviours, although findings were limited by the methodological 
quality of the studies included. In a more recent study in almost 3,000 healthy individuals, 
perceived social support acted as a motivator towards healthy eating practices 
(McSpadden et al., 2016).  
Social support has also been found to be an important factor in the implementation of 
healthy dietary behaviours in cancer survivors. A study of cancer survivors in the USA 
(n=128) showed that survivors who consumed more than 5 portions of fruit and 
vegetables per day had higher social support from the spouse/partner, compared to 
survivors who consumed less than 5 portions daily (Coleman et al., 2014). Another study 
in South Korea showed that support from the family was particularly helpful for the 
adoption of a healthy diet, increasing self-leadership and self-management of disease in 
patients with colorectal cancer (Lee et al., 2018). It should, however, be noted that the 
impact of family may be different in different cultures.  
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In the current study, the role of the family – particularly the spouse – was evident in food 
preparation and food purchasing, which were described either as shared task or sole 
responsibility of a family member. Also, several survey respondents reported receiving 
advice and support in diet and nutrition from a family member or a friend. Family support 
was perceived as an important facilitator in the self-management of diet and nutrition in 
relation to the disease (also highlighted in section 7.7). Food consumption with family 
members was another important aspect of participants’ social life and a few highlighted 
how the spouse’s/partner’s or children’s nutritional preferences influenced their own. 
Preparation of meals by family members was also the main form of support for survivors 
with nutritional problems, such as lack of appetite. Regarding nutritional problems related 
to cancer, literature to date has mostly focussed on advanced cancer. In advanced 
cancer, the role of the family carer is crucial and challenging, as they may be in charge of 
food preparation, but also need to encourage the patient to engage in self-help by eating. 
Involuntary weight loss has been shown to occur to both the patient and the family carer in 
advanced cancer (Hopkinson, 2018). 
Considering the influence of family on different aspects of nutrition for cancer survivors 
(purchasing, preparation, consumption), it is important to note that nutritional education 
and support should not only target the survivor, but also the family or people who care for 
the survivor. In this study, the needs of carers were not examined, but previous literature 
has shown carers exhibit needs in relation not only to the patient’s care but also their own. 
Caregivers of a patient with cancer have been shown to be more distressed and to exhibit 
higher anxiety scores compared with the cancer patients they were caring for (Sklenarova 
et al., 2015). Carers’ information needs were highlighted in relation to the patient’s 
physical state and treatment side effects, as well as for their own health, including eating 
and sleeping adequately (Sklenarova et al., 2015).   
Support from family members/carers needs to be reflected in the nutritional support 
provided to cancer survivors. Guidance and support from healthcare professionals, 
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support groups or other sources should also target carers, so that informed decisions 
towards care are taken from everyone involved. The family’s daily involvement in different 
aspects of nutritional care can be an additional “tool” that can facilitate patient education, 
influence dietary change, and improve self-management. For example, if a survivor has 
their meals cooked by the spouse, it is reasonable for the spouse to be involved in the 
conversations about adequate nutrition and suitable meals for the survivor’s needs. It also 
important that the spouse is educated on diet and nutrition in relation to the disease and 
that the spouse’s own needs and concerns around diet are also met. 
 
7.7. The ability to self-manage diet after diagnosis 
The National Health Service initiative for improving cancer care (Department of Health et 
al., 2013) emphasises the provision of all necessary support to promote self-management 
in the survivorship phase. Self-management is a dynamic process in which people 
manage a chronic disease, such as cancer, in relation to symptoms, medication and 
interaction with the healthcare system (Richard and Shea, 2011). Schulman-Green et al. 
(2012) conducted a meta-synthesis of studies which described self-management 
processes and identified three main categories: processes that focus on illness needs, 
resources (e.g. family and healthcare professionals) and coping with the illness. All three 
categories are relevant in diet and nutrition and were evident in the present study. For 
example, illness needs related to management of treatment side effects and weight 
issues. Family was identified as a main component of support in nutrition and dietary 
advice; health professionals were the reliable source of information. Integration of illness 
into the individual’s life related to the notion of “maintaining normality”, which was an 
important qualitative finding. In this study, self-management of diet was a result of 
contextual influences and receipt of support and information.  
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A number of enablers and barriers towards dietary change and self-management were 
identified from the qualitative interviews. Presence and/or severity of treatment side 
effects, perceptions of weight status and body image, concerns over weight changes, 
support in diet and nutrition by the family, personal knowledge in the area of nutrition and 
perceived healthy dietary habits pre-diagnosis which were still currently implemented; 
were all factors which the patients evaluated before deciding whether dietary change was 
necessary for them and how dietary change could be achieved. 
For many, diet and nutrition was seen as a “vehicle” to get well soon and get back to pre-
diagnosis life. Living with a chronic illness, such as cancer, is a process that requires 
constant integration of the illness into an individual’s daily life. Not only physical, but also 
emotional aspects of the illness are identified and need to be managed and improved 
(Schulman-Green et al., 2012). An early, qualitative study by Ekman et al. (2004) showed 
that maintenance of normal life and being high-spirited were essential characteristics for 
women with an ovarian cancer diagnosis. A more recent qualitative study in breast and 
prostate cancer survivors also confirmed that there was a strong desire for their lives to 
get back to normal. Going back to normality was described as both a physical and a 
psychological need and was a core social and behavioural process following treatment 
(Walker et al., 2015). None of these studies linked normality to any lifestyle factors, as the 
focus was on treatment side effects and emotional stability. In this mixed-methods study, 
a healthy diet was a supportive means for activity, which in turn was linked to 
maintenance of normality. Concerns regarding body weight and body image had a 
negative emotional impact, indicating that issues around weight are important not only in 
relation to physical health, but also psychological health. 
In this study, activity was considered an important lifestyle component in regaining 
normality. Although this PhD did not assess physical activity, it is worth mentioning that 
both eating and activity behaviours are targeted in behavioural change interventions and 
in weight loss strategies (de Vet et al., 2011).  
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Several interviewees managed their disease well and were able to adjust dietary habits to 
address potential side effects, including weight issues. For others, challenges related to 
self-management included the inability to afford healthy foods and to cook meals using 
raw ingredients. Presence of comorbidities and disabilities also negatively affected the 
ability to self-manage. Inadequate nutritional support from the healthcare team and 
conflicting information from other sources (the internet or the media) further reinforced the 
challenges to manage any dietary problems. Qualitative studies have highlighted that 
although cancer diagnosis is often perceived as a “teachable moment”, it does not always 
lead to behaviour change, as barriers can outweigh the motivation to eat healthily (Coa et 
al., 2015, Corbett et al., 2018). 
Content of support and information could be grouped in main categories; alleviation of 
side effects (particularly gastrointestinal problems, appetite issues and fatigue in the pelvic 
groups); weight management and future health overall It is also clear that each patient 
had individual needs that needed to be addressed. A holistic approach to provision of 
dietary information needs to be implemented, which should take into account how to have 
a healthy diet while on a low-budget and how to cook healthy meals easily and quickly.  
Also, dietary approaches need to take into account other comorbidities and presence of 
permanent or temporary ostomies. Components of a healthy diet and weight control are 
essential to overall health and there are clear benefits of dietary or lifestyle interventions 
on managing hypertension (Semlitsch et al., 2016, Graudal et al., 2017) and improving 
arthritis problems (Khanna et al., 2017) (those comorbidities were the most commonly 
reported in the surveyed sample). Finally, the need to regain normalcy in life after 
diagnosis should also be strongly considered when planning for the survivor’s care, 
including diet, nutrition but also the feeling of being well and active. The emotional impact 
of diagnosis and treatment should not be overlooked when addressing behavioural 




7.8. Strengths and limitations 
One of the main strengths of this project is the mixed-methods design, which was adopted 
to provide a better understanding of unmet needs for information and support in relation to 
diet and nutrition after a cancer diagnosis. Quantitative and qualitative findings brought 
together important insights to the research questions and set the foundations for policy 
implementation and further research, with a view to better support cancer patients in this 
area.  
Albeit the absence of a suitable, validated questionnaire, a non-validated questionnaire 
was used to explore the research questions in the quantitative arm; however, every effort 
to obtain face validity was made. The questionnaire was assessed by Patient and Public 
Involvement contributors in the first phase to ensure no ambiguous, complex or double-
barrelled questions, technical jargon or uncommon words were used. Any word that was 
perceived as technical had an explanation underneath. Also, every effort was made to add 
neutral and not leading questions.  
However, several limitations in relation to the development of the survey occurred. The 
survey did not include information about gender. As a result, gender was assumed from 
cancer diagnosis (men had a prostate cancer diagnosis and women had a gynaecological 
cancer diagnosis) and from personal details provided for the purpose of an interview (for 
all other diagnoses). This omission resulted in an amount of missing data about gender 
(n=22). This had an impact in the descriptive analysis but not the logistic regression 
analysis, in which the variable “gender” was not entered in any of the models (high 
correlation with the variable “cancer diagnosis”). Also, the survey did not include the food 
group “red meat” in the section about dietary changes; therefore, no quantitative data 
were available about change of red meat consumption following diagnosis. Due to this 
omission, every effort was made to discuss red meat consumption in the interviews. 
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As expected, missing data occurred for some questions in the survey, although for most of 
these questions there were only few missing data. More missing data occurred for 
sensitive questions, such as date of birth (missing data n=12), body weight (n=10) and 
body weight changes (n=10). 
Several limitations in relation to methodological quality of the mixed-methods study should 
be mentioned. Recruitment of cancer patients took place from one Trust (Oxford 
University Hospitals NHS Foundation Trust) and, more specifically, one department 
(Radiotherapy Department, Cancer and Haematology Centre). Patients diagnosed in 
other counties of the UK may have different socioeconomic, clinical or health 
characteristics and, therefore, different needs for nutritional support. Also, patients with a 
pelvic cancer diagnosis who have received chemotherapy, hormone therapy and/or 
surgery but not radiotherapy may have different needs in diet and nutrition. However, 
receipt of radiotherapy was one of the inclusion criteria for this PhD. 
It should be acknowledged that the recruited sample includes cancer diagnoses that share 
common characteristics (e.g. obesity rates, pelvic radiotherapy, increasing survival rates) 
but can also vary considerably. The differences were mainly shown in relation to treatment 
side effects, which may reflect the different treatment regimens for each cancer diagnosis. 
For example, prostate cancer may be treated with radiotherapy and/or surgery and/or 
hormone therapy, whereas hormone therapy is not a treatment option for a lower GI or a 
gynaecological cancer. These differences may lead to different needs for dietary advice. 
Analysis according to cancer diagnosis (urological, lower GI, gynaecological) was 
conducted to identify these differences, although sample size per group was small and the 
sample may not be representative. 
Non-probability sampling was used to recruit participants for the survey (i.e. every pelvic 
cancer patient who underwent radiotherapy between November 2017 and February 2019 
for the on-treatment group and every patient treated with radiotherapy between April 2016 
and September 2017, with the exception of prostate cancer subgroup for the post-
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treatment group) and maximum variation sampling for the interviews. It is not known 
whether all pelvic cancer patients that underwent radiotherapy during the specified 
timeframe were invited to take part from the collaborating nurses and radiographers. 
Increased workload of clinical staff and heavy agendas during clinical review meetings 
may have led to some patients not being informed about the study. Regardless, this form 
of recruitment was considered the most effective, given the time restrictions and 
resources of the PhD studies, but it is acknowledged that the ability to generalise the 
findings to other pelvic cancer survivors may be limited.  
Notably, very small numbers of survivors of a bladder and a gynaecological cancer 
participated in the survey. Under-representation of these cancer groups should be taken 
into consideration when interpreting the results to cancer patients receiving pelvic 
radiotherapy. Studies targeting specific cancer groups (i.e. a study in which the sample 
size is gynaecological cancers only) may be a more effective strategy to investigate unmet 
needs in diet and nutrition, rather than recruitment based on treatment regimen. In the 
current study, larger samples of these cancer populations were expected but, 
unfortunately, it proved challenging in the given timeframe and was further impacted due 
to low response. Response rate for the gynaecological cancer group was 26%, as 
opposed to the prostate cancer patients, where 46% returned the survey. 
Other potential forms of bias include non-response and response bias. The overall survey 
response rate was 38%, and it was not possible to gather data on non-responders and 
therefore determine whether there were differences in demographic or clinical 
characteristics between people who responded to the survey and people who did not. It is 
possible that people who are more interested in the topic of diet and nutrition decided to 
take part in the survey and the interviews. In order to reduce non-response bias, the 
questionnaire was assessed by Patient and Public Involvement contributors before 
administration to ensure it was easy and quick to complete and it included as few 
sensitive questions (mainly demographics) as possible. Regarding response bias, it is 
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possible that participants were interested in filling in the survey and being interviewed, but 
they also wanted to be “good subjects” by answering in a way that made them look more 
favourable. In order to reduce the effect of response bias, leading questions in the survey 
and interviews were avoided through rigorous survey design/assessment and interviewer 
training, respectively. Anonymity and confidentiality of data was also assured. However, 
the fact that the vast majority of respondents were aware of the nutritional 
recommendations for cancer prevention/survivorship – an unexpected finding – may 
indicate that response bias might have affected the findings. 
It is also important to acknowledge potential self-report bias for the survey and recall bias 
for both the survey and the interviews. Self-report bias was possible in the completion of 
survey, as it was a self-administered questionnaire. Recall bias may have occurred in the 
post-treatment group, as some questions asked were related to their treatment which took 
place 6-24 months before of the administration of the survey and conduct of interviews. 
Regarding regression analysis, methodological limitations, such as response bias, non-
response bias and selection bias (non-random sampling), could have influenced the 
strength of the detected associations. In order to avoid heterogeneity bias in the analysis, 
sub-group analyses were conducted where possible, but sample size was considerably 
smaller, possibly increasing the chance of error. All possible explanatory variables were 
entered in the models and multicollinearity was assessed. However, none of these 
variables was examined as a confounding factor in the regression models. 
Researcher bias in the qualitative analysis may have occurred, as the person who 
performed the analysis (the PhD researcher) had a nutrition and dietetics qualification. For 
this reason, analysis was closely monitored by one Co-Director of Studies (Prof Eila 
Watson) and a qualitative researcher (Dr Lauren Matheson), neither of whom have 
nutrition or dietetics background. Finally, the survey was completed by patients who were 
predominantly married, retired and identified themselves as white. Generalisability of 
results may not be possible for non-married patients, patients living alone, patients of 
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working age and people who identify themselves as Black, Asian and Minority Ethnic 
(BAME). In the qualitative interviews, though, the use of maximal variation was essential 
in identifying and interviewing patients that belonged to these groups. Further research in 
“harder-to-reach” groups could shed light to different information and support needs to the 
findings of this PhD project. 
Finally, as discussed in Chapter 1, available guidelines for diet and nutrition suitable for 
people after a cancer diagnosis exist from ESPEN (Arends et al., 2016) and the WCRF 
(World Cancer Research Fund/American Institute for Cancer Research, 2018). The 
ESPEN guidelines focus on preventing or managing malnutrition, primarily in the clinical 
setting. This includes adequate nutrition (energy and protein), artificial nutrition and 
intervention, where appropriate. The WCRF recommendations focus on promoting 
wellbeing after the end of treatments and possibly reducing recurrence. The use of WCRF 
recommendations in the current survey may have undermined some more complex needs 
of patients on-treatment, primarily related to adequate nutrition and 
prevention/management of malnutrition. 
The concept of saturation in qualitative research, evolved from the notion of theoretical 
saturation in grounded theory, is described as the point at which no new information 
emerge from data and has been used in the mixed methods study to terminate the 
conduct of qualitative interviews. Braun and Clarke disagree that saturation could 
determine sample size in qualitative research, as the philosophy of thematic analysis is 
based on interpretation of data during continuous and concurrent collection and analysis. 
Therefore, sample size cannot be determined before data analysis – and perhaps the 
concept of sample size is not even applicable in thematic analysis (Braun and Clarke, 
2019). A clear distinction between types of thematic analysis has been proposed 
(codebook, coding reliability and reflexive thematic analysis), where the first two types use 
a mix of deductive and inductive approach and reflexive thematic analysis relies on 
analytic process and interpretation (Braun and Clarke, 2016, Braun and Clarke, 2019). In 
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codebook and coding reliability, the concept of information redundancy could be an option 
in estimating sample size, while this would not be the case in reflexive thematic analysis. 
In this mixed-methods study, the sample size for the qualitative arm was not determined a 
priori; however, based on previous research, some of which is included in the systematic 
review (Chapter 2), and for the purposes of ethical approval, an initial estimation was 
made (40 participants; 20 from the on-treatment and 20 from the post-treatment group). 
Due to the heterogeneity of the recruited sample (on/post-treatment, different diagnoses 
of pelvic cancer), it was assumed that the required sample would be larger than qualitative 
studies whose sample had a single cancer diagnosis. After each interview, the researcher 
wrote a reflexive summary of the conversation. Based on the information of the 
summaries, the conduct of interviews was terminated after 28 interviews. It is 
acknowledged that the concept of “data saturation” was used to complete data collection 
prior to analysis but sample size was not determined prior to data collection. For a novice 
researcher, such as a PhD student with limited background in qualitative research, it was 
deemed important to recognise qualitative research as a pragmatic activity, shaped and 










Chapter 8. Online sources 
Availability and quality assessment of online nutrition 
information materials for pelvic cancer patients in the UK 





In light of the limited nutritional support in the healthcare setting shown in our mixed-
methods study, phase 3 of this PhD project aimed to identify and assess the quality of 
online diet and nutrition information suitable for people with a pelvic cancer. Patient 
Information Materials (PIMs) available from the NHS, cancer centres and charitable 
organisations were assessed for quality of content and readability. Consumer feedback 
was sought through Patient and Public Involvement (PPI) groups. Results showed limited 
availability of online PIMs for cancer survivors and even fewer tailored to pelvic cancers. 




Results from the mixed-methods study (Chapters 4-6) showed the lack or routine 
nutritional support after a pelvic cancer diagnosis and highlighted the patients’ need for 
provision of advice and support. High rates of obesity, presence of side effects and 
comorbidities, in combination with lack of discussions about diet and nutrition in the 
healthcare setting, show the need for development of services to support cancer survivors 
to live as healthy a life for as long as possible. Participants were keen in receiving 
information and guidance on weight management, nutritional management of treatment 
side effects, which persist up to two years after the end of radiotherapy treatment, as well 
as future wellbeing. Content and quality of information are essential determinants of 
promoting healthy behaviours. Results from also showed that provision of written 
information was the most preferred method of dietary support for this sample of pelvic 
cancer survivors. 
Patient Information Materials (PIMs) complement verbal messages from healthcare 
professionals and are considered an essential source of additional support for patients 
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(Wills and Holmes-Rovner, 2003, Wallace et al., 2009). PIMs that provide simple, 
targeted, evidence-based and culturally appropriate messages on diet and nutrition from 
credible sources such as clinical settings and charitable organisations, and are available 
to all cancer patients, could prompt behaviour change. It is, however, acknowledged that 
information processing and, consequently, elaboration to behaviour change are complex 
procedures that rely on perceived relevance of the topic, quality of the message and 
credibility of the source that provides that message (Wilson, 2007). 
Guidance on the development of comprehensive PIMs includes evidence-based 
preparation, readability assessment, content assessment and consumer testing (Lampert 
et al., 2016, Beaunoyer et al., 2017). Patient involvement has been reported as an 
essential part of the quality assessment of PIMs, as it reflects patients’ perceived 
information needs (Smith et al., 2014). 
Although health professionals are considered the most reliable providers of dietary 
information, inadequate support may turn patients to look for information on other 
resources (Playdon et al., 2016, Hartoonian et al., 2014). PIMs in diet and nutrition 
available online may be a useful aid both for symptom management and for the 
prevention or management of other diseases, such as cardiovascular diseases, diabetes 
or a secondary cancer. The aim of this study was therefore to identify the availability and 
assess the quality of PIMs in relation to diet, nutrition and cancer survivorship suitable for 
patients with pelvic cancers. 
 
8.3. Methods 
8.3.1. Identification of Patient Information Materials (PIMs) 
Online PIMs related to diet and nutrition for pelvic cancers (anal, bladder, bowel and 
reproductive organs) were identified through systematic searches of the National Health 
Service websites (NHS; official websites and cancer centres) and charitable organisations 
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websites in the UK. PIMs were included if they provided information about diet and 
nutrition for general health, weight management or management of treatment-related side 
effects for pelvic cancer. PIMs which provide dietary information for generic cancer were 
also included, as they were deemed relevant for pelvic cancer patients. 
The NHS websites for England, Scotland, Wales and Northern Ireland were searched for 
any available PIMs in diet and nutrition after a cancer diagnosis. Focus was given to the 
NHS Choices, section “Cancer” (2017), NHS Inform Scotland, section “Cancer” (2017), 
NHS Direct Wales, section “Cancer” (2017) and Health and Social Care Online Northern 
Ireland (2017) websites. All sections relevant to cancer in these websites were searched. 
The keywords ‘cancer’, ‘diet’ and ‘nutrition’ were also used in each website’s search box 
to ensure that no sections were missed. For the identification of cancer centres, there is 
currently no comprehensive list of these in England available. Cancer centres were 
identified from the NHS Choices website, section “Services” (2017), the Organisation of 
European Cancer Institutes (2017) and a Google search. The key phrase ‘cancer centre’ 
was used in the NHS Choices and Google search boxes. Cancer centres in Scotland, 
Wales and Northern Ireland were identified from the National Cancer Patient Experience 
Surveys for Scotland (2016), Wales (2014) and Northern Ireland (2015) respectively. 
Cancer centres in England could not be identified through the National Cancer Patient 
Experience Survey for England, because it was not possible to distinguish between 
cancer centres and NHS Trusts that provide cancer treatment and care. In every cancer 
centre’s website, information under the sections “patient information leaflets” and 
“dietetics and nutrition” were searched. 
Identification of charities was through the Charity Commission for England and Wales 
(2017), the Charity Commission for Northern Ireland (2017) and the Office for the Scottish 
Charity Regulator (OSCR) (2017). Charity commissions and OSCR are independent 
regulators and registars for organisations that have been recognised as charitable by law, 
including community groups, schools, universities and care providers. Their role as 
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regulators ensures increased public confidence in charities work. Charities that relate to 
each pelvic cancer type, as well as generic cancer, were searched. Using the advanced 
search option, each of the following keywords was typed in the keyword box: cancer 
(when looking for generic cancer charities), prostate cancer, testicular cancer, ovarian 
cancer, bladder cancer, urological cancer, cervical cancer, bowel cancer, colorectal 
cancer, rectal cancer, anal cancer, endometrial cancer, uterine cancer, vulvar cancer, 
womb cancer, male cancer, gynaecological cancer and female cancer. Keywords were 
searched in charity names, objects or activities. Examples of search are shown in Figures 
8.1 and 8.2. To identify PIMs relevant to the aim of this study, only charities with a remit 
relating to the advancement of health and/ or the provision of advice, advocacy or 
information were included. The Charity Commission for England and Wales limits the 
amount of charities shown to 500 for resource reasons. Therefore, due to the large 
number of generic cancer charities in England and Wales, search was further refined to 
the ones with an income over £25,000 (financial year 2016-2017). Any materials available 




Figure 8.1: An example search of charities in the Charity Commission for England and 
Wales website (2017). Keyword is “prostate cancer” and keyword is searched in charity 
name, charity objects and charity activities. To further refine the search, under the section 
“How the charity operates”, the option “307 Provides advocacy/advice/information” was 





Figure 8.2: An example search of charities in the Office for the Scottish Charity Regulator 
(OSCR) website (2017). Keyword is “prostate cancer”. To further refine the search, under 






8.3.2. Assessment of content 
An adapted version (Coulter et al., 2006) of “The International Patient Decision Aids 
Standards instrument” (IPDASi) (Elwyn et al., 2006) was used for the assessment of 
content. IPDASi is a validated assessment tool, which was originally developed to assess 
decision aids about treatment or screening options. Coulter et al. (2006) slightly adapted 
the IPDASi with elements from the DISCERN instrument (Charnock et al., 1999) to reflect 
differences in the assessment of the content of health-related materials, including healthy 
eating and obesity. The adapted checklist underwent three rounds of pilot testing before 
use. It consists of eight categories (Table 8.1). In each category, a minimum of one point 
and a maximum of five could be given, depending on the clarity of information provided. 
One point was given when the material did not meet the criteria in any way and five points 
when the material completely fulfilled the quality criteria. Scores of 2, 3 and 4 were 
awarded for materials which partially met the criteria with the actual score depending on 
the assessor’s evaluation. The lowest score that a PIM could receive was 8 and the 
highest was 40. The higher the score, the better the quality of the content was. An 
additional point was given if the material provides information on social care issues. A 
copy of the checklist is available on Appendix 6.  
 
Table 8.1: Checklist for content assessment (Coulter et al., 2006). 
Does the information leaflet/website… Maximum points  
Start with a clear statement of aims?  /5 
Provide unbiased and detailed information about options?  /5 
Present probabilities of outcomes in an understandable way? /5 
Contain accurate information? /5 
Help patients to make appropriate decisions /5 
Disclose conflicts of interest? /5 
Have a clear structure and layout? /5 





The content of all PIMs was assessed by the lead researcher and a subsample by an 
academic collaborator (Dr Jo Brett). Any uncertainties were discussed among all authors, 
until an agreement was reached. 
 
8.3.3. Assessment of readability 
The readability of PIMs was determined using the Flesch-Kincaid Grade Level (FKGL) 
(Kincaid et al., 1975) and the Simplified Measure of Gobbledygook (SMOG) Grade 
(McLaughlin, 1969). FKGL is a widely used readability tool, and the SMOG grade is 
considered the gold standard in health-related information and education materials (Ley 
and Florio, 1996). All tools have been previously validated and shown good reliability (Ley 
and Florio, 1996). FKGL uses the number of words per sentence and the number of 
syllables per word in an equation to calculate the US school grade level necessary to 
understand the text (Kincaid et al., 1975). The SMOG grade also reflects to the US school 
grade and is based on the square root of the number of words with three or more syllables 
on a total of thirty sentences (McLaughlin, 1969).  
A random sample of approximately 500 words from each PIM was examined using 
software that includes both instruments described above (Automatic Readability Checker, 
2017). Results of the readability assessment for each PIM sample included reading grade 
level, corresponding age range and reading ability, as shown in Table 8.2. A readability 
level of US grade 8 corresponds to the reading ability of 13-14 years old and is generally 
considered the upper acceptable level for the US population. The Joint Commission 
suggests PIMs should read on a grade 5 level or lower, which corresponds to the reading 





Table 8.2: Reading grade level (US) and corresponding age range and reading difficulty. 
Reading grade level (US) Age range (years) Reading difficulty 
5 10-11 Very easy 
6 11-12 Easy 
7 12-13 Fairly easy 
8-9 13-15 Standard 
10-12 15-18 Fairly difficult 
>13 >18 Difficult or very difficult 
 
8.3.4. Assessment of face validity 
Face validity is defined as the extent to which a test is subjectively viewed as covering the 
concept it purports to measure (Holden, 2010). Public involvement was sought to assess 
the face validity of a number of PIMs. The national advisory body INVOLVE defines public 
involvement in research as “research carried out ‘with’ or ‘by’ members of the public rather 
than ‘to’, ‘about’ or ‘for’ them”. The term “public” includes patients, carers and everyone 
who uses social and health care services. Public involvement is encouraged in health 
research design and implementation, as it improves the quality of research and makes it 
more relevant to the target population. The importance of public involvement is depicted 
on the fact that funding bodies and National Research Ethics Committees in the UK seek 
information on how the researchers have involved or plan to involve the public in the 
research (INVOLVE, 2012).  
In order to conduct a more comprehensive evaluation of the identified PIMs, public 
involvement was sought. People who had been diagnosed and treated for a cancer were 
invited to give their feedback on the quality and content of selected PIMs. It was 
considered essential to have PIMs evaluated by people who would, in theory, benefit from 
such materials. 
Patient and Public Involvement (PPI) contributors were invited through advisory groups, 
support groups and PPI web forums, such as the National Cancer Research Institute 
Consumer Forum group, the Oxfordshire Prostate Cancer support group, the “Patients 
205 
 
active in Research” website (https://patientsactiveinresearch.org.uk/) and the Public 
Involvement in Primary Care research group at the Nuffield Department of Primary Care 
(advertisement in the “Involvement Matters” monthly newsletter). An example of the 
invitation letter to gatekeepers is in Appendix 6b. Those who expressed an interest were 
asked to provide feedback anonymously by answering four open-ended questions 
regarding the quality of the content, the ease of reading and whether the information they 
contained was helpful for them. The document that was sent to interested members 
included the following questions (Appendix 6c): 
 How would you rate the information provided in this leaflet? 
 How easy was it for you to understand the information? 
 How helpful was the leaflet for you? 
 Would you change anything? 
Invitation to give feedback took place after the evaluation of the content and readability of 
the PIMs and PPI contributors were provided with PIMs with a range of scores in terms of 
content and readability. Each contributor was given up to three PIMs. Where possible, 
members reviewed PIMs that were related to their own type of cancer diagnosis. For 
example, a prostate cancer survivor would review a PIM from a prostate cancer charity.  
Sample size is not determined in Patient and Public Involvement, as people act as 
advisors and contributors to the project, rather than research participants (INVOLVE, 
2012). The aim was to collect feedback from a diverse group of people previously 
diagnosed with a pelvic malignancy. Regarding sample size, a recent paper on the 
readability of health-related PIMs recruited five people to evaluate face validity (Williams 
et al., 2015b). Because of the different cancer diagnoses in the pelvic area and the 
potential diversity of the sample, it was estimated that feedback from up to 20 people 




8.3.5. Analysis  
Content and readability scores were analysed descriptively using the SPSS Statistical 
Package, version 23.0 (SPSS INC., Chicago, IL, USA). Normality of the content and 
readability data distribution for was assessed with the Shapiro-Wilk test and it was found 
that data were not normally distributed. Mann-Whitney U test was used to compare 
content and readability scores of PIMs from different sources. Results are presented as 
median and Interquartile Range [Median (IQR)]. Statistical significance was set at P<0.05.  
Feedback from PPI is presented as a summary. There was no aim to conduct qualitative 
analysis to the feedback, as we treated the participants as contributors to help shape 
future research. 
 
8.3.6. Ethics and ethical considerations 
Ethical approval was granted for the contribution of PPI members was granted by the 
University Research Ethics Committee (UREC), Oxford Brookes University (UREC 
171150). Consent was implied by the return of the completed questionnaire. 
Contact with PPI contributors was only via email to ensure minimal disruption and 
inconvenience. Questionnaires were completely anonymous and no personal information 
was sought by the research team. Only data about gender are presented in the results. 
No quotes were used in the presentation of results, minimising the possibility of any 




8.4.1. Identification of PIMs 
No information regarding diet or nutrition for any cancer type was found in NHS Choices, 
NHS Direct Wales or Health and Social Care Northern Ireland. The NHS Inform Scotland 
website had information under the sections “Exercise, diet and healthy living” and “Eating 
and digestion”. In all NHS websites, there were links to various charities’ website pages. 
Macmillan Cancer Support and Cancer Research UK were the most frequently mentioned 
sources for information on diet and nutrition after a cancer diagnosis. 
Fifteen cancer centres were identified, eight of which provided information about diet 
(Table 8.3). Across these eight centres, a total of 26 PIMs were identified online, all of 
which were generic cancer PIMs and in the form of leaflets or booklets (Table 8.4). PIMs 
covered mainly topics related to diet during treatment, such as management of treatment-
related side effects (eating problems, gastrointestinal disturbances and reduced appetite) 
and use of soft/liquidised food. PIMs from all cancer centres were available to download 
and print.  
Search for charitable sector organisations yielded 319 results. After removing duplicates 
(n=37) and checking all websites, eight charities were found to provide information about 
diet after cancer diagnosis. Four charities provided cancer-specific PIMs and four charities 
provided generic PIMs (Table 8.3). Thirteen online PIMs were identified and assessed 
(Table 8.4). Topics covered in the materials include healthy eating, management of 
treatment-related side effects (eating problems, gastrointestinal disturbances and reduced 
appetite) and weight management. All charities provided information about diet in the form 
of booklets available to download and print, with the exception of Cancer Research UK, 





Table 8.3: Cancer Centres and Charitable Organisations that provided online PIMs for diet 
and nutrition. 
Cancer Centres  
Christie Foundation NHS Trust, England 
Clatterbridge Cancer Centre NHS Trust, England 
The Royal Marsden NHS Foundation Trust, England 
Leeds Teaching Hospitals NHS Trust, England 
St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, England 
South East Scotland Cancer Network (Edinburgh Cancer Centre), Scotland 
Velindre Cancer Centre, Wales 
Belfast Cancer Centre, Northern Ireland 
Charitable Organisations 
Prostate Cancer UK  
Fight Bladder Cancer 
Beating Bowel Cancer 
Bowel Cancer UK 
World Research Cancer Fund/UK 
Cancer Research UK  
Macmillan Cancer Support 
Penny Brohn UK 
 
8.4.2. Assessment of content 
A total of 40 PIMs were assessed.  There was a wide range of scores for content (16 – 
37/40). Overall, materials from charities scored higher [32 (4); n=13] than those from 
cancer centres [23 (11), P<0.001; n=26]. Comparison of PIMs from NHS sources with 
PIMs from other sources could not be performed, due to the small number of PIMs from 
the NHS (n=1). Most materials scored high in the categories “Clarity of aims” and “Clear 
structure and layout” (4 – 5/5). PIMs from six charities and four cancer centres (n=17) had 
the Information Standard logo, indicating that the organisations “have been certified as a 
producer of reliable health and social care information”. The range in scores is primarily a 
result of the content quality of PIMs provided by cancer centres. Materials from five cancer 
centres had an overall high content score whereas materials from three centres scored 
low in most categories of the checklist (Table 8.4).  
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8.4.3. Assessment of readability 
Table 4 shows the grade reading level of all PIMs. The median reading grade level was 
7.5 (2.1) for FKGL and 7.4 (1.7) for SMOG (P>0.05). No PIM scored as low as the 
recommended level of 5th grade (reading ability of 10-11 years old). Eight PIMs from 
charities (61.5%) and 21 PIMs from NHS/cancer centres (77.8%) had a readability score 
within acceptable reading grades (6th to 8th grade level; reading ability of 11-14 years old). 
Eleven PIMs (27.5%) scored higher than 8th grade level (reading ability of 13-14 years 
old). Materials from charities had a similar average readability level [8.1 (2.1)] to materials 
from cancer centres [7.2 (1.8); P=0.076]. 
 
8.4.4. Assessment of face validity 
Sixteen PPI members (7 females, 9 males) evaluated eleven PIMs; seven were 
developed by charities (four pelvic-cancer specific and three generic) and four by cancer 
centres (Table 8.5). PIMs had a variety of scores in content (18-37/40) and readability 
(6.2-11.0).  
PPI contributors generally praised the quality of these PIMs, as information was generally 
considered up-to-date with the latest evidence. Information was presented in a simple, 
direct and straightforward way, especially for smaller PIMs. Also, some PIMs had 
references for external sources of information and support, which was perceived as 
positive. However, two PPI contributors questioned the accuracy of information related to 
consumption of sugar, fizzy drinks and alcohol in some PIMs. Also, according to feedback, 
pictures did not reflect the educational purpose of the PIMs, as it was not clear what they 
were trying to portray. For example, an older cancer patient would not perceive a picture 




Table 8.4: Content and readability scores of available online PIMs (n 40). 




(in U.S. grades) 
 





(Scotland) Eating and digestion/Exercise, diet and healthy living (2017) 23 7.5 7.4 7.5 (0.1) 13-14 
Cancer 
Centre 
Eating – Help yourself (2015) 30 10.8 8.7 9.8 (1.5) 15-16 
Advice about soft/liquidised food (2016) 29 6.6 7.0 6.8 (0.3) 12-13 
Eating well following treatment and recovery from cancer 
(2013) 30 6.8 7.2 7.0 (0.3) 12-13 
Eating well and coping with side effects (2016) 35 6.8 7.0 6.9 (0.1) 12-13 
Eating well when you have cancer (2016) 33 9.0 8.0 8.5 (0.7) 14-15 
Eating well during treatment (2017) 33 5.8 6.1 6.0 (0.2) 11-12 
Eating well during cancer treatment (2017) 34 7.2 7.3 7.3 (0.1) 12-13 
Healthy eating (2013) 23 7.7 7.6 7.7 (0.1) 13-14 
Eating well through your treatment (2013) 23 8.6 8.6 8.6 (0.0) 14-15 
Taste changes (2013) 23 5.3 6.0 5.7 (0.5) 11-12 
Soft diet (2013) 23 7.5 7.7 7.6 (0.1) 13-14 
Nausea and vomiting (2013) 23 8.7 8.0 8.4 (0.5) 13-14 
Loss of appetite (2013) 22 13.6 11.5 12.6 (1.5) >18 
Diarrhoea (2013) 24 10.8 10.1 10.5 (0.5) 16-17 
Constipation (2013) 21 7.0 7.4 7.2 (0.3) 12-13 
Soft diet (2014) 20 7.0 7.5 7.3 (0.4) 12-13 
Dry mouth (2014) 18 5.9 6.4 6.2 (0.4) 11-12 
 Nausea and vomiting (2014) 21 6.3 6.1 6.2 (0.1) 11-12 




FKGL, Flesch-Kincaid Grade Level; SMOG, Simplified Measure of Gobbledygook; SD, Standard Deviation; NHS, National Health Service; N/A Not Available. 
  




(in U.S. grades) 
 






Taste changes (2014) 19 6.7 6.4 6.6 (0.2) 12-13 
Low fibre diet (2013) 19 6.6 6.8 6.7 (0.1) 12-13 
Poor appetite (2013) 23 7.4 7.2 7.3 (0.1) 12-13 
Constipation (2013) 17 6.5 7.0 6.8 (0.4) 12-13 
Diarrhoea (2013) 16 7.7 8.1 7.9 (0.3) 13-14 
Taste changes (2013) 16 6.5 6.7 6.6 (0.1) 12-13 
Soft diet (2013) 18 9.8 8.7 9.3 (0.8) 14-15 
Charity Eating well – Living with bowel cancer (2017) 26 11.9 10.0 11.0 (1.3) 16-17 
 Your diet and lifestyle – Living with and beyond cancer (2017) 34 8.7 7.9 8.3 (0.6) 13-14 
Diet and physical activity for men with prostate cancer (2015) 31 6.9 7.0 7.0 (0.1) 12-13 
Diet and Nutrition (N/A) 26 8.4 8.5 8.5 (0.1) 14-15 
Healthy Living After Cancer (2016) 33 10.1 9.0 9.6 (0.8) 15-16 
Eating well during cancer (2017) 32 10.0 8.9 9.5 (0.8) 15-16 
Healthy Eating Guidelines (2017) 31 9.5 9.0 9.3 (0.4) 14-15 
Healthy Eating and Cancer (2017) 37 7.6 6.7 7.2 (0.6) 12-13 
Managing weight gain after cancer treatment (2016) 34 7.6 7.1 7.4 (0.4) 12-13 
Recipes for people affected by cancer (2015) 32 6.3 6.3 6.3 (0.0) 11-12 
The Building-up diet  (2017) 35 7.2 7.3 7.3 (0.1) 12-13 
Eating problems (2017) 35 8.2 7.9 8.1 (0.2) 13-14 
Coping with cancer/Coping physically/Diet problems (2014-




Table 8.5: PIMs assessed for face validity by PPI contributors. 
Title of material PPI feedback (n)  
Diet and physical activity for men with prostate cancer  6 
Healthy Living After Cancer 6 
Helpful tips for people with dry mouth  1 
Eating well through treatment  1 
Eating – help yourself; A guide for patients with eating problems, and 
their families  5 
Healthy eating and cancer  5 
Your diet & Lifestyle  3 
Eating Well, Living With Bowel Cancer  3 
Diet & Nutrition  1 
Eat well during cancer  1 
Eat well when you have cancer 1 
 
Most PIMs were easy to read and structure was appropriate to navigate easily and find 
relevant information. Language was considered simple in most PIMs and layout was clear. 
In larger PIMs, consumers noted that a more concise version would be easier to read.  
PPI members thought that the content of most PIMs contained useful information and they 
would make an informed decision about diet based on it. Most of them did not find the 
information relevant to their current health status (which was expected), but noted that 
most PIMs would be useful to newly diagnosed cancer patients, patients who have not 
considered changing their lifestyle before, or patients who experience specific side effects. 
Some PIMs would benefit from information about special diets (e.g. vegetarian), according 
to feedback. In some PIMs, purpose and target audience needed to be explicitly 
mentioned at the beginning of the material. Consumers found that PIMs related to healthy 
eating after cancer treatment did not include advice for nutrition issues during treatment 
and vice versa. Finally, feedback for generic leaflets highlighted the need to address 
individual needs and provide some information for specific cancers, particularly the 
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common ones (e.g. prostate). PPI feedback was generally positive for all given PIMs, 
irrespective of their content or readability scores. 
 
8.5. Discussion 
This study identified 40 online PIMs available from nine NHS sources (NHS Inform 
Scotland and eight NHS cancer centres) and eight charitable organisations. Considering 
the importance of providing sound nutritional advice after a cancer diagnosis in relation to 
weight management, nutritional management of side effects and healthy eating for future 
wellbeing (Demark-Wahnefried et al., 2015, Richman et al., 2012, Koutoukidis et al., 2015, 
Van Blarigan and Meyerhardt, 2015), it is important that such information is widely 
available. Development of materials from cancer centres indicates that information may be 
provided in some geographical regions of the UK. However, not all cancer centres had 
information about diet and nutrition online. Similarly, the NHS Scotland website had 
information about diet and nutrition in cancer survivorship, whereas the NHS England, 
Wales or Northern Ireland websites did not. Williams et al. (2015b) has highlighted the 
lack of any information about lifestyle (diet, physical activity, alcohol or smoking) in cancer 
survivorship in the NHS England website, despite it being the most preferred source of 
information for many patients in England (Rozmovits et al., 2004). 
Patients may choose to look for nutritional information from a charity specific to their 
cancer, as they may expect to find information tailored to their individual needs. This study 
showed that only four cancer specific charities provided such information. Few charities 
websites had external links of information to generic cancer charities (this was not further 
assessed) but most websites did not include any information on diet and nutrition. 
Consumer feedback highlighted the need for tailored nutritional information from reliable 
sources, especially post-treatment. Results from qualitative studies have shown that when 
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cancer patients receive dietary advice, it is often broad and does not meet their current 
needs and expectations (Hardcastle et al., 2018, Kwok et al., 2015, Sutton et al., 2017).  
The variety in content scores from the checklist was not reflected in PPI consumers’ 
feedback. According to the checklist, most PIMs had a clear structure and layout and 
included information based on the available (limited) scientific evidence; however, some 
PIMs would benefit from modifications. On the other hand, consumers’ comments 
focussed mostly on the quality and the practicality of the information, which was 
considered adequate to make an informed decision in most cases. The IPDASi checklist 
contains some elements which may not be perceived as essential for cancer survivors, 
such as presentation of a reference list or the authors’ credentials. Nevertheless, provision 
of PIMs from reliable sources, such as cancer centres and charities, may lead survivors to 
believe that PIMs have been created from experts who use the latest available evidence; 
hence the reason why no comments on credentials or references were made where this 
information was missing.  
In terms of readability, although most of the PIMs in this study had an overall acceptable 
readability score, 28% of them may be perceived as hard to read. Given that 43% of the 
working population in the UK has low health literacy (Protheroe et al., 2017), it may be 
difficult for all cancer patients to fully understand the content of the current PIMs and this 
could contribute to health inequalities (Protheroe et al., 2017, Public Health England, 
2015). Even though health literacy may not predict adherence to nutritional guidelines, 
especially among patients with chronic non-communicable diseases (Carrara and Schulz, 
2018), PIMs should score within acceptable readability levels to enhance understanding.  
The importance of patient and public involvement (PPI) in health and social care research 
has been highlighted in a recent systematic review (Brett et al., 2014). Feedback from PPI 
contributors in our study highlighted a number of positive and negative points about the 
PIMs that could not have been identified from the evaluation of content or readability. 
Involvement of service users is strongly recommended in the design of new PIMs and 
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upgrade of existing ones and could possibly contribute to greater understanding and 
adherence (Smith et al., 2014, Dellson et al., 2016). 
This study has both strengths and limitations. Assessment of quality was performed using 
three parameters; content, readability and face validity, as suggested by Beaunoyer et al. 
(2017) for the evaluation of online health information. It was not possible to assess the 
evidence base for the preparation of these materials. The content assessment tool was 
previously used in the assessment of health-related PIMs produced by UK organisations. 
One section of the checklist (presentation of probabilities of outcomes) was not relevant to 
PIMs about diet and nutrition but may be useful for the assessment of other health-related 
information materials. Also, involvement of patients provided in-depth information about 
the usefulness of the PIMs; patients or consumers active in research are often highly 
educated and more knowledgeable about healthcare issues and their views may not 
reflect the views of all pelvic cancer patients. PPI contributors’ level of participation was 
limited to the provision of feedback based on four open ended questions.  
This is not an exhaustive study of resources, as only materials available online were 
evaluated. For cancer centres, PIMs provided at the healthcare settings may be different 
to the ones currently available on the websites, as the websites may have not been 
updated with the latest versions. Access to online information may still be a challenge for 
older populations, who may have low digital literacy. Finally, the authors acknowledge that 
new PIMs may have been created and current PIMs may have been updated since the 
end of the evaluation (December 2017). 
In conclusion, the current study found a limited number of online PIMs in diet and nutrition 
suitable for pelvic cancer populations. Most PIMs had a comprehensive content; however, 
some PIMs may benefit from modifications. PPI contributors were more interested in the 
practical information within the PIMs and provided overall positive feedback, irrespective 
of content or readability score. They also highlighted the need for tailored and evidence-
based information in diet and nutrition for symptoms management and improving health. 
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In future, accessible, evidence-based diet and nutrition information should be made more 









Chapter 9. Conclusions, 
recommendations and 
future implications  
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9.1. Summary of unmet needs and practice recommendations 
Findings from the mixed-methods study conducted in pelvic cancer survivors and from the 
study on availability and assessment of online nutrition materials for pelvic cancer 
populations have revealed a number of unmet needs, which could be taken into 
consideration for future practice. 
 The offer of information in diet and nutrition after a cancer diagnosis 
Research in diet and nutrition post-diagnosis is ongoing and there is strong interest from 
the scientific community in this field. The evidence base on diet, nutrition and cancer 
survivorship is still limited; however pelvic cancer survivors are interested in learning 
about diet and nutrition in relation to their diagnosis (Section 4.11).  
Lack of routine provision of support (Section 4.9.1; Section 5.4/Theme 1), the expression 
of interest to learn more about diet and nutrition (Section 4.11) as well as the fact that only 
a minority considered nutrition unimportant in relation to future health (Section 4.8), all 
provide evidence of existing unmet needs. Even for people who did get support (from their 
healthcare team or other sources), a small proportion reported dissatisfaction with the 
level of advice (Sections 4.9.1, 4.10.1, 5.4.1). There is already sufficient evidence to 
suggest that healthy eating patterns could contribute to improved QoL and that overweight 
and obesity are associated with increased cancer mortality and overall mortality. Initiation 
of and engagement in conversations about diet and nutrition during and after the end of 
treatments and signposting to appropriate sources outside the clinical environment 
(support groups, online sources, health professionals outside the hospital) could be an 
important aspect of routine support. It may also be helpful to involve family members and 
people who care for survivors in conversations around diet, so that family/carers 




 Addressing diet and nutrition in relation to treatment side effects and 
comorbidities  
Considering the large number of participants who reported treatment side effects, 
particularly GI problems (Section 4.3), positive attitudes on the role of nutrition in 
alleviating side effects (Section 4.8), the low numbers who received support on this topic 
(n=33 from healthcare team and n=19 from other sources; Sections 4.9.1 and 4.10.1) and 
the number of people who didn’t have discussions but would like to (n=39; Section 4.9.1), 
it is evident that survivors of a pelvic cancer faced nutritional challenges related to 
treatment side effects. Findings from this study suggest that some treatment side effects 
may be more frequent in the on-treatment phase compared to the post-treatment phase, 
but others seem to persist at least up to two years after the end of radiotherapy. Regular, 
long-term monitoring of nutritional problems could help patients to maintain optimal 
nutritional status, alleviate side effects and build the foundations for healthy eating habits 
and improved QoL in the future.  
Acknowledging the presence of comorbidities and addressing nutritional issues relevant to 
comorbidities in an older population, like the sample in the mixed-methods study (Sections 
4.2.2 and 4.2.4), could also be an important aspect of support. Strategies on management 
of diabetes (10% of surveyed sample) and hypertension (33% of surveyed sample) 
incorporate modifications on a person’s diet. Also, weight management (mainly weight 
loss) is an effective strategy for the management of hypertension, arthritis and diabetes.  
 Addressing weight management issues 
Most participants had a BMI>25 kg/m2 (Section 4.2.4) and several experienced weight 
changes during and after cancer treatment (Section 4.4), which sometimes had a 
significant emotional impact (Sections 5.4.6 and 5.4.7), but support was limited (Sections 
4.9.1 and 4.10.1). Whether the concerns involved keeping a stable weight for radiotherapy 
treatment or achieving weight loss for future health and to reduce the likelihood of cancer 
recurrence post-treatment (Sections 5.4.6 and 5.4.7), it was evident that some participants 
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struggled and would have liked guidance. Engagement in conversations about weight 
management would be welcome from patients and could influence them to consider 
changing lifestyle behaviours to achieve optimal weight. The “teachable moment” of a 
cancer diagnosis may serve as a stronger motivator for successful weight loss, compared 
to previous attempts. 
 Provision of evidence based information 
In order to influence behaviour change, patients need to be convinced of the importance 
of diet and nutrition in the survivorship phase. Although the majority of participants 
considered diet and nutrition an important topic in survivorship outcomes (Section 4.8), a 
number of barriers were identified for lack of dietary change or lack of interest in 
considering diet and nutrition post-diagnosis (Section 5.10). Provision of information 
should be based on the latest scientific evidence from credible sources. It should, 
however, be acknowledged that there is still a lot to understand on the link between diet 
and cancer survivorship outcomes. 
 Signposting to reliable alternative sources of information 
As the study on PIMs showed (Chapter 8), there is some reliable information available to 
cancer patients from credible resources, but these resources are limited and materials are 
predominantly generic and designed to be useful across a range of cancer types. 
Addressing needs and concerns on an individual basis and provision of tailored 
information are core components of supporting effective self-management. Therefore, 
current materials are inadequate (can only serve as an additional form of support). As the 
results from the mixed-methods project showed, only a few participants looked at online 
sources, indicating that online sources may not be a priority source for information (as 
opposed to healthcare professionals). Also, several participants were not satisfied with the 
information they obtained (Section 4.10.1), highlighting a potential need for reliable and 
tailored information. Signposting to reliable alternative sources of information would 
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reduce some of the burden to healthcare professionals. Other sources, such as support 
groups, could also be considered. 
 Education for health professionals on diet, nutrition and its relation to 
cancer 
All of the points above may be difficult to implement without the input from health 
professionals, as they are the main contact after a cancer diagnosis and are seen as the 
‘experts’ by patients. Dietitians are the experts in relation to diet and nutrition; however, 
not every cancer patient is seen by a dietitian. In the absence of a dietitian, other health 
professionals could be educated (perhaps by dietitians) so they can provide reliable 
information / signposting to patients. It is important for health professionals to be educated 
on the role of diet and nutrition post diagnosis, from management of side effects to optimal 
nutritional status to weight management throughout treatment and post-treatment, and be 
provided with the appropriate resources. Although this PhD does not include “the health 
professional’s view” on diet and nutrition, there was some indication of dissatisfaction 
(needs not well met from survey findings; “trial and error” approach from interviews). 
 
9.2. Future research directions  
This PhD project has provided valuable input in identifying and understanding pelvic 
cancer survivors’ unmet needs for information and support in diet and nutrition after 
diagnosis. In order to implement successful strategies and interventions for behaviour 
change, Mitchie, Atkins and West (2014) suggested that the first step is to understand the 
behaviour. Understanding the behaviour signifies the need to define the problem in 
behavioural terms, select and specify the target behaviour and identify what needs to 
change. It is important to first understand the nature and range of the unmet needs – from 
management of side effects to weight issues – before designing and trialling successful 
dietary or lifestyle interventions. Interventions could include information resources, weight 
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loss programmes, nutritional counselling and /or physical activity and fatigue 
management.  
Moreover, as the samples of women with gynaecological cancer and people with bladder 
cancer were very small in the current project, it would be very useful to further explore diet 
and nutrition issues of these cancer groups, with the potential to identify unique unmet 
needs that this project may have not highlighted. 
In relation to the development of reliable written information materials in diet and nutrition, 
new materials should take into account needs that arise from each individual cancer 
diagnosis and provide tailored information. They could also follow guidelines for 
development which could improve content and readability.  
Apart from “the patient’s view”, it is also important to explore the “health professional’s 
view” with regards to provision of support to pelvic cancer patients and their level of 
awareness in diet and nutrition issues, with a view to identify potential unmet education 
and support needs. Interventions with the aim of enhancing health professionals’ 
knowledge could further impact on initiating discussions around diet and nutrition with 
cancer patients.  
 
9.3. Personal reflections 
Undertaking PhD studies is a learning process. Throughout the past three years of my 
studies I have come across a number of difficulties and challenges, from design and 
implementation to analysis and interpretation. 
 
9.3.1. Reflections on study design 
Regarding the study design, the formation of a questionnaire from scratch was a 
challenging procedure, as there was no existing suitable questionnaire. The input from 
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clinical colleagues and members of the NIHR Cancer and Nutrition infrastructure 
collaboration PPI Group was valuable to ensure the questionnaire was easy and quick to 
complete but also able to capture the important points of the research questions. 
Obtaining ethics approval for the mixed-methods study was also a time-consuming 
process, from which I got valuable experience regarding the complexities of obtaining 
ethics from NRES and HRA. Overall, the study needed to be approved by four committees 
(FREC, NRES, HRA & OUH R&D) before implementation and it took overall six months 
(April – October 2017) to get the final approval. 
Had I had the opportunity to repeat any part of the PhD, I would have made a few 
changes. I would have preferred to have the survey administered to the same sample 
twice; once during treatment and once around 12 months post-treatment. This way, I 
would have had comparable data of dietary changes, nutritional awareness and nutritional 
support over time. Although this design had been suggested, it would have been 
impossible to implement within the time restrictions of this PhD. Instead, the design was 
cross-sectional and the two groups (on-treatment, post-treatment) were different. 
Moreover, the questionnaire would have included questions regarding gender and red 
meat consumption.  
 
9.3.2. Relying on others for recruitment of the required sample 
The mixed-methods study involved the recruitment of cancer patients from the healthcare 
setting; however, I am not a NHS staff member and recruitment relied exclusively on 
members of the clinical team. Acknowledging that cancer nurses and radiographers have 
a very busy schedule daily, it has been very much appreciated that they invested time to 
administer the survey to eligible participants. All collaborators at OUH NHS trust were very 
helpful throughout the recruitment period. However, it is understood that some suitable 
patients may have not been invited to participate if clinical staff forgot or did not have 
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sufficient time to discuss it with them (on-treatment group). After all, there are certain 
priorities in a review clinical meeting and discussions about the study were made at the 
end of this meeting.  
 
9.3.3. First exposure to qualitative research 
Possibly the most challenging, and at the same time exciting part of this PhD, was the first 
exposure to qualitative research. I designed the topic guide, decided which individuals I 
would interview, transcribed verbatim and undertook the analysis using Framework; all 
were new to me.  
Telephone interviews proved to be a successful method of interviewing, as all participants 
felt comfortable enough to describe their dietary habits and experiences of nutritional 
support. There were few exceptions, mainly in relation to describing cancer diagnosis and 
treatments (this was the opening topic for the first two interviews), in which participants 
were hesitant in being open about their disease. Since this was not the main focus of the 
interviews, I changed the opening discussion topic and no problems occurred. Lack of 
confidence from my side was apparent in the first two telephone interviews but improved 
rapidly in the next interviews. 
A few more challenges during the interviews occurred. One participant got emotional as 
they described their experiences and it was difficult to offer support and comfort over the 
phone. The only thing I was able to do is ask if they were alright and if they wanted the 
interview to stop. Had it been a face-to-face interview, I might have been able to be more 
supportive. There were also – luckily very few – rude people who decided to drop out but 
expressed themselves in a rude way before hanging up. All distressing events were 
discussed in detail with the supervisory team.  
Throughout the study I have used a research diary and made summaries of the content 
for each interview and some personal comments and reflections. The research diary 
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helped me understand the point I reached “data saturation” and aided in reflecting on my 
role as a nutritionist and researcher in conducting interviews and analysing the data. 
 
9.3.4. Reflection on analysis 
Due to the exploratory nature of the PhD, logistic regression analysis proved more difficult 
than initially anticipated. After thorough reading of relevant literature, I identified several 
factors that could be included in the logistic regression models and I was very careful on 
which factors I would include in my final model. There were more data generated than 
initially planned, which significantly increased my analysis workload but it was also 
exciting to explore new combinations between variables. Due to the large amount of non-
parametric tests of associations, I decided to set the level of confidence at 99% (p<0.01) 
to minimise the probability of Type-I error.  
Regarding analysis of qualitative data, Framework proved a valuable tool for a researcher 
without prior experience in qualitative research. The Excel spreadsheet provided the right 
structure I needed to organise data and allowed me a clear view of where the codes could 
be combined. Some data would not “fit” under my initial themes but after discussion with 
the supervisors and Dr Lauren Matheson, these issues were successfully resolved.  
 
9.3.5. Dissemination activities and involvement with WCRF 
During the past three years, I have been invited to disseminate findings from my PhD in 
six conferences (in three of them I received a bursary), one networking meeting, one 
Masterclass (scholarship from the WCRF), two postgraduate research events at OBU and 
a clinical team meeting. My work attracted interest in the scientific community and I was 




The highlight of my PhD studies is the recognition of my work by the WCRF, which 
awarded me with an Academy fellowship to attend the Nutrition and Cancer Masterclass 
in Holland in 2019. I am now one of the few WCRF Academy Fellows and an 
“ambassador” of their work. 
 
9.4. Conclusion 
Overall, this PhD thesis makes a significant and novel contribution to the understanding of 
the information and support needs that people diagnosed with a pelvic cancer have in 
relation to diet and nutrition. Research in the role of diet and nutrition in survivorship 
outcomes is emerging and is relatively new. Despite known benefits of healthy dietary 
patterns in cancer survivors, research has generally focussed on breast cancer survivors 
and other populations have been under researched. Identification of unmet needs is the 
first step towards the design of successful behaviour change interventions and this PhD 
contributes to knowledge regarding unmet needs through the implementation of a mixed-
methods research design.  
The findings highlight that diet and nutrition is valued as an important lifestyle component 
in survivorship and that some improvements in clinical practice are warranted to ensure 
pelvic cancer patients have the information they require and feel well supported. 
Identification of the unmet needs can also feed into the development of future dietary 
interventions in these populations with the aim of improving future wellbeing. Appropriate 
guidance that leads to effective self-management is a core component of the NHS 
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APPENDIX 1: Chapter 2 (Systematic review) 
1a. Search strategy – Web of Science 
#1 TOPIC: (Cancer* OR oncolog* OR neoplas* OR *carcinoma* OR tumo?r* OR 
malignan*)  
DocType=All document types; Language=All languages;  
#2 TOPIC: (Pelvi* OR urolog* OR bladder or gyn?ecolog* OR ovarian OR 
endometrial OR cervical OR uterine OR vaginal OR vulvar OR rectal OR colorectal OR 
testicular OR prostate OR anal OR "reproductive organs" OR bowel)  
DocType=All document types; Language=All languages;  
#3 TOPIC: (Support* OR advice* OR education* OR counsel* OR information OR 
guidance OR communication)  
DocType=All document types; Language=All languages; 
#4 TOPIC: (Need* OR view* OR concern* OR perception* OR perceived)  
DocType=All document types; Language=All languages; 
#5 TOPIC: (Diet* OR nutrition* OR food* OR feed OR feeding OR lifestyle OR 
nourishment OR supplement* OR *enteral* OR artificial)  
DocType=All document types; Language=All languages; 
#6 TOPIC: (diagnosis OR treatment* OR patient* OR survivor*)  
DocType=All document types; Language=All languages; 
#7 #6 AND #5 AND #4 AND #3 AND #2 AND #1  







































































truth value:  
Credibility  




























1 0 2 2 1 1 1 2 2 2 0 2 3 1 1 1 1 1 
Theoretical 
Connectednes
s to enable 













2 3 3 3 1 2 3 1 1 2 3 1 2 2 2 3 3 2 
TOTAL 
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* Part of a mixed-methods paper. ** Based on score, a study is assessed as good, fair or poor;  Good: Total score of 18-24 indicates that 75% to 100% of the total criteria were met; Fair: 




1b. Quality assessment of cross-sectional studies  











































1 Were the aims/objectives clear? Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
2 Was the study design appropriate for the 
stated aim(s)? Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
3 Was the sample size justified? N N N N N N N N N N N N N N 
4 Was the target/reference population clearly 
defined? Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
5 Was the sample frame taken from an 
appropriate population base so that it 
closely represented the target/reference 
population under investigation? 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
6 Was the selection process likely to select 
subjects/participants that were 
representative of the target/reference 
population under investigation? 
N N Y N N N N N N N N N N Y 
7 Were measures undertaken to address and 
categorise non-responders? N N N N N N N N N N N N N N 
8 Were the risk factor and outcome variables 
measured appropriate to the aims of the 
study? 
Y Y Y Y Y N Y Y Y Y Y Y Y Y 
9 Were the risk factor and outcome variables 
measured correctly using instruments that 
had been trialled, piloted or published 
previously? 
N Y Y N Y N N Y N N N N Y Y 
10 Is it clear what was used to determined 
statistical significance and/or precision 
estimates?  















































11 Were the methods (including statistical 
methods) sufficiently described to enable 
them to be repeated? 
Y Y Y Y Y N Y Y Y N Y N Y Y 
12 Were the basic data adequately described? Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
13 Does the response rate raise concerns 
about non-response bias? Y Y Y N Y Y Y Y Y Y Y Y N Y 
14 If appropriate, was information about non-
responders described? Y Y Y N N N N N N N N N N N 
15 Were the results internally consistent? N Y N Y Y Y N Y N Y Y Y Y Y 
16 Were the results for the analyses described 
in the methods, presented? Y Y Y N Y Y Y Y Y Y Y Y N Y 
17 Were the authors’ discussions and 
conclusions justified by the results? Y Y Y Y Y N Y Y Y Y Y Y Y Y 
18 Were the limitations of the study 
discussed? Y Y Y N N Y Y Y Y Y Y Y Y Y 
19 Were there any funding sources or conflicts 
of interest that may affect the authors’ 
interpretation of the results? 
N DK N N DK N N N N Y DK DK N N 
20 Was ethical approval or consent of 
participants attained? Y DK Y Y Y Y Y Y Y Y DK DK Y Y 




APPENDIX 2: Chapter 3 (Methodology and Methods) 
2a. Study Invitation Letter (on-treatment participants) 
 
 
FREC study number: 2016/43 
REC Reference: 17/ES/0112 
04 September 2017 
 
Reference: Nutrition and pelvic cancer: A study to explore dietary habits, 
nutritional awareness and patient experiences. 
 
I am writing to invite you to consider taking part in a research study being conducted by 
researchers at Oxford Brookes University, in collaboration with the Radiotherapy 
Department, Cancer and Haematology Centre, Oxford University Hospitals NHS 
Foundation Trust.  
The study aims to explore dietary and nutrition experiences and concerns in people 
who are being treated with radiotherapy for cancer in the pelvic area. Cancer in the 
pelvic area includes cancers of the anus, bladder, rectum, gynaecological cancers 
(cervix, womb, ovaries, vulva and vagina) and male cancers (prostate and testes).  
The research team would like to know about your current dietary habits, what you have 
heard about dietary guidelines, and what information and support you may have 
received in this area, or would like to have received. Taking part in the study would 
involve completing the questionnaire enclosed with this letter and returning it in the 
reply paid envelope provided.  The study findings will help us to understand how we 
can best support patients in this area.   
A patient information sheet is included with this letter, which contains more details 
about this study. Involvement in the study is entirely voluntary. If you decide not 
to participate in the study your care will not be affected in any way. If you do 
decide to participate you can withdraw at any time without giving any reason.  
If you have any further questions that have not been answered in the patient 
information sheet, please do not hesitate to contact the research team for further 
information (George Saltaouras – email: 16021065@brookes.ac.uk, tel: 01865 482669 
or Professor Eila Watson – email: ewatson@brookes.ac.uk, tel: 01865 482665). 
 
Thank you for taking the time to read this letter. 
 
Yours sincerely,   
Dr Amanda Horne, MB BCH BAO MRCP FRCR 









FREC study number: 2016/43 
REC reference: 17/ES/0112 
 
Study title 
Nutrition and pelvic cancer: A study to explore dietary habits, nutritional 
awareness and patient experiences – the patient’s view. 
 
Invitation paragraph 
You are being invited to take part in a research study. Before you decide whether or 
not to take part, it is important for you to understand why the research is being done 
and what it will involve. Please take time to read the following information explaining 
the study and your involvement within it. Thank you for your time. 
 
What is the purpose of the study? 
Cancer incidence continues to increase but so does cancer survival, due to early 
detection and improved treatment regimes. Cancer in the pelvic area includes cancers 
of the anus, bladder, rectum, gynaecological cancers (cervix, womb, ovaries, vulva and 
vagina) and male cancers (prostate and testes). Patients with pelvic cancer can 
sometimes experience effects of treatment which impact on diet e.g. bowel problems 
and lack of energy. Many patients are also interested in changing their diet to help 
keep them healthy following treatment. 
The aim of this study is to find out about the experiences, awareness and concerns of 
people treated with radiotherapy for cancer in the pelvic area in relation to diet and 
nutrition. We would like to know about your current dietary habits, what you have heard 
about dietary guidelines, and what information and support you may have received in 
this area, or would like to have received. Participants will be recruited over a period of 
approximately 12 months. 
 
Why have I been invited to participate? 
You are being invited to participate because you have been diagnosed with cancer in 
the pelvis (anus, bladder, rectum, endometrium/womb, cervix, ovaries, vulva, vagina, 
prostate or testes) and you are being treated or have been treated in the past with 
radiotherapy.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part. Your involvement with this study is 
entirely voluntary and will not affect the care you receive in any way.  
 
What will happen to me if I take part? 
If you are willing to take part we ask you to complete the questionnaire that is included 
in the study pack with this information sheet and return it in the reply paid envelope 
provided. We hope to get 200 completed questionnaires returned.  
We would also like to conduct an interview with a sample of those who complete the 
questionnaire to explore their experiences and views in greater detail. At the end of the 
questionnaire there is a space for you to fill in your contact details, only if you are 




blank. If you provide your contact details, the sheet will be detached from your 
questionnaire on receipt and your answers will be kept with your name removed.  
The questionnaire should take no longer than 30 minutes to complete. If there is any 
question you do not wish to answer, please feel free to leave it blank and carry on to 
the next question. 
The follow on interview would last approximately 35-40 minutes.  It would be done over 
the telephone at a time convenient for you. With permission, we would like to record 
the interviews.    
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part in this study. However, the information 
you and others provide will help inform how best to support patients in this area in the 
future.  
 
What are the possible disadvantages of taking part? 
Discussing issues related to your cancer care could be upsetting and this may 
sometimes be a disadvantage of taking part. We also appreciate that there is time 
involved in completing the questionnaire and participating in an interview, although we 
have tried to keep this to a minimum. If any distress has been caused by participation, 
please contact a member of your clinical team. Also, if any worries are raised, you 
could contact Macmillan Cancer Support at 0808 808 0000 or Cancer Research UK at 
0808 800 4040 (free from UK landlines). 
 
Will what I say in this study be kept confidential? 
Your right to privacy will be respected. All information collected about you in this study 
will be kept strictly confidential subject to legal limitations. If you provide contact details, 
the sheet will be detached from your questionnaire. Therefore, data from the 
questionnaire will be completely anonymous. Also, the questionnaire and your personal 
data will be stored separately.  
 
Data collected from you will be assigned a random number and can only be traced to 
you by the researcher. Data from the questionnaire and data from the interview (if 
provided) will be only linked with a unique ID code. Your questionnaire responses will 
be entered onto a secure, password protected and encrypted computer at Oxford 
Brookes University. In accordance with the University’s policy on Academic Integrity 
the data will be kept for a period of 10 years, after which point it will be carefully 
destroyed.   
 
What should I do if I want to take part? 
If you wish to take part in the study, please complete the questionnaire found in this 
pack.  Instructions on completing the questionnaire can be found on the first page. 
Your questionnaire can be returned via the reply paid envelope. We would ideally like 
you to complete and return the questionnaire within one week after your clinical team 
has given it to you. By returning the questionnaire, you consent to take part in the 
study.  
 
At the end of the questionnaire, you can indicate if you are willing to be interviewed and 
we will be in touch to arrange a time convenient for you to have a telephone interview. 






What will happen to the results of the research study? 
The results will be analysed and reported as a PhD thesis. Results will also be 
discussed and presented at University and external research conferences. We also aim 
to publish the results in appropriate nutrition and oncology journals. If you want to get a 
summary of the findings, please get in touch with Professor Eila Watson, Department 
of Nursing on 01865 482565 or Dr Helen Lightowler, Department of Sport and Health 
Sciences  on 01865 483283 who will be able to provide a copy. 
 
Who is organising and funding the research? 
The study is being conducted by a PhD student at Oxford Brookes University, who is 
supervised by Professor Eila Watson, Dr Helen Lightowler and Dr Shelly Coe. The 
study has been funded by the Faculty of Health and Life Sciences, Oxford Brookes 
University. 
 
Who has reviewed the study? 
This study has been discussed with a clinical team, consisting of research nurses, 
therapeutic radiographers and clinical oncologists. Feedback for the survey has also 
been received by a group of cancer survivors. 
The study had approval from the Faculty Research Ethics Committee at Oxford 
Brookes University and a National Research Ethics Service. 
 
Contact for Further Information 
If you have any further questions about the study, please get in touch with George 
Saltaouras (PhD student) or Professor Eila Watson (supervisor). Please find contact 
details below.  
 
George Saltaouras (student) Professor Eila Watson (supervisor) 
Tel: 01865 482669 or 01865 483283 Tel: 01865 482665 
Email: 16021065@brookes.ac.uk Email: ewatson@brookes.ac.uk  
 
If you have any concerns regarding how this study has been conducted please contact 
the Chair of the Faculty Research Ethics Committee at Oxford Brookes University, 
Kellie Tune on kelly.tune@brookes.ac.uk. 
 
 
Thank you for taking time to read the information sheet. 
  
FREC Reference: 2016/43 




2c: Dietary habits, nutritional awareness and 
patient experiences in pelvic cancer 
 
Thank you for considering taking part in this study. We would like to know about your dietary habits, 
your knowledge and experiences regarding diet and nutrition after cancer diagnosis. We hope our 
research will help inform service developments in the future. The survey is made up of five sections 
and should take approximately 30 minutes to complete. 
Enclosed are a patient information sheet and a FREEPOST envelope. Please read the patient 
information sheet before completing the questionnaire. Participation in this research study is 
voluntary.  If you do decide to participate in the study, please complete and return the questionnaire.  
By doing this, you consent for us to use your responses (anonymously) in our research.  
Please read each question carefully. There are no right or wrong answers to these questions. If you 
decide there are any questions you would rather not answer please just go to the next question.  
After we have received these survey responses, we would also like to interview a sample of the 
people who have responded to the survey to gain a more detailed understanding of diet and nutrition 
experiences and needs. If you are interested in being contacted for an interview, please fill in your 
contact details in section F. This section will be detached upon receipt and stored separately, so that 
your answers are kept with your name removed. If you are not interested, please leave that section 
blank when you return your questionnaire. 
All the information you give will be treated as strictly confidential. 
If you have any questions about any aspect of completing the questionnaire, or if you require the 
questionnaire to be supplied in large print, please contact George Saltaouras on tel: 01865 483283 or 
01865 482669 or email: 16021065@brookes.ac.uk. 
 
Thank you very much for your help 
Date of survey completion:             /          /                 (DD/MM/YYYY) 
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SECTION A: YOUR DIAGNOSIS 
These questions are about your type of cancer, your diagnosis and your treatment. 
A1. When was your cancer diagnosed? 





A2. What type of cancer were you 
diagnosed with? 
Tick () all that apply 

1 Anus 7 Rectum 

2 Bladder 8 Testes 

3 Cervix 9 Vagina 

4 Endometrium (womb) 10 Vulva 

5 Ovary 0 Other (please specify) 

6 Prostate  
 
A3. What treatment(s) are you 
having/have you had? 












A4. Which of the following best describes 
your current situation regarding 
radiotherapy treatment? 

1 I am currently receiving treatment 
 How many weeks have  
you been on treatment? 
________ weeks 
 How many weeks will  
your treatment last in total? 
________ weeks 

2 I have finished treatment 




A5. Is this your first cancer diagnosis? 1 Yes 2 No 
 
SECTION B: TREATMENT EFFECTS 
These questions are about gastrointestinal symptoms and appetite issues that you may experience as a 
result of your treatment. 
B1.  Are you currently experiencing any of the following effects as a result of your treatment?  
(Tick () all that apply) 

1 Loss of appetite 5 Nausea/Vomiting 9 Dry mouth 

2 Changes in taste 6 Diarrhoea 10 Incontinence 

3 Changes in smell 7 Constipation 11 Mouth sores 

4 Wind/bloating 8 Fatigue/Lack of energy 12 Difficulty swallowing 

0 Other (please specify)  

13 No effects 
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B2. In your opinion, how important is the role 
of diet in: 
Please tick () in the appropriate box for each question. 
Not important 










i. Reducing gastrointestinal symptoms, such 
as wind, constipation, diarrhoea & nausea? 
    
ii. Reducing appetite symptoms, such as 
changes in smell/taste & lack of appetite? 
    
iii. Reducing the feeling of fatigue? 
    
 
SECTION C: YOUR DIETARY HABITS 
These questions are about your diet since diagnosis, including dietary habits and use of supplements. 
C1.  Have you changed your diet since 
diagnosis? 

(1) Yes  
Please go to question C2   

(2) No  
Please go to question C5  
C2. Why did you change your diet? 
(Tick () all that apply) 

(1) To reduce the risk of cancer recurrence/spread 

(2) To assist with treatment side-effects  

(3) To maintain general health 

(4) To support therapy/recovery 





C3.  In which of the following food groups have 
you increased/decreased consumption? 
Please tick () in the appropriate box for each question. 
Increased (1) Decreased (2) No change (3) 
i. Whole grains  e.g. whole wheat bread or pasta, 
brown or wild rice, whole oats, whole rye, whole barley, 






ii. Refined grains  e.g. white bread, pasta & rice, 
cornbread, sourdough bread, white flour or corn flakes  
   
iii. Fruit    
iv. Vegetables    
v. Low fat milk and dairy products     
vi. Full fat milk and dairy products    
vii. Lean, low fat meat and poultry    
viii. Oily fish e.g. salmon, tuna, trout or mackerel    
ix. White fish e.g. cod, haddock or sea bass    
ix. Sugary foods and drinks    
x. Processed meats  e.g. bacon, salami, sausage, 
ham, corned beef, beef jerky, hotdog and canned meat 
   
xi. Alcohol    
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C5. How familiar are you with the following 
dietary recommendations? 
Please tick () in the appropriate box for each question. 
Never heard 







i. Be a healthy weight – Keep your weight as 
low as you can within the healthy range. 
    
ii. Limit high-calorie foods and avoid sugary 
drinks. 
    
iii. Eat a wide variety of wholegrains, 
vegetables, fruit and pulses, such as beans. 
    
iv. Aim for at least 5 portions of fruit and 
vegetables a day. 
    
v. Eat no more than 500 grams of red meat a 
week and avoid processed meat. 
    
vi. Don’t drink alcohol. If you do, limit 
alcoholic drinks and follow national 
guidelines (up to 14 units per week). 
A pint of beer or a large glass of wine is approximately 2 
units of alcohol. A single gin & tonic (25 ml gin) corresponds 
to 1 unit of alcohol, whereas a double gin & tonic is 2 units. 
    
vii. Limit your salt intake to less than 6 grams 
a day. 
    
viii. Eat a healthy diet rather than relying on 
supplements. 
    
C6. In your opinion, how important is the role 
of diet in: 
Please tick () in the appropriate box for each question. 
Not important 










i. Preventing cancer recurrence/spread?     
ii. Improving overall health?     
iii. Supporting therapy and recovery?     
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C7. Since diagnosis, have you been 
taking any vitamin/mineral 
supplements? 

(1) Yes  
Please go to 
question C8  

(2) No  
Please go to 
question C10   

(3) Used to, but not 
anymore  
Please go to question C10   
C8. If yes, which vitamin/mineral 
supplements have you been taking? 




(2) Vitamin D  

(3) Omega 3/Fish oils 

(4) B vitamins 













C9. Why have you been taking 
vitamin/mineral supplements? 
(Tick () all that apply) 

(1) To reduce the risk of cancer recurrence/spread 

(2) To assist with treatment side-effects  

(3) To maintain general health 

(4) To support therapy/recovery 





C10. How much water/fluids do you 
generally consume daily?  
A glass of water/fluids is 
250 ml, as shown in the 
picture. Fluids include 
milk, coffee, tea and juice. 

(1) 0-2 glasses/day  

(2) 3-5 glasses/day  

(3) 6-8 glasses/day 

(4) >9 glasses/day 
C11. Who do you usually have meals 
with? 








(4) No one 

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C12. Who prepares your meals? 
(Tick () all that apply) 

(1) Spouse/partner   

(2) Family members   

(3) Friends   

(4) No one – I prepare my own meals and/or the family 
meals    





C13. During the past 4 weeks, how often 
did you cook your meals from 
scratch or were offered home-made 
meals? 




(2) 1-3 times/month 

(3) 1-4 times/week 

(4) 5 times/week or more 
C14. During the past 4 weeks, how often 
did you eat ready-to-eat meals? 
Ready-to-eat meals include salads, soups, 
sandwiches and cooked meals that only require 
adding water or heating up. You can get all 
these from supermarkets or grocery stores. 




(2) 1-3 times/month 

(3) 1-4 times/week 

(4) 5 times/week or more 
 
SECTION D: DIET AND NUTRITION SUPPORT 
These questions are about support you may have received from different sources regarding your diet. 
Please fill in sub-sections (I) – ‘Diet and Nutrition support from a healthcare professional’, (II) – ‘Diet and 
Nutrition support from an online or other source’ and (III) – ‘General questions’. 
(I): Diet and Nutrition support from a healthcare professional 
D1.  Have you received any nutrition 
support in relation to your cancer 
from your healthcare team? 

(1) Yes 
Please answer questions D2-D9   

(2) No 
Please go to question D10  
D2. Who did you receive diet and 
nutrition information from? 
(Tick () all that apply) 

(1) Dietitian/Cancer specialist dietitian 
A dietitian provides diet and nutrition support for the management of 
your disease. They provide special diets for cancer. They are part of a 
healthcare team and work in the NHS and in private clinics. 

(2) Cancer or Radiotherapy Specialist Nurse 

(3) Radiographer/Clinical Oncologist   

(4) Nutritionist 
A nutritionist provides information about food and healthy eating for 
disease prevention. A nutritionist usually works as a freelance outside 
the NHS setting. 

(5) General Practitioner (GP)  

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D3.  What diet and nutrition information 
were you provided? 
(Tick () all that apply) 

(1) General healthy eating 

(2) Nutritional management of symptoms 

(3) Weight management 

(4) Healthy Recipes 

(5) Survivorship courses/classes/workshops 

(6) Vitamin/mineral supplements 

(7) Other supplements 





D4.  I received diet and nutrition 
information in the form of: 
Tick () all that apply 

(1) Written information/leaflets 

(2) Links for websites 

(3) Face to face assistance 

(4) Telephone assistance 





D5.  In your opinion, how well were your nutrition needs met? 
 
(1) Not at all 
well 

(2) Not very  
well 

(3) Neutral (4) Well  (5) Very well 









(4) Consistent (5) Very 
consistent 





(2) Difficult (3) Neither difficult 
nor easy 

(4) Easy (5) Very easy 
D8.  Did dietary information/advice influence you to 
change dietary habits? 

(1) Yes (2) No 
          Please explain why:  
 
 




Please go to Question D12. 
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 If you answered No to D1, please answer Questions D10-D11. 
D10. Why didn’t you receive any support? 
 (Tick () all that apply) 

(1) I chose not to receive any 

(2) I was not offered any 

(3) I did not know it existed   

(4) I did not think nutrition was important 





D11. What, if any, diet and nutrition 
information would you like to have 
received from your healthcare team? 
(Tick () all that apply) 

(1) General healthy eating 

(2) Nutritional management of symptoms 





(5) Survivorship courses/classes/workshops 

(6) Vitamin/mineral supplements 

(7) Other supplements 

(8) I did not want any information 





(II): Diet and Nutrition support from an online or other source 
D12. Did you seek any information or 
support on diet and nutrition in 
relation to your cancer online or 
from another source? 

(1) Yes 
Please answer questions D13-D18  

(2) No 
Please go to question D19 
D13. Which source did you receive diet 
and nutrition information from? 
(Tick () all that apply) 

(1) A cancer charity website  
(e.g. Macmillan Cancer Support, Cancer Research UK) 

(2) A medical website  
(e.g. NHS choices) 

(3) A blog/social media webpage 

(4) A newspaper/magazine/book 

(5) A recipe book 

(6) Family member/friend 

(7) Other patient 

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D14.  What diet and nutrition information 
were you provided? 
(Tick () all that apply) 

(1) General healthy eating 

(2) Nutritional management of symptoms 

(3) Weight management 

(4) Healthy Recipes 

(5) Survivorship courses/classes/workshops 

(6) Vitamin/mineral supplements 

(7) Other supplements 





D15.  In your opinion, how well were your nutrition needs met? 




Not very  
well 

(3) Neutral (4) Well  (5) Very well 
D16.  In your opinion, how consistent was the advice you received? 
 (1) Very 
inconsistent 





(4) Consistent (5) Very 
consistent 
D17.  In your opinion, how easy was the advice to follow? 
 (1) Very 
difficult 

(2) Difficult (3) Neither difficult 
nor easy 

(4) Easy (5) Very easy 
D18.  Did dietary information/advice influence you to 
change dietary habits? 

(1) Yes (2) No 
          Please explain why:  
 
 
(III): General questions 
D19.  Would you be interested in receiving more information about your diet in relation to your cancer? 
 (1) Not interested 
at all 












D20.  What mode(s) of delivery would you 
prefer? 
(Tick () all that apply) 

(1) Face to face by a healthcare professional  









(0) Other (please specify) 
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D21.  At which time point(s) would you 
prefer to receive information about 
your diet? 
 (Tick () all that apply) 

(1) At diagnosis or soon after 

(2) During treatment 

(3) At the end of treatment   

(4) On a follow up visit 

(5) Any time 
 
SECTION E: ABOUT YOU 
This section contains questions about your background and domestic circumstances.  This information is 
sought for the purpose of analysing and organising our results, and to help us to be confident that our 
results are representative. 
E1.  What is your date of birth? DD/MM/YYYY 
 
E2.  What is your height? 
If unsure, please give your closest estimation. 
                ft                  in  OR                       cm 
 
E3.  What is your current weight? 
If unsure, please give your closest estimation. 
                                lb  OR                     kg 
 
E4. Has your weight changed since 
diagnosis? 
Please tick () one 

(1) Yes, I have gained weight 

(2) Yes, I have lost weight 

(3) No, my weight has not changed 
E5. Which of the following groups 
regarding smoking would you say you 
belong to? 
Please tick () one 

(1) I am a current smoker 

(2) I used to smoke, but not anymore 




(3) I never smoked 
E6.  Have you been diagnosed with any of 
the following conditions? 
Please tick () all that apply 

(1) Heart problems e.g. 
angina, heart failure, prior 
heart attack or stroke 

(8) Problems with your 
stomach or gallbladder 

(2) Diabetes (9) Kidney disease 

(3) High blood pressure 10 Liver disease 

(4) Asthma/other chronic 
chest problem 

11 Alzheimer’s disease or 
dementia 

(5) Arthritis 12 Epilepsy 

(6) Osteoporosis 13 Other long standing 
neurological problem 
 (7) Problems with your 
pancreas 

(0) I do not have any of 
these health conditions 

(15) Other (please specify) 
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E7.  What is your current marital status? 
Please tick () one 

(1) Married or living as married 







(0) Other (please specify) 
 
 
E8.  Which of these best describes your 
current employment status? 
Please tick () one 

(1) In paid work (including self-employment) – full or 
part time 





(4) Retired from paid work 

(5) Unable to work because of long-term disability or ill 
health 

(6) In full-time education, training or work experience 

(0) Other  (please specify) 
 
 
E9. Which of the following ethnic groups 
would you say you belong to? 
Please tick () one and circle as required 

(1) White: British / other white groups  

(2) Black: British / African / Caribbean / other black 
groups  

(3) Asian: British / Indian / Pakistani / Bangladeshi / 
other Asian groups 

(4) Chinese: British / other Chinese groups  
E10.  What is your highest formal 
qualification? 
Please tick () one 

(1) ‘O’ level, GCSE or equivalent 

(2) ‘A’ level or equivalent 

(3) Clerical or commercial qualification 

(4) Professional qualification  

(5) College or university degree, HND or HNC 

(6) Postgraduate qualification e.g. MA, MSc 

(7) None of these 
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Anything we missed? 
Are there any other issues about your diet that you think might be important for us to know about? 
Please use this space to have your say.  Feel free to continue on a separate sheet if you need to. 
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We very much appreciate the time and thought you have put into completing this survey. If 
reflecting on your diet has caused anxiety or uncertainty in any way, please do not hesitate to 
contact a member of your clinical team. 
You can also call Macmillan Cancer Support at 0808 808 0000 or Cancer Research UK at 0808 
800 4040 (free from UK landlines). Specialist nurses are there to listen to your concerns, and 
offer support and helpful information. 
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SECTION F: FURTHER WORK 
Can we contact you again?  
Thank you for your participation in this survey.  The results will help us to better understand some of 
the important nutrition issues pelvic cancer patients face after cancer diagnosis. 
We would like to conduct some informal interviews with a number of patients who have completed the 
questionnaire to explore nutrition issues and concerns in greater depth. If you are interested in taking 
part in an interview, please fill in your contact details below and we will be in touch. 
Completing this expression of interest does not commit you to anything - Eligible patients will be given 
full details of the interview to allow them to decide whether or not they wish to take part. 
Your contact details will be detached from the questionnaire and kept securely and strictly 
confidential.  They will not be passed on to anyone else.  We will keep a record to enable us to contact 
you about this study only.  If you have any questions about this, please contact George Saltaouras on 
tel: 01865 483283 or 01865 482669 or email: 16021065@brookes.ac.uk. 
 Would you be interested in taking part 
in an interview? 
Please tick () one 

(1) No, I am not interested 
Do not complete the section below.   

(2) Yes, I am happy to be contacted for an interview 
Please complete contact details below.  
    
 Please give your contact details:   
    
Name   
    
Address  Home telephone   
   Work telephone   
   Mobile telephone   
Postcode  Email address   






Please return in the envelope supplied to: 
George Saltaouras 
Faculty of Health and Life Sciences 
Oxford Brookes University 
Jack Straws Lane, Marston 
Oxford, OX3 0FL  
Unique study ID 








































2d. Pre-determined script  
 
 
Study title: Nutrition & Pelvic Cancer 
 




The project is conducted by researchers at Oxford Brookes University. They would like 
to invite you to fill in a survey about your experiences of diet and nutrition in relation to 
cancer. This is a study pack with all necessary information, a copy of the survey and a 
FREEPOST envelope. Please read the information carefully and if you are interested, 
fill in the survey and send it back in the envelope provided. There is no time limit on 
when to complete the survey by, although the research team would be grateful if you 
can complete and return it within a week. If you have any further questions about the 















FREC study number: 2016/43 
REC Reference: 17/ES/0112 
 
01 March 2018 
 
 
Reference: Nutrition and pelvic cancer: A study to explore dietary habits, 
nutritional awareness and patient experiences. 
 
I am writing to invite you to consider taking part in a research study being 
conducted by researchers at Oxford Brookes University, in collaboration with 
the Radiotherapy Department, Cancer and Haematology Centre, Oxford 
University Hospitals NHS Foundation Trust.  
The study aims to explore dietary and nutrition experiences and concerns in 
people who have been treated with radiotherapy for cancer in the pelvic area. 
Cancer in the pelvic area includes cancers of the anus, bladder, rectum, 
gynaecological cancers (cervix, womb, ovaries, vulva and vagina) and male 
cancers (prostate and testes). We are inviting people who completed treatment 
between 6 -24 months ago. 
The research team would like to know about your current dietary habits, what 
you have heard about dietary guidelines, and what information and support you 
may have received in this area, or would like to have received. Taking part in 
the study would involve completing the questionnaire enclosed with this letter 
and returning it in the reply paid envelope provided.  The study findings will help 
us to understand how we can best support patients in this area.   
A patient information sheet is included with this letter, which contains more 
details about this study. Involvement in the study is entirely voluntary. If you 
decide not to participate in the study your care will not be affected in any 
way. If you do decide to participate you can withdraw at any time without 
giving any reason.  
If you have any further questions that have not been answered in the patient 
information sheet, please do not hesitate to contact the research team for 
further information (George Saltaouras – email: 16021065@brookes.ac.uk, tel: 
01865 482669 or Professor Eila Watson – email: ewatson@brookes.ac.uk, tel: 
01865 482665). 
Thank you for taking the time to read this letter. 
 
Yours sincerely,   
 
Dr Amanda Horne, MB BCH BAO MRCP FRCR 
Consultant in Clinical Oncology  
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Participant Consent Form 
Nutrition and pelvic cancer: A study to explore dietary habits, nutritional awareness and patient 
experiences – the patient’s view. 
 
Please initial if you agree with the following statements: 
1. I confirm that I have read and understood the information sheet for the above study, that I 
have had the opportunity to ask questions and have had these answered satisfactorily as 
required. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving reason.  
3. I agree to be interviewed.  
4. I understand that the interview will be audio-recorded.  
5. I agree to take part in the above study.  
 
Please circle yes or no in response to the following statements: 
 
6. I understand that by taking part, I am agreeing that the researchers may use anonymous 
extracts from the transcripts of my audio recording in publications and presentations about 
the findings of this study.  
 
7. I agree that my data gathered in this study will be stored (after it has been anonymised) at 
Oxford Brookes University and may be used for future research purposes such as 
publications related to this study after the completion of the study.  
 
8. I give consent for the research team to share anonymised written and recorded material 
collected in this study with other researchers.  
 
Name of participant (please print): ____________________________________________ Date: __________ 
Signature: _______________________________________________________________________________ 
Name of researcher (please print): ____________________________________________ Date: __________ 
Signature: _______________________________________________________________________________ 
 
Contact details:  
George Saltaouras, PhD student 





Yes      No 
Yes      No 
Yes      No 
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2g: Topic guide (interviews) 
 
Study Title: Nutrition and pelvic cancer patients: a mixed-methods study to explore 
dietary habits, nutritional awareness and patient experiences 
 
The following broad topic guide addresses the objectives of the study: 
 Current dietary habits and changes since diagnosis 
 Beliefs and views of the role of diet in the management of symptoms and keeping 
healthy 
 Patient experiences of nutrition support during and after cancer treatment. 
Interview Topic Guide with participants 
Topics Prompts 
Introduction Introduction Who I am 
Aim of study/interview 
Get verbal consent 
Cancer history(1) Would you like to tell me a bit 
about yourself? 
When diagnosed 
Type of cancer  
Type of treatment 
Dietary habits Current dietary habits Any food groups, particular 
foods/supplements/dietary 
patterns? 
Have you changed your 




Any food groups, particular 
foods/supplements 
added/removed? 
Dietary supplements (2) Do you consume? 
What is your opinion about them? 
Cooking and shopping 
practices (2) 
Who cooks? How do you cook? 
Who shops? Where do you 
shop? 
Weight changes Weight gain/loss? 
Beliefs about diet and 
managing symptoms 





Any food groups, particular 
foods/supplements/dietary 
patterns? 
Keeping healthy (for 
example – reducing the 
risk of cancer recurrence 
or development of other 
conditions) 
What is your understanding of 
“keeping healthy”? What does 
it mean to you? 
 
Any food groups, particular 
foods/supplements/dietary 
patterns? 
Sources of information 
regarding diet 
Who from Clinic team/other health 
professional/anyone else 
Any other sources? 





Other information wanted Any other information you wanted 
or that you have tried to access? 
If so, what type of information, 
when and from whom would you 
prefer it? 
I think I got all the information I need. Is there anything else you would like to 
add? 
Conclusion Resources of nutrition 
information 
I have a few sources of 
information that you may find 
useful. Would you like me to 
discuss this with you? 
 
Inform participants of reliable 
online sources for nutrition advice 
(Macmillan Cancer Support, 
Cancer Research UK and, if 
applicable, a cancer-specific site 
such as Prostate Cancer UK) 
 Conclusion Thank participants for their time 
and contribution. 
(1) Question removed as it was found to make participants feel uncomfortable in the first two interviews (pilot 
interviews). 
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APPENDIX 3: Collinearity statistics – Chapter 3 (Methodology and methods) 
 
3a: Collinearity statistics for the variables included in the logistic regression model 
for dietary change and detailed multivariate logistic regression data. 
Variables Tolerance VIF 
Treatment status .887 1.127 
Diagnosis dummy 1 (prostate cancer) .482 2.073 
Diagnosis dummy 2 (lower GI cancer) .474 2.109 
Age  .430 2.324 
Body Mass Index  .898 1.114 
Qualifications .890 1.124 
Employment .497 2.011 
Marital status .894 1.118 
Presence of a comorbidity .795 1.258 
Presence of a side effect .913 1.095 
Supplement use .876 1.141 
Nutrition support from health professional .908 1.101 
 
3b: Collinearity statistics for the variables included in the logistic regression model 
for supplement use and detailed multivariate logistic regression data. 
Model Tolerance VIF 
Treatment status .915 1.093 
Diagnosis dummy 1 (prostate cancer) .491 2.035 
Diagnosis dummy 2 (lower GI cancer) .504 1.983 
Age  .432 2.313 
Body Mass Index  .900 1.111 
Qualifications .903 1.107 
Employment .498 2.010 
Marital status .894 1.118 
Presence of a comorbidity .795 1.258 
Presence of a side effect .933 1.072 





3c: Collinearity statistics for the variables included in the logistic regression model 
for support from health professionals. 
(Constant) Tolerance VIF 
Treatment status .895 1.118 
Diagnosis dummy 1 (prostate cancer) .482 2.076 
Diagnosis dummy 2 (lower GI cancer) .475 2.103 
Age  .432 2.317 
Body Mass Index  .896 1.116 
Qualifications .881 1.135 
Employment .502 1.991 
Marital status .903 1.108 
Presence of a comorbidity .796 1.256 
Presence of a side effect .905 1.105 
Supplement use .884 1.131 
Report of a dietary change .917 1.091 
 
Appendix 3d: Collinearity statistics for the variables included in the logistic 
regression model for support from other sources. 
Constant Tolerance VIF 
Treatment status .892 1.121 
Diagnosis dummy 1 (prostate cancer) .482 2.076 
Diagnosis dummy 2 (lower GI cancer) .469 2.130 
Age  .431 2.318 
Body Mass Index .891 1.122 
Qualifications .872 1.147 
Employment .499 2.006 
Marital status .892 1.122 
Presence of a comorbidity .796 1.256 
Presence of a side effect .891 1.123 
Supplement use .867 1.153 
Report of a dietary change .849 1.177 





APPENDIX 4: Chapter 4 (Survey results) 
4a: Demographic, clinical and health characteristics of the study sample (n=251). 






Mean (SD) 68.8 (10.5) 68.1 (9.8) 69.3 (11.0) 
Median (IQR) 70.0 (62-77) 70.0 (62-76) 71.0 (62-77) 
Range 30-92 43-84 30-92 
Missing (n (%)) 12 (5) 4 (4) 8 (5) 
Gender  n (%) n (%) n (%) 
Male 153 (61) 66 (65) 87 (58) 
Female 76 (30) 28 (27) 48 (32) 
Missing  22 (9) 8 (8) 14 (10) 
Chi-squared test (treatment status): x2(1)=1.052, P=0.305 
Marital status  n (%) n (%) n (%) 
Married or living as married 186 (74) 74 (73) 112 (75) 
Divorced or separated 17 (7) 8 (8) 9 (6) 
Widowed 21 (8) 8 (8) 13 (9) 
Single 23 (9) 11 (11) 12 (8) 
Missing 4 (2) 1 (1) 3 (2) 
Chi-squared test (treatment status): Married Vs all other categories: x2(1)=0.381, P=0.537 
Chi-squared test (cancer diagnosis): Married Vs all other categories: x2(2)=6.514, P=0.038 
Chi-squared tests were performed between groups “married” and “not married”. All categories except 
“married” were combined as the numbers were very small. 
Employment status  n (%) n (%) n (%) 
In paid work (full-time or part-time) 51 (20) 20 (20) 31 (21) 
Retired 165 (66) 65 (64) 100 (67) 
Other 30 (12) 16 (16) 14 (9) 
Missing 5 (2) 1 (1) 4 (3) 
Chi-squared test (treatment status): Retired Vs all other categories: x2(1)=0.204, P=0.652 
Chi-squared test (cancer diagnosis): Retired Vs all other categories: x2(2)=41.188, P<0.001 
Chi-squared tests were performed between groups “retired” and “not retired”. All categories except “retired” 
were combined as the numbers were very small. 
Ethnicity  n (%) n (%) n (%) 
White 242 (96) 99 (97) 143 (96) 
Black/Asian/Other 5 (2) 2 (2) 3 (2) 
Missing 4 (2) 1 (1) 3 (2) 
Education n (%) n (%) n (%) 
O level/GCSE 36 (14) 17 (17) 19 (13) 
A level 19 (8) 5 (5) 14 (9) 
Clerical or commercial qualification 13 (5) 4 (4) 9 (6) 
Professional qualification 42 (17) 14 (14) 28 (19) 
College or University qualification 60 (24) 25 (24) 35 (23) 
 
315 
Postgraduate qualification 21 (8) 9 (9) 12 (8) 
None of the above 49 (20) 23 (22) 26 (17) 
Missing 11 (4) 5 (5) 6 (4) 
Chi-squared tests (treatment status): <=High school Vs > High school: x2(1)=0.219, P=0.640 
Chi-squared tests (cancer diagnosis): Retired Vs all other categories: x2(2)=2.331, P=0.312 
Chi-squared tests were performed between groups “<=high school” and “some qualification”. The category 
“<=high school” included O level/GCSE and A level; the category “some qualification” included clerical, 
commercial, professional, college, university or postgraduate qualification 
 





Treatment n (%) n (%) n (%) 
Radiotherapy only 83 (33) 33 (32) 50 (34) 
Radiotherapy and chemotherapy 57 (23) 21 (21) 36 (24) 
Radiotherapy and hormone therapy 44 (18) 20 (20) 24 (16) 
Radiotherapy and surgery 24 (10) 12 (12) 12 (8) 
Radiotherapy, chemotherapy and surgery 47 (19) 18 (18) 29 (19) 
Time since the end of treatment  n (%) n (%) n (%) 
6-12 months N/A N/A 66 (44) 
13-18 months N/A N/A 40 (27) 
19-24 months N/A N/A 36 (24) 
Missing N/A N/A 7 (5) 
First cancer diagnosis n (%) n (%) n (%) 
Yes 209 (83) 77 (75) 132 (89) 
No 33 (13) 23 (23) 10 (7) 
Missing 9 (4) 2 (2) 7 (5) 
 





Smoking status n (%) n (%) n (%) 
Current smoker 15 (6) 4 (4) 11 (7) 
Ex-smoker 132 (53) 54 (53) 78 (52) 
Never smoked 97 (39) 43 (42) 54 (36) 
Missing 7 (3) 1 (1) 6 (4) 
 
 
Chi-squared tests for comorbidities 
Chi-squared tests (treatment status):  
Heart disease: x2(1)=0.350, P=0.554 
Diabetes: x2(1)=0.325, P=0.569 
High blood pressure: x2(1)=1.891, P=0.169 
Asthma: x2(1)=0.017, P=0.896 
Arthritis: x2(1)=1.767, P=0.184 
Stomach/gallbladder: x2(1)=1.461, P=0.227 
Osteoporosis: Continuity correction=0.439, P=0.507. 
Chi-squared tests (cancer diagnosis):  
Heart disease: x2(2)=10.679, P=0.005 
Diabetes: x2(2)=1.023, P=0.600 
High blood pressure: x2(2)=5.975, P=0.050 
Asthma: x2(2)=3.685, P=0.158 
Arthritis: x2(2)=0.844, P=0.656 
Stomach/gallbladder: x2(1)=3.424, P=0.181 












 n (%) n (%) n (%) 
Fatigue 135 (54) 63 (62) 72 (48) 
Wind/bloating 103 (41) 52 (51) 51 (34) 
Diarrhoea 66 (26) 36 (35) 30 (20) 
Incontinence 38 (15) 11 (11) 27 (18) 
Dry mouth 44 (18) 22 (22) 22 (15) 
Constipation 36 (14) 18 (18) 18 (12) 
Change in taste 35 (14) 21 (21) 14 (9) 
Loss of appetite 29 (12) 18 (18) 11 (7) 
Other gastrointestinal problems 11 (4) 3 (3) 8 (5) 
Nausea and vomiting 23 (9) 16 (16) 7 (5) 
Changes in smell 9 (4) 3 (3) 6 (4) 
Urinary dysfunction 9 (4) 4 (4) 5 (3) 
Other side effects (1) 31 (12) 10 (10) 21 (14) 
No side effects 45 (18) 13 (13) 32 (21) 
Missing 3 (1) 0 (0) 3 (2) 
Chi-squared tests (treatment status): Fatigue: x2(1)=3.752, P=0.053; wind/bloating: x2(1)=6.369, P=0.012; 
diarrhoea: x2(1)=6.686, P =0.010; incontinence: x2(1)=2.750, P =0.097; dry mouth: x2(1)=1.738, P =0.187; 
constipation: x2(1)=1.369, P =0.242; changes in taste: x2(1)=5.993, P =0.014; loss of appetite: x2(1)=5.947, P 
=0.015; nausea and vomiting: x2(1)=8.466, P =0.004. 
Chi-squared tests (cancer diagnosis): Fatigue: x2(2)=0.093, P=0.955; wind/bloating: x2(2)=0.613, P 
=0.736; diarrhoea: x2(2)=5.882, P =0.053; incontinence: x2(2)=3.691, P =0.158; dry mouth: x2(2)=7.896, P 
=0.019; constipation: x2(2)=7.336, P =0.026; changes in taste: x2(2)=18.708, P <0.001; loss of appetite: 
x2(2)=20.514, P <0.001; nausea and vomiting: x2(2)=17.568, P <0.001. 
(1) Other side effects include hot flushes (n=5), mouth sores (n=5), difficulty swallowing (n=5), weight changes (n=3), pain 
(n=3), itching (n=1), erectile dysfunction (n=1), mucus (n=1), irritable bladder (n=1), radiation induced cystitis (n=1), 
lymphoedema (n=1), blood in urine (n=1), depression (n=1), lack of concentration (n=1), infection of the buttocks (n=1). 
 








Weight changes (1) n (%) n (%) n (%) 
Weight gain 82 (33) 28 (27) 54 (36) 
Weight loss 65 (26) 33 (32) 32 (21) 
No weight changes 98 (39) 38 (37) 60 (40) 
Missing 10 (4) 3 (3) 7 (5) 
Chi-squared tests (treatment status): Weight gain: x2(1)=2.634, P=0.105; weight loss: x2(1)=3.271, 
P=0.071; no weight changes: x2(1)=0.441, P =0.507.  
Chi-squared tests (cancer diagnosis): Weight gain: x2(2)=3.102, P=0.212; weight loss: x2(2)=8.587, P 
=0.014; no weight changes: x2(2)=3.102, P =0.210. 





4d: Dietary habits and dietary changes since diagnosis (n=251). 





Have you changed your diet since diagnosis?  n (%) n (%) n (%) 
Yes 170 (68) 70 (69) 100 (67) 
No 81 (32) 32 (31) 49 (33) 






To reduce the risk of recurrence 52 (31) 18 (26) 34 (34) 
To assist with treatment side effects 77 (45) 43 (61) 34 (34) 
To maintain general health 99 (58) 35 (50) 64 (64) 
To support therapy and recovery 70 (41) 36 (51) 34 (34) 
Other (3) 11 (6) 1 (1) 10 (10) 
Missing 35 (21) 15 (22) 20 (20) 
Chi-squared tests (treatment status): Reduce the risk of recurrence: x2(1)=1.314, P=0.252; to assist with 
treatment side effects: x2(1)=16.934, P <0.001; to maintain general health: x2(1)=4.463, P =0.035; to support 
therapy and recovery: x2(1)=6.879, P =0.009. 
Chi-squared tests (cancer diagnosis): Reduce the risk of recurrence: x2(2)=0.250, P=0.882; to assist with 
treatment side effects: x2(2)=0.138, P <0.933; to maintain general health: x2(2)=3.022, P =0.221; to support 
therapy and recovery: x2(2)=0.515, P =0.773. 
 (1) This question was answered only by participants who responded “Yes” in the question “Have you changed your diet since 
diagnosis?. N=100 for the post-treatment group, N=70 for the on-treatment group”.  
(2) More than one answers possible. The percentage values exceed 100%. 
(3) Other responses included losing weight (n=4), diagnosis of diabetes (n=3), gaining weight (n=1), inability to eat specific 





4d: Dietary changes and chi-squared tests according to treatment status. 
 
 
4d: Dietary changes and chi-squared tests according to diagnosis. 
Dietary changes 
Increased consumption Decreased consumption 
Urological Lower GI Gynaecological Urological Lower GI Gynaecological 
Whole grains   
33/124 18/78 7/27 2/124 20/78 6/27 
x2(2)=0.322, P=0.851 x2(2)=28.608, P<0.001 
Refined grains   
6/122 12/77 4/28 26/11 22/77 11/28 
x2(2)=6.907, P=0.032 x2(2)=4.228, P=0.121 
Fruit 
34/129 32/78 11/28 5/129 15/78 2/28 
x2(2)=5.361, P=0.069 x2(2)=13.691, P=0.001 
Dietary changes. 
Increased consumption Decreased consumption 
On treatment Post treatment On treatment Post treatment 
Whole grains   
23/98 38/144 16/98 15/144 
x2(1)=0.264, P=0.608 x2(1)=1.824, P=0.177 
Refined grains   
16/97 7/142 18/97 45/142 
x2(1)=8.863, P=0.003 x2(1)=5.121, P=0.024 
Fruit 
31/101 51/147 14/101 9/147 
x2(1)=0.433, P=0.511 x2(1)=4.261, P=0.039 
Vegetables 
25/98 55/148 9/98 5/148 
x2(1)=3.648, P=0.056 x2(1)=3.702, P=0.054 
Low fat milk and dairy products  
12/99 19/141 10/99 12/141 
x2(1)=0.095, P=0.758 x2(1)=0.177, P=0.674 
Full fat milk and dairy products 
6/94 5/140 25/94 43/140 
x2(1)=0.992, P=0.319 x2(1)=0.463, P=0.496 
Lean, low fat meat and poultry 
24/100 26/143 8/100 14/143 
x2(1)=1.219, P=0.270 x2(1)=0.229, P=0.632 
Oily fish  
22/99 48/145 7/99 1/145 
x2(1)=3.405, P=0.065 Continuity correction 5.676, P=0.017 
White fish  
24/99 39/145 2/99 2/145 
x2(1)=0.216, P=0.642 Continuity correction <0.001, P=1.000 
Sugary foods and drinks 
6/101 0/145 50/101 68/145 
Continuity correction 6.509, P=0.011 x2(1)=0.162, P=0.687 
Processed meats   
2/100 0/145 39/100 60/145 
Continuity correction 0.975, P=0.323 x2(1)=0.139, P=0.709 
Alcohol 
0/102 2/143 53/102 47/143 




38/129 30/75 9/29 4/129 8/75 2/29 
x2(2)=2.443, P=0.295 Fisher’s Exact Test=4.890, P=0.073 
Low fat milk and 
dairy products  
19/127 8/72 3/28 9/127 6/72 4/28 
x2(2)=0.768, P=0.681 x2(2)=1.552, P=0.461 
Full fat milk and 
dairy products 
4/122 6/74 1/25 33/122 22/74 9/25 
Fisher’s Exact Test=2.258, P=0.310 x2(2)=0.840, P=0.657 
Lean, low fat meat 
and poultry 
23/127 17/76 6/27 6/127 9/76 5/27 
x2(2)=0.633, P=0.729 x2(2)=6.752, P=0.034 
Oily fish  
31/126 25/77 8/28 3/126 3/77 2/28 
x2(2)=1.488, P=0.475 Fisher’s Exact Test=2.019, P=0.323 
White fish  
24/127 26/76 8/28 0/127 4/76 0/28 
x2(2)=6.132, P=0.047 Fisher’s Exact Test=6.408, P=0.026 
Sugary foods and 
drinks 
2/127 2/77 2/29 58/127 37/77 17/29 
Fisher’s Exact Test=2.765, P=0.214 x2(2)=1.586, P=0.452 
Processed meats   
1/127 0/76 1/29 42/127 38/76 15/29 
Fisher’s Exact Test=2.722, P=0.341 x2(1)=7.227, P=0.027 
Alcohol 
2/127 0/77 0/29 48/127 33/77 15/29 
Fisher’s Exact Test=1.188, P=0.638 x2(2)=2.021, P=0.364 
 
4d: Other dietary habits (n=251). 





How much water or fluids do you consume 
daily? 
n (%) n (%) n (%) 
0-2 glasses/day 12 (5) 1 (1) 11 (7) 
3-5 glasses/day 69 (27) 25 (25) 44 (30) 
6-8 glasses/day 126 (50) 54 (53) 72 (48) 
>9 glasses/day 40 (16) 21 (21) 19 (13) 
Missing 4 (2) 1 (1) 3 (2) 
Who do you usually have meals with? (1) n (%) n (%) n (%) 
Spouse/partner 181 (72) 77 (75) 104 (70) 
Family members 63 (25) 24 (24) 39 (26) 
Friends 26 (10) 9 (9) 17 (11) 
No one 57 (23) 24 (24) 33 (22) 
Missing 2 (1) 0 (0) 2 (1) 
Chi-squared tests (treatment status): Spouse/partner: x2(1)=0.682, P=0.409; family members: 
x2(1)=0.287, P=0.592; friends: x2(1)=0.484, P =0.487; no one: x2(1)=0.040, P =0.842. 
Chi-squared tests (cancer diagnosis): Spouse/partner: x2(2)=6.316, P=0.043; family members: 







Who prepares your meals? (1)  n (%) n (%) n (%) 
Spouse/partner only 93 (37) 44 (43) 49 (33) 
I prepare my own meals – only me 94 (37) 39 (39) 55 (37) 
Shared task with spouse/partner 60 (24) 17 (17) 43 (29) 
Family members 23 (9) 10 (10) 13 (9) 
Friends 6 (2) 1 (1) 5 (3) 
Other (2) 2 (1) 0 (0) 2 (1) 
Chi-squared tests (treatment status): Spouse/partner: x2(1)=2.372, P=0.123; own meals: x2(1)=0.045, 
P=0.832; shared task: : x2(1)=4.928, P=0.026; family members: x2(1)=0.085, P=0.771. 
Chi-squared tests (cancer diagnosis): Spouse/partner only: x2(2)=24.628, P<0.001; own meals: 
x2(2)=19.952, P<0.001; shared task: : x2(1)=2.252, P=0.324; family members: x2(1)=1.216, P=0.545. 
How often have you had homemade meals 
during the past 4 weeks? n (%) n (%) n (%) 
Never 13 (5) 4 (4) 9 (6) 
1-3 times/month 13 (5) 5 (5) 8 (5) 
1-4 times/week 61 (24) 31 (30) 30 (20) 
5 times/week or more 160 (64) 59 (58) 101 (68) 
Missing 3 (1) 2 (2) 1 (1) 
Chi-squared tests (treatment status): x2(1)=5.575, P=0.233.  
Chi-squared tests (cancer diagnosis): x2(2)=7.586, P=0.475. 
How often have you had ready meals during 
the past 4 weeks? n (%) n (%) n (%) 
Never 79 (31) 30 (29) 49 (33) 
1-3 times/month 109 (43) 42 (41) 67 (45) 
1-4 times/week 51 (20) 25 (24) 26 (17) 
5 times/week or more 9 (4) 3 (3) 6 (4) 
Missing 3 (1) 2 (2) 1 (1) 
Chi-squared test (treatment status): x2(1)=2.112, P=0.549 
Chi-squared test (cancer diagnosis): x2(2)=22.379, P=0.001. 
(1) More than one answers possible. The percentage values exceed 100%. 
(2) Other responses included food being prepared by a nursing home (n=1) and eating meals out (n=1). 
 
4d: Logistic regression (dietary changes). 
Whole sample – multivariate logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Age -0.026 0.094 0.974 0.944 1.005 
Nutritional support by health 
professional 











Urological cancers – multivariate logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Body Mass Index 0.140 0.039 1.150 1.007 1.313 
Qualifications -0.974 0.104 0.378 0.117 1.223 
Nutritional support by health 
professional 
1.229 0.017 3.418 1.243 9.403 
 
Lower GI cancers – multivariate logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Age -0.059 0.041 0.943 0.891 0.997 
Body Mass Index -0.136 0.076 0.873 0.751 1.014 
Nutritional support by health 
professional 
1.555 0.028 4.737 1.180 19.009 
 
4e: Supplement use (n=251). 






Have you been taking any supplements since 
diagnosis? 
n (%) n (%) n (%) 
Yes 77 (31) 26 (25) 51 (34) 
No 172 (68) 76 (75) 96 (64) 
Missing 2 (1) 0 (0) 2 (2) 






To reduce the risk of recurrence 8 (10) 2 (8) 6 (12) 
To assist with treatment side effects 18 (23) 8 (31) 10 (20) 
To maintain general health 54 (70) 19 (73) 35 (79) 
To support therapy and recovery 21 (27) 7 (27) 14 (27) 
Other (3) 10 (13) 4 (15) 10 (20) 
Missing 2 (3) 0 (0) 2 (4) 
Chi-squared tests (treatment status): Reduce the risk of recurrence: Continuity correction=0.046, 
P=0.830; to assist with treatment side effects: x2(1)=1.000, P =0.317; to maintain general health: 
x2(1)=0.023, P =0.880; to support therapy and recovery: x2(1)=0.023, P =0.880. 
Chi-squared tests (cancer diagnosis): Reduce the risk of recurrence: Fisher’s Exact Test=4.365, P=0.094; 
to assist with treatment side effects: Fisher’s Exact Test=3.491, P =0.178; to maintain general health: 












Which supplements have you been taking? (2) n (%) n (%) n (%) 
Vitamin D 38 (49) 14 (54) 24 (47) 
Omega 3 32 (42) 9 (35) 23 (45) 
Multivitamins 27 (35) 10 (38) 17 (33) 
Vitamin C 22 (29) 7 (27) 15 (29) 
Glucosamine sulphate  9 (12) 1 (4) 8 (16) 
B vitamins 10 (13) 5 (19) 5 (10) 
Iron 6 (8) 1 (4) 5 (10) 
Calcium 9 (12) 4 (16) 5 (10) 
Zinc 6 (8) 2 (8) 4 (8) 
Other (4) 34 (44) 9 (35) 25 (50) 
Chi-squared tests (treatment status): Vitamin D: x2(1)=0.317, P =0.573; Omega-3: x2(1)=0.779, P =0.377; 
Multivitamins: x2(1)=0.199, P =0.656; Vitamin C: x2(1)=0.052, P =0.819.  
Chi-squared tests (cancer diagnosis): Vitamin D: x2(2)=0.491, P =0.782; Omega-3: x2(2)=0.309, P=0.857; 
Multivitamins: x2(2)=2.171, P =0.338; Vitamin C: x2(2)=1.265, P =0.531. 
 (1) This question was answered only by participants who responded “Yes” in the question “Have you been taking 
supplements since diagnosis?”. 
(2) More than one answers possible. The percentage values exceed 100%. 
(3) Other responses included vitamin D deficiency (n=4), bone health (n=3), problems with joints (n=2), mobility problems 
(n=1), finger nails splitting (n=1), General Practitioner instructions (n=1), reduction of the risk of illness (n=1) and use before 
diagnosis (n=1). 
(4) Other responses included magnesium (n=4), selenium (n=3), evening primrose (n=3), vitamin B12 (n=3), coenzyme Q10 
(n=2), probiotics (n=2), garlic (n=2), iodine (n=2), turmeric (n=2), folic acid (n=1), chromium (n=1), vitamin K (n=1), dietary 
fibre (n=1), cranberry (n=1), boron (n=1), quercetin (n=1), milk thistle (n=1), berberine (n=1), evening primrose (n=1) and 
peppermint capsules (n=1). 
 
4e: Logistic regression (supplement use). 
Whole sample – multivariate logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Treatment status 0.626 0.085 1.871 0.916 3.820 
Report of side effect 0.900 0.049 2.459 1.005 6.021 
Nutritional support from 
health professional 
0.567 0.095 1.764 0.906 3.433 
 
Urological cancers – multivariate logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Report of a side effect 1.313 0.053 3.718 0.984 14.051 
 
Lower GI cancers – multivariate logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 





4f: Nutritional awareness (n=251). 
How familiar are you with each of the following 
dietary recommendations? 
Never 







 n (%) n (%) n (%) n (%) 
Be a healthy weight (n=247) 4 (2) 18 (7) 53 (21) 172 (70) 
Limit high calorie foods (n=245) 6 (2) 16 (7) 51 (21) 172 (70) 
Eat a variety of wholegrains, vegetables, fruit and 
pulses (n=247) 7 (3) 15 (6) 53 (21) 172 (70) 
Aim for at least 5 portions of fruit and vegetables a 
day (n=248) 3 (1) 10 (4) 41 (17) 194 (78) 
Limit red meat and avoid processed meats (n=247) 18 (7) 53 (21) 73 (30) 103 (42) 
Do not drink alcohol (n=245) 3 (1) 16 (7) 49 (20) 177 (72) 
Limit salt intake (n=247) 10 (4) 32 (13) 63 (26) 142 (57) 
Do not rely on supplements (n=247) 5 (2) 9 (4) 45 (18) 188 (76) 
 
4g: Perceptions of the role of diet after diagnosis (n=251). 








  n (%) n (%) n (%) n (%) n (%) 
Reducing GI side effects? 12 (5) 34 (14) 85 (34) 109 (43) 11 (4) 
Chi-squared test (Treatment status): x2(3)=1.805, P=0.614 
Chi-squared test (Cancer diagnosis): Fisher’s Exact test=4.063, P=0.669 
  n (%) n (%) n (%) n (%) n (%) 
Reducing appetite side effects?  45 (18) 46 (18) 76 (30) 51 (20) 33 (13) 
Chi-squared test (Treatment status): x2(3)=1.972, P=0.578 
Chi-squared test (Cancer diagnosis): x2(6)=5.629, P=0.466 
  n (%) n (%) n (%) n (%) n (%) 
Reducing the feeling of fatigue?  38 (15) 30 (12) 71 (28) 93 (37) 19 (8) 
Chi-squared test (Treatment status): x2(3)=2.273, P=0.518 
Chi-squared test (Cancer diagnosis): x2(6)=6.644, P=0.355 
  n (%) n (%) n (%) n (%) n (%) 
Preventing cancer recurrence?  19 (8) 39 (16) 82 (33) 102 (41) 9 (4) 
Chi-squared test (Treatment status): x2(3)=1.346, P=0.718 
Chi-squared test (Cancer diagnosis): x2(6)=1.565, P=0.955 
  n (%) n (%) n (%) n (%) n (%) 
Improving overall health?  1 (<1) 10 (4) 73 (29) 163 (65) 4 (2) 
Chi-squared test (Treatment status): Fisher’s Exact test=4.171, P=0.201 
Chi-squared test (Cancer diagnosis): Fisher’s Exact test=2.257, P=0.970 
  n (%) n (%) n (%) n (%) n (%) 
Supporting therapy and recovery?  4 (2) 22 (9) 82 (33) 135 (54) 7 (3) 
Chi-squared test (Treatment status): Fisher’s Exact test=4.657, P=0.185 





4h: Support from health professionals (n=251) 
Participants who received support by a health professional (n=108) 





Source of information n (%) n (%) n (%) 
Dietitian 18 (17) 5 (10) 13 (22) 
Cancer or Radiotherapy specialist nurse 64 (59) 34 (71) 30 (50) 
Radiographer/Oncologist 21 (19) 15 (31) 6 (10) 
Nutritionist 6 (6) 1 (2) 5 (8) 
General Practitioner 10 (9) 4 (8) 6 (10) 
Other (1) 8 (7) 2 (4) 6 (10) 
Missing 7 (6) 1 (2) 6 (10) 
Chi-squared tests (treatment status): Dietitian: x2(1)=3.097, P=0.078; Nurse: x2(1)=3.050, P=0.081; 
Radiographer/oncologist: x2(1)=6.604, P=0.010; Nutritionist: Continuity Correction=1.189, P=0.276; 
General Practitioner: Continuity Correction=0.011, P=0.918. 
Chi-squared tests (cancer diagnosis): Dietitian: x2(2)=6.904, P=0.032; Nurse: x2(2)=5.442, P=0.066; 
Radiographer/oncologist: x2(2)=3.580, P=0.167; Nutritionist: Fisher’s exact Test=0.696, P=0.821; General 
Practitioner: Fisher’s Exact Test=3.162, P=0.168. 
Content of information n (%) n (%) n (%) 
General healthy eating 81 (75) 33 (69) 48 (80) 
Nutritional management of side effects 33 (31) 19 (40) 14 (23) 
Weight management 17 (16) 7 (15) 10 (17) 
Recipes 10 (9) 3 (7) 7 (12) 
Vitamin/mineral/other supplements 9 (8) 4 (8) 5 (8) 
Other (2) 11 (10) 7 (15) 4 (7) 
Missing 1 (1) 0 (0) 1 (1) 
Chi-squared tests (treatment status): General healthy eating: x2(1)=2.286, P=0.131; Nutritional 
management of side effects: x2(1)=3.119, P=0.077; Weight management: x2(1)=0.111, P=0.739; Healthy 
recipes: Continuity correction=0.434, P=0.510; Vitamin and mineral supplements: Continuity 
correction<0.001, P=1.000. 
Chi-squared tests (cancer diagnosis): General healthy eating: x2(2)=0.453, P=0.797; Nutritional 
management of side effects: x2(2)=1.134, P=0.567; Weight management: x2(2)=2.976, P=0.226; Healthy 
recipes: Fisher’s exact test=1.966, P=0.317; Vitamin and mineral supplements: Fisher’s Exact Test=0.262, 
P=1.000. 
Format of information n (%) n (%) n (%) 
Written information/leaflets 77 (71) 35 (73) 42 (70) 
Links for websites 9 (8) 5 (10) 4 (7) 
Face to face assistance 54 (50) 27 (56) 27 (45) 
Telephone assistance 7 (6) 2 (4) 5 (8) 
Survivorship courses 3 (3) 2 (4) 1 (2) 
Missing 3 (3) 2 (4) 1 (2) 
Chi-squared tests (treatment status): Leaflets: x2(1)=0.317, P=0.573; Websites: Continuity 
correction=0.153, P=0.695; Face to face assistance: x2(1)=1.731, P=0.188; Telephone assistance: 
Continuity correction=0.200, P=0.655. 
Chi-squared tests (cancer diagnosis): Leaflets: x2(2)=1.341, P=0.512; Websites: Fisher’s Exact 
Test=0.836, P=0.658; Face to face assistance: x2(2)=1.462, P=0.481; Telephone assistance: Fisher’s 
Exact Test=4.130, P=0.127. 
(1)Other responses include collection of publications (n=3), stoma specialist nurse (n=2), physiotherapist (n=1), Maggies 
centre (n=1), nursing home  (n=1). 
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(2) Other information include fluid intake (n=2), foods to avoid during treatment (n=2), nutritional management of diabetes 
(n=2), nutritional management of heart disease (n=1), management of ileostomy bag (n=1), instructions to consume 
carbohydrates during treatment (n=1), food safety (n=1) and avoiding dairy products (n=1). 
 
Satisfaction with information (n=108) 






How well were your needs met?  n (%) n (%) n (%) 
Not at all well 0 (0) 0 (0) 0 (0) 
Not very well 6 (6) 2 (4) 4 (7) 
Neutral 30 (28) 10 (21) 20 (33) 
Well 47 (44) 27 (56) 20 (33) 
Very well 25 (23) 9 (19) 16 (27) 
How consistent was the advice you received?  n (%) n (%) n (%) 
Very inconsistent 1 (1) 0 (0) 1 (2) 
Inconsistent 7 (6) 3 (6) 4 (7) 
Neither inconsistent nor consistent 22 (20) 7 (15) 15 (25) 
Consistent 52 (48) 23 (48) 29 (48) 
Very consistent 26 (24) 15 (31) 11 (18) 
How easy was the advice to follow?  n (%) n (%) n (%) 
Very difficult 0 (0) 0 (0) 0 (0) 
Difficult 5 (5) 2 (4) 3 (5) 
Neither difficult nor easy 29 (27) 11 (23) 18 (31) 
Easy 49 (45) 23 (48) 26 (45) 
Very easy 23 (21) 12 (25) 11 (19) 
Did information influence you to change your 
diet?  
n (%) n (%) n (%) 
Yes 73 (67) 38 (79) 35 (58) 
No 33 (31) 10 (21) 23 (38) 
Missing 2 (2) 0 (0) 2 (3) 
 
 
Participants who did not receive support by a health professional (n=143) 






Why didn’t you receive any support? (1) n (%) n (%) n (%) 
I chose not to receive any 13 (9) 8 (15) 5 (6) 
I was not offered any 101 (71) 35 (65) 66 (74) 
I did not know it existed 46 (32) 16 (30) 30 (34) 
I did not think nutrition was important 5 (3) 2 (4) 3 (3) 
Other (2) 6 (4) 3 (6) 3 (4) 
Missing 5 (3) 1 (2) 4 (4) 
Chi-squared tests (treatment status): I chose not to receive any: Continuity correction=2.257, P=0.133; I 
was not offered any: x2(1)=2.242, P =0.134; I did not know support existed: x2(1)=0.383, P =0.536 
Chi-squared tests (cancer diagnosis): I chose not to receive any: Fisher’s Exact Test=4.397, P=0.083; I 
was not offered any: x2(2)=0.193, P =0.908; I did not know support existed: x2(2)=1.868, P =0.393. 
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What, if any, diet and nutrition information 
would you like to have received from your 
healthcare team? (1)  
n (%) n (%) n (%) 
Healthy eating 53 (37) 22 (41) 31 (35) 
Nutritional management of side effects 39 (27) 19 (35) 20 (22) 
Weight management 37 (26) 11 (20) 26 (29) 
Healthy recipes 23 (16) 11 (20) 12 (13) 
Survivorship classes/courses/workshops 7 (5) 0 (0) 7 (8) 
Nutritional supplements 30 (21) 11 (20) 19 (25) 
I did not want any information 40 (28) 12 (22) 28 (33) 
Other (3) 8 (6) 1 (2) 7 (8) 
Missing 8 (6) 3 (6) 5 (6) 
Chi-squared tests (treatment status): General healthy eating: x2(1)=0.517, P=0.472; Nutritional 
management of side effects: x2(1)=2.793, P=0.095; Weight management: x2(1)=1.404, P=0.236; Healthy 
recipes: x2(1)=1.191, P=0.275, P=0.510; Supplements: x2(1)=0.049, P=0.824. 
Chi-squared tests (cancer diagnosis): General healthy eating: x2(2)=5.537, P=0.063; Nutritional 
management of side effects: x2(2)=1.909, P=0.385; Weight management: x2(2)=9.564, P=0.008; Healthy 
recipes: x2(2)=4.995, P=0.082; Supplements: Fisher’s Exact Test=1.613, P=0.416. 
(1) More than one answers possible. The percentage values exceed 100%. 
(2) Other responses included increased awareness on diet and nutrition (n=4) and perception of having a healthy diet (n=2). 
(3) Other responses included perception of having a healthy diet (n=2), receipt of information related to other diseases (n=2), 
need for tailored information (n=2), information related to stoma reversal (n=1) and information about medical cannabis 
(n=1). 
 
4h: Logistic regression (support from health professionals). 
Whole sample – logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Report of a dietary change 1.326 <0.001 3.766 1.902 7.458 
 
Urological cancers – logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Age -0.129 0.009 0.879 0.797 0.968 
Report of dietary change 1.215 0.017 3.370 1.239 9.166 
 
Lower GI cancers – logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Marital status -1.311 0.117 0.270 0.052 1.388 







4i: Support from another source (n=251). 
Participants who received support by other sources (n=79) 





Source of information (1) n (%) n (%) n (%) 
Cancer charity website 46 (58) 22 (79) 24 (47) 
Medical website 28 (35) 12 (43) 16 (31) 
Blog/social media webpage 7 (9) 2 (7) 5 (10) 
Newspaper/magazine/book 17 (22) 7 (25) 10 (20) 
Recipe book 15 (19) 6 (21) 9 (18) 
Family member/friend 19 (24) 7 (25) 12 (24) 
Other patient 5 (6) 3 (11) 2 (4) 
Other (2) 6 (8) 0 (0) 6 (12) 
Missing 5 (6) 0 (0) 5 (10) 
Content of information (1) n (%) n (%) n (%) 
General healthy eating 61 (77) 22 (79) 39 (76) 
Nutritional management of side effects 19 (24) 10 (36) 9 (18) 
Weight management 15 (19) 7 (25) 8 (16) 
Recipes 22 (28) 8 (29) 14 (27) 
Vitamin/mineral/other supplements 13 (16) 5 (18) 8 (16) 
Other (3) 5 (6) 1 (4) 4 (8) 
Missing  4 (5) 1 (4) 3 (6) 
(1) More than one answers possible. The percentage values exceed 100%. 
(2) Other responses included medical programmes (n=1), a supplement-specific website (n=1), a weight loss company 
website (n=1), the World Health Organisation website (n=1), other websites (not specified; n=1) and a Macmillan booklet 
(n=1) 
(3) Other responses included information tailored to cancer (n=1), rainbow diet (n=1), reduction of sugar (n=1) and 





Satisfaction with information (n=79) 






How well were your needs met?  n (%) n (%) n (%) 
Not at all well 3 (4) 1 (4) 2 (4) 
Not very well 6 (8) 2 (7) 4 (8) 
Neutral 28 (35) 10 (36) 18 (35) 
Well 31 (39) 12 (43) 19 (37) 
Very well 11 (14) 3 (11) 8 (16) 
How consistent was the advice you received?  n (%) n (%) n (%) 
Very inconsistent 1 (1) 0 (0) 1 (2) 
Inconsistent 3 (4) 1 (4) 2 (4) 
Neither inconsistent nor consistent 23 (29) 7 (25) 16 (32) 
Consistent 36 (46) 15 (54) 21 (41) 
Very consistent 11 (14) 4 (14) 7 (14) 
Missing 5 (6) 1 (4) 4 (8) 
How easy was the advice to follow?  n (%) n (%) n (%) 
Very difficult 1 (1) 0 (0) 1 (2) 
Difficult 5 (10) 2 (7) 3 (6) 
Neither difficult nor easy 22 (28) 10 (36) 12 (24) 
Easy 33 (42) 10 (36) 23 (45) 
Very easy 14 (18) 4 (14) 10 (20) 
Missing 4 (5) 2 (7) 2 (4) 
 
4i: Logistic regression (support from other sources). 
Whole sample – logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Body Mass Index -0.081 0.054 0.923 0.850 1.001 
Report of a dietary change 1.324 0.001 3.759 1.668 8.471 
Support from HP 0.775 0.031 2.171 1.071 4.402 
 
Urological cancers –  logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Support from HP 1.019 0.045 2.769 1.024 7.492 









Lower GI cancers – logistic regression stepwise method 
    95% CI for Exp (B) 
 B P value Exp (B) Lower Higher 
Age -0.053 0.081 0.948 0.894 1.006 
BMI -0.244 0.012 0.783 0.648 0.947 
 
4j: Interest in getting more information (n=251). 





Would you be interested in receiving more 
information about your diet in relation to your 
cancer? 
n (%) n (%) n (%) 
Not interested at all (1) 35 (14) 10 (10) 25 (17) 
A little interested (1) 37 (15) 15 (15) 22 (15) 
Somewhat interested (2) 43 (17) 14 (14) 29 (19) 
Very interested (2) 75 (30) 37 (36) 38 (26) 
Extremely interested (2) 53 (21) 23 (23) 30 (20) 
Missing  8 (3) 3 (3) 5 (3) 
Chi-squared test (treatment status): Yes (somewhat, very or extremely interested) Vs No (not or little 
interested): x2(1)=1.535, P=0.215 
Chi-squared test (cancer diagnosis): Yes (somewhat, very or extremely interested) Vs No (not or little 
interested): x2 (2)=3.832, P=0.147 
What mode(s) of delivery would you prefer? (3) n (%) n (%) n (%) 
Face to face by a healthcare professional 71 (28) 30 (29) 41 (28) 
Brochures 145 (58) 64 (63) 81 (54) 
Internet 56 (22) 19 (19) 37 (21) 
DVD 13 (5) 7 (7) 6 (4) 
Telephone  25 (10) 5 (5) 20 (13) 
Missing 45 (18) 16 (16) 29 (19) 
Chi-squared tests (treatment status): Face to face: x2(1)=0.011, P=0.915; brochures x2(1)=1.150, 
P=0.283; internet x2(1)=1.933, P=0.164; DVD: x2(1)=0.835, P=0.361; telephone: x2(1)=5.534, P=0.019. 
Chi-squared test (cancer diagnosis): Face to face: x2(2)=0.547, P=0.761; brochures x2(2)=0.891, 
P=0.640; internet x2(2)=5.849, P=0.054; DVD: x2(2)=3.583, P=0.167; telephone: x2(2)=2.528, P=0.283. 
At which time point(s) would you prefer to 
receive information about your diet? (1) n (%) n (%) n (%) 
At diagnosis 57 (23) 30 (29) 27 (18) 
During treatment 59 (24) 30 (29) 29 (19) 
At the end of treatment 53 (21) 23 (23) 30 (20) 
On a follow up visit 31 (12) 12 (12) 19 (13) 
Any time 88 (35) 29 (28) 59 (40) 
Missing 34 (14) 13 (13) 21 (14) 
(1) Categorised as No for the chi-squared test 
(2) Categorised as Yes for the chi-squared test 




APPENDIX 5: Chapter 5 – Findings from interviews  
 
Coding Framework  
One overarching concept: Managing diet post-diagnosis 
Seven themes: 
1. Impact of diagnosis and treatments on dietary choices 
a. Managing altered gastrointestinal function: Any dietary changes related to 
the presence of bowel problems, techniques to manage and support bowel 
issues, level of support from healthcare team or other sources  
b. Managing altered appetite: Same as above, but in relation to altered 
appetite (increasing or reduced) 
c. Impact of an ostomy: Same as above, but focussed on the presence of an 
ostomy 
d. Treatment related adjustments: Any comments on dietary changes to 
adjust to radiotherapy or other treatments’ requirements e.g. water, coffee, 
alcohol 
e. The “teachable moment”: Any changes that are result the “teachable 
moment” of a cancer diagnosis e.g. reduced red meat and alcohol, more 
fruit and vegetables. Also, any comments on support from healthcare team 
or other sources to support future wellbeing. 
f. Impact of treatments on body weight: Any information on weight changes, 
gain, loss, fluctuations and the level of support from health professionals or 
other sources in relation to weight management. Body weight changes due 
to treatments or any other reason. 
g. Perceptions of weight status and changes: Emotions, thoughts, concerns 
and attitudes in relation to body weight, body image. Acknowledging weight 
issues and requesting support.  
h. Need for healthcare professional support: Description of requests on 
support in diet and nutrition, past experiences, comments on credibility of 
health professionals as resources of information. 
2. Personal resources   
a. Pre-existing knowledge: Understanding the link between diet and health, 
describing healthy eating habits, knowledge of healthy and less healthy 
foods (whether they practice these habits or not), having knowledge (e.g. 
nurse background), health literacy, awareness of research, interest in 
lifestyle, general beliefs- e.g in body’s awareness of what it needs? 
b. Ability to cook: Any comments on cooking practices, managing to cook for 
the household, preparing fresh food from scratch as opposed to ready 
meals. 
c. Ability to access healthy foods: Having a garden, being able/unable to 
afford higher quality/more expensive food, access to markets. 
3. Social resources 
a. Spousal support: Role of spouse in preparing food, describing sharing task 
with spouse, experiences of spouse contributing to recovery (esp. during 
treatment) in relation to food and impact of living alone. Also any 
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advice/motive/suggestions in relation to food from spouse to contribute to 
participant’s health. 
b. Dietary habits of family: Spouse/partner/children’s dietary habits affecting 
participant’s dietary habits.  
4. Comorbidities and disabilities: Examples of managing comorbidities 
nutritionally, having disabilities and how it affects food preparation 
5. Influence of work: Any description of work or traveling commitments affecting 
dietary management of cancer, weight management, side effects. 
6. Being active and mobile: Describing sense of “going back to normal”, keep 
active, keep mobile to carry on with everyday activities, how diet can assist to 
keeping active, going back to pre-diagnosis habits, general comments about diet 
keeping them healthy from now on. 
7. Barriers for change: Any barriers towards implementing changes in diet; includes 
lack of interest, lack of time, lack of evidence, perceived ineffectiveness, perceived 







APPENDIX 6: (Chapter 8 – Online sources) 




6b: Invitation letter to gatekeepers (example) 
 
 
My name is George and I am a PhD student at Oxford Brookes University supervised by 
Professor Eila Watson, Dr Helen Lightowler and Dr Shelly Coe. I am writing because I seek 
feedback on written literature in order to inform my project. 
My project is about diet and nutrition after cancer diagnosis in the pelvis. As part of it, I aim 
to assess the quality of existing leaflets that provide information about diet and nutrition 
after cancer treatment. I am inviting you to read two of those leaflets and give me your 
opinion about them by answering the following questions: 
 How would you rate the information provided in this leaflet? 
 How easy was for you to understand the information? 
 How helpful was the leaflet for you? 
The materials I would like you to read and comment on are: 
 Eating well when you have cancer – provided by The Royal Marsden NHS 
Foundation Trust 
 Managing weight gain after cancer treatment – provided by Macmillan Cancer 
Support 
We appreciate there is time involved in reading the leaflets. Your involvement is entirely 
voluntary and you are free to withdraw without any explanation. If you decide not to 
participate, your care will not be affected in any way. No personal information will be 
recorded and your feedback will be kept confidential. 
If you are interested in getting involved, please let us know and we will send you the 
materials. My contact details and those of Professor Eila Watson are available at the end 
of this letter. 
Your help will be greatly appreciated. Thank you for taking the time to read this letter. 
 
Yours sincerely,  
 
George Saltaouras Prof Eila Watson 
PhD researcher Professor in Supportive Care 
Oxford Brookes University Oxford Brookes University 
Jack Straw’s Lane, OX3 0FL Jack Straw’s Lane, OX3 0FL 
Tel: 01865 322669 Tel: 01865 322665 
Mobile: 07592 995370 Email: ewatson@brookes.ac.uk  




6c: Questionnaire for PPI feedback 
 
Assessing the face validity of patient information 
leaflets – Diet, nutrition and pelvic cancers 
Title of the leaflet:  
If you need more space, please feel free to continue on a separate sheet. 
How would you rate the information provided in this leaflet? Did you learn more 
about diet and nutrition by reading the leaflet? 
 
 
How easy was it for you to understand the information? How did you find the 






How helpful was the leaflet for you? Would it help you make an informed decision 
about your diet? Would it answer your questions? 
 
 
Would you change anything? Would you want any other information in this booklet? 
Would you prefer e.g. a different format? 
 
 
For any question, please contact George Saltaouras. 
Tel: 01865 482669 
Mobile: 07592 995370  
Email: 16021065@brookes.ac.uk.  
 
 
